Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:antiatherosclerotic agent
go back to main search page
Accession:CHEBI:145947 term browser browse the term
Definition:A cardiovascular drug that prevents atherosclerosis (a disease in which the inside of an artery narrows due to the build up of plaque). Compare with antiatherogenic agent.
Synonyms:related_synonym: anti-atherosclerotic agent;   anti-atherosclerotic agents;   anti-atherosclerotic drug;   anti-atherosclerotic drugs;   antiatherosclerotic agents;   antiatherosclerotic drug;   antiatherosclerotic drugs



show annotations for term's descendants           Sort by:
baicalin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ache acetylcholinesterase multiple interactions
increases expression
ISO baicalin results in increased expression of and results in increased activity of ACHE protein
baicalin results in increased expression of ACHE mRNA
CTD PMID:27019979 NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
JBrowse link
G Ahr aryl-hydrocarbon receptor increases activity EXP
ISO
baicalin results in increased activity of AHR protein CTD PMID:17869316 PMID:26204831 NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
JBrowse link
G Aif1 allograft inflammatory factor 1 multiple interactions EXP baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of AIF1 protein] CTD PMID:38016618 NCBI chr17:35,389,967...35,394,977
Ensembl chr17:35,389,967...35,395,044
JBrowse link
G Alb albumin multiple interactions EXP baicalin inhibits the reaction [Arsenic Trioxide results in decreased expression of ALB protein] CTD PMID:35088608 NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
JBrowse link
G Alox5 arachidonate 5-lipoxygenase multiple interactions ISO baicalin inhibits the reaction [Hydrogen Peroxide affects the localization of and results in increased activity of ALOX5 protein] CTD PMID:20139896 NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139
JBrowse link
G Angpt1 angiopoietin 1 multiple interactions ISO baicalin inhibits the reaction [Streptozocin results in decreased expression of ANGPT1 mRNA] CTD PMID:34414639 NCBI chr15:42,288,063...42,540,373
Ensembl chr15:42,288,119...42,540,373
JBrowse link
G Atf2 activating transcription factor 2 multiple interactions ISO baicalin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of ATF2 protein] CTD PMID:24312512 NCBI chr 2:73,646,853...73,723,094
Ensembl chr 2:73,646,853...73,722,983
JBrowse link
G Bax BCL2-associated X protein increases expression
multiple interactions
ISO
EXP
baicalin results in increased expression of BAX protein
baicalin affects the reaction [Rotenone results in increased expression of BAX mRNA]; baicalin inhibits the reaction [Rotenone results in increased expression of BAX protein]
baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of BAX mRNA]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of BAX protein]; baicalin inhibits the reaction [Gentamicins results in increased expression of BAX mRNA]; baicalin inhibits the reaction [Gentamicins results in increased expression of BAX protein]
baicalin inhibits the reaction [Rotenone affects the expression of BAX protein]
CTD PMID:21457722 PMID:25423838 PMID:31021006 PMID:34333357 PMID:35088608 More... NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
JBrowse link
G Bcl2 B cell leukemia/lymphoma 2 multiple interactions
decreases expression
ISO
EXP
baicalin inhibits the reaction [Rotenone affects the expression of BCL2 protein]
baicalin affects the reaction [Rotenone results in decreased expression of BCL2 mRNA]; baicalin inhibits the reaction [Rotenone results in decreased expression of BCL2 protein]
baicalin results in decreased expression of BCL2 protein
baicalin inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 mRNA]; baicalin inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 protein]; baicalin inhibits the reaction [Gentamicins results in decreased expression of BCL2 mRNA]; baicalin inhibits the reaction [Gentamicins results in decreased expression of BCL2 protein]
CTD PMID:25423838 PMID:31021006 PMID:34333357 PMID:35088608 PMID:36446982 NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
JBrowse link
G Casp1 caspase 1 multiple interactions EXP baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CASP1 protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of CASP1 protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of CASP1 protein]] CTD PMID:38016618 NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
JBrowse link
G Casp3 caspase 3 multiple interactions ISO
EXP
baicalin inhibits the reaction [Rotenone affects the expression of CASP3 protein]
baicalin affects the reaction [Rotenone results in decreased activity of CASP3 protein]
baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 mRNA]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein]; baicalin inhibits the reaction [Gentamicins results in increased cleavage of CASP3 protein]
CTD PMID:25423838 PMID:31021006 PMID:34333357 PMID:35088608 PMID:36446982 NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
JBrowse link
G Cat catalase multiple interactions EXP baicalin inhibits the reaction [Arsenic Trioxide results in decreased activity of CAT protein] CTD PMID:34333357 PMID:35088608 NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
JBrowse link
G Ccna2 cyclin A2 decreases expression ISO baicalin results in decreased expression of CCNA2 protein CTD PMID:21457722 NCBI chr 3:36,619,014...36,627,187
Ensembl chr 3:36,619,014...36,626,299
JBrowse link
G Ccnd1 cyclin D1 increases expression
decreases expression
multiple interactions
ISO baicalin results in increased expression of CCND1 mRNA
baicalin results in decreased expression of CCND1 protein
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of CCND1 mRNA]
CTD PMID:19160421 PMID:21457722 NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
JBrowse link
G Col1a2 collagen, type I, alpha 2 multiple interactions ISO baicalin inhibits the reaction [TGFB1 protein results in increased expression of COL1A2 mRNA] CTD PMID:19474275 NCBI chr 6:4,505,618...4,541,543
Ensembl chr 6:4,504,814...4,541,544
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions
increases expression
ISO 3',4'-dimethoxyflavone inhibits the reaction [baicalin results in increased expression of CYP1A1 mRNA]; 3',4'-dimethoxyflavone inhibits the reaction [baicalin results in increased expression of CYP1A1 protein]; baicalin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]
baicalin results in increased expression of CYP1A1 mRNA; baicalin results in increased expression of CYP1A1 protein
CTD PMID:18451504 PMID:26204831 NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions
increases expression
ISO
EXP
3',4'-dimethoxyflavone inhibits the reaction [baicalin results in increased expression of CYP1A2 mRNA]; 3',4'-dimethoxyflavone inhibits the reaction [baicalin results in increased expression of CYP1A2 protein]
resveratrol inhibits the reaction [baicalin results in increased expression of CYP1A2 mRNA]; resveratrol inhibits the reaction [baicalin results in increased expression of CYP1A2 protein]
baicalin results in increased expression of CYP1A2 mRNA; baicalin results in increased expression of CYP1A2 protein
CTD PMID:26204831 NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
JBrowse link
G Egf epidermal growth factor multiple interactions ISO baicalin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; baicalin inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein] CTD PMID:25625231 NCBI chr 3:129,471,223...129,548,971
Ensembl chr 3:129,471,214...129,548,965
JBrowse link
G Egfr epidermal growth factor receptor multiple interactions ISO baicalin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] CTD PMID:25625231 NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
JBrowse link
G Elk1 ELK1, member of ETS oncogene family multiple interactions ISO baicalin inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein] CTD PMID:25625231 NCBI chr  X:20,799,634...20,816,847
Ensembl chr  X:20,799,634...20,816,847
JBrowse link
G Ern1 endoplasmic reticulum to nucleus signalling 1 multiple interactions EXP baicalin inhibits the reaction [Palmitic Acid results in increased phosphorylation of ERN1 protein] CTD PMID:29031535 NCBI chr11:106,285,474...106,378,701
Ensembl chr11:106,285,476...106,378,678
JBrowse link
G Foxa2 forkhead box A2 decreases expression ISO baicalin results in decreased expression of FOXA2 mRNA; baicalin results in decreased expression of FOXA2 protein CTD PMID:32687838 NCBI chr 2:147,884,797...147,888,889
Ensembl chr 2:147,884,797...147,888,889
JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1, soluble multiple interactions ISO baicalin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GOT1 protein] CTD PMID:15645217 NCBI chr19:43,488,191...43,514,743
Ensembl chr19:43,488,191...43,513,044
JBrowse link
G Gpt glutamic pyruvic transaminase, soluble multiple interactions ISO
EXP
baicalin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GPT protein]
baicalin inhibits the reaction [Arsenic Trioxide results in increased activity of GPT protein]
CTD PMID:15645217 PMID:35088608 NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
JBrowse link
G Hes1 hes family bHLH transcription factor 1 increases expression
multiple interactions
ISO baicalin results in increased expression of HES1 mRNA
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HES1 mRNA]
CTD PMID:19160421 NCBI chr16:29,883,259...29,886,614
Ensembl chr16:29,883,202...29,886,614
JBrowse link
G Hey1 hairy/enhancer-of-split related with YRPW motif 1 increases expression
multiple interactions
ISO baicalin results in increased expression of HEY1 mRNA
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HEY1 mRNA]
CTD PMID:19160421 NCBI chr 3:8,728,419...8,732,098
Ensembl chr 3:8,728,419...8,732,316
JBrowse link
G Hey2 hairy/enhancer-of-split related with YRPW motif 2 multiple interactions
increases expression
ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HEY2 mRNA] CTD PMID:19160421 NCBI chr10:30,708,355...30,718,779
Ensembl chr10:30,708,355...30,718,797
JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions
increases expression
EXP
ISO
[baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of HMOX1 protein; baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of HMOX1 protein]; baicalin promotes the reaction [Carbon Tetrachloride results in increased expression of HMOX1 mRNA]; baicalin promotes the reaction [Carbon Tetrachloride results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [[baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of HMOX1 protein]
baicalin results in increased expression of HMOX1 mRNA; baicalin results in increased expression of HMOX1 protein
CTD PMID:16824337 PMID:18187930 PMID:38016618 NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
JBrowse link
G Hnf1a HNF1 homeobox A multiple interactions
decreases expression
ISO
EXP
baicalin inhibits the reaction [HNF4A protein binds to HNF1A promoter]; HNF1A protein promotes the reaction [baicalin results in decreased secretion of Hepatitis B Surface Antigens]; HNF4A protein promotes the reaction [baicalin results in decreased expression of HNF1A mRNA]; HNF4A protein promotes the reaction [baicalin results in decreased expression of HNF1A protein]
baicalin results in decreased expression of HNF1A mRNA; baicalin results in decreased expression of HNF1A protein
CTD PMID:32687838 NCBI chr 5:115,087,039...115,109,121
Ensembl chr 5:115,087,039...115,109,153
JBrowse link
G Hnf4a hepatic nuclear factor 4, alpha multiple interactions
decreases expression
ISO
EXP
baicalin inhibits the reaction [HNF4A protein binds to HNF1A promoter]; HNF4A protein promotes the reaction [baicalin results in decreased expression of HNF1A mRNA]; HNF4A protein promotes the reaction [baicalin results in decreased expression of HNF1A protein]; HNF4A protein promotes the reaction [baicalin results in decreased secretion of Hepatitis B Surface Antigens]
baicalin results in decreased expression of HNF4A protein
baicalin results in decreased expression of HNF4A mRNA; baicalin results in decreased expression of HNF4A protein
CTD PMID:32687838 NCBI chr 2:163,348,731...163,414,827
Ensembl chr 2:163,348,728...163,414,830
JBrowse link
G Hspb1 heat shock protein 1 multiple interactions ISO baicalin inhibits the reaction [Streptozocin results in increased phosphorylation of HSPB1 protein] CTD PMID:34414639 NCBI chr 5:135,916,773...135,918,417
Ensembl chr 5:135,916,773...135,918,417
JBrowse link
G Il1b interleukin 1 beta multiple interactions EXP
ISO
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B mRNA]; baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B mRNA]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B protein]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of IL1B protein]; baicalin inhibits the reaction [Palmitic Acid results in increased secretion of IL1B protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B protein]]
baicalin inhibits the reaction [Rotenone results in increased expression of IL1B protein]
CTD PMID:29031535 PMID:35088608 PMID:36446982 PMID:38016618 NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
JBrowse link
G Il6 interleukin 6 decreases expression
multiple interactions
ISO
EXP
baicalin results in decreased expression of IL6 mRNA; baicalin results in decreased expression of IL6 protein
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL6 mRNA]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL6 mRNA]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of IL6 protein]; baicalin inhibits the reaction [Palmitic Acid results in increased secretion of IL6 protein]
CTD PMID:22019745 PMID:29031535 PMID:34333357 PMID:35088608 PMID:38016618 NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
JBrowse link
G Ins1 insulin I multiple interactions ISO baicalin inhibits the reaction [Streptozocin results in decreased expression of INS1 protein] CTD PMID:34414639 NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914
JBrowse link
G Itga4 integrin alpha 4 multiple interactions ISO baicalin inhibits the reaction [ITGA4 protein results in increased expression of KDR protein]; baicalin inhibits the reaction [ITGA4 protein results in increased expression of VEGFA protein] CTD PMID:36731809 NCBI chr 2:79,084,767...79,163,458
Ensembl chr 2:79,085,770...79,163,467
JBrowse link
G Jak2 Janus kinase 2 multiple interactions EXP baicalin promotes the reaction [Arsenic Trioxide results in increased phosphorylation of JAK2 protein] CTD PMID:35088608 NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
JBrowse link
G Kdr kinase insert domain protein receptor multiple interactions ISO baicalin inhibits the reaction [ITGA4 protein results in increased expression of KDR protein] CTD PMID:36731809 NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118
JBrowse link
G Keap1 kelch-like ECH-associated protein 1 multiple interactions EXP baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of KEAP1 protein]; baicalin promotes the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in decreased expression of KEAP1 protein] CTD PMID:38016618 NCBI chr 9:21,141,026...21,150,628
Ensembl chr 9:21,141,026...21,150,657
JBrowse link
G Mapk1 mitogen-activated protein kinase 1 multiple interactions ISO baicalin inhibits the reaction [Streptozocin results in increased phosphorylation of MAPK1 protein] CTD PMID:34414639 NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
JBrowse link
G Mapk3 mitogen-activated protein kinase 3 multiple interactions ISO baicalin inhibits the reaction [Streptozocin results in increased phosphorylation of MAPK3 protein] CTD PMID:34414639 NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
JBrowse link
G Myd88 myeloid differentiation primary response gene 88 decreases expression ISO baicalin results in decreased expression of MYD88 protein CTD PMID:22019745 NCBI chr 9:119,165,000...119,169,084
Ensembl chr 9:119,165,000...119,170,477
JBrowse link
G Nfe2l2 nuclear factor, erythroid derived 2, like 2 multiple interactions EXP [baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] affects the localization of NFE2L2 protein; baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of NFE2L2 protein]; baicalin inhibits the reaction [[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased ubiquitination of NFE2L2 protein]; baicalin promotes the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NFE2L2 protein]; baicalin promotes the reaction [[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NFE2L2 protein]; NFE2L2 protein affects the reaction [[baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of CASP1 protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NLRP3 protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of PYCARD protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased phosphorylation of RELA protein]] CTD PMID:38016618 NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
JBrowse link
G Nfkbia nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha increases expression ISO baicalin results in increased expression of NFKBIA protein CTD PMID:22019745 NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
JBrowse link
G Nlrp3 NLR family, pyrin domain containing 3 multiple interactions EXP baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of NLRP3 protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NLRP3 protein]; baicalin inhibits the reaction [Palmitic Acid results in increased expression of NLRP3 protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NLRP3 protein]] CTD PMID:29031535 PMID:38016618 NCBI chr11:59,432,395...59,457,781
Ensembl chr11:59,432,394...59,457,782
JBrowse link
G Nos2 nitric oxide synthase 2, inducible multiple interactions
decreases expression
EXP
ISO
baicalin inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 mRNA]; baicalin inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 protein]
baicalin results in decreased expression of NOS2 mRNA; baicalin results in decreased expression of NOS2 protein
baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; mifobate inhibits the reaction [baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]]
CTD PMID:18187930 PMID:22019745 PMID:24312512 NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
JBrowse link
G Notch1 notch 1 increases activity
increases expression
ISO baicalin results in increased activity of NOTCH1 protein
baicalin results in increased expression of NOTCH1 mRNA
CTD PMID:19160421 NCBI chr 2:26,347,914...26,393,834
Ensembl chr 2:26,347,915...26,406,675
JBrowse link
G Nr1h3 nuclear receptor subfamily 1, group H, member 3 increases expression ISO Baicalin increases expression of NR1H3 mRNA and protein in foam cells RGD PMID:27389392 RGD:401842390 NCBI chr 2:91,014,406...91,033,189
Ensembl chr 2:91,014,406...91,033,179
JBrowse link
G Pkm pyruvate kinase, muscle increases activity ISO baicalin results in increased activity of PKM protein CTD PMID:25388478 NCBI chr 9:59,563,859...59,586,655
Ensembl chr 9:59,563,651...59,586,658
JBrowse link
G Pparg peroxisome proliferator activated receptor gamma multiple interactions ISO baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased phosphorylation of and results in decreased activity of PPARG protein] CTD PMID:24312512 NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
JBrowse link
G Prima1 proline rich membrane anchor 1 increases expression ISO baicalin results in increased expression of PRIMA1 mRNA CTD PMID:27019979 NCBI chr12:103,160,712...103,208,967
Ensembl chr12:103,163,167...103,208,409
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 decreases expression ISO baicalin results in decreased expression of PTGS2 mRNA; baicalin results in decreased expression of PTGS2 protein CTD PMID:22019745 NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
JBrowse link
G Pycard PYD and CARD domain containing multiple interactions EXP baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PYCARD protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of PYCARD protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of PYCARD protein]] CTD PMID:38016618 NCBI chr 7:127,590,545...127,593,039
Ensembl chr 7:127,588,880...127,593,039
JBrowse link
G Rela v-rel reticuloendotheliosis viral oncogene homolog A (avian) multiple interactions ISO
EXP
baicalin affects the localization of and results in decreased expression of RELA protein
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased phosphorylation of RELA protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased phosphorylation of RELA protein]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased phosphorylation of RELA protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased phosphorylation of RELA protein]]
CTD PMID:22019745 PMID:34333357 PMID:38016618 NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
JBrowse link
G Snca synuclein, alpha multiple interactions EXP [baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] affects the localization of NFE2L2 protein; [baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of HMOX1 protein; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of CASP1 protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B mRNA]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL6 mRNA]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NLRP3 protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of PYCARD protein]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of TNF mRNA]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased phosphorylation of RELA protein]; baicalin inhibits the reaction [[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased ubiquitination of NFE2L2 protein]; baicalin promotes the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in decreased expression of KEAP1 protein]; baicalin promotes the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NFE2L2 protein]; baicalin promotes the reaction [[benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NFE2L2 protein]; NFE2L2 protein affects the reaction [[baicalin co-treated with 1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of CASP1 protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of IL1B protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of NLRP3 protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of PYCARD protein]]; NFE2L2 protein affects the reaction [baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased phosphorylation of RELA protein]] CTD PMID:38016618 NCBI chr 6:60,708,557...60,806,839
Ensembl chr 6:60,708,559...60,806,839
JBrowse link
G Stat3 signal transducer and activator of transcription 3 multiple interactions EXP baicalin promotes the reaction [Arsenic Trioxide results in increased phosphorylation of STAT3 protein] CTD PMID:35088608 NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
JBrowse link
G Tek TEK receptor tyrosine kinase multiple interactions ISO baicalin inhibits the reaction [Streptozocin results in decreased expression of TEK mRNA] CTD PMID:34414639 NCBI chr 4:94,627,322...94,763,213
Ensembl chr 4:94,627,526...94,763,213
JBrowse link
G Tfam transcription factor A, mitochondrial decreases expression
multiple interactions
ISO baicalin results in decreased expression of TFAM mRNA
baicalin inhibits the reaction [Rotenone results in decreased expression of TFAM mRNA]
CTD PMID:36446982 NCBI chr10:71,061,298...71,074,157
Ensembl chr10:71,061,294...71,074,110
JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions ISO baicalin inhibits the reaction [Streptozocin results in decreased expression of TGFB1 mRNA]; baicalin inhibits the reaction [TGFB1 protein results in increased expression of COL1A2 mRNA] CTD PMID:19474275 PMID:34414639 NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
JBrowse link
G Th tyrosine hydroxylase multiple interactions EXP baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TH protein] CTD PMID:38016618 NCBI chr 7:142,446,516...142,453,732
Ensembl chr 7:142,446,489...142,484,865
JBrowse link
G Tlr4 toll-like receptor 4 decreases expression
multiple interactions
ISO
EXP
baicalin results in decreased expression of TLR4 protein
baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of TLR4 protein]
baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 protein]
CTD PMID:22019745 PMID:24312512 PMID:34333357 NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
JBrowse link
G Tnf tumor necrosis factor multiple interactions
decreases expression
EXP
ISO
baicalin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNF mRNA]; baicalin inhibits the reaction [[1-Methyl-4-phenylpyridinium co-treated with SNCA protein] results in increased expression of TNF mRNA]; baicalin inhibits the reaction [Arsenic Trioxide results in increased expression of TNF protein]; baicalin inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF mRNA]; baicalin inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF protein]
baicalin results in decreased expression of TNF mRNA; baicalin results in decreased expression of TNF protein
baicalin inhibits the reaction [Paraquat results in increased expression of TNF protein]
CTD PMID:16824337 PMID:18187930 PMID:22019745 PMID:34333357 PMID:35088608 More... NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
G Trp53 transformation related protein 53 increases expression ISO baicalin results in increased expression of TP53 protein CTD PMID:21457722 NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
JBrowse link
G Txnip thioredoxin interacting protein multiple interactions EXP baicalin inhibits the reaction [Palmitic Acid results in increased expression of TXNIP protein]; dorsomorphin inhibits the reaction [baicalin inhibits the reaction [Palmitic Acid results in increased expression of TXNIP protein]] CTD PMID:29031535 NCBI chr 3:96,465,273...96,469,173
Ensembl chr 3:96,465,273...96,469,199
JBrowse link
G Usp27x ubiquitin specific peptidase 27, X chromosome multiple interactions ISO baicalin inhibits the reaction [Streptozocin results in increased expression of USP27X protein] CTD PMID:34414639 NCBI chr  X:7,238,830...7,242,069
Ensembl chr  X:7,237,513...7,242,069
JBrowse link
G Vegfa vascular endothelial growth factor A multiple interactions ISO baicalin inhibits the reaction [ITGA4 protein results in increased expression of VEGFA protein] CTD PMID:36731809 NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
JBrowse link
G Vegfc vascular endothelial growth factor C multiple interactions ISO baicalin inhibits the reaction [Streptozocin results in decreased expression of VEGFC mRNA] CTD PMID:34414639 NCBI chr 8:54,530,567...54,639,489
Ensembl chr 8:54,530,641...54,640,131
JBrowse link
G Xdh xanthine dehydrogenase multiple interactions EXP baicalin inhibits the reaction [[Biological Products co-treated with potassium oxonate] results in increased activity of XDH protein] CTD PMID:34044073 NCBI chr17:74,190,890...74,257,191
Ensembl chr17:74,190,890...74,257,191
JBrowse link
dextran sulfate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abat 4-aminobutyrate aminotransferase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ABAT mRNA CTD PMID:29950665 NCBI chr16:8,331,293...8,439,432
Ensembl chr16:8,331,293...8,439,432
JBrowse link
G Abca1 ATP-binding cassette, sub-family A member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ABCA1 mRNA CTD PMID:29950665 NCBI chr 4:53,030,789...53,159,988
Ensembl chr 4:53,030,787...53,159,895
JBrowse link
G Abca17 ATP-binding cassette, sub-family A member 17 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ABCA17 mRNA CTD PMID:29950665 NCBI chr17:24,483,231...24,570,079
Ensembl chr17:24,483,233...24,570,042
JBrowse link
G Abcb11 ATP-binding cassette, sub-family B member 11 decreases expression EXP Dextran Sulfate results in decreased expression of ABCB11 mRNA; Dextran Sulfate results in decreased expression of ABCB11 protein CTD PMID:27580383 NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,958
JBrowse link
G Abcb1a ATP-binding cassette, sub-family B member 1A multiple interactions
increases response to substance
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ABCB1A mRNA; ABCB1A protein affects the susceptibility to [Dextran Sulfate co-treated with 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine]
ABCB1A gene mutant form results in increased susceptibility to Dextran Sulfate
Dextran Sulfate results in decreased expression of ABCB1A mRNA
CTD PMID:29950665 PMID:30102254 PMID:30701287 PMID:35093514 NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
JBrowse link
G Abcb1b ATP-binding cassette, sub-family B member 1B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ABCB1B mRNA; ABCB1B protein affects the susceptibility to [Dextran Sulfate co-treated with 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] CTD PMID:29950665 PMID:30701287 NCBI chr 5:8,848,147...8,916,314
Ensembl chr 5:8,848,147...8,916,315
JBrowse link
G Abcb4 ATP-binding cassette, sub-family B member 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ABCB4 mRNA CTD PMID:29950665 NCBI chr 5:8,943,614...9,009,226
Ensembl chr 5:8,943,717...9,009,231
JBrowse link
G Abcb6 ATP-binding cassette, sub-family B member 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ABCB6 mRNA CTD PMID:29950665 NCBI chr 1:75,148,284...75,157,066
Ensembl chr 1:75,148,361...75,157,036
JBrowse link
G Abcc10 ATP-binding cassette, sub-family C member 10 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ABCC10 mRNA CTD PMID:29950665 NCBI chr17:46,614,146...46,638,954
Ensembl chr17:46,614,147...46,639,278
JBrowse link
G Abcc2 ATP-binding cassette, sub-family member 2 decreases expression
affects response to substance
multiple interactions
EXP Dextran Sulfate results in decreased expression of ABCC2 mRNA; Dextran Sulfate results in decreased expression of ABCC2 protein
ABCC2 protein affects the susceptibility to Dextran Sulfate
ABCC2 protein affects the susceptibility to [Dextran Sulfate co-treated with 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine]
CTD PMID:27580383 PMID:30701287 NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
JBrowse link
G Abcc3 ATP-binding cassette, sub-family C member 3 decreases expression
multiple interactions
affects response to substance
EXP Dextran Sulfate results in decreased expression of ABCC3 mRNA; Dextran Sulfate results in decreased expression of ABCC3 protein
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ABCC3 mRNA; ABCC3 protein affects the susceptibility to [Dextran Sulfate co-treated with 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine]
ABCC3 protein affects the susceptibility to Dextran Sulfate
CTD PMID:27580383 PMID:29950665 PMID:30701287 NCBI chr11:94,234,121...94,283,843
Ensembl chr11:94,234,121...94,283,823
JBrowse link
G Abcc4 ATP-binding cassette, sub-family C member 4 multiple interactions
decreases expression
EXP [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of ABCC4 mRNA; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ABCC4 mRNA
Dextran Sulfate results in decreased expression of ABCC4 mRNA; Dextran Sulfate results in decreased expression of ABCC4 protein
CTD PMID:26271895 PMID:27580383 PMID:29950665 NCBI chr14:118,720,104...118,945,475
Ensembl chr14:118,720,104...118,943,631
JBrowse link
G Abcc5 ATP-binding cassette, sub-family C member 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ABCC5 mRNA CTD PMID:29950665 NCBI chr16:20,150,053...20,245,178
Ensembl chr16:20,150,053...20,245,144
JBrowse link
G Abcc6 ATP-binding cassette, sub-family C member 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ABCC6 mRNA CTD PMID:29950665 NCBI chr 7:45,625,804...45,679,915
Ensembl chr 7:45,616,979...45,679,726
JBrowse link
G Abcc9 ATP-binding cassette, sub-family C member 9 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ABCC9 mRNA CTD PMID:29950665 NCBI chr 6:142,533,592...142,648,472
Ensembl chr 6:142,533,588...142,648,041
JBrowse link
G Abcf2 ATP-binding cassette, sub-family F member 2 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of ABCF2 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of ABCF2 protein]
CTD PMID:32272095 NCBI chr 5:24,770,339...24,782,465
Ensembl chr 5:24,770,343...24,782,465
JBrowse link
G Abcg1 ATP binding cassette subfamily G member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ABCG1 mRNA CTD PMID:29950665 NCBI chr17:31,276,668...31,336,958
Ensembl chr17:31,276,649...31,336,962
JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 (Junior blood group) multiple interactions
affects response to substance
decreases expression
EXP
ISO
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ABCG2 mRNA; ABCG2 protein affects the susceptibility to [Dextran Sulfate co-treated with 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine]
ABCG2 protein affects the susceptibility to Dextran Sulfate
Rifampin promotes the reaction [Dextran Sulfate results in decreased expression of ABCG2 mRNA]
Dextran Sulfate results in decreased expression of ABCG2 mRNA; Dextran Sulfate results in decreased expression of ABCG2 protein
CTD PMID:29950665 PMID:30701287 PMID:38423481 NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
JBrowse link
G Abi1 abl interactor 1 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of ABI1 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of ABI1 protein]
CTD PMID:32272095 NCBI chr 2:22,830,085...22,930,207
Ensembl chr 2:22,830,085...22,930,253
JBrowse link
G Acaa1a acetyl-Coenzyme A acyltransferase 1A multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACAA1A mRNA CTD PMID:29950665 NCBI chr 9:119,170,113...119,179,361
Ensembl chr 9:119,168,742...119,179,365
JBrowse link
G Acaa1b acetyl-Coenzyme A acyltransferase 1B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACAA1B mRNA CTD PMID:29950665 NCBI chr 9:118,977,111...118,986,149
Ensembl chr 9:118,977,091...118,986,161
JBrowse link
G Acaa2 acetyl-CoA acyltransferase 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACAA2 mRNA CTD PMID:29950665 NCBI chr18:74,912,283...74,939,278
Ensembl chr18:74,912,268...74,939,279
JBrowse link
G Acaca acetyl-Coenzyme A carboxylase alpha multiple interactions
increases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in increased expression of ACACA protein] CTD PMID:32272095 NCBI chr11:84,020,461...84,292,477
Ensembl chr11:84,020,498...84,292,477
JBrowse link
G Acads acyl-Coenzyme A dehydrogenase, short chain multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACADS mRNA CTD PMID:29950665 NCBI chr 5:115,248,358...115,257,405
Ensembl chr 5:115,248,358...115,257,405
JBrowse link
G Acadsb acyl-Coenzyme A dehydrogenase, short/branched chain multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACADSB mRNA CTD PMID:29950665 NCBI chr 7:131,012,330...131,047,940
Ensembl chr 7:131,012,330...131,050,673
JBrowse link
G Ace angiotensin I converting enzyme multiple interactions
increases abundance
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ACE mRNA
dextran sodium sulfate increases abundance of Ace protein in small and large intestine extracellular space
CTD
RGD
PMID:29950665 PMID:26401072 RGD:11555935 NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
JBrowse link
G Ache acetylcholinesterase multiple interactions
decreases activity
EXP [Chlorpyrifos co-treated with Dextran Sulfate] results in decreased activity of ACHE protein; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ACHE mRNA
Dextran Sulfate results in decreased activity of ACHE protein
CTD PMID:29950665 PMID:31226429 PMID:31807802 NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
JBrowse link
G Ackr1 atypical chemokine receptor 1 (Duffy blood group) multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ACKR1 mRNA CTD PMID:29950665 NCBI chr 1:173,159,457...173,161,079
Ensembl chr 1:173,159,453...173,161,317
JBrowse link
G Ackr2 atypical chemokine receptor 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ACKR2 mRNA CTD PMID:29950665 NCBI chr 9:121,727,421...121,740,177
Ensembl chr 9:121,727,421...121,740,140
JBrowse link
G Ackr3 atypical chemokine receptor 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ACKR3 mRNA CTD PMID:29950665 NCBI chr 1:90,131,702...90,143,446
Ensembl chr 1:90,131,702...90,144,473
JBrowse link
G Ackr4 atypical chemokine receptor 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACKR4 mRNA CTD PMID:29950665 NCBI chr 9:103,974,881...104,003,842
Ensembl chr 9:103,961,356...104,004,132
JBrowse link
G Acsbg2 acyl-CoA synthetase bubblegum family member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACSBG2 mRNA CTD PMID:29950665 NCBI chr17:57,150,103...57,181,505
Ensembl chr17:57,150,103...57,181,447
JBrowse link
G Acsm1 acyl-CoA synthetase medium-chain family member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ACSM1 mRNA CTD PMID:29950665 NCBI chr 7:119,217,035...119,261,738
Ensembl chr 7:119,206,249...119,261,738
JBrowse link
G Acsm3 acyl-CoA synthetase medium-chain family member 3 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of ACSM3 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of ACSM3 protein]
CTD PMID:32272095 NCBI chr 7:119,360,106...119,384,119
Ensembl chr 7:119,360,146...119,386,736
JBrowse link
G Acss1 acyl-CoA synthetase short-chain family member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACSS1 mRNA CTD PMID:29950665 NCBI chr 2:150,460,031...150,510,160
Ensembl chr 2:150,460,025...150,510,420
JBrowse link
G Acss2 acyl-CoA synthetase short-chain family member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACSS2 mRNA CTD PMID:29950665 NCBI chr 2:155,359,963...155,404,663
Ensembl chr 2:155,359,868...155,427,644
JBrowse link
G Actl6a actin-like 6A multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of ACTL6A protein] CTD PMID:32272095 NCBI chr 3:32,762,695...32,781,122
Ensembl chr 3:32,760,447...32,781,122
JBrowse link
G Actn1 actinin, alpha 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ACTN1 mRNA CTD PMID:29950665 NCBI chr12:80,214,316...80,307,165
Ensembl chr12:80,214,321...80,307,145
JBrowse link
G Actn2 actinin alpha 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ACTN2 mRNA CTD PMID:29950665 NCBI chr13:12,284,312...12,355,613
Ensembl chr13:12,284,312...12,355,641
JBrowse link
G Actr2 actin related protein 2 decreases expression EXP Dextran Sulfate results in decreased expression of ACTR2 protein CTD PMID:35999755 NCBI chr11:20,012,304...20,062,951
Ensembl chr11:20,012,304...20,062,913
JBrowse link
G Actr3 ARP3 actin-related protein 3 decreases expression EXP Dextran Sulfate results in decreased expression of ACTR3 protein CTD PMID:35999755 NCBI chr 1:125,320,642...125,363,464
Ensembl chr 1:125,320,642...125,363,464
JBrowse link
G Acvr1 activin A receptor, type 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ACVR1 mRNA CTD PMID:29950665 NCBI chr 2:58,336,450...58,456,840
Ensembl chr 2:58,278,656...58,457,169
JBrowse link
G Acy1 aminoacylase 1 multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of ACY1 protein CTD PMID:35999755 NCBI chr 9:106,310,180...106,315,594
Ensembl chr 9:106,310,180...106,315,518
JBrowse link
G Ada adenosine deaminase multiple interactions
increases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in increased expression of ADA protein] CTD PMID:32272095 NCBI chr 2:163,565,703...163,592,154
Ensembl chr 2:163,568,504...163,592,159
JBrowse link
G Adam17 a disintegrin and metallopeptidase domain 17 multiple interactions
affects response to substance
increases expression
EXP ADAM17 protein affects the reaction [Dextran Sulfate results in decreased expression of SIRT1 mRNA]; ADAM17 protein affects the reaction [Dextran Sulfate results in decreased expression of TIMP3 mRNA]; ADAM17 protein affects the reaction [Dextran Sulfate results in increased expression of IFNG protein]; ADAM17 protein affects the reaction [Dextran Sulfate results in increased expression of IL17A protein]; ADAM17 protein affects the reaction [Dextran Sulfate results in increased expression of IL1B protein]; ADAM17 protein affects the reaction [Dextran Sulfate results in increased expression of IL6 protein]; ADAM17 protein affects the reaction [Dextran Sulfate results in increased expression of TNF protein]; resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of ADAM17 mRNA]
ADAM17 protein affects the susceptibility to Dextran Sulfate
CTD PMID:24548422 NCBI chr12:21,373,510...21,423,633
Ensembl chr12:21,373,510...21,423,633
JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADAMTS1 mRNA CTD PMID:29950665 NCBI chr16:85,590,715...85,600,001
Ensembl chr16:85,590,715...85,600,001
JBrowse link
G Adamts14 ADAM metallopeptidase with thrombospondin type 1 motif 14 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADAMTS14 mRNA CTD PMID:29950665 NCBI chr10:61,032,886...61,109,447
Ensembl chr10:61,032,891...61,109,217
JBrowse link
G Adamts2 ADAM metallopeptidase with thrombospondin type 1 motif 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADAMTS2 mRNA CTD PMID:29950665 NCBI chr11:50,492,912...50,698,400
Ensembl chr11:50,492,911...50,698,400
JBrowse link
G Adamts4 ADAM metallopeptidase with thrombospondin type 1 motif 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADAMTS4 mRNA CTD PMID:29950665 NCBI chr 1:171,077,698...171,089,836
Ensembl chr 1:171,077,990...171,088,206
JBrowse link
G Adamts5 ADAM metallopeptidase with thrombospondin type 1 motif 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADAMTS5 mRNA CTD PMID:29950665 NCBI chr16:85,655,045...85,698,013
Ensembl chr16:85,653,061...85,698,716
JBrowse link
G Adcy2 adenylate cyclase 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADCY2 mRNA CTD PMID:29950665 NCBI chr13:68,768,162...69,147,719
Ensembl chr13:68,768,162...69,147,660
JBrowse link
G Adcy4 adenylate cyclase 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADCY4 mRNA CTD PMID:29950665 NCBI chr14:56,006,513...56,021,552
Ensembl chr14:56,006,514...56,021,552
JBrowse link
G Adcy6 adenylate cyclase 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADCY6 mRNA CTD PMID:29950665 NCBI chr15:98,484,982...98,508,119
Ensembl chr15:98,487,854...98,507,957
JBrowse link
G Adcy7 adenylate cyclase 7 multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADCY7 mRNA
Dextran Sulfate results in decreased expression of ADCY7 mRNA
CTD PMID:29950665 PMID:35093514 NCBI chr 8:88,998,818...89,056,593
Ensembl chr 8:88,999,031...89,056,590
JBrowse link
G Adcyap1 adenylate cyclase activating polypeptide 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADCYAP1 mRNA CTD PMID:29950665 NCBI chr17:93,506,448...93,513,967
Ensembl chr17:93,506,445...93,513,965
JBrowse link
G Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADCYAP1R1 mRNA CTD PMID:29950665 NCBI chr 6:55,428,486...55,478,440
Ensembl chr 6:55,428,963...55,478,436
JBrowse link
G Adgra2 adhesion G protein-coupled receptor A2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADGRA2 mRNA CTD PMID:29950665 NCBI chr 8:27,575,546...27,613,464
Ensembl chr 8:27,575,611...27,613,464
JBrowse link
G Adgrb1 adhesion G protein-coupled receptor B1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADGRB1 mRNA CTD PMID:29950665 NCBI chr15:74,388,045...74,461,314
Ensembl chr15:74,388,044...74,461,314
JBrowse link
G Adgre1 adhesion G protein-coupled receptor E1 increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of ADGRE1 protein
flavokawain B inhibits the reaction [Dextran Sulfate results in increased expression of ADGRE1 protein]
CTD PMID:38583725 NCBI chr17:57,665,650...57,790,527
Ensembl chr17:57,665,691...57,790,527
JBrowse link
G Adgre5 adhesion G protein-coupled receptor E5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADGRE5 mRNA CTD PMID:29950665 NCBI chr 8:84,449,874...84,467,812
Ensembl chr 8:84,449,880...84,467,955
JBrowse link
G Adgrf1 adhesion G protein-coupled receptor F1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADGRF1 mRNA CTD PMID:29950665 NCBI chr17:43,581,174...43,636,767
Ensembl chr17:43,581,220...43,635,628
JBrowse link
G Adgrf5 adhesion G protein-coupled receptor F5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADGRF5 mRNA CTD PMID:29950665 NCBI chr17:43,671,225...43,770,448
Ensembl chr17:43,671,342...43,770,448
JBrowse link
G Adh1 alcohol dehydrogenase 1 (class I) multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADH1 mRNA CTD PMID:29950665 NCBI chr 3:137,983,346...137,996,459
Ensembl chr 3:137,966,752...137,996,459
JBrowse link
G Adh5 alcohol dehydrogenase 5 (class III), chi polypeptide multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADH5 mRNA CTD PMID:29950665 NCBI chr 3:138,142,961...138,161,260
Ensembl chr 3:138,148,854...138,161,260
JBrowse link
G Adm adrenomedullin multiple interactions
increases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADM mRNA
Dextran Sulfate results in increased expression of ADM mRNA
CTD PMID:29950665 PMID:35093514 NCBI chr 7:110,226,864...110,229,027
Ensembl chr 7:110,226,868...110,229,027
JBrowse link
G Adora2a adenosine A2a receptor multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADORA2A mRNA CTD PMID:29950665 NCBI chr10:75,152,711...75,170,626
Ensembl chr10:75,152,711...75,170,618
JBrowse link
G Adora2b adenosine A2b receptor multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of ADORA2B mRNA CTD PMID:29950665 NCBI chr11:62,139,810...62,157,278
Ensembl chr11:62,139,810...62,157,279
JBrowse link
G Adora3 adenosine A3 receptor multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADORA3 mRNA CTD PMID:29950665 NCBI chr 3:105,811,737...105,816,244
Ensembl chr 3:105,778,174...105,816,242
JBrowse link
G Adra2a adrenergic receptor, alpha 2a multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADRA2A mRNA CTD PMID:29950665 NCBI chr19:54,033,690...54,037,413
Ensembl chr19:54,032,582...54,037,413
JBrowse link
G Adrb2 adrenergic receptor, beta 2 multiple interactions EXP [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of ADRB2 mRNA; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADRB2 mRNA CTD PMID:26271895 PMID:29950665 NCBI chr18:62,310,784...62,313,052
Ensembl chr18:62,310,887...62,313,030
JBrowse link
G Agt angiotensinogen multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of AGT mRNA
Dextran Sulfate results in decreased expression of AGT mRNA
CTD PMID:29950665 PMID:35093514 NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
JBrowse link
G Ahnak AHNAK nucleoprotein decreases expression EXP Dextran Sulfate results in decreased expression of AHNAK mRNA CTD PMID:35093514 NCBI chr19:8,966,640...9,054,299
Ensembl chr19:8,966,648...9,054,278
JBrowse link
G Ahr aryl-hydrocarbon receptor increases response to substance
multiple interactions
EXP AHR gene mutant form results in increased susceptibility to Dextran Sulfate
AHR gene mutant form promotes the reaction [Dextran Sulfate results in increased expression of CXCL1 mRNA]; AHR gene mutant form promotes the reaction [Dextran Sulfate results in increased expression of CXCL2 mRNA]; AHR gene mutant form promotes the reaction [Dextran Sulfate results in increased expression of IL17A mRNA]; AHR gene mutant form promotes the reaction [Dextran Sulfate results in increased expression of IL1B mRNA]; AHR gene mutant form promotes the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; AHR gene mutant form promotes the reaction [Dextran Sulfate results in increased expression of LCN2 mRNA]; AHR gene mutant form promotes the reaction [Dextran Sulfate results in increased expression of PTGS2 mRNA]
CTD PMID:36519841 NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
JBrowse link
G Ahsp alpha hemoglobin stabilizing protein decreases expression EXP Dextran Sulfate results in decreased expression of AHSP protein CTD PMID:35999755 NCBI chr 7:127,902,016...127,902,926
Ensembl chr 7:127,901,969...127,902,930
JBrowse link
G Ak1 adenylate kinase 1 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of AK1 protein
[Dextran Sulfate co-treated with bisphenol A] results in increased expression of AK1 protein
CTD PMID:35999755 NCBI chr 2:32,511,770...32,525,070
Ensembl chr 2:32,511,770...32,525,070
JBrowse link
G Akap12 A kinase anchor protein 12 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of AKAP12 mRNA CTD PMID:29950665 NCBI chr10:4,216,329...4,309,471
Ensembl chr10:4,216,380...4,309,470
JBrowse link
G Akap5 A kinase anchor protein 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of AKAP5 mRNA CTD PMID:29950665 NCBI chr12:76,371,652...76,380,925
Ensembl chr12:76,371,665...76,380,927
JBrowse link
G Akr1b1 aldo-keto reductase family 1 member B decreases expression
increases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of AKR1B1 protein
Dextran Sulfate results in increased expression of AKR1B1 mRNA
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of AKR1B1 mRNA
CTD PMID:29950665 PMID:35093514 PMID:35999755 NCBI chr 6:34,280,865...34,294,424
Ensembl chr 6:34,279,369...34,294,413
JBrowse link
G Akr1c12 aldo-keto reductase family 1, member C12 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of AKR1C12 mRNA CTD PMID:29950665 NCBI chr13:4,318,171...4,329,398
Ensembl chr13:4,318,175...4,329,432
JBrowse link
G Akr1c13 aldo-keto reductase family 1, member C13 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of AKR1C13 mRNA CTD PMID:29950665 NCBI chr13:4,241,167...4,255,601
Ensembl chr13:4,241,149...4,255,595
JBrowse link
G Akr1c14 aldo-keto reductase family 1, member C14 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of AKR1C14 mRNA CTD PMID:29950665 NCBI chr13:4,099,015...4,140,569
Ensembl chr13:4,099,011...4,140,688
JBrowse link
G Akr1c18 aldo-keto reductase family 1, member C18 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of AKR1C18 mRNA CTD PMID:29950665 NCBI chr13:4,182,614...4,200,645
Ensembl chr13:4,182,614...4,200,653
JBrowse link
G Akr1c19 aldo-keto reductase family 1, member C19 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of AKR1C19 mRNA CTD PMID:29950665 NCBI chr13:4,283,499...4,298,360
Ensembl chr13:4,278,699...4,302,842
JBrowse link
G Akt1 thymoma viral proto-oncogene 1 multiple interactions EXP
ISO
[APC protein affects the susceptibility to Dextran Sulfate] which results in increased phosphorylation of AKT1 protein; resorcinol inhibits the reaction [[APC protein affects the susceptibility to Dextran Sulfate] which results in increased phosphorylation of AKT1 protein]
banxia xiexin decoction inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased phosphorylation of AKT1 protein]; Dextran Sulfate results in increased expression of and results in increased phosphorylation of AKT1 protein; palmatine inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased phosphorylation of AKT1 protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased phosphorylation of AKT1 protein]
CTD PMID:26262998 PMID:36806191 NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
JBrowse link
G Alb albumin multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of ALB protein; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ALB mRNA CTD PMID:29950665 PMID:35999755 NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
JBrowse link
G Aldh1a1 aldehyde dehydrogenase family 1, subfamily A1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ALDH1A1 mRNA CTD PMID:29950665 NCBI chr19:20,469,947...20,620,827
Ensembl chr19:20,470,079...20,620,829
JBrowse link
G Aldh1a7 aldehyde dehydrogenase family 1, subfamily A7 multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ALDH1A7 mRNA
Dextran Sulfate results in decreased expression of ALDH1A7 mRNA
CTD PMID:29950665 PMID:35093514 NCBI chr19:20,670,318...20,704,920
Ensembl chr19:20,670,317...20,704,926
JBrowse link
G Aldh1b1 aldehyde dehydrogenase 1 family, member B1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ALDH1B1 mRNA CTD PMID:29950665 NCBI chr 4:45,799,022...45,804,608
Ensembl chr 4:45,799,022...45,804,604
JBrowse link
G Aldh2 aldehyde dehydrogenase 2, mitochondrial multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ALDH2 mRNA CTD PMID:29950665 NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
JBrowse link
G Aldh3a2 aldehyde dehydrogenase family 3, subfamily A2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ALDH3A2 mRNA CTD PMID:29950665 NCBI chr11:61,114,240...61,158,267
Ensembl chr11:61,114,243...61,158,290
JBrowse link
G Aldh7a1 aldehyde dehydrogenase family 7, member A1 multiple interactions
increases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in increased expression of ALDH7A1 protein] CTD PMID:32272095 NCBI chr18:56,657,794...56,706,112
Ensembl chr18:56,642,759...56,706,023
JBrowse link
G Aldoc aldolase C, fructose-bisphosphate decreases expression EXP Dextran Sulfate results in decreased expression of ALDOA protein; Dextran Sulfate results in decreased expression of ALDOC mRNA CTD PMID:35093514 PMID:35999755 NCBI chr11:78,213,899...78,218,607
Ensembl chr11:78,213,794...78,218,607
JBrowse link
G Alox12 arachidonate 12-lipoxygenase decreases expression EXP Dextran Sulfate results in decreased expression of ALOX12 protein CTD PMID:35999755 NCBI chr11:70,132,283...70,146,206
Ensembl chr11:70,132,283...70,146,179
JBrowse link
G Alox12b arachidonate 12-lipoxygenase, 12R type multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ALOX12B mRNA CTD PMID:29950665 NCBI chr11:69,047,898...69,060,617
Ensembl chr11:69,047,815...69,060,618
JBrowse link
G Alox5 arachidonate 5-lipoxygenase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ALOX5 mRNA CTD PMID:29950665 NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139
JBrowse link
G Alox5ap arachidonate 5-lipoxygenase activating protein multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ALOX5AP mRNA CTD PMID:29950665 NCBI chr 5:149,201,814...149,224,963
Ensembl chr 5:149,201,577...149,224,963
JBrowse link
G Alpl alkaline phosphatase, liver/bone/kidney multiple interactions
increases activity
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ALPL mRNA
Dextran Sulfate results in increased activity of ALPL protein
CTD PMID:29950665 PMID:30489199 NCBI chr 4:137,469,042...137,523,695
Ensembl chr 4:137,469,044...137,523,695
JBrowse link
G Angpt4 angiopoietin 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ANGPT4 mRNA CTD PMID:29950665 NCBI chr 2:151,753,127...151,787,257
Ensembl chr 2:151,753,130...151,787,257
JBrowse link
G Angptl4 angiopoietin-like 4 increases expression EXP Dextran Sulfate results in increased expression of ANGPTL4 mRNA CTD PMID:35093514 NCBI chr17:33,993,874...34,000,549
Ensembl chr17:33,992,724...34,000,804
JBrowse link
G Ano1 anoctamin 1, calcium activated chloride channel multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ANO1 mRNA CTD PMID:29950665 NCBI chr 7:144,142,286...144,305,762
Ensembl chr 7:144,142,286...144,305,711
JBrowse link
G Ano10 anoctamin 10 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ANO10 mRNA CTD PMID:29950665 NCBI chr 9:122,004,958...122,123,440
Ensembl chr 9:122,004,940...122,123,489
JBrowse link
G Ano6 anoctamin 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ANO6 mRNA CTD PMID:29950665 NCBI chr15:95,688,724...95,873,353
Ensembl chr15:95,688,724...95,872,632
JBrowse link
G Ano7 anoctamin 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ANO7 mRNA CTD PMID:29950665 NCBI chr 1:93,301,518...93,332,026
Ensembl chr 1:93,301,652...93,332,025
JBrowse link
G Ano9 anoctamin 9 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ANO9 mRNA CTD PMID:29950665 NCBI chr 7:140,681,125...140,697,719
Ensembl chr 7:140,681,125...140,697,719
JBrowse link
G Anxa1 annexin A1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ANXA1 mRNA CTD PMID:29950665 NCBI chr19:20,350,798...20,368,035
Ensembl chr19:20,350,792...20,368,308
JBrowse link
G Anxa4 annexin A4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ANXA4 mRNA CTD PMID:29950665 NCBI chr 6:86,713,822...86,770,616
Ensembl chr 6:86,713,822...86,770,566
JBrowse link
G Ap1m1 adaptor-related protein complex AP-1, mu subunit 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of AP1M1 mRNA CTD PMID:29950665 NCBI chr 8:72,993,857...73,011,230
Ensembl chr 8:72,993,862...73,011,229
JBrowse link
G Ap1s1 adaptor protein complex AP-1, sigma 1 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of AP1S1 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of AP1S1 protein]
CTD PMID:32272095 NCBI chr 5:137,063,852...137,074,917
Ensembl chr 5:137,063,847...137,074,989
JBrowse link
G Apc APC, WNT signaling pathway regulator affects response to substance
multiple interactions
EXP APC affects the susceptibility to Dextran Sulfate; APC protein affects the susceptibility to Dextran Sulfate
[APC protein affects the susceptibility to Dextran Sulfate] which affects the activity of MPO protein; [APC protein affects the susceptibility to Dextran Sulfate] which results in increased chemical synthesis of PTEN protein modified form; [APC protein affects the susceptibility to Dextran Sulfate] which results in increased phosphorylation of AKT1 protein; PDE4B protein affects the reaction [APC protein affects the susceptibility to Dextran Sulfate]; resorcinol inhibits the reaction [[APC protein affects the susceptibility to Dextran Sulfate] which affects the activity of MPO protein]; resorcinol inhibits the reaction [[APC protein affects the susceptibility to Dextran Sulfate] which results in increased chemical synthesis of PTEN protein modified form]; resorcinol inhibits the reaction [[APC protein affects the susceptibility to Dextran Sulfate] which results in increased phosphorylation of AKT1 protein]
CTD PMID:16049979 PMID:26262998 PMID:30188895 NCBI chr18:34,353,350...34,455,243
Ensembl chr18:34,353,977...34,455,605
JBrowse link
G Apcs amyloid P component, serum increases expression EXP Dextran Sulfate results in increased expression of APCS protein CTD PMID:35999755 NCBI chr 1:172,721,528...172,722,516
Ensembl chr 1:172,721,528...172,722,608
JBrowse link
G Apln apelin multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of APLN mRNA
Dextran Sulfate results in decreased expression of APLN mRNA
CTD PMID:29950665 PMID:35093514 NCBI chr  X:47,114,023...47,123,730
Ensembl chr  X:47,114,023...47,123,730
JBrowse link
G Apoa2 apolipoprotein A-II multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of APOA2 protein CTD PMID:35999755 NCBI chr 1:171,049,133...171,053,948
Ensembl chr 1:171,052,623...171,053,948
JBrowse link
G Apoa4 apolipoprotein A-IV multiple interactions
decreases expression
EXP [Dextran Sulfate co-treated with bisphenol A] results in increased expression of APOA4 protein; Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of APOA4 protein] CTD PMID:32272095 PMID:35999755 NCBI chr 9:46,152,142...46,154,756
Ensembl chr 9:46,151,994...46,154,757
JBrowse link
G Apob apolipoprotein B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of APOB mRNA CTD PMID:29950665 NCBI chr12:8,027,629...8,066,839
Ensembl chr12:8,027,648...8,066,835
JBrowse link
G Apoc2 apolipoprotein C2 multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in increased expression of APOC2 protein CTD PMID:35999755 NCBI chr 7:19,405,504...19,411,866
Ensembl chr 7:19,405,504...19,411,866
JBrowse link
G Apoe apolipoprotein E multiple interactions
increases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in increased expression of APOE protein] CTD PMID:32272095 NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
JBrowse link
G App amyloid beta precursor protein multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of APP mRNA CTD PMID:29950665 NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654
JBrowse link
G Aqp1 aquaporin 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of AQP1 mRNA CTD PMID:29950665 NCBI chr 6:55,313,284...55,325,540
Ensembl chr 6:55,313,417...55,325,540
JBrowse link
G Aqp11 aquaporin 11 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of AQP11 mRNA CTD PMID:29950665 NCBI chr 7:97,375,586...97,387,454
Ensembl chr 7:97,373,213...97,387,496
JBrowse link
G Aqp2 aquaporin 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of AQP2 mRNA CTD PMID:29950665 NCBI chr15:99,476,937...99,482,426
Ensembl chr15:99,476,936...99,482,428
JBrowse link
G Aqp3 aquaporin 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of AQP3 mRNA CTD PMID:29950665 NCBI chr 4:41,092,724...41,098,183
Ensembl chr 4:41,092,722...41,098,183
JBrowse link
G Aqp8 aquaporin 8 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of AQP8 mRNA CTD PMID:29950665 NCBI chr 7:123,061,517...123,067,226
Ensembl chr 7:123,061,514...123,067,227
JBrowse link
G Aqp9 aquaporin 9 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of AQP9 mRNA CTD PMID:29950665 NCBI chr 9:71,017,941...71,075,170
Ensembl chr 9:71,017,941...71,075,964
JBrowse link
G Ar androgen receptor multiple interactions
increases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of AR mRNA
Dextran Sulfate results in increased expression of AR mRNA
CTD PMID:27920257 PMID:29950665 NCBI chr  X:97,192,363...97,366,824
Ensembl chr  X:97,192,375...97,366,821
JBrowse link
G Arf3 ARF GTPase 3 decreases expression EXP Dextran Sulfate results in decreased expression of ARF3 protein CTD PMID:35999755 NCBI chr15:98,635,505...98,660,999
Ensembl chr15:98,634,515...98,661,095
JBrowse link
G Arg1 arginase, liver multiple interactions
decreases expression
EXP [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ARG1 mRNA; [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ARG1 protein; BCL6 protein inhibits the reaction [Dextran Sulfate results in decreased expression of ARG1 mRNA]; BCL6 protein inhibits the reaction [Dextran Sulfate results in decreased expression of ARG1 protein]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in decreased expression of ARG1 mRNA]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in decreased expression of ARG1 protein]]; IRF4 protein promotes the reaction [Dextran Sulfate results in decreased expression of ARG1 mRNA]; IRF4 protein promotes the reaction [Dextran Sulfate results in decreased expression of ARG1 protein]; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ARG1 mRNA]; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ARG1 protein]
Dextran Sulfate results in decreased expression of ARG1 mRNA; Dextran Sulfate results in decreased expression of ARG1 protein
CTD PMID:25026504 PMID:38164749 NCBI chr10:24,791,105...24,803,368
Ensembl chr10:24,791,119...24,803,382
JBrowse link
G Arhgap1 Rho GTPase activating protein 1 decreases expression EXP Dextran Sulfate results in decreased expression of ARHGAP1 protein CTD PMID:35999755 NCBI chr 2:91,480,463...91,502,670
Ensembl chr 2:91,480,205...91,502,671
JBrowse link
G Arhgap15 Rho GTPase activating protein 15 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ARHGAP15 mRNA CTD PMID:29950665 NCBI chr 2:43,638,786...44,285,965
Ensembl chr 2:43,638,836...44,285,965
JBrowse link
G Arhgap20 Rho GTPase activating protein 20 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ARHGAP20 mRNA CTD PMID:29950665 NCBI chr 9:51,676,651...51,765,158
Ensembl chr 9:51,676,637...51,765,156
JBrowse link
G Arhgap25 Rho GTPase activating protein 25 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ARHGAP25 mRNA CTD PMID:29950665 NCBI chr 6:87,435,526...87,510,241
Ensembl chr 6:87,435,527...87,510,241
JBrowse link
G Arhgap40 Rho GTPase activating protein 40 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ARHGAP40 mRNA CTD PMID:29950665 NCBI chr 2:158,354,682...158,392,786
Ensembl chr 2:158,354,716...158,392,682
JBrowse link
G Arhgdia Rho GDP dissociation inhibitor alpha decreases expression EXP Dextran Sulfate results in decreased expression of ARHGDIA protein CTD PMID:35999755 NCBI chr11:120,468,925...120,472,450
Ensembl chr11:120,468,930...120,472,450
JBrowse link
G Arhgdib Rho, GDP dissociation inhibitor beta increases expression
multiple interactions
decreases expression
EXP Dextran Sulfate results in increased expression of ARHGDIB mRNA
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ARHGDIB mRNA
Dextran Sulfate results in decreased expression of ARHGDIB protein
CTD PMID:23894361 PMID:29950665 PMID:35999755 NCBI chr 6:136,900,653...136,918,895
Ensembl chr 6:136,900,653...136,918,897
JBrowse link
G Arhgef1 Rho guanine nucleotide exchange factor 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ARHGEF1 mRNA CTD PMID:29950665 NCBI chr 7:24,601,762...24,626,019
Ensembl chr 7:24,602,337...24,626,019
JBrowse link
G Arhgef12 Rho guanine nucleotide exchange factor 12 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ARHGEF12 mRNA CTD PMID:29950665 NCBI chr 9:42,875,138...43,017,069
Ensembl chr 9:42,875,138...43,018,534
JBrowse link
G Arhgef6 Rac/Cdc42 guanine nucleotide exchange factor 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ARHGEF6 mRNA CTD PMID:29950665 NCBI chr  X:56,276,845...56,384,119
Ensembl chr  X:56,276,845...56,384,089
JBrowse link
G Arl3 ADP-ribosylation factor-like 3 increases expression EXP Dextran Sulfate results in increased expression of ARL3 mRNA CTD PMID:35093514 NCBI chr19:46,519,548...46,561,621
Ensembl chr19:46,519,535...46,561,637
JBrowse link
G Arl9 ADP-ribosylation factor-like 9 increases expression EXP Dextran Sulfate results in increased expression of ARL9 mRNA CTD PMID:35093514 NCBI chr 5:77,146,054...77,158,806
Ensembl chr 5:77,151,902...77,158,453
JBrowse link
G Arpc2 actin related protein 2/3 complex, subunit 2 decreases expression EXP Dextran Sulfate results in decreased expression of ARPC2 protein CTD PMID:35999755 NCBI chr 1:74,275,656...74,307,368
Ensembl chr 1:74,275,243...74,307,368
JBrowse link
G Arpc3 actin related protein 2/3 complex, subunit 3 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of ARPC3 protein
[Dextran Sulfate co-treated with bisphenol A] results in decreased expression of ARPC3 protein
CTD PMID:35999755 NCBI chr 5:122,529,941...122,544,244
Ensembl chr 5:122,529,941...122,552,247
JBrowse link
G Arpc4 actin related protein 2/3 complex, subunit 4 decreases expression EXP Dextran Sulfate results in decreased expression of ARPC4 protein CTD PMID:35999755 NCBI chr 6:113,355,074...113,367,408
Ensembl chr 6:113,355,076...113,367,409
JBrowse link
G Arrb2 arrestin, beta 2 multiple interactions EXP [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of ARRB2 mRNA CTD PMID:26271895 NCBI chr11:70,323,051...70,331,654
Ensembl chr11:70,323,461...70,331,654
JBrowse link
G Arsb arylsulfatase B decreases expression EXP Dextran Sulfate results in decreased expression of ARSB mRNA CTD PMID:35093514 NCBI chr13:93,908,187...94,079,524
Ensembl chr13:93,908,138...94,079,524
JBrowse link
G Asb2 ankyrin repeat and SOCS box-containing 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ASB2 mRNA CTD PMID:29950665 NCBI chr12:103,287,401...103,322,260
Ensembl chr12:103,287,401...103,322,260
JBrowse link
G Asic4 acid-sensing ion channel family member 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ASIC4 mRNA CTD PMID:29950665 NCBI chr 1:75,426,467...75,450,984
Ensembl chr 1:75,427,080...75,450,987
JBrowse link
G Ass1 argininosuccinate synthetase 1 decreases expression EXP Dextran Sulfate results in decreased expression of ASS1 mRNA CTD PMID:35093514 NCBI chr 2:31,360,282...31,410,682
Ensembl chr 2:31,360,219...31,410,684
JBrowse link
G Atg5 autophagy related 5 multiple interactions
increases expression
EXP 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG5 mRNA]]; 6-formylindolo(3,2-b)carbazole promotes the reaction [Dextran Sulfate results in increased expression of ATG5 mRNA]; [Dietary Fats co-treated with Dextran Sulfate] results in decreased expression of ATG5 mRNA; alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG5 mRNA]; ATG5 protein affects the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]]; ATG5 protein affects the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein]]; Leucine inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG5 mRNA]]; obeticholic acid inhibits the reaction [[Dietary Fats co-treated with Dextran Sulfate] results in decreased expression of ATG5 mRNA] CTD PMID:27611972 PMID:31676321 PMID:35439472 NCBI chr10:44,144,325...44,240,295
Ensembl chr10:44,144,354...44,240,287
JBrowse link
G Atg7 autophagy related 7 multiple interactions
increases expression
EXP 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG7 mRNA]]; 6-formylindolo(3,2-b)carbazole promotes the reaction [Dextran Sulfate results in increased expression of ATG7 mRNA]; alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG7 mRNA]; Leucine inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG7 mRNA]] CTD PMID:31676321 NCBI chr 6:114,620,075...114,837,565
Ensembl chr 6:114,620,058...114,837,575
JBrowse link
G Atic 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase decreases expression EXP Dextran Sulfate results in decreased expression of ATIC protein CTD PMID:35999755 NCBI chr 1:71,596,315...71,618,562
Ensembl chr 1:71,596,309...71,618,790
JBrowse link
G Atp10a ATPase, class V, type 10A multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP10A mRNA CTD PMID:29950665 NCBI chr 7:58,305,896...58,479,783
Ensembl chr 7:58,305,914...58,479,168
JBrowse link
G Atp11b ATPase, class VI, type 11B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ATP11B mRNA CTD PMID:29950665 NCBI chr 3:35,808,104...35,910,425
Ensembl chr 3:35,808,255...35,910,425
JBrowse link
G Atp12a ATPase, H+/K+ transporting, nongastric, alpha polypeptide multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP12A mRNA CTD PMID:29950665 NCBI chr14:56,602,525...56,626,008
Ensembl chr14:56,602,525...56,626,007
JBrowse link
G Atp1a1 ATPase, Na+/K+ transporting, alpha 1 polypeptide multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ATP1A1 mRNA CTD PMID:29950665 NCBI chr 3:101,483,535...101,512,023
Ensembl chr 3:101,483,535...101,512,000
JBrowse link
G Atp1a3 ATPase, Na+/K+ transporting, alpha 3 polypeptide multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ATP1A3 mRNA CTD PMID:29950665 NCBI chr 7:24,677,592...24,705,338
Ensembl chr 7:24,677,592...24,705,383
JBrowse link
G Atp1a4 ATPase, Na+/K+ transporting, alpha 4 polypeptide multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP1A4 mRNA CTD PMID:29950665 NCBI chr 1:172,051,075...172,085,991
Ensembl chr 1:172,051,080...172,085,981
JBrowse link
G Atp1b1 ATPase, Na+/K+ transporting, beta 1 polypeptide multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ATP1B1 mRNA CTD PMID:29950665 NCBI chr 1:164,264,668...164,285,924
Ensembl chr 1:164,264,678...164,285,924
JBrowse link
G Atp1b3 ATPase, Na+/K+ transporting, beta 3 polypeptide multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP1B3 mRNA CTD PMID:29950665 NCBI chr 9:96,214,708...96,246,368
Ensembl chr 9:96,214,708...96,246,495
JBrowse link
G Atp2a1 ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP2A1 mRNA CTD PMID:29950665 NCBI chr 7:126,045,032...126,062,245
Ensembl chr 7:126,045,030...126,062,280
JBrowse link
G Atp2a3 ATPase, Ca++ transporting, ubiquitous multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ATP2A3 mRNA CTD PMID:29950665 NCBI chr11:72,851,995...72,883,869
Ensembl chr11:72,851,995...72,883,870
JBrowse link
G Atp2b1 ATPase, Ca++ transporting, plasma membrane 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ATP2B1 mRNA CTD PMID:29950665 NCBI chr10:98,750,243...98,862,005
Ensembl chr10:98,750,268...98,862,005
JBrowse link
G Atp2c2 ATPase, Ca++ transporting, type 2C, member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of ATP2C2 mRNA CTD PMID:29950665 NCBI chr 8:120,426,748...120,484,457
Ensembl chr 8:120,426,748...120,484,456
JBrowse link
G Atp4b ATPase, H+/K+ exchanging, beta polypeptide multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ATP4B mRNA CTD PMID:29950665 NCBI chr 8:13,436,209...13,446,778
Ensembl chr 8:13,436,205...13,446,825
JBrowse link
G Atp6v0a2 ATPase, H+ transporting, lysosomal V0 subunit A2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ATP6V0A2 mRNA CTD PMID:29950665 NCBI chr 5:124,767,117...124,801,519
Ensembl chr 5:124,766,641...124,801,519
JBrowse link
G Atp6v0a4 ATPase, H+ transporting, lysosomal V0 subunit A4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP6V0A4 mRNA CTD PMID:29950665 NCBI chr 6:38,025,418...38,101,521
Ensembl chr 6:38,025,418...38,101,521
JBrowse link
G Atp6v0d2 ATPase, H+ transporting, lysosomal V0 subunit D2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP6V0D2 mRNA CTD PMID:29950665 NCBI chr 4:19,876,838...19,922,566
Ensembl chr 4:19,876,841...19,922,605
JBrowse link
G Atp6v1e2 ATPase, H+ transporting, lysosomal V1 subunit E2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ATP6V1E2 mRNA CTD PMID:29950665 NCBI chr17:87,251,537...87,255,315
Ensembl chr17:87,251,537...87,255,325
JBrowse link
G Atp6v1f ATPase, H+ transporting, lysosomal V1 subunit F increases expression EXP Dextran Sulfate results in increased expression of ATP6V1F mRNA CTD PMID:35093514 NCBI chr 6:29,467,782...29,470,508
Ensembl chr 6:29,467,717...29,470,511
JBrowse link
G Atp6v1g3 ATPase, H+ transporting, lysosomal V1 subunit G3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP6V1G3 mRNA CTD PMID:29950665 NCBI chr 1:138,201,476...138,217,200
Ensembl chr 1:138,201,476...138,217,200
JBrowse link
G Atp7a ATPase, copper transporting, alpha polypeptide multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP7A mRNA CTD PMID:29950665 NCBI chr  X:105,070,830...105,171,766
Ensembl chr  X:105,070,882...105,168,532
JBrowse link
G Atp8b1 ATPase, class I, type 8B, member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ATP8B1 mRNA CTD PMID:29950665 NCBI chr18:64,662,050...64,794,342
Ensembl chr18:64,662,038...64,794,338
JBrowse link
G Atp8b2 ATPase, class I, type 8B, member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP8B2 mRNA CTD PMID:29950665 NCBI chr 3:89,846,795...89,870,645
Ensembl chr 3:89,846,788...89,870,815
JBrowse link
G Avpr1a arginine vasopressin receptor 1A multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of AVPR1A mRNA CTD PMID:29950665 NCBI chr10:122,284,404...122,289,358
Ensembl chr10:122,284,404...122,289,357
JBrowse link
G Avpr1b arginine vasopressin receptor 1B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of AVPR1B mRNA CTD PMID:29950665 NCBI chr 1:131,526,908...131,539,740
Ensembl chr 1:131,526,977...131,539,738
JBrowse link
G Avpr2 arginine vasopressin receptor 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of AVPR2 mRNA CTD PMID:29950665 NCBI chr  X:72,935,371...72,938,034
Ensembl chr  X:72,935,708...72,939,108
JBrowse link
G Axin2 axin 2 multiple interactions EXP [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of AXIN2 mRNA; [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of AXIN2 protein; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of AXIN2 mRNA]; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of AXIN2 protein] CTD PMID:31715269 NCBI chr11:108,808,687...108,841,609
Ensembl chr11:108,811,175...108,841,609
JBrowse link
G B3gnt3 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of B3GNT3 mRNA CTD PMID:29950665 NCBI chr 8:72,144,017...72,155,270
Ensembl chr 8:72,143,400...72,154,433
JBrowse link
G B3gnt7 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of B3GNT7 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of B3GNT7 protein]
CTD PMID:32272095 NCBI chr 1:86,230,943...86,235,027
Ensembl chr 1:86,230,554...86,235,027
JBrowse link
G B3gnt8 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of B3GNT8 mRNA CTD PMID:29950665 NCBI chr 7:25,327,025...25,328,917
Ensembl chr 7:25,326,079...25,334,525
JBrowse link
G Baat bile acid-Coenzyme A: amino acid N-acyltransferase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BAAT mRNA CTD PMID:29950665 NCBI chr 4:49,489,416...49,507,915
Ensembl chr 4:49,489,422...49,506,557
JBrowse link
G Banf1 BAF nuclear assembly factor 1 multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of BANF1 protein] CTD PMID:32272095 NCBI chr19:5,414,661...5,416,904
Ensembl chr19:5,414,666...5,417,196
JBrowse link
G Bank1 B cell scaffold protein with ankyrin repeats 1 increases expression EXP Dextran Sulfate results in increased expression of BANK1 mRNA CTD PMID:23894361 NCBI chr 3:135,759,124...136,031,902
Ensembl chr 3:135,759,124...136,031,827
JBrowse link
G Bax BCL2-associated X protein multiple interactions
increases expression
EXP [RASSF1 gene mutant form results in increased susceptibility to Dextran Sulfate] which results in increased expression of BAX mRNA; [RASSF1 gene mutant form results in increased susceptibility to Dextran Sulfate] which results in increased expression of BAX protein; daphnetin inhibits the reaction [Dextran Sulfate results in increased expression of BAX protein]; flavokawain B inhibits the reaction [Dextran Sulfate results in increased cleavage of BAX protein]; flavokawain B inhibits the reaction [Dextran Sulfate results in increased expression of BAX protein] CTD PMID:24146755 PMID:37209277 PMID:38583725 NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
JBrowse link
G Bche butyrylcholinesterase multiple interactions
decreases activity
EXP [Chlorpyrifos co-treated with Dextran Sulfate] results in decreased activity of BCHE protein
Dextran Sulfate results in decreased activity of BCHE protein
CTD PMID:31226429 PMID:31807802 NCBI chr 3:73,543,138...73,615,767
Ensembl chr 3:73,543,141...73,615,748
JBrowse link
G Bcl2 B cell leukemia/lymphoma 2 multiple interactions
decreases expression
EXP [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein; Aspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein]; Camptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein]; daphnetin inhibits the reaction [Dextran Sulfate results in decreased expression of BCL2 protein]; flavokawain B inhibits the reaction [Dextran Sulfate results in decreased expression of BCL2 protein]; Plant Extracts inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein] CTD PMID:25449198 PMID:37209277 PMID:38583725 NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
JBrowse link
G Bcl6 B cell leukemia/lymphoma 6 multiple interactions EXP BCL6 protein inhibits the reaction [Dextran Sulfate results in decreased expression of and results in decreased secretion of IL10 protein]; BCL6 protein inhibits the reaction [Dextran Sulfate results in decreased expression of ARG1 mRNA]; BCL6 protein inhibits the reaction [Dextran Sulfate results in decreased expression of ARG1 protein]; BCL6 protein inhibits the reaction [Dextran Sulfate results in decreased expression of MRC1 mRNA]; BCL6 protein inhibits the reaction [Dextran Sulfate results in decreased expression of MRC1 protein]; BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased secretion of IL1B protein]; BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased secretion of IL6 protein]; BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased secretion of TNF protein]; BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of CD86 mRNA]; BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of CD86 protein]; BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 mRNA]; BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 protein]; BCL6 protein inhibits the reaction [Dextran Sulfate results in increased phosphorylation of JAK2 protein]; BCL6 protein inhibits the reaction [Dextran Sulfate results in increased phosphorylation of STAT3 protein]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in decreased expression of and results in decreased secretion of IL10 protein]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in decreased expression of ARG1 mRNA]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in decreased expression of ARG1 protein]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in decreased expression of MRC1 mRNA]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in decreased expression of MRC1 protein]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased secretion of IL1B protein]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased secretion of IL6 protein]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased secretion of TNF protein]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of CD86 mRNA]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of CD86 protein]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 mRNA]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 protein]] CTD PMID:38164749 NCBI chr16:23,780,058...23,807,602
Ensembl chr16:23,783,802...23,807,602
JBrowse link
G Bcl7c B cell CLL/lymphoma 7C increases expression EXP Dextran Sulfate results in increased expression of BCL7C mRNA CTD PMID:35093514 NCBI chr 7:127,260,626...127,307,938
Ensembl chr 7:127,260,628...127,308,105
JBrowse link
G Bdkrb1 bradykinin receptor, beta 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of BDKRB1 mRNA CTD PMID:29950665 NCBI chr12:105,570,350...105,571,770
Ensembl chr12:105,569,344...105,571,687
JBrowse link
G Bdkrb2 bradykinin receptor, beta 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of BDKRB2 mRNA CTD PMID:29950665 NCBI chr12:105,529,431...105,561,503
Ensembl chr12:105,529,485...105,561,496
JBrowse link
G Becn1 beclin 1, autophagy related multiple interactions
increases expression
EXP
ISO
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[Dextran Sulfate co-treated with alpinetin] results in increased expression of BECN1 protein]; [Dextran Sulfate co-treated with 6-formylindolo(3,2-b)carbazole] results in increased expression of BECN1 protein; [Dextran Sulfate co-treated with alpinetin] results in increased expression of BECN1 protein; [Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of BECN1 protein; [HU 308 co-treated with Dextran Sulfate] affects the expression of BECN1 protein; CNR2 protein affects the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of BECN1 protein]; HU 308 promotes the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of BECN1 protein]; Leucine inhibits the reaction [[Dextran Sulfate co-treated with alpinetin] results in increased expression of BECN1 protein]; Nicotine promotes the reaction [Dextran Sulfate results in increased expression of BECN1 protein]
dorsomorphin inhibits the reaction [Nicotine promotes the reaction [Dextran Sulfate results in increased expression of BECN1 protein]]; Nicotine promotes the reaction [Dextran Sulfate results in increased expression of BECN1 protein]
CTD PMID:27611972 PMID:31676321 PMID:31926917 NCBI chr11:101,179,084...101,193,112
Ensembl chr11:101,176,778...101,193,112
JBrowse link
G Best1 bestrophin 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BEST1 mRNA CTD PMID:29950665 NCBI chr19:9,962,536...9,978,997
Ensembl chr19:9,962,538...9,978,997
JBrowse link
G Bgn biglycan multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of BGN mRNA CTD PMID:29950665 NCBI chr  X:72,527,207...72,539,542
Ensembl chr  X:72,527,208...72,539,539
JBrowse link
G Bin2 bridging integrator 2 decreases expression EXP Dextran Sulfate results in decreased expression of BIN2 protein CTD PMID:35999755 NCBI chr15:100,538,963...100,567,384
Ensembl chr15:100,538,958...100,567,434
JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 multiple interactions EXP [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BIRC5 protein; Aspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BIRC5 protein]; Camptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BIRC5 protein]; Plant Extracts inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BIRC5 protein] CTD PMID:25449198 NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
JBrowse link
G Birc6 baculoviral IAP repeat-containing 6 decreases expression EXP Dextran Sulfate results in decreased expression of BIRC6 mRNA CTD PMID:35093514 NCBI chr17:74,835,247...75,010,351
Ensembl chr17:74,835,290...75,010,351
JBrowse link
G Bmp1 bone morphogenetic protein 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of BMP1 mRNA CTD PMID:29950665 NCBI chr14:70,711,998...70,758,280
Ensembl chr14:70,711,998...70,757,674
JBrowse link
G Bmp10 bone morphogenetic protein 10 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of BMP10 mRNA CTD PMID:29950665 NCBI chr 6:87,405,976...87,411,494
Ensembl chr 6:87,405,976...87,414,659
JBrowse link
G Bmp7 bone morphogenetic protein 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of BMP7 mRNA CTD PMID:29950665 NCBI chr 2:172,709,805...172,782,114
Ensembl chr 2:172,709,805...172,782,114
JBrowse link
G Bmpr1b bone morphogenetic protein receptor, type 1B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of BMPR1B mRNA CTD PMID:29950665 NCBI chr 3:141,540,230...141,875,335
Ensembl chr 3:141,542,897...141,875,186
JBrowse link
G Bmpr2 bone morphogenetic protein receptor type 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BMPR2 mRNA CTD PMID:29950665 NCBI chr 1:59,802,721...59,917,240
Ensembl chr 1:59,802,559...59,918,173
JBrowse link
G Bpifa1 BPI fold containing family A, member 1 multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in increased expression of BPIFA1 protein CTD PMID:35999755 NCBI chr 2:153,984,800...153,991,137
Ensembl chr 2:153,984,800...153,991,139
JBrowse link
G Bspry B-box and SPRY domain containing increases expression EXP Dextran Sulfate results in increased expression of BSPRY mRNA CTD PMID:35093514 NCBI chr 4:62,398,248...62,415,537
Ensembl chr 4:62,398,290...62,415,535
JBrowse link
G Bst1 bone marrow stromal cell antigen 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of BST1 mRNA CTD PMID:29950665 NCBI chr 5:43,976,235...44,000,810
Ensembl chr 5:43,976,227...44,001,328
JBrowse link
G Btf3l4 basic transcription factor 3-like 4 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of BTF3L4 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of BTF3L4 protein]
CTD PMID:32272095 NCBI chr 4:108,671,489...108,691,445
Ensembl chr 4:108,671,492...108,690,811
JBrowse link
G C1galt1 core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of C1GALT1 mRNA CTD PMID:29950665 NCBI chr 6:7,845,224...7,872,042
Ensembl chr 6:7,844,842...7,875,687
JBrowse link
G C1galt1c1 C1GALT1-specific chaperone 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of C1GALT1C1 mRNA CTD PMID:29950665 NCBI chr  X:37,719,660...37,724,020
Ensembl chr  X:37,719,662...37,723,964
JBrowse link
G C1qa complement component 1, q subcomponent, alpha polypeptide multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of C1QA mRNA CTD PMID:29950665 NCBI chr 4:136,623,227...136,626,155
Ensembl chr 4:136,623,228...136,626,114
JBrowse link
G C1qb complement component 1, q subcomponent, beta polypeptide multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of C1QB mRNA CTD PMID:29950665 NCBI chr 4:136,607,437...136,613,511
Ensembl chr 4:136,607,440...136,613,498
JBrowse link
G C1qtnf6 C1q and tumor necrosis factor related protein 6 decreases expression EXP Dextran Sulfate results in decreased expression of C1QTNF6 mRNA CTD PMID:35093514 NCBI chr15:78,407,546...78,416,370
Ensembl chr15:78,407,546...78,415,616
JBrowse link
G C1ra complement component 1, r subcomponent A multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of C1RA mRNA CTD PMID:29950665 NCBI chr 6:124,489,580...124,500,399
Ensembl chr 6:124,489,364...124,500,402
JBrowse link
G C1s1 complement component 1, s subcomponent 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of C1S1 mRNA CTD PMID:29950665 NCBI chr 6:124,507,303...124,519,340
Ensembl chr 6:124,507,304...124,519,318
JBrowse link
G C1s2 complement component 1, s subcomponent 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of C1S2 mRNA CTD PMID:29950665 NCBI chr 6:124,601,584...124,613,044
Ensembl chr 6:124,601,584...124,613,044
JBrowse link
G C3 complement component 3 multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in increased expression of C3 protein; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of C3 mRNA CTD PMID:29950665 PMID:35999755 NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
JBrowse link
G C3ar1 complement component 3a receptor 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of C3AR1 mRNA CTD PMID:29950665 NCBI chr 6:122,824,099...122,833,116
Ensembl chr 6:122,824,097...122,833,120
JBrowse link
G C4b complement C4B (Chido blood group) multiple interactions
increases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of C4B mRNA; Erianin inhibits the reaction [Dextran Sulfate results in increased expression of C4B protein] CTD PMID:29950665 PMID:32272095 NCBI chr17:34,947,249...34,962,876
Ensembl chr17:34,947,354...34,962,856
JBrowse link
G C4bp complement component 4 binding protein multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of C4BP mRNA CTD PMID:29950665 NCBI chr 1:130,562,510...130,589,365
Ensembl chr 1:130,562,510...130,589,369
JBrowse link
G C5ar1 complement component 5a receptor 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of C5AR1 mRNA CTD PMID:29950665 NCBI chr 7:15,980,668...15,993,465
Ensembl chr 7:15,980,668...15,993,465
JBrowse link
G Cab39 calcium binding protein 39 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CAB39 mRNA CTD PMID:29950665 NCBI chr 1:85,707,796...85,779,298
Ensembl chr 1:85,721,162...85,779,297
JBrowse link
G Cacna1f calcium channel, voltage-dependent, alpha 1F subunit multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CACNA1F mRNA CTD PMID:29950665 NCBI chr  X:7,473,342...7,501,435
Ensembl chr  X:7,473,322...7,501,435
JBrowse link
G Cacna1s calcium channel, voltage-dependent, L type, alpha 1S subunit multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CACNA1S mRNA CTD PMID:29950665 NCBI chr 1:135,980,549...136,047,268
Ensembl chr 1:135,980,488...136,047,560
JBrowse link
G Calca calcitonin/calcitonin-related polypeptide, alpha multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CALCA mRNA CTD PMID:29950665 NCBI chr 7:114,225,223...114,236,145
Ensembl chr 7:114,230,713...114,235,592
JBrowse link
G Calcb calcitonin-related polypeptide, beta multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CALCB mRNA CTD PMID:29950665 NCBI chr 7:114,315,790...114,322,603
Ensembl chr 7:114,317,878...114,322,600
JBrowse link
G Calm1 calmodulin 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CALM1 mRNA CTD PMID:29950665 NCBI chr12:100,165,694...100,176,083
Ensembl chr12:100,165,694...100,176,073
JBrowse link
G Calm2 calmodulin 2 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of CALM2 protein
[Dextran Sulfate co-treated with bisphenol A] results in decreased expression of CALM2 protein
CTD PMID:35999755 NCBI chr17:87,740,829...87,754,363
Ensembl chr17:87,740,840...87,754,363
JBrowse link
G Calr calreticulin decreases expression EXP Dextran Sulfate results in decreased expression of CALR protein CTD PMID:35999755 NCBI chr 8:85,568,717...85,573,560
Ensembl chr 8:85,568,479...85,573,563
JBrowse link
G Camk2g calcium/calmodulin-dependent protein kinase II gamma multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CAMK2G mRNA CTD PMID:29950665 NCBI chr14:20,784,943...20,844,225
Ensembl chr14:20,784,943...20,844,156
JBrowse link
G Camk4 calcium/calmodulin-dependent protein kinase IV multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CAMK4 mRNA CTD PMID:29950665 NCBI chr18:33,067,995...33,328,820
Ensembl chr18:33,067,984...33,324,281
JBrowse link
G Camkk1 calcium/calmodulin-dependent protein kinase kinase 1, alpha multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CAMKK1 mRNA CTD PMID:29950665 NCBI chr11:72,906,869...72,932,899
Ensembl chr11:72,909,834...72,932,899
JBrowse link
G Cap1 cyclase associated actin cytoskeleton regulatory protein 1 decreases expression EXP Dextran Sulfate results in decreased expression of CAP1 protein CTD PMID:35999755 NCBI chr 4:122,752,841...122,779,869
Ensembl chr 4:122,752,840...122,779,849
JBrowse link
G Capn13 calpain 13 multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of CAPN13 protein] CTD PMID:32272095 NCBI chr17:73,613,451...73,706,376
Ensembl chr17:73,613,459...73,707,861
JBrowse link
G Capzb capping actin protein of muscle Z-line subunit beta decreases expression EXP Dextran Sulfate results in decreased expression of CAPZB protein CTD PMID:35999755 NCBI chr 4:138,920,210...139,019,131
Ensembl chr 4:138,920,210...139,019,129
JBrowse link
G Car2 carbonic anhydrase 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CAR2 mRNA CTD PMID:29950665 NCBI chr 3:14,951,329...14,965,830
Ensembl chr 3:14,951,333...14,965,830
JBrowse link
G Car3 carbonic anhydrase 3 increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of CA3 protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of CA3 protein]
CTD PMID:32272095 NCBI chr 3:14,928,598...14,937,441
Ensembl chr 3:14,928,572...14,937,583
JBrowse link
G Car4 carbonic anhydrase 4 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of CA4 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of CA4 protein]
CTD PMID:32272095 NCBI chr11:84,848,580...84,856,880
Ensembl chr11:84,848,612...84,856,870
JBrowse link
G Casp1 caspase 1 multiple interactions
increases expression
EXP
ISO
3-methyladenine affects the reaction [[HU 308 co-treated with Dextran Sulfate] affects the cleavage of CASP1 protein]; [Dextran Sulfate co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein; [Dextran Sulfate co-treated with Zearalenone] results in increased expression of CASP1 mRNA; [Dextran Sulfate co-treated with Zearalenone] results in increased expression of CASP1 protein; [HU 308 co-treated with Dextran Sulfate] affects the cleavage of CASP1 protein; [Streptozocin co-treated with Dextran Sulfate] results in increased cleavage of CASP1 protein; ATG5 protein affects the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]]; CNR2 protein affects the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]; Dextran Sulfate results in increased activity of and results in increased cleavage of CASP1 protein; dorsomorphin inhibits the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]]; HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]; hydroxysafflor yellow A inhibits the reaction [Dextran Sulfate results in increased activity of and results in increased cleavage of CASP1 protein]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased activity of and results in increased cleavage of CASP1 protein]
Dextran Sulfate results in increased expression of CASP1 mRNA; Dextran Sulfate results in increased expression of CASP1 protein
celastrol inhibits the reaction [Dextran Sulfate results in increased expression of CASP1 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Dextran Sulfate results in increased expression of CASP1 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide promotes the reaction [celastrol inhibits the reaction [Dextran Sulfate results in increased expression of CASP1 protein]]
CTD PMID:27611972 PMID:30270565 PMID:32470352 PMID:34964214 PMID:37001609 NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
JBrowse link
G Casp3 caspase 3 increases cleavage
multiple interactions
increases activity
EXP Dextran Sulfate results in increased cleavage of CASP3 protein
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpinetin inhibits the reaction [Dextran Sulfate results in increased cleavage of CASP3 protein]]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [Dextran Sulfate results in increased cleavage of CASP3 protein]; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CASP3 mRNA; alpinetin inhibits the reaction [Dextran Sulfate results in increased cleavage of CASP3 protein]; biochanin A inhibits the reaction [Dextran Sulfate results in increased cleavage of CASP3 protein]; daphnetin inhibits the reaction [Dextran Sulfate results in increased cleavage of CASP3 protein]; EIF2AK2 protein affects the reaction [Dextran Sulfate results in increased activity of CASP3 protein]; gingerol inhibits the reaction [Dextran Sulfate results in increased activity of CASP3 protein]; Leucine inhibits the reaction [alpinetin inhibits the reaction [Dextran Sulfate results in increased cleavage of CASP3 protein]]; Plant Extracts inhibits the reaction [Dextran Sulfate results in increased cleavage of CASP3 protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased activity of CASP3 protein]
CTD PMID:21989142 PMID:27920257 PMID:28421826 PMID:29950665 PMID:31676321 More... NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
JBrowse link
G Casp8 caspase 8 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of CASP8 protein
dihydrotanshinone I inhibits the reaction [Dextran Sulfate results in decreased expression of CASP8 protein]
CTD PMID:29496522 NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
JBrowse link
G Cat catalase decreases activity
multiple interactions
increases activity
EXP Dextran Sulfate results in decreased activity of CAT protein
[Streptozocin co-treated with Dextran Sulfate] results in decreased expression of CAT protein; Fatty Acids, Omega-3 inhibits the reaction [Dextran Sulfate results in increased activity of CAT protein]; gingerol inhibits the reaction [Dextran Sulfate results in decreased activity of CAT protein]; mangiferin inhibits the reaction [Dextran Sulfate results in decreased activity of CAT protein]; Qingdai compound inhibits the reaction [Dextran Sulfate results in decreased activity of CAT protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in decreased activity of CAT protein]
CTD PMID:27125760 PMID:28421826 PMID:30489199 PMID:31737179 PMID:34964214 NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
JBrowse link
G Cavin2 caveolae associated 2 decreases expression EXP Dextran Sulfate results in decreased expression of CAVIN2 protein CTD PMID:35999755 NCBI chr 1:51,328,285...51,342,119
Ensembl chr 1:51,328,285...51,342,119
JBrowse link
G Cbr1 carbonyl reductase 1 decreases expression EXP Dextran Sulfate results in decreased expression of CBR1 protein CTD PMID:35999755 NCBI chr16:93,404,752...93,407,226
Ensembl chr16:93,402,741...93,407,393
JBrowse link
G Cbr3 carbonyl reductase 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CBR3 mRNA CTD PMID:29950665 NCBI chr16:93,480,107...93,487,879
Ensembl chr16:93,480,103...93,487,878
JBrowse link
G Ccdc12 coiled-coil domain containing 12 increases expression EXP Dextran Sulfate results in increased expression of CCDC12 mRNA CTD PMID:35093514 NCBI chr 9:110,483,376...110,540,661
Ensembl chr 9:110,485,571...110,540,674
JBrowse link
G Ccdc124 coiled-coil domain containing 124 increases expression EXP Dextran Sulfate results in increased expression of CCDC124 mRNA CTD PMID:35093514 NCBI chr 8:71,320,870...71,326,134
Ensembl chr 8:71,320,871...71,326,579
JBrowse link
G Ccdc13 coiled-coil domain containing 13 increases expression EXP Dextran Sulfate results in increased expression of CCDC13 mRNA CTD PMID:35093514 NCBI chr 9:121,626,690...121,668,581
Ensembl chr 9:121,626,693...121,668,527
JBrowse link
G Ccdc158 coiled-coil domain containing 158 multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of CCDC158 protein] CTD PMID:32272095 NCBI chr 5:92,756,096...92,823,327
Ensembl chr 5:92,755,813...92,823,130
JBrowse link
G Ccdc88b coiled-coil domain containing 88B increases expression EXP Dextran Sulfate results in increased expression of CCDC88B mRNA CTD PMID:35093514 NCBI chr19:6,821,991...6,835,586
Ensembl chr19:6,821,991...6,835,579
JBrowse link
G Ccdc9 coiled-coil domain containing 9 increases expression EXP Dextran Sulfate results in increased expression of CCDC9 mRNA CTD PMID:35093514 NCBI chr 7:16,005,938...16,020,713
Ensembl chr 7:16,007,967...16,020,720
JBrowse link
G Ccdc96 coiled-coil domain containing 96 increases expression EXP Dextran Sulfate results in increased expression of CCDC96 mRNA CTD PMID:35093514 NCBI chr 5:36,641,932...36,645,515
Ensembl chr 5:36,641,932...36,645,516
JBrowse link
G Cchcr1 coiled-coil alpha-helical rod protein 1 increases expression EXP Dextran Sulfate results in increased expression of CCHCR1 mRNA CTD PMID:35093514 NCBI chr17:35,827,914...35,841,912
Ensembl chr17:35,827,997...35,841,912
JBrowse link
G Cckbr cholecystokinin B receptor multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CCKBR mRNA CTD PMID:29950665 NCBI chr 7:105,075,201...105,085,546
Ensembl chr 7:105,074,938...105,120,105
JBrowse link
G Ccl11 C-C motif chemokine ligand 11 increases secretion
multiple interactions
increases expression
EXP Dextran Sulfate results in increased secretion of CCL11 protein
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCL11 mRNA; Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of CCL11 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Dextran Sulfate results in increased secretion of CCL11 protein]
CTD PMID:21858153 PMID:29950665 PMID:32033881 NCBI chr11:81,948,658...81,953,781
Ensembl chr11:81,948,649...81,953,781
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 increases secretion
multiple interactions
increases expression
EXP Dextran Sulfate results in increased secretion of CCL2 protein
[RASSF1 gene mutant form results in increased susceptibility to Dextran Sulfate] which results in increased secretion of CCL2 protein; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCL2 mRNA; flavokawain B inhibits the reaction [Dextran Sulfate results in increased expression of CCL2 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Dextran Sulfate results in increased secretion of CCL2 protein]
CTD PMID:19645018 PMID:20079348 PMID:21858153 PMID:24146755 PMID:29950665 More... NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
JBrowse link
G Ccl21a C-C motif chemokine ligand 21 (serine) multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCL21A mRNA CTD PMID:29950665 NCBI chr 4:42,772,860...42,773,991
Ensembl chr 4:42,772,860...42,773,993
JBrowse link
G Ccl24 C-C motif chemokine ligand 24 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCL24 mRNA CTD PMID:29950665 NCBI chr 5:135,598,789...135,601,977
Ensembl chr 5:135,598,791...135,601,903
JBrowse link
G Ccl25 C-C motif chemokine ligand 25 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CCL25 mRNA CTD PMID:29950665 NCBI chr 8:4,375,207...4,410,020
Ensembl chr 8:4,375,210...4,410,020
JBrowse link
G Ccl27a C-C motif chemokine ligand 27A increases expression EXP Dextran Sulfate results in increased expression of CCL27A mRNA CTD PMID:35093514 NCBI chr 4:41,769,467...41,774,251
Ensembl chr 4:41,769,467...41,774,247
JBrowse link
G Ccl28 C-C motif chemokine ligand 28 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CCL28 mRNA CTD PMID:29950665 NCBI chr13:120,085,355...120,115,895
Ensembl chr13:120,085,355...120,115,895
JBrowse link
G Ccl3 C-C motif chemokine ligand 3 increases expression
multiple interactions
EXP
ISO
Dextran Sulfate results in increased expression of CCL3 mRNA
Dextran Sulfate results in increased expression of CCL3 protein
Hesperidin inhibits the reaction [Dextran Sulfate results in increased expression of CCL3 protein]
ligustilide inhibits the reaction [Dextran Sulfate results in increased expression of CCL3 mRNA]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased expression of CCL3 mRNA]
CTD PMID:19645018 PMID:30811821 PMID:33130971 NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
JBrowse link
G Ccl4 C-C motif chemokine ligand 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCL4 mRNA CTD PMID:29950665 NCBI chr11:83,553,410...83,555,509
Ensembl chr11:83,553,410...83,555,509
JBrowse link
G Ccl6 C-C motif chemokine ligand 6 decreases expression
increases expression
EXP Dextran Sulfate results in decreased expression of CCL6 mRNA
Dextran Sulfate results in increased expression of CCL6 mRNA
CTD PMID:19645018 PMID:35093514 NCBI chr11:83,478,712...83,483,913
Ensembl chr11:83,478,708...83,483,913
JBrowse link
G Ccl7 C-C motif chemokine ligand 7 increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of CCL7 mRNA
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCL7 mRNA; Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of CCL7 mRNA]
CTD PMID:19645018 PMID:29950665 PMID:32033881 NCBI chr11:81,936,538...81,938,351
Ensembl chr11:81,936,538...81,938,351
JBrowse link
G Ccl8 C-C motif chemokine ligand 8 increases expression EXP Dextran Sulfate results in increased expression of CCL8 mRNA CTD PMID:19645018 PMID:23894361 NCBI chr11:82,006,011...82,007,625
Ensembl chr11:82,006,011...82,007,625
JBrowse link
G Ccl9 C-C motif chemokine ligand 9 multiple interactions
increases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCL9 mRNA
Dextran Sulfate results in increased expression of CCL9 mRNA
CTD PMID:29950665 PMID:35093514 NCBI chr11:83,463,743...83,469,462
Ensembl chr11:83,463,745...83,469,462
JBrowse link
G Ccnd1 cyclin D1 multiple interactions EXP [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of CCND1 mRNA; [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of CCND1 protein; [Dietary Fats co-treated with Dextran Sulfate] results in decreased expression of CCND1 protein; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of CCND1 mRNA]; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of CCND1 protein]; obeticholic acid inhibits the reaction [[Dietary Fats co-treated with Dextran Sulfate] results in decreased expression of CCND1 protein] CTD PMID:31715269 PMID:35439472 NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
JBrowse link
G Ccr2 C-C motif chemokine receptor 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCR2 mRNA CTD PMID:29950665 NCBI chr 9:123,901,954...123,913,594
Ensembl chr 9:123,901,987...123,913,594
JBrowse link
G Ccr4 C-C motif chemokine receptor 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCR4 mRNA CTD PMID:29950665 NCBI chr 9:114,319,384...114,334,544
Ensembl chr 9:114,319,384...114,333,984
JBrowse link
G Ccr5 C-C motif chemokine receptor 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCR5 mRNA CTD PMID:29950665 NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
JBrowse link
G Ccr7 C-C motif chemokine receptor 7 multiple interactions EXP Melatonin inhibits the reaction [Dextran Sulfate results in increased expression of CCR7 mRNA]; Melatonin inhibits the reaction [Dextran Sulfate results in increased expression of CCR7 protein] CTD PMID:36265525 NCBI chr11:99,035,025...99,045,903
Ensembl chr11:99,035,022...99,045,903
JBrowse link
G Ccr8 C-C motif chemokine receptor 8 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCR8 mRNA CTD PMID:29950665 NCBI chr 9:119,921,199...119,923,972
Ensembl chr 9:119,921,180...119,923,972
JBrowse link
G Ccrl2 C-C motif chemokine receptor-like 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCRL2 mRNA CTD PMID:29950665 NCBI chr 9:110,883,902...110,886,586
Ensembl chr 9:110,883,554...110,886,587
JBrowse link
G Ccsap centriole, cilia and spindle associated protein increases expression EXP Dextran Sulfate results in increased expression of CCSAP mRNA CTD PMID:35093514 NCBI chr 8:124,566,712...124,586,948
Ensembl chr 8:124,567,570...124,586,948
JBrowse link
G Cd14 CD14 antigen multiple interactions
affects response to substance
EXP [Dextran Sulfate affects the susceptibility to CD14 protein] which affects the expression of IFNG mRNA; CD14 protein inhibits the reaction [Dextran Sulfate results in increased expression of TNF mRNA] CTD PMID:28411859 NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
JBrowse link
G Cd163 CD163 antigen increases expression EXP Dextran Sulfate results in increased expression of CD163 mRNA CTD PMID:35093514 NCBI chr 6:124,281,596...124,307,488
Ensembl chr 6:124,281,615...124,307,486
JBrowse link
G Cd177 CD177 antigen increases expression EXP Dextran Sulfate results in increased expression of CD177 mRNA CTD PMID:23894361 NCBI chr 7:24,443,408...24,459,759
Ensembl chr 7:24,443,408...24,459,736
JBrowse link
G Cd180 CD180 antigen increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of CD180 mRNA
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CD180 mRNA
CTD PMID:23894361 PMID:29950665 NCBI chr13:102,830,055...102,843,139
Ensembl chr13:102,830,066...102,876,137
JBrowse link
G Cd19 CD19 antigen increases expression EXP Dextran Sulfate results in increased expression of CD19 mRNA CTD PMID:23894361 NCBI chr 7:126,007,620...126,016,401
Ensembl chr 7:126,007,622...126,014,061
JBrowse link
G Cd200 CD200 molecule multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CD200 mRNA CTD PMID:29950665 NCBI chr16:45,202,474...45,229,419
Ensembl chr16:45,202,498...45,229,416
JBrowse link
G Cd209f CD209f antigen decreases expression EXP Dextran Sulfate results in decreased expression of CD209F mRNA CTD PMID:35093514 NCBI chr 8:4,152,784...4,155,838
Ensembl chr 8:4,152,787...4,155,835
JBrowse link
G Cd247 CD247 antigen multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CD247 mRNA CTD PMID:29950665 NCBI chr 1:165,607,514...165,698,722
Ensembl chr 1:165,616,250...165,704,846
JBrowse link
G Cd274 CD274 antigen multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CD274 mRNA CTD PMID:29950665 NCBI chr19:29,339,428...29,365,495
Ensembl chr19:29,344,855...29,365,495
JBrowse link
G Cd28 CD28 antigen multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CD28 mRNA CTD PMID:29950665 NCBI chr 1:60,785,547...60,812,521
Ensembl chr 1:60,755,959...60,812,518
JBrowse link
G Cd34 CD34 antigen decreases expression EXP Dextran Sulfate results in decreased expression of CD34 mRNA CTD PMID:35093514 NCBI chr 1:194,621,239...194,643,587
Ensembl chr 1:194,621,127...194,643,587
JBrowse link
G Cd4 CD4 antigen multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CD4 mRNA CTD PMID:29950665 NCBI chr 6:124,841,656...124,865,210
Ensembl chr 6:124,841,655...124,865,184
JBrowse link
G Cd44 CD44 antigen multiple interactions EXP [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of CD44 mRNA CTD PMID:26271895 NCBI chr 2:102,641,486...102,732,014
Ensembl chr 2:102,641,486...102,732,010
JBrowse link
G Cd52 CD52 antigen increases expression EXP Dextran Sulfate results in increased expression of CD52 mRNA CTD PMID:23894361 NCBI chr 4:133,820,849...133,822,384
Ensembl chr 4:133,809,759...133,822,393
JBrowse link
G Cd53 CD53 antigen increases expression EXP Dextran Sulfate results in increased expression of CD53 mRNA CTD PMID:23894361 NCBI chr 3:106,666,177...106,697,465
Ensembl chr 3:106,667,237...106,697,465
JBrowse link
G Cd55 CD55 molecule, decay accelerating factor for complement multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CD55 mRNA CTD PMID:29950665 NCBI chr 1:130,357,526...130,390,513
Ensembl chr 1:130,366,764...130,390,481
JBrowse link
G Cd55b CD55 molecule, decay accelerating factor for complement B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CD55B mRNA CTD PMID:29950665 NCBI chr 1:130,316,263...130,350,831
Ensembl chr 1:130,316,274...130,350,746
JBrowse link
G Cd68 CD68 antigen increases expression EXP dextran sulfate increases expression of CD68 protein in colonic lamina propria of mice RGD PMID:25004394 RGD:40925931 NCBI chr11:69,555,039...69,556,996
Ensembl chr11:69,555,039...69,556,979
JBrowse link
G Cd72 CD72 antigen increases expression EXP Dextran Sulfate results in increased expression of CD72 mRNA CTD PMID:23894361 NCBI chr 4:43,447,724...43,454,708
Ensembl chr 4:43,446,462...43,454,628
JBrowse link
G Cd74 CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) increases expression
decreases expression
EXP Dextran Sulfate results in increased expression of CD74 mRNA
Dextran Sulfate results in decreased expression of CD74 mRNA
CTD PMID:23894361 PMID:35093514 NCBI chr18:60,936,921...60,945,724
Ensembl chr18:60,936,920...60,945,724
JBrowse link
G Cd79a CD79A antigen (immunoglobulin-associated alpha) increases expression EXP Dextran Sulfate results in increased expression of CD79A mRNA CTD PMID:23894361 NCBI chr 7:24,596,922...24,601,283
Ensembl chr 7:24,596,806...24,601,622
JBrowse link
G Cd79b CD79B antigen increases expression EXP Dextran Sulfate results in increased expression of CD79B mRNA CTD PMID:23894361 NCBI chr11:106,202,167...106,205,388
Ensembl chr11:106,202,167...106,205,588
JBrowse link
G Cd81 CD81 antigen decreases expression EXP Dextran Sulfate results in decreased expression of CD81 mRNA CTD PMID:35093514 NCBI chr 7:142,606,487...142,621,667
Ensembl chr 7:142,606,476...142,621,671
JBrowse link
G Cd86 CD86 antigen multiple interactions
increases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CD86 mRNA; BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of CD86 mRNA]; BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of CD86 protein]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of CD86 mRNA]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of CD86 protein]]; IRF4 protein promotes the reaction [Dextran Sulfate results in increased expression of CD86 mRNA]; IRF4 protein promotes the reaction [Dextran Sulfate results in increased expression of CD86 protein]
Dextran Sulfate results in increased expression of CD86 mRNA; Dextran Sulfate results in increased expression of CD86 protein
CTD PMID:29950665 PMID:38164749 NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
JBrowse link
G Cda cytidine deaminase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CDA mRNA CTD PMID:29950665 NCBI chr 4:138,065,839...138,095,623
Ensembl chr 4:138,065,735...138,095,303
JBrowse link
G Cdh1 cadherin 1 multiple interactions
decreases expression
EXP 7-hydroxyl-1-methylindole-3-acetonitrile inhibits the reaction [Dextran Sulfate results in decreased expression of CDH1 protein]; [Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CDH1 protein; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CDH1 mRNA
Dextran Sulfate results in decreased expression of CDH1 mRNA; Dextran Sulfate results in decreased expression of CDH1 protein
CTD PMID:29950665 PMID:34273909 PMID:36543318 PMID:37385329 NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878
JBrowse link
G Cdh2 cadherin 2 multiple interactions
increases expression
EXP 7-hydroxyl-1-methylindole-3-acetonitrile inhibits the reaction [Dextran Sulfate results in increased expression of CDH2 protein]; [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CDH2 protein CTD PMID:34273909 PMID:36543318 NCBI chr18:16,721,934...16,942,303
Ensembl chr18:16,721,934...16,942,303
JBrowse link
G Cdh5 cadherin 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CDH5 mRNA CTD PMID:29950665 NCBI chr 8:104,828,247...104,871,136
Ensembl chr 8:104,828,257...104,871,143
JBrowse link
G Cdhr2 cadherin-related family member 2 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of CDHR2 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of CDHR2 protein]
CTD PMID:32272095 NCBI chr13:54,849,276...54,884,475
Ensembl chr13:54,849,274...54,884,475
JBrowse link
G Cdk11b cyclin dependent kinase 11B increases expression EXP Dextran Sulfate results in increased expression of CDK11B mRNA CTD PMID:35093514 NCBI chr 4:155,709,303...155,734,392
Ensembl chr 4:155,709,311...155,734,395
JBrowse link
G Cdkn1c cyclin dependent kinase inhibitor 1C multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CDKN1C mRNA CTD PMID:29950665 NCBI chr 7:143,012,076...143,014,735
Ensembl chr 7:143,012,076...143,014,787
JBrowse link
G Cdx2 caudal type homeobox 2 multiple interactions
increases expression
decreases expression
EXP 6-formylindolo(3,2-b)carbazole inhibits the reaction [Dextran Sulfate results in increased expression of CDX2 protein]; nitazoxanide inhibits the reaction [Dextran Sulfate results in decreased expression of CDX2 protein] CTD PMID:29680209 PMID:38663798 NCBI chr 5:147,237,710...147,244,059
Ensembl chr 5:147,237,615...147,244,080
JBrowse link
G Ceacam12 CEA cell adhesion molecule 12 increases expression EXP Dextran Sulfate results in increased expression of CEACAM12 mRNA CTD PMID:23894361 NCBI chr 7:17,799,854...17,811,911
Ensembl chr 7:17,799,854...17,811,911
JBrowse link
G Cebpd CCAAT/enhancer binding protein delta increases expression EXP Dextran Sulfate results in increased expression of CEBPD mRNA CTD PMID:35093514 NCBI chr16:15,705,150...15,707,409
Ensembl chr16:15,705,150...15,708,895
JBrowse link
G Cel carboxyl ester lipase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CEL mRNA CTD PMID:29950665 NCBI chr 2:28,445,831...28,453,415
Ensembl chr 2:28,445,807...28,453,415
JBrowse link
G Cep131 centrosomal protein 131 increases expression EXP Dextran Sulfate results in increased expression of CEP131 mRNA CTD PMID:35093514 NCBI chr11:119,955,247...119,977,684
Ensembl chr11:119,955,256...119,977,653
JBrowse link
G Ces1d carboxylesterase 1D multiple interactions
decreases expression
EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of CES1D protein; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CES1D mRNA
Dextran Sulfate results in decreased expression of CES1D mRNA
CTD PMID:29950665 PMID:35093514 PMID:35999755 NCBI chr 8:93,892,700...93,924,432
Ensembl chr 8:93,892,696...93,924,466
JBrowse link
G Ces1e carboxylesterase 1E multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CES1E mRNA CTD PMID:29950665 NCBI chr 8:93,927,846...93,956,233
Ensembl chr 8:93,927,846...93,956,247
JBrowse link
G Ces2a carboxylesterase 2A multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CES2A mRNA CTD PMID:29950665 NCBI chr 8:105,460,635...105,468,266
Ensembl chr 8:105,460,635...105,468,266
JBrowse link
G Ces2c carboxylesterase 2C multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CES2C mRNA CTD PMID:29950665 NCBI chr 8:105,573,700...105,581,115
Ensembl chr 8:105,573,700...105,581,115
JBrowse link
G Ces2e carboxylesterase 2E multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CES2E mRNA CTD PMID:29950665 NCBI chr 8:105,652,892...105,661,304
Ensembl chr 8:105,652,892...105,661,304
JBrowse link
G Ces2g carboxylesterase 2G multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CES2G mRNA CTD PMID:29950665 NCBI chr 8:105,688,350...105,696,169
Ensembl chr 8:105,688,350...105,696,169
JBrowse link
G Cfap45 cilia and flagella associated protein 45 increases expression EXP Dextran Sulfate results in increased expression of CFAP45 mRNA CTD PMID:35093514 NCBI chr 1:172,348,697...172,373,437
Ensembl chr 1:172,348,368...172,373,437
JBrowse link
G Cfb complement factor B multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in increased expression of CFB protein CTD PMID:35999755 NCBI chr17:35,075,350...35,081,492
Ensembl chr17:35,075,350...35,081,494
JBrowse link
G Cfd complement factor D increases expression EXP Dextran Sulfate results in increased expression of CFD protein CTD PMID:35999755 NCBI chr10:79,726,687...79,728,489
Ensembl chr10:79,726,687...79,728,489
JBrowse link
G Cfh complement component factor h multiple interactions
increases expression
EXP [Dextran Sulfate co-treated with bisphenol A] results in increased expression of CFH protein; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CFH mRNA; Erianin inhibits the reaction [Dextran Sulfate results in increased expression of CFH protein]
Dextran Sulfate results in increased expression of CFH mRNA; Dextran Sulfate results in increased expression of CFH protein
CTD PMID:29950665 PMID:32272095 PMID:35093514 PMID:35999755 NCBI chr 1:140,013,593...140,111,149
Ensembl chr 1:140,012,446...140,111,502
JBrowse link
G Cfl1 cofilin 1, non-muscle decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of CFL1 protein
[Dextran Sulfate co-treated with bisphenol A] results in decreased expression of CFL1 protein
CTD PMID:35999755 NCBI chr19:5,540,483...5,544,059
Ensembl chr19:5,540,483...5,545,229
JBrowse link
G Cflar CASP8 and FADD-like apoptosis regulator multiple interactions EXP [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein; Aspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein]; Camptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein]; Plant Extracts inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein] CTD PMID:25449198 NCBI chr 1:58,750,353...58,798,043
Ensembl chr 1:58,750,667...58,798,043
JBrowse link
G Cftr cystic fibrosis transmembrane conductance regulator multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFTR mRNA CTD PMID:29950665 NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767
JBrowse link
G Cgref1 cell growth regulator with EF hand domain 1 multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in increased expression of CGREF1 protein CTD PMID:35999755 NCBI chr 5:31,090,487...31,102,771
Ensembl chr 5:31,090,487...31,102,935
JBrowse link
G Chaf1a chromatin assembly factor 1, subunit A increases expression EXP Dextran Sulfate results in increased expression of CHAF1A mRNA CTD PMID:35093514 NCBI chr17:56,347,404...56,375,027
Ensembl chr17:56,347,439...56,379,289
JBrowse link
G Cherp calcium homeostasis endoplasmic reticulum protein decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of CHERP protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of CHERP protein]
CTD PMID:32272095 NCBI chr 8:73,214,327...73,229,077
Ensembl chr 8:73,214,333...73,229,070
JBrowse link
G Chil3 chitinase-like 3 multiple interactions EXP [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CHIL3 mRNA; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CHIL3 mRNA] CTD PMID:25026504 NCBI chr 3:106,054,870...106,074,852
Ensembl chr 3:106,054,870...106,074,880
JBrowse link
G Chmp2a charged multivesicular body protein 2A decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of CHMP2A protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of CHMP2A protein]
CTD PMID:32272095 NCBI chr 7:12,765,933...12,768,704
Ensembl chr 7:12,765,937...12,768,734
JBrowse link
G Chmp4b charged multivesicular body protein 4B increases expression EXP Dextran Sulfate results in increased expression of CHMP4B mRNA CTD PMID:35093514 NCBI chr 2:154,498,949...154,536,703
Ensembl chr 2:154,493,625...154,536,705
JBrowse link
G Chn2 chimerin 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CHN2 mRNA CTD PMID:29950665 NCBI chr 6:54,016,917...54,278,797
Ensembl chr 6:54,016,539...54,278,795
JBrowse link
G Chrdl2 chordin-like 2 increases expression EXP Dextran Sulfate results in increased expression of CHRDL2 mRNA CTD PMID:23894361 NCBI chr 7:99,655,611...99,683,935
Ensembl chr 7:99,655,379...99,683,935
JBrowse link
G Chrm4 cholinergic receptor, muscarinic 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CHRM4 mRNA CTD PMID:29950665 NCBI chr 2:91,752,531...91,760,180
Ensembl chr 2:91,757,594...91,759,033
JBrowse link
G Chrna2 cholinergic receptor nicotinic alpha 2 subunit multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CHRNA2 mRNA CTD PMID:29950665 NCBI chr14:66,370,685...66,390,397
Ensembl chr14:66,372,488...66,390,397
JBrowse link
G Chrna7 cholinergic receptor, nicotinic, alpha polypeptide 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CHRNA7 mRNA CTD PMID:29950665 NCBI chr 7:62,748,440...62,862,274
Ensembl chr 7:62,748,440...62,862,317
JBrowse link
G Chrnb3 cholinergic receptor, nicotinic, beta polypeptide 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CHRNB3 mRNA CTD PMID:29950665 NCBI chr 8:27,858,688...27,889,758
Ensembl chr 8:27,858,739...27,889,758
JBrowse link
G Chrne cholinergic receptor, nicotinic, epsilon polypeptide multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CHRNE mRNA CTD PMID:29950665 NCBI chr11:70,505,709...70,510,074
Ensembl chr11:70,505,709...70,510,042
JBrowse link
G Chst11 carbohydrate sulfotransferase 11 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CHST11 mRNA CTD PMID:29950665 NCBI chr10:82,820,274...83,031,738
Ensembl chr10:82,821,332...83,031,734
JBrowse link
G Chuk conserved helix-loop-helix ubiquitous kinase increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of CHUK protein modified form
notoginsenoside R1 inhibits the reaction [Dextran Sulfate results in increased expression of CHUK protein modified form]
CTD PMID:25472953 NCBI chr19:44,061,773...44,095,940
Ensembl chr19:44,061,774...44,095,919
JBrowse link
G Ckb creatine kinase, brain decreases expression EXP Dextran Sulfate results in decreased expression of CKB protein CTD PMID:35999755 NCBI chr12:111,635,789...111,638,772
Ensembl chr12:111,635,795...111,638,772
JBrowse link
G Ckm creatine kinase, muscle decreases expression EXP Dextran Sulfate results in decreased expression of CKM protein CTD PMID:35999755 NCBI chr 7:19,145,019...19,155,508
Ensembl chr 7:19,138,701...19,156,766
JBrowse link
G Clca1 chloride channel accessory 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CLCA1 mRNA CTD PMID:29950665 NCBI chr 3:144,710,298...144,738,537
Ensembl chr 3:144,709,578...144,738,537
JBrowse link
G Clca4a chloride channel accessory 4A increases expression EXP Dextran Sulfate results in increased expression of CLCA4 mRNA CTD PMID:23894361 NCBI chr 3:144,658,247...144,680,806
Ensembl chr 3:144,658,241...144,680,806
JBrowse link
G Clcn2 chloride channel, voltage-sensitive 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CLCN2 mRNA CTD PMID:29950665 NCBI chr16:20,521,185...20,536,496
Ensembl chr16:20,521,714...20,536,496
JBrowse link
G Clcn3 chloride channel, voltage-sensitive 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CLCN3 mRNA CTD PMID:29950665 NCBI chr 8:61,363,423...61,436,351
Ensembl chr 8:61,363,423...61,436,334
JBrowse link
G Cldn1 claudin 1 decreases expression
multiple interactions
increases expression
EXP Dextran Sulfate results in decreased expression of CLDN1 protein
7-hydroxyl-1-methylindole-3-acetonitrile inhibits the reaction [Dextran Sulfate results in increased expression of CLDN1 protein]; [(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone co-treated with Dextran Sulfate] results in decreased expression of CLDN1 protein; [SB 203580 co-treated with Dextran Sulfate] results in decreased expression of CLDN1 protein; biochanin A inhibits the reaction [Dextran Sulfate results in decreased expression of CLDN1 protein]; hydroxysafflor yellow A inhibits the reaction [Dextran Sulfate results in decreased expression of CLDN1 protein]
CTD PMID:27920472 PMID:36543318 PMID:37001609 PMID:38648921 NCBI chr16:26,175,395...26,190,589
Ensembl chr16:26,175,392...26,190,591
JBrowse link
G Cldn11 claudin 11 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CLDN11 mRNA CTD PMID:29950665 NCBI chr 3:31,204,069...31,218,475
Ensembl chr 3:31,204,069...31,218,473
JBrowse link
G Cldn2 claudin 2 multiple interactions
increases expression
EXP 6-formylindolo(3,2-b)carbazole inhibits the reaction [Dextran Sulfate results in increased expression of CLDN2 mRNA]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [Dextran Sulfate results in increased expression of CLDN2 protein]; 7-hydroxyl-1-methylindole-3-acetonitrile inhibits the reaction [Dextran Sulfate results in increased expression of CLDN2 protein]; [Benzo(a)pyrene co-treated with Dextran Sulfate] results in decreased expression of CLDN2 mRNA
Dextran Sulfate results in increased expression of CLDN2 mRNA; Dextran Sulfate results in increased expression of CLDN2 protein
CTD PMID:26271895 PMID:29680209 PMID:36543318 NCBI chr  X:138,701,552...138,712,135
Ensembl chr  X:138,701,577...138,712,135
JBrowse link
G Clec10a C-type lectin domain family 10, member A increases expression EXP Dextran Sulfate results in increased expression of CLEC10A mRNA CTD PMID:35093514 NCBI chr11:70,057,449...70,061,662
Ensembl chr11:70,047,023...70,061,660
JBrowse link
G Clic1 chloride intracellular channel 1 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of CLIC1 protein
[Dextran Sulfate co-treated with bisphenol A] results in decreased expression of CLIC1 protein
CTD PMID:35999755 NCBI chr17:35,269,219...35,277,695
Ensembl chr17:35,268,942...35,277,725
JBrowse link
G Cma1 chymase 1, mast cell multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CMA1 mRNA CTD PMID:29950665 NCBI chr14:56,178,908...56,182,132
Ensembl chr14:56,178,908...56,182,132
JBrowse link
G Cmas cytidine monophospho-N-acetylneuraminic acid synthetase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CMAS mRNA CTD PMID:29950665 NCBI chr 6:142,702,468...142,721,440
Ensembl chr 6:142,702,412...142,721,440
JBrowse link
G Cmpk1 cytidine/uridine monophosphate kinase 1 decreases expression EXP Dextran Sulfate results in decreased expression of CMPK1 protein CTD PMID:35999755 NCBI chr 4:114,817,810...114,844,425
Ensembl chr 4:114,816,533...114,844,438
JBrowse link
G Cnga4 cyclic nucleotide gated channel alpha 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CNGA4 mRNA CTD PMID:29950665 NCBI chr 7:105,049,247...105,057,981
Ensembl chr 7:105,053,775...105,057,949
JBrowse link
G Cnn2 calponin 2 decreases expression EXP Dextran Sulfate results in decreased expression of CNN2 protein CTD PMID:35999755 NCBI chr10:79,824,434...79,831,234
Ensembl chr10:79,824,418...79,831,896
JBrowse link
G Cnr1 cannabinoid receptor 1 decreases response to substance
multiple interactions
increases expression
EXP CNR1 results in decreased susceptibility to Dextran Sulfate
SB 203580 inhibits the reaction [Dextran Sulfate results in increased expression of CNR1 protein]; Serotonin inhibits the reaction [Dextran Sulfate results in increased expression of CNR1 protein]
CTD PMID:15085199 PMID:27920472 PMID:30611738 NCBI chr 4:33,923,171...33,948,831
Ensembl chr 4:33,924,593...33,948,831
JBrowse link
G Cnr2 cannabinoid receptor 2 multiple interactions
increases expression
affects response to substance
increases response to substance
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CNR2 mRNA; CNR2 gene mutant form promotes the reaction [Dextran Sulfate results in increased secretion of MPO protein]; CNR2 protein affects the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in decreased expression of SQSTM1 protein]; CNR2 protein affects the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]; CNR2 protein affects the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of and results in increased secretion of IL1B protein]; CNR2 protein affects the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of BECN1 protein]; CNR2 protein affects the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA]; CNR2 protein affects the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of NLRP3 protein]; CNR2 protein affects the reaction [Dextran Sulfate results in decreased phosphorylation of MTOR protein]; CNR2 protein affects the reaction [Dextran Sulfate results in decreased phosphorylation of RPS6KB1 protein]; CNR2 protein affects the susceptibility to [Azoxymethane co-treated with Dextran Sulfate]; SB 203580 inhibits the reaction [Dextran Sulfate results in increased expression of CNR2 protein]
CNR2 protein affects the susceptibility to Dextran Sulfate
CNR2 gene mutant form results in increased susceptibility to Dextran Sulfate
CTD PMID:27611972 PMID:27920472 PMID:29950665 PMID:30102254 PMID:32942172 NCBI chr 4:135,622,500...135,647,530
Ensembl chr 4:135,622,705...135,647,518
JBrowse link
G Cntfr ciliary neurotrophic factor receptor multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CNTFR mRNA CTD PMID:29950665 NCBI chr 4:41,657,498...41,697,091
Ensembl chr 4:41,657,498...41,697,089
JBrowse link
G Cntn1 contactin 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CNTN1 mRNA CTD PMID:29950665 NCBI chr15:91,949,034...92,239,834
Ensembl chr15:91,949,046...92,239,848
JBrowse link
G Cog1 component of oligomeric golgi complex 1 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of COG1 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of COG1 protein]
CTD PMID:32272095 NCBI chr11:113,540,004...113,560,157
Ensembl chr11:113,539,995...113,557,880
JBrowse link
G Col11a1 collagen, type XI, alpha 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL11A1 mRNA CTD PMID:29950665 NCBI chr 3:113,823,933...114,014,405
Ensembl chr 3:113,824,189...114,014,367
JBrowse link
G Col14a1 collagen, type XIV, alpha 1 multiple interactions
increases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL14A1 mRNA; Erianin inhibits the reaction [Dextran Sulfate results in increased expression of COL14A1 protein] CTD PMID:29950665 PMID:32272095 NCBI chr15:55,171,040...55,384,199
Ensembl chr15:55,171,146...55,384,199
JBrowse link
G Col16a1 collagen, type XVI, alpha 1 increases expression EXP Dextran Sulfate results in increased expression of COL16A1 mRNA CTD PMID:35093514 NCBI chr 4:129,941,638...129,993,070
Ensembl chr 4:129,941,633...129,993,076
JBrowse link
G Col18a1 collagen, type XVIII, alpha 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL18A1 mRNA CTD PMID:29950665 NCBI chr10:76,888,013...77,002,351
Ensembl chr10:76,888,012...77,002,382
JBrowse link
G Col1a1 collagen, type I, alpha 1 multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL1A1 mRNA
Dextran Sulfate results in decreased expression of COL1A1 mRNA
CTD PMID:29950665 PMID:35093514 NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
JBrowse link
G Col1a2 collagen, type I, alpha 2 decreases expression EXP Dextran Sulfate results in decreased expression of COL1A2 mRNA CTD PMID:35093514 NCBI chr 6:4,505,618...4,541,543
Ensembl chr 6:4,504,814...4,541,544
JBrowse link
G Col22a1 collagen, type XXII, alpha 1 increases expression EXP Dextran Sulfate results in increased expression of COL22A1 mRNA CTD PMID:35093514 NCBI chr15:71,667,644...71,906,087
Ensembl chr15:71,667,644...71,906,076
JBrowse link
G Col23a1 collagen, type XXIII, alpha 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL23A1 mRNA CTD PMID:29950665 NCBI chr11:51,180,508...51,474,752
Ensembl chr11:51,180,747...51,474,745
JBrowse link
G Col28a1 collagen, type XXVIII, alpha 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL28A1 mRNA CTD PMID:29950665 NCBI chr 6:7,997,100...8,193,709
Ensembl chr 6:7,997,808...8,192,617
JBrowse link
G Col3a1 collagen, type III, alpha 1 decreases expression EXP Dextran Sulfate results in decreased expression of COL3A1 mRNA CTD PMID:35093514 NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866
JBrowse link
G Col4a1 collagen, type IV, alpha 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL4A1 mRNA CTD PMID:29950665 NCBI chr 8:11,248,423...11,362,889
Ensembl chr 8:11,248,423...11,362,826
JBrowse link
G Col4a2 collagen, type IV, alpha 2 multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL4A2 mRNA; Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of COL4A2 protein] CTD PMID:29950665 PMID:32272095 NCBI chr 8:11,362,878...11,499,287
Ensembl chr 8:11,362,805...11,499,287
JBrowse link
G Col5a1 collagen, type V, alpha 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL5A1 mRNA CTD PMID:29950665 NCBI chr 2:27,776,393...27,929,522
Ensembl chr 2:27,776,437...27,929,526
JBrowse link
G Col5a2 collagen, type V, alpha 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL5A2 mRNA CTD PMID:29950665 NCBI chr 1:45,413,491...45,542,442
Ensembl chr 1:45,413,481...45,542,442
JBrowse link
G Col6a1 collagen, type VI, alpha 1 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of COL6A1 mRNA; Dextran Sulfate results in decreased expression of COL6A1 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of COL6A1 protein]
CTD PMID:32272095 PMID:35093514 NCBI chr10:76,544,626...76,561,869
Ensembl chr10:76,544,626...76,562,002
JBrowse link
G Col6a2 collagen, type VI, alpha 2 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of COL6A2 mRNA; Dextran Sulfate results in decreased expression of COL6A2 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of COL6A2 protein]
CTD PMID:32272095 PMID:35093514 NCBI chr10:76,431,590...76,459,464
Ensembl chr10:76,431,596...76,459,464
JBrowse link
G Col6a4 collagen, type VI, alpha 4 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of COL6A4 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of COL6A4 protein]
CTD PMID:32272095 NCBI chr 9:105,867,284...105,975,729
Ensembl chr 9:105,866,653...105,973,982
JBrowse link
G Col8a1 collagen, type VIII, alpha 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL8A1 mRNA CTD PMID:29950665 NCBI chr16:57,444,619...57,575,100
Ensembl chr16:57,444,621...57,575,100
JBrowse link
G Coro1a coronin, actin binding protein 1A decreases expression EXP Dextran Sulfate results in decreased expression of CORO1A protein CTD PMID:35999755 NCBI chr 7:126,298,946...126,303,925
Ensembl chr 7:126,298,945...126,306,959
JBrowse link
G Coro1c coronin, actin binding protein 1C decreases expression EXP Dextran Sulfate results in decreased expression of CORO1C protein CTD PMID:35999755 NCBI chr 5:113,980,500...114,046,767
Ensembl chr 5:113,980,497...114,046,819
JBrowse link
G Cotl1 coactosin like F-actin binding protein 1 decreases expression EXP Dextran Sulfate results in decreased expression of COTL1 protein CTD PMID:35999755 NCBI chr 8:120,535,953...120,567,318
Ensembl chr 8:120,535,961...120,567,283
JBrowse link
G Cox5b cytochrome c oxidase subunit 5B increases expression EXP Dextran Sulfate results in increased expression of COX5B mRNA CTD PMID:35093514 NCBI chr 1:36,730,568...36,732,469
Ensembl chr 1:36,730,530...36,732,762
JBrowse link
G Cp ceruloplasmin multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CP mRNA CTD PMID:29950665 NCBI chr 3:20,011,097...20,063,914
Ensembl chr 3:20,011,218...20,063,309
JBrowse link
G Cpa1 carboxypeptidase A1, pancreatic multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CPA1 mRNA CTD PMID:29950665 NCBI chr 6:30,639,217...30,645,360
Ensembl chr 6:30,639,217...30,645,362
JBrowse link
G Cpb2 carboxypeptidase B2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CPB2 mRNA CTD PMID:29950665 NCBI chr14:75,479,727...75,520,995
Ensembl chr14:75,479,727...75,520,995
JBrowse link
G Cr2 complement receptor 2 increases expression EXP Dextran Sulfate results in increased expression of CR2 mRNA CTD PMID:23894361 NCBI chr 1:194,819,120...194,859,096
Ensembl chr 1:194,819,119...194,859,024
JBrowse link
G Cracd capping protein inhibiting regulator of actin increases expression EXP Dextran Sulfate results in increased expression of CRACD mRNA CTD PMID:35093514 NCBI chr 5:76,803,225...77,021,393
Ensembl chr 5:76,804,359...77,021,392
JBrowse link
G Crhr1 corticotropin releasing hormone receptor 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CRHR1 mRNA CTD PMID:29950665 NCBI chr11:104,021,289...104,066,349
Ensembl chr11:104,023,681...104,066,349
JBrowse link
G Crhr2 corticotropin releasing hormone receptor 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CRHR2 mRNA CTD PMID:29950665 NCBI chr 6:55,067,033...55,110,001
Ensembl chr 6:55,067,034...55,110,001
JBrowse link
G Crisp4 cysteine-rich secretory protein 4 decreases expression EXP Dextran Sulfate results in decreased expression of CRISP1 protein CTD PMID:35999755 NCBI chr 1:18,185,113...18,216,126
Ensembl chr 1:18,185,415...18,216,126
JBrowse link
G Crtap cartilage associated protein multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CRTAP mRNA CTD PMID:29950665 NCBI chr 9:114,204,204...114,219,743
Ensembl chr 9:114,204,202...114,219,743
JBrowse link
G Csf1 colony stimulating factor 1 (macrophage) multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CSF1 mRNA CTD PMID:29950665 NCBI chr 3:107,648,364...107,668,048
Ensembl chr 3:107,648,364...107,667,785
JBrowse link
G Csf2 colony stimulating factor 2 (granulocyte-macrophage) increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of CSF2 mRNA; Dextran Sulfate results in increased expression of CSF2 protein
[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [Dextran Sulfate results in increased expression of CSF2 protein]; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CSF2 mRNA; Polymyxin B inhibits the reaction [Dextran Sulfate results in increased expression of CSF2 protein]; Rutin inhibits the reaction [Dextran Sulfate results in increased expression of CSF2 mRNA]; TLR4 protein affects the reaction [Dextran Sulfate results in increased expression of CSF2 protein]
CTD PMID:15652231 PMID:29950665 PMID:31442584 NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
JBrowse link
G Csf2rb2 colony stimulating factor 2 receptor, beta 2, low-affinity (granulocyte-macrophage) multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CSF2RB2 mRNA CTD PMID:29950665 NCBI chr15:78,166,707...78,189,921
Ensembl chr15:78,166,707...78,189,921
JBrowse link
G Csf3 colony stimulating factor 3 (granulocyte) multiple interactions
increases expression
EXP Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of CSF3 mRNA] CTD PMID:32033881 NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
JBrowse link
G Csf3r colony stimulating factor 3 receptor multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CSF3R mRNA CTD PMID:29950665 NCBI chr 4:125,917,241...125,938,233
Ensembl chr 4:125,918,343...125,938,233
JBrowse link
G Ctnnb1 catenin beta 1 increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of CTNNB1 protein
[2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with Dextran Sulfate] results in increased expression of CTNNB1 protein; [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with Dextran Sulfate] results in increased mutagenesis of CTNNB1 gene; [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of CTNNB1 protein; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of CTNNB1 protein]; CTNNB1 gene mutant form results in increased susceptibility to [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with Dextran Sulfate]
CTD PMID:15459021 PMID:16049979 PMID:27664423 PMID:31715269 NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573
JBrowse link
G Ctps1 cytidine 5'-triphosphate synthase 1 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of CTPS1 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of CTPS1 protein]
CTD PMID:32272095 NCBI chr 4:120,397,065...120,427,473
Ensembl chr 4:120,397,065...120,427,473
JBrowse link
G Ctsc cathepsin C decreases expression EXP Dextran Sulfate results in decreased expression of CTSC mRNA CTD PMID:35093514 NCBI chr 7:87,927,233...87,960,083
Ensembl chr 7:87,927,293...87,960,096
JBrowse link
G Ctsd cathepsin D multiple interactions
increases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in increased expression of CTSD protein] CTD PMID:32272095 NCBI chr 7:141,929,647...141,941,564
Ensembl chr 7:141,929,648...141,941,775
JBrowse link
G Ctsk cathepsin K multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CTSK mRNA CTD PMID:29950665 NCBI chr 3:95,406,521...95,416,698
Ensembl chr 3:95,406,567...95,416,673
JBrowse link
G Ctsl cathepsin L multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of CTSL protein; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CTSL mRNA CTD PMID:29950665 PMID:35999755 NCBI chr13:64,509,704...64,518,586
Ensembl chr13:64,507,151...64,518,704
JBrowse link
G Ctss cathepsin S decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of CTSS protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of CTSS protein]
CTD PMID:32272095 NCBI chr 3:95,434,097...95,463,716
Ensembl chr 3:95,434,097...95,463,714
JBrowse link
G Cubn cubilin multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CUBN mRNA CTD PMID:29950665 NCBI chr 2:13,281,149...13,496,687
Ensembl chr 2:13,281,149...13,496,624
JBrowse link
G Cx3cr1 C-X3-C motif chemokine receptor 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CX3CR1 mRNA CTD PMID:29950665 NCBI chr 9:119,877,749...119,897,362
Ensembl chr 9:119,877,749...119,898,945
JBrowse link
G Cxadr coxsackie virus and adenovirus receptor multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CXADR mRNA CTD PMID:29950665 NCBI chr16:78,098,114...78,156,673
Ensembl chr16:78,098,377...78,156,662
JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 multiple interactions EXP [Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CXCL10 mRNA; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CXCL10 mRNA] CTD PMID:25026504 NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 decreases expression EXP Dextran Sulfate results in decreased expression of CXCL12 mRNA CTD PMID:35093514 NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328
JBrowse link
G Cxcl13 C-X-C motif chemokine ligand 13 increases expression EXP Dextran Sulfate results in increased expression of CXCL13 mRNA CTD PMID:23894361 PMID:35093514 NCBI chr 5:96,104,785...96,108,927
Ensembl chr 5:96,104,810...96,108,927
JBrowse link
G Cxcl14 C-X-C motif chemokine ligand 14 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CXCL14 mRNA CTD PMID:29950665 NCBI chr13:56,436,456...56,444,624
Ensembl chr13:56,436,456...56,444,364
JBrowse link
G Cxcl15 C-X-C motif chemokine ligand 15 increases expression
multiple interactions
EXP
ISO
Dextran Sulfate results in increased expression of CXCL15 protein; Dextran Sulfate results in increased expression of CXCL8 protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of CXCL8 protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased expression of CXCL8 protein]
Dextran Sulfate results in increased expression of CXCL8 mRNA
CTD PMID:20637373 PMID:32272095 PMID:38423481 NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 multiple interactions
increases expression
EXP 17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid inhibits the reaction [Dextran Sulfate results in increased expression of CXCL2 protein]; AHR gene mutant form promotes the reaction [Dextran Sulfate results in increased expression of CXCL2 mRNA]; Benzo(a)pyrene inhibits the reaction [Dextran Sulfate results in increased expression of CXCL2 mRNA]; Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of CXCL2 mRNA]; resolvin D1 inhibits the reaction [Dextran Sulfate results in increased expression of CXCL2 protein]; resolvin D2 inhibits the reaction [Dextran Sulfate results in increased expression of CXCL2 protein]
Dextran Sulfate results in increased expression of CXCL2 mRNA; Dextran Sulfate results in increased expression of CXCL2 protein
CTD PMID:21724996 PMID:32033881 PMID:34998820 PMID:36519841 NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 multiple interactions
increases expression
increases secretion
EXP 17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid inhibits the reaction [Dextran Sulfate results in increased expression of CXCL1 protein]; [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CXCL1 protein; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CXCL1 mRNA; AHR gene mutant form promotes the reaction [Dextran Sulfate results in increased expression of CXCL1 mRNA]; Benzo(a)pyrene inhibits the reaction [Dextran Sulfate results in increased expression of CXCL1 mRNA]; resolvin D1 inhibits the reaction [Dextran Sulfate results in increased expression of CXCL1 protein]; resolvin D2 inhibits the reaction [Dextran Sulfate results in increased expression of CXCL1 protein]; Tetrachlorodibenzodioxin inhibits the reaction [Dextran Sulfate results in increased secretion of CXCL1 protein]
Dextran Sulfate results in increased expression of CXCL1 mRNA; Dextran Sulfate results in increased expression of CXCL1 protein
CTD PMID:19645018 PMID:20079348 PMID:21724996 PMID:21858153 PMID:29950665 More... NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
JBrowse link
G Cxcl5 C-X-C motif chemokine ligand 5 increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of CXCL5 mRNA
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CXCL5 mRNA
CTD PMID:19645018 PMID:29950665 NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483
JBrowse link
G Cxcl9 C-X-C motif chemokine ligand 9 increases expression EXP Dextran Sulfate results in increased expression of CXCL9 mRNA CTD PMID:23894361 NCBI chr 5:92,469,190...92,475,938
Ensembl chr 5:92,469,206...92,475,938
JBrowse link
G Cxcr2 C-X-C motif chemokine receptor 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CXCR2 mRNA CTD PMID:29950665 NCBI chr 1:74,193,153...74,200,405
Ensembl chr 1:74,193,150...74,200,405
JBrowse link
G Cyba cytochrome b-245, alpha polypeptide increases expression EXP Dextran Sulfate results in increased expression of CYBA protein CTD PMID:20637373 NCBI chr 8:123,151,510...123,159,679
Ensembl chr 8:123,151,515...123,159,669
JBrowse link
G Cybb cytochrome b-245, beta polypeptide increases expression EXP Dextran Sulfate results in increased expression of CYBB mRNA; Dextran Sulfate results in increased expression of CYBB protein CTD PMID:20637373 PMID:23894361 NCBI chr  X:9,301,493...9,354,005
Ensembl chr  X:9,301,491...9,354,010
JBrowse link
G Cyfip1 cytoplasmic FMR1 interacting protein 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYFIP1 mRNA CTD PMID:29950665 NCBI chr 7:55,491,556...55,582,381
Ensembl chr 7:55,491,493...55,582,350
JBrowse link
G Cyfip2 cytoplasmic FMR1 interacting protein 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYFIP2 mRNA CTD PMID:29950665 NCBI chr11:46,084,676...46,203,686
Ensembl chr11:46,084,677...46,203,686
JBrowse link
G Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 decreases expression EXP Dextran Sulfate results in decreased expression of CYP11A1 mRNA CTD PMID:35093514 NCBI chr 9:57,905,307...57,934,314
Ensembl chr 9:57,913,694...57,934,306
JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 decreases expression EXP Dextran Sulfate results in decreased expression of CYP17A1 mRNA CTD PMID:35093514 NCBI chr19:46,655,604...46,661,439
Ensembl chr19:46,655,604...46,661,611
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions
decreases expression
EXP 6-formylindolo(3,2-b)carbazole inhibits the reaction [Dextran Sulfate results in decreased expression of CYP1A1 mRNA]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [Dextran Sulfate results in decreased expression of CYP1A1 protein]; Dextran Sulfate inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]
Dextran Sulfate results in decreased expression of CYP1A1 mRNA; Dextran Sulfate results in decreased expression of CYP1A1 protein
CTD PMID:29680209 PMID:34998820 NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 decreases activity
multiple interactions
ISO Dextran Sulfate results in decreased activity of CYP1A2 protein
[Dextran Sulfate results in decreased activity of CYP1A2 protein] which results in decreased chemical synthesis of Acetaminophen
CTD PMID:28438436 NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
JBrowse link
G Cyp21a1 cytochrome P450, family 21, subfamily a, polypeptide 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP21A1 mRNA CTD PMID:29950665 NCBI chr17:35,020,322...35,023,400
Ensembl chr17:35,020,322...35,023,535
JBrowse link
G Cyp24a1 cytochrome P450, family 24, subfamily a, polypeptide 1 increases expression EXP Dextran Sulfate results in increased expression of CYP24A1 protein CTD PMID:38588969 NCBI chr 2:170,324,877...170,339,065
Ensembl chr 2:170,324,628...170,339,065
JBrowse link
G Cyp26b1 cytochrome P450, family 26, subfamily b, polypeptide 1 decreases expression EXP Dextran Sulfate results in decreased expression of CYP26B1 mRNA CTD PMID:35093514 NCBI chr 6:84,548,396...84,570,890
Ensembl chr 6:84,548,396...84,570,890
JBrowse link
G Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP27B1 mRNA
Dextran Sulfate results in decreased expression of CYP27B1 protein
CTD PMID:29950665 PMID:38588969 NCBI chr10:126,884,115...126,891,897
Ensembl chr10:126,884,119...126,888,875
JBrowse link
G Cyp2b10 cytochrome P450, family 2, subfamily b, polypeptide 10 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYP2B10 mRNA CTD PMID:29950665 NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
JBrowse link
G Cyp2b13 cytochrome P450, family 2, subfamily b, polypeptide 13 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2B13 mRNA CTD PMID:29950665 NCBI chr 7:25,760,813...25,795,622
Ensembl chr 7:25,760,922...25,795,622
JBrowse link
G Cyp2c23 cytochrome P450, family 2, subfamily c, polypeptide 23 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYP2C23 mRNA CTD PMID:29950665 NCBI chr19:43,993,461...44,017,695
Ensembl chr19:43,993,461...44,017,647
JBrowse link
G Cyp2c29 cytochrome P450, family 2, subfamily c, polypeptide 29 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2C29 mRNA CTD PMID:29950665 NCBI chr19:39,275,541...39,319,157
Ensembl chr19:39,257,849...39,319,157
JBrowse link
G Cyp2c38 cytochrome P450, family 2, subfamily c, polypeptide 38 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2C38 mRNA CTD PMID:29950665 NCBI chr19:39,379,109...39,451,519
Ensembl chr19:39,378,000...39,451,519
JBrowse link
G Cyp2c40 cytochrome P450, family 2, subfamily c, polypeptide 40 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2C40 mRNA CTD PMID:29950665 NCBI chr19:39,755,517...39,801,258
Ensembl chr19:39,755,515...39,801,258
JBrowse link
G Cyp2c50 cytochrome P450, family 2, subfamily c, polypeptide 50 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2C50 mRNA CTD PMID:29950665 NCBI chr19:40,078,123...40,102,399
Ensembl chr19:40,078,132...40,102,394
JBrowse link
G Cyp2c55 cytochrome P450, family 2, subfamily c, polypeptide 55 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2C55 mRNA CTD PMID:29950665 NCBI chr19:38,995,384...39,031,134
Ensembl chr19:38,995,463...39,031,137
JBrowse link
G Cyp2c65 cytochrome P450, family 2, subfamily c, polypeptide 65 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2C65 mRNA CTD PMID:29950665 NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
JBrowse link
G Cyp2c66 cytochrome P450, family 2, subfamily c, polypeptide 66 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2C66 mRNA CTD PMID:29950665 NCBI chr19:39,102,342...39,175,200
Ensembl chr19:39,102,342...39,175,516
JBrowse link
G Cyp2c67 cytochrome P450, family 2, subfamily c, polypeptide 67 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2C67 mRNA CTD PMID:29950665 NCBI chr19:39,597,288...39,637,497
Ensembl chr19:39,597,286...39,637,495
JBrowse link
G Cyp2c68 cytochrome P450, family 2, subfamily c, polypeptide 68 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2C68 mRNA CTD PMID:29950665 NCBI chr19:39,677,280...39,729,545
Ensembl chr19:39,677,278...39,729,498
JBrowse link
G Cyp2c69 cytochrome P450, family 2, subfamily c, polypeptide 69 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2C69 mRNA CTD PMID:29950665 NCBI chr19:39,831,104...39,875,213
Ensembl chr19:39,831,258...39,875,243
JBrowse link
G Cyp2d10 cytochrome P450, family 2, subfamily d, polypeptide 10 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2D10 mRNA CTD PMID:29950665 NCBI chr15:82,287,046...82,291,449
Ensembl chr15:82,287,047...82,291,396
JBrowse link
G Cyp2d11 cytochrome P450, family 2, subfamily d, polypeptide 11 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2D11 mRNA CTD PMID:29950665 NCBI chr15:82,273,355...82,278,223
Ensembl chr15:82,273,355...82,278,223
JBrowse link
G Cyp2d12 cytochrome P450, family 2, subfamily d, polypeptide 12 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2D12 mRNA CTD PMID:29950665 NCBI chr15:82,439,244...82,443,614
Ensembl chr15:82,439,273...82,444,604
JBrowse link
G Cyp2d26 cytochrome P450, family 2, subfamily d, polypeptide 26 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2D26 mRNA CTD PMID:29950665 NCBI chr15:82,674,308...82,678,653
Ensembl chr15:82,674,302...82,678,495
JBrowse link
G Cyp2d9 cytochrome P450, family 2, subfamily d, polypeptide 9 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2D9 mRNA CTD PMID:29950665 NCBI chr15:82,336,578...82,341,028
Ensembl chr15:82,317,638...82,341,046
JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 decreases activity
multiple interactions
ISO Dextran Sulfate results in decreased activity of CYP2E1 protein
[Dextran Sulfate results in decreased activity of CYP2E1 protein] which results in decreased chemical synthesis of 6-hydroxychlorzoxazone
CTD PMID:28438436 NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
JBrowse link
G Cyp2j13 cytochrome P450, family 2, subfamily j, polypeptide 13 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2J13 mRNA CTD PMID:29950665 NCBI chr 4:95,930,897...95,965,803
Ensembl chr 4:95,915,771...95,965,783
JBrowse link
G Cyp2j6 cytochrome P450, family 2, subfamily j, polypeptide 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2J6 mRNA CTD PMID:29950665 NCBI chr 4:96,404,375...96,449,835
Ensembl chr 4:96,404,375...96,441,898
JBrowse link
G Cyp2j8 cytochrome P450, family 2, subfamily j, polypeptide 8 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2J8 mRNA CTD PMID:29950665 NCBI chr 4:96,332,187...96,395,634
Ensembl chr 4:96,332,833...96,395,623
JBrowse link
G Cyp2j9 cytochrome P450, family 2, subfamily j, polypeptide 9 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2J9 mRNA CTD PMID:29950665 NCBI chr 4:96,456,661...96,480,748
Ensembl chr 4:96,456,666...96,479,815
JBrowse link
G Cyp2r1 cytochrome P450, family 2, subfamily r, polypeptide 1 multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2R1 mRNA; Cholecalciferol inhibits the reaction [Dextran Sulfate results in decreased expression of CYP2R1 protein] CTD PMID:29950665 PMID:38588969 NCBI chr 7:114,149,358...114,162,283
Ensembl chr 7:114,148,917...114,162,207
JBrowse link
G Cyp2s1 cytochrome P450, family 2, subfamily s, polypeptide 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2S1 mRNA CTD PMID:29950665 NCBI chr 7:25,501,894...25,515,950
Ensembl chr 7:25,501,900...25,516,338
JBrowse link
G Cyp3a11 cytochrome P450, family 3, subfamily a, polypeptide 11 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP3A11 mRNA CTD PMID:29950665 NCBI chr 5:145,791,417...145,816,664
Ensembl chr 5:145,791,236...145,816,774
JBrowse link
G Cyp3a13 cytochrome P450, family 3, subfamily a, polypeptide 13 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP3A13 mRNA CTD PMID:29950665 NCBI chr 5:137,891,195...137,923,872
Ensembl chr 5:137,891,194...137,919,881
JBrowse link
G Cyp3a16 cytochrome P450, family 3, subfamily a, polypeptide 16 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP3A16 mRNA CTD PMID:29950665 NCBI chr 5:145,373,119...145,406,550
Ensembl chr 5:145,373,119...145,406,533
JBrowse link
G Cyp4a10 cytochrome P450, family 4, subfamily a, polypeptide 10 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP4A10 mRNA CTD PMID:29950665 NCBI chr 4:115,375,484...115,390,846
Ensembl chr 4:115,375,461...115,390,846
JBrowse link
G Cyp4a14 cytochrome P450, family 4, subfamily a, polypeptide 14 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP4A14 mRNA CTD PMID:29950665 NCBI chr 4:115,343,397...115,353,355
Ensembl chr 4:115,343,397...115,353,339
JBrowse link
G Cyp4b1 cytochrome P450, family 4, subfamily b, polypeptide 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP4B1 mRNA CTD PMID:29950665 NCBI chr 4:115,481,895...115,504,918
Ensembl chr 4:115,481,922...115,504,920
JBrowse link
G Cyp4f13 cytochrome P450, family 4, subfamily f, polypeptide 13 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP4F13 mRNA CTD PMID:29950665 NCBI chr17:33,143,662...33,166,389
Ensembl chr17:33,143,662...33,166,376
JBrowse link
G Cyp4f14 cytochrome P450, family 4, subfamily f, polypeptide 14 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP4F14 mRNA CTD PMID:29950665 NCBI chr17:33,122,331...33,136,353
Ensembl chr17:33,124,044...33,136,316
JBrowse link
G Cyp4f17 cytochrome P450, family 4, subfamily f, polypeptide 17 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP4F17 mRNA CTD PMID:29950665 NCBI chr17:32,725,404...32,749,132
Ensembl chr17:32,725,024...32,749,117
JBrowse link
G Cyp4f39 cytochrome P450, family 4, subfamily f, polypeptide 39 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYP4F39 mRNA CTD PMID:29950665 NCBI chr17:32,671,670...32,712,294
Ensembl chr17:32,671,697...32,712,294
JBrowse link
G Cyp4f40 cytochrome P450, family 4, subfamily f, polypeptide 40 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP4F40 mRNA CTD PMID:29950665 NCBI chr17:32,877,860...32,895,893
Ensembl chr17:32,877,874...32,895,888
JBrowse link
G Cyp7a1 cytochrome P450, family 7, subfamily a, polypeptide 1 decreases expression EXP Dextran Sulfate results in decreased expression of CYP7A1 mRNA CTD PMID:27580383 NCBI chr 4:6,265,612...6,275,632
Ensembl chr 4:6,265,612...6,275,633
JBrowse link
G Cyp7b1 cytochrome P450, family 7, subfamily b, polypeptide 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYP7B1 mRNA CTD PMID:29950665 NCBI chr 3:18,126,108...18,298,054
Ensembl chr 3:18,126,114...18,297,502
JBrowse link
G Dbt dihydrolipoamide branched chain transacylase E2 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of DBT protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of DBT protein]
CTD PMID:32272095 NCBI chr 3:116,306,776...116,343,630
Ensembl chr 3:116,306,719...116,343,630
JBrowse link
G Dcn decorin multiple interactions
increases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DCN mRNA; Erianin inhibits the reaction [Dextran Sulfate results in increased expression of DCN protein] CTD PMID:29950665 PMID:32272095 NCBI chr10:97,315,362...97,354,025
Ensembl chr10:97,315,471...97,354,005
JBrowse link
G Ddr2 discoidin domain receptor family, member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DDR2 mRNA CTD PMID:29950665 NCBI chr 1:169,799,874...169,938,525
Ensembl chr 1:169,799,876...169,938,331
JBrowse link
G Depp1 DEPP1 autophagy regulator increases expression EXP Dextran Sulfate results in increased expression of DEPP1 mRNA CTD PMID:35093514 NCBI chr 6:116,627,645...116,629,808
Ensembl chr 6:116,627,570...116,629,755
JBrowse link
G Derl3 Der1-like domain family, member 3 increases expression EXP Dextran Sulfate results in increased expression of DERL3 mRNA CTD PMID:23894361 NCBI chr10:75,729,232...75,731,775
Ensembl chr10:75,729,247...75,731,775
JBrowse link
G Dgkb diacylglycerol kinase, beta multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DGKB mRNA CTD PMID:29950665 NCBI chr12:37,930,169...38,684,238
Ensembl chr12:37,867,725...38,684,238
JBrowse link
G Dgki diacylglycerol kinase, iota multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of DGKI mRNA CTD PMID:29950665 NCBI chr 6:36,814,316...37,281,034
Ensembl chr 6:36,822,957...37,277,119
JBrowse link
G Dhcr24 24-dehydrocholesterol reductase decreases expression EXP Dextran Sulfate results in decreased expression of DHCR24 mRNA CTD PMID:35093514 NCBI chr 4:106,418,279...106,446,310
Ensembl chr 4:106,418,235...106,446,310
JBrowse link
G Dhrs9 dehydrogenase/reductase 9 increases expression EXP Dextran Sulfate results in increased expression of DHRS9 mRNA CTD PMID:23894361 NCBI chr 2:69,210,806...69,233,430
Ensembl chr 2:69,210,789...69,234,877
JBrowse link
G Dhrsx dehydrogenase/reductase X linked increases expression EXP Dextran Sulfate results in increased expression of DHRSX mRNA CTD PMID:35093514 NCBI chr 4:156,390,105...156,410,432 JBrowse link
G Dkk2 dickkopf WNT signaling pathway inhibitor 2 multiple interactions EXP [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of DKK2 mRNA; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of DKK2 mRNA] CTD PMID:31715269 NCBI chr 3:131,791,027...131,886,065
Ensembl chr 3:131,791,053...131,886,065
JBrowse link
G Dlk1 delta like non-canonical Notch ligand 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DLK1 mRNA CTD PMID:29950665 NCBI chr12:109,418,411...109,429,262
Ensembl chr12:109,418,749...109,429,262
JBrowse link
G Dmpk dystrophia myotonica-protein kinase multiple interactions EXP [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of DMPK mRNA CTD PMID:26271895 NCBI chr 7:18,817,571...18,827,746
Ensembl chr 7:18,817,774...18,827,746
JBrowse link
G Dmrta1 doublesex and mab-3 related transcription factor like family A1 decreases expression EXP Dextran Sulfate results in decreased expression of DMRTA1 mRNA CTD PMID:35093514 NCBI chr 4:89,576,435...89,583,003
Ensembl chr 4:89,567,673...89,583,009
JBrowse link
G Dmwd dystrophia myotonica-containing WD repeat motif increases expression EXP Dextran Sulfate results in increased expression of DMWD mRNA CTD PMID:35093514 NCBI chr 7:18,810,002...18,816,701
Ensembl chr 7:18,810,152...18,816,701
JBrowse link
G Dnajc10 DnaJ heat shock protein family (Hsp40) member C10 multiple interactions
increases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in increased expression of DNAJC10 protein] CTD PMID:32272095 NCBI chr 2:80,145,790...80,184,399
Ensembl chr 2:80,145,810...80,184,387
JBrowse link
G Dnm1 dynamin 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DNM1 mRNA CTD PMID:29950665 NCBI chr 2:32,198,483...32,243,361
Ensembl chr 2:32,198,483...32,243,350
JBrowse link
G Dnm3 dynamin 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DNM3 mRNA CTD PMID:29950665 NCBI chr 1:161,810,022...162,305,890
Ensembl chr 1:161,810,022...162,305,603
JBrowse link
G Dok2 docking protein 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DOK2 mRNA CTD PMID:29950665 NCBI chr14:71,003,336...71,015,934
Ensembl chr14:71,003,476...71,015,935
JBrowse link
G Dpep1 dipeptidase 1 multiple interactions
increases expression
EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of DPEP1 protein; Erianin inhibits the reaction [Dextran Sulfate results in increased expression of DPEP1 protein] CTD PMID:32272095 PMID:35999755 NCBI chr 8:123,913,069...123,928,551
Ensembl chr 8:123,912,981...123,928,551
JBrowse link
G Dpep2 dipeptidase 2 multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of DPEP2 protein; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DPEP2 mRNA CTD PMID:29950665 PMID:35999755 NCBI chr 8:106,711,577...106,732,658
Ensembl chr 8:106,711,576...106,718,391
Ensembl chr 8:106,711,576...106,718,391
JBrowse link
G Dpyd dihydropyrimidine dehydrogenase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of DPYD mRNA CTD PMID:29950665 NCBI chr 3:118,355,758...119,226,573
Ensembl chr 3:118,355,778...119,226,573
JBrowse link
G Drap1 DR1 associated protein 1 increases expression EXP Dextran Sulfate results in increased expression of DRAP1 mRNA CTD PMID:35093514 NCBI chr19:5,472,832...5,475,007
Ensembl chr19:5,472,833...5,475,007
JBrowse link
G Drd4 dopamine receptor D4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of DRD4 mRNA CTD PMID:29950665 NCBI chr 7:140,871,931...140,874,868
Ensembl chr 7:140,871,919...140,876,377
JBrowse link
G Drd5 dopamine receptor D5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of DRD5 mRNA CTD PMID:29950665 NCBI chr 5:38,476,742...38,479,868
Ensembl chr 5:38,476,710...38,479,861
JBrowse link
G Dtx1 deltex 1, E3 ubiquitin ligase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DTX1 mRNA CTD PMID:29950665 NCBI chr 5:120,818,268...120,850,879
Ensembl chr 5:120,818,267...120,849,992
JBrowse link
G Duoxa2 dual oxidase maturation factor 2 increases expression EXP Dextran Sulfate results in increased expression of DUOXA2 mRNA CTD PMID:23894361 NCBI chr 2:122,129,381...122,133,088
Ensembl chr 2:122,129,381...122,133,366
JBrowse link
G Dusp1 dual specificity phosphatase 1 multiple interactions
increases expression
EXP DUSP1 protein affects the reaction [Butylated Hydroxyanisole affects the reaction [Dextran Sulfate affects the expression of IL6 protein]]; DUSP1 protein affects the reaction [Butylated Hydroxyanisole affects the reaction [Dextran Sulfate affects the expression of TNF protein]]; DUSP1 protein affects the reaction [Butylated Hydroxyanisole inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein]]; DUSP1 protein affects the reaction [Resveratrol affects the reaction [Dextran Sulfate affects the expression of IL6 protein]]; DUSP1 protein affects the reaction [Resveratrol affects the reaction [Dextran Sulfate affects the expression of TNF protein]]; DUSP1 protein affects the reaction [Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein]]; DUSP1 protein affects the susceptibility to [Azoxymethane co-treated with Dextran Sulfate]
Dextran Sulfate results in increased expression of DUSP1 mRNA
CTD PMID:30844440 PMID:35093514 NCBI chr17:26,724,565...26,727,446
Ensembl chr17:26,724,564...26,781,102
JBrowse link
G Eci1 enoyl-Coenzyme A delta isomerase 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ECI1 mRNA CTD PMID:29950665 NCBI chr17:24,645,657...24,658,290
Ensembl chr17:24,645,615...24,658,322
JBrowse link
G Ecpas Ecm29 proteasome adaptor and scaffold decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of ECPAS protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of ECPAS protein]
CTD PMID:32272095 NCBI chr 4:58,797,234...58,917,748
Ensembl chr 4:58,798,911...58,912,749
JBrowse link
G Eda ectodysplasin-A multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of EDA mRNA CTD PMID:29950665 NCBI chr  X:99,019,212...99,444,366
Ensembl chr  X:99,019,212...99,444,368
JBrowse link
G Eda2r ectodysplasin A2 receptor multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of EDA2R mRNA CTD PMID:29950665 NCBI chr  X:96,375,936...96,420,786
Ensembl chr  X:96,377,446...96,420,822
JBrowse link
G Edf1 endothelial differentiation-related factor 1 increases expression EXP Dextran Sulfate results in increased expression of EDF1 mRNA CTD PMID:35093514 NCBI chr 2:25,447,838...25,452,096
Ensembl chr 2:25,447,859...25,452,094
JBrowse link
G Edn1 endothelin 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of EDN1 mRNA CTD PMID:29950665 NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
JBrowse link
G Edn2 endothelin 2 increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of EDN2 protein
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of EDN2 mRNA
CTD PMID:16216902 PMID:29950665 NCBI chr 4:120,018,403...120,024,557
Ensembl chr 4:120,018,403...120,024,557
JBrowse link
G Ednra endothelin receptor type A multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of EDNRA mRNA CTD PMID:29950665 NCBI chr 8:78,389,658...78,451,081
Ensembl chr 8:78,389,660...78,451,093
JBrowse link
G Eef1g eukaryotic translation elongation factor 1 gamma decreases expression EXP Dextran Sulfate results in decreased expression of EEF1G protein CTD PMID:35999755 NCBI chr19:8,944,405...8,955,544
Ensembl chr19:8,944,405...8,955,843
JBrowse link
G Efemp2 epidermal growth factor-containing fibulin-like extracellular matrix protein 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of EFEMP2 mRNA CTD PMID:29950665 NCBI chr19:5,523,974...5,532,548
Ensembl chr19:5,523,982...5,532,545
JBrowse link
G Efhd2 EF hand domain containing 2 increases expression EXP Dextran Sulfate results in increased expression of EFHD2 mRNA CTD PMID:35093514 NCBI chr 4:141,585,453...141,602,231
Ensembl chr 4:141,585,453...141,602,231
JBrowse link
G Efna1 ephrin A1 multiple interactions EXP [Benzo(a)pyrene co-treated with Dextran Sulfate] results in decreased expression of EFNA1 mRNA CTD PMID:26271895 NCBI chr 3:89,179,037...89,188,258
Ensembl chr 3:89,179,040...89,188,449
JBrowse link
G Egln2 egl-9 family hypoxia-inducible factor 2 increases expression EXP Dextran Sulfate results in increased expression of EGLN2 mRNA CTD PMID:35093514 NCBI chr 7:26,858,083...26,866,227
Ensembl chr 7:26,858,083...26,866,227
JBrowse link
G Ehd1 EH-domain containing 1 decreases expression EXP Dextran Sulfate results in decreased expression of EHD1 protein CTD PMID:35999755 NCBI chr19:6,326,926...6,350,126
Ensembl chr19:6,326,755...6,350,126
JBrowse link
G Ehd4 EH-domain containing 4 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of EHD4 protein
[Dextran Sulfate co-treated with bisphenol A] results in decreased expression of EHD4 protein
CTD PMID:35999755 NCBI chr 2:119,919,958...119,985,028
Ensembl chr 2:119,919,656...119,985,087
JBrowse link
G Ehhadh enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of EHHADH mRNA CTD PMID:29950665 NCBI chr16:21,580,035...21,606,589
Ensembl chr16:21,580,037...21,606,557
JBrowse link
G Ehmt2 euchromatic histone lysine N-methyltransferase 2 increases expression EXP Dextran Sulfate results in increased expression of EHMT2 mRNA CTD PMID:35093514 NCBI chr17:35,117,427...35,133,049
Ensembl chr17:35,117,445...35,133,028
JBrowse link
G Eif2ak2 eukaryotic translation initiation factor 2-alpha kinase 2 multiple interactions
increases phosphorylation
EXP EIF2AK2 protein affects the reaction [Dextran Sulfate results in increased activity of CASP3 protein]; EIF2AK2 protein affects the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; EIF2AK2 protein affects the reaction [Dextran Sulfate results in increased expression of NOS2 mRNA]; EIF2AK2 protein affects the reaction [Dextran Sulfate results in increased phosphorylation of RELA protein]; GW 506033X inhibits the reaction [Dextran Sulfate results in increased phosphorylation of EIF2AK2 protein] CTD PMID:27920257 NCBI chr17:79,157,933...79,190,001
Ensembl chr17:79,159,993...79,190,002
JBrowse link
G Eif3a eukaryotic translation initiation factor 3, subunit A multiple interactions EXP [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of EIF3A mRNA CTD PMID:26271895 NCBI chr19:60,749,554...60,779,131
Ensembl chr19:60,749,555...60,779,096
JBrowse link
G Eif5a eukaryotic translation initiation factor 5A decreases expression EXP Dextran Sulfate results in decreased expression of EIF5A protein CTD PMID:35999755 NCBI chr11:69,807,538...69,812,784
Ensembl chr11:69,807,540...69,812,784
JBrowse link
G Eif5b eukaryotic translation initiation factor 5B increases expression EXP Dextran Sulfate results in increased expression of EIF5B mRNA CTD PMID:35093514 NCBI chr 1:38,037,091...38,094,660
Ensembl chr 1:38,037,091...38,094,660
JBrowse link
G Elane elastase, neutrophil expressed multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ELANE mRNA CTD PMID:29950665 NCBI chr10:79,722,146...79,724,050
Ensembl chr10:79,722,081...79,724,049
JBrowse link
G Elmo2 engulfment and cell motility 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ELMO2 mRNA CTD PMID:29950665 NCBI chr 2:165,129,951...165,168,421
Ensembl chr 2:165,129,951...165,168,399
JBrowse link
G Emc2 ER membrane protein complex subunit 2 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of EMC2 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of EMC2 protein]
CTD PMID:32272095 NCBI chr15:43,340,603...43,391,174
Ensembl chr15:43,340,625...43,391,159
JBrowse link
G Emp2 epithelial membrane protein 2 decreases expression EXP Dextran Sulfate results in decreased expression of EMP2 mRNA CTD PMID:35093514 NCBI chr16:10,099,613...10,131,832
Ensembl chr16:10,099,613...10,131,832
JBrowse link
G Eng endoglin decreases expression EXP Dextran Sulfate results in decreased expression of ENG mRNA CTD PMID:35093514 NCBI chr 2:32,536,607...32,572,681
Ensembl chr 2:32,536,607...32,572,681
JBrowse link
G Eno1 enolase 1, alpha non-neuron decreases expression EXP Dextran Sulfate results in decreased expression of ENO1 protein CTD PMID:35999755 NCBI chr 4:150,321,165...150,333,336
Ensembl chr 4:150,321,178...150,333,336
Ensembl chr18:150,321,178...150,333,336
JBrowse link
G Eno3 enolase 3, beta muscle decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of ENO3 protein
[Dextran Sulfate co-treated with bisphenol A] results in increased expression of ENO3 protein; Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of ENO3 protein]
CTD PMID:32272095 PMID:35999755 NCBI chr11:70,543,973...70,553,339
Ensembl chr11:70,548,028...70,553,339
JBrowse link
G Enpep glutamyl aminopeptidase increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of ENPEP protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of ENPEP protein]
CTD PMID:32272095 NCBI chr 3:129,062,826...129,126,398
Ensembl chr 3:129,062,824...129,126,369
JBrowse link
G Entpd5 ectonucleoside triphosphate diphosphohydrolase 5 multiple interactions EXP [Benzo(a)pyrene co-treated with Dextran Sulfate] results in decreased expression of ENTPD5 mRNA CTD PMID:26271895 NCBI chr12:84,420,649...84,455,803
Ensembl chr12:84,420,631...84,455,803
JBrowse link
G Ep300 E1A binding protein p300 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of EP300 mRNA CTD PMID:29950665 NCBI chr15:81,470,329...81,536,273
Ensembl chr15:81,469,552...81,536,278
JBrowse link
G Ephx1 epoxide hydrolase 1, microsomal decreases expression EXP Dextran Sulfate results in decreased expression of EPHX1 mRNA CTD PMID:35093514 NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
JBrowse link
G Erbb2 erb-b2 receptor tyrosine kinase 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ERBB2 mRNA CTD PMID:29950665 NCBI chr11:98,303,310...98,328,542
Ensembl chr11:98,303,296...98,328,542
JBrowse link
G Erbb3 erb-b2 receptor tyrosine kinase 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ERBB3 mRNA CTD PMID:29950665 NCBI chr10:128,403,392...128,425,504
Ensembl chr10:128,403,392...128,425,521
JBrowse link
G Erbb4 erb-b2 receptor tyrosine kinase 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ERBB4 mRNA CTD PMID:29950665 NCBI chr 1:68,071,063...69,147,756
Ensembl chr 1:68,071,345...69,147,218
JBrowse link
G Ereg epiregulin decreases response to substance
increases expression
EXP EREG protein results in decreased susceptibility to Dextran Sulfate
dextran sodium sulfate increases expression of Ereg protein in colonic mucosa
CTD
RGD
PMID:15456865 PMID:20498653 RGD:39457688 NCBI chr 5:91,222,476...91,241,508
Ensembl chr 5:91,222,481...91,241,505
JBrowse link
G Errfi1 ERBB receptor feedback inhibitor 1 increases expression EXP Dextran Sulfate results in increased expression of ERRFI1 mRNA CTD PMID:35093514 NCBI chr 4:150,938,253...150,953,346
Ensembl chr 4:150,938,376...150,953,349
JBrowse link
G Esam endothelial cell-specific adhesion molecule multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ESAM mRNA CTD PMID:29950665 NCBI chr 9:37,439,385...37,449,615
Ensembl chr 9:37,439,374...37,449,615
JBrowse link
G Esr1 estrogen receptor 1 (alpha) decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of ESR1 mRNA
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ESR1 mRNA
CTD PMID:29950665 PMID:30270565 NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
JBrowse link
G Esr2 estrogen receptor 2 (beta) multiple interactions EXP Dextran Sulfate promotes the reaction [Zearalenone results in increased expression of ESR2 mRNA] CTD PMID:30270565 NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
JBrowse link
G Evl Ena-vasodilator stimulated phosphoprotein multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of EVL mRNA CTD PMID:29950665 NCBI chr12:108,520,942...108,654,775
Ensembl chr12:108,520,979...108,654,775
JBrowse link
G Ewsr1 Ewing sarcoma breakpoint region 1 increases expression EXP Dextran Sulfate results in increased expression of EWSR1 mRNA CTD PMID:35093514 NCBI chr11:5,019,687...5,049,314
Ensembl chr11:5,019,689...5,049,266
JBrowse link
G F10 coagulation factor X multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of F10 mRNA CTD PMID:29950665 NCBI chr 8:13,087,308...13,106,676
Ensembl chr 8:13,087,308...13,106,676
JBrowse link
G F11 coagulation factor XI multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of F11 protein CTD PMID:35999755 NCBI chr 8:45,693,696...45,715,092
Ensembl chr 8:45,694,211...45,715,068
JBrowse link
G F13a1 coagulation factor XIII, A1 subunit multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of F13A1 mRNA CTD PMID:29950665 NCBI chr13:37,051,150...37,234,220
Ensembl chr13:37,051,152...37,234,220
JBrowse link
G F2r coagulation factor II thrombin receptor multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of F2R mRNA CTD PMID:29950665 NCBI chr13:95,738,288...95,754,974
Ensembl chr13:95,738,311...95,754,995
JBrowse link
G F2rl1 F2R like trypsin receptor 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of F2RL1 mRNA CTD PMID:29950665 NCBI chr13:95,648,226...95,661,748
Ensembl chr13:95,648,240...95,661,735
JBrowse link
G F5 coagulation factor V multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of F5 mRNA CTD PMID:29950665 NCBI chr 1:163,979,396...164,048,539
Ensembl chr 1:163,979,407...164,047,846
JBrowse link
G Faah fatty acid amide hydrolase multiple interactions EXP [Serotonin co-treated with Dextran Sulfate] results in decreased expression of FAAH protein CTD PMID:30611738 NCBI chr 4:115,853,866...115,876,034
Ensembl chr 4:115,824,342...115,875,123
JBrowse link
G Fabp4 fatty acid binding protein 4, adipocyte multiple interactions
increases expression
EXP [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of FABP4 mRNA; Erianin inhibits the reaction [Dextran Sulfate results in increased expression of FABP4 protein] CTD PMID:26271895 PMID:32272095 NCBI chr 3:10,269,406...10,273,653
Ensembl chr 3:10,269,148...10,273,636
JBrowse link
G Fabp6 fatty acid binding protein 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FABP6 mRNA CTD PMID:29950665 NCBI chr11:43,486,867...43,492,389
Ensembl chr11:43,486,876...43,492,367
JBrowse link
G Fads1 fatty acid desaturase 1 decreases expression EXP Dextran Sulfate results in decreased expression of FADS1 mRNA CTD PMID:35093514 NCBI chr19:10,160,245...10,174,238
Ensembl chr19:10,160,252...10,174,241
JBrowse link
G Fads2 fatty acid desaturase 2 decreases expression EXP Dextran Sulfate results in decreased expression of FADS2 mRNA CTD PMID:35093514 NCBI chr19:10,040,129...10,078,867
Ensembl chr19:10,040,129...10,079,110
JBrowse link
G Fam229a family with sequence similarity 229, member A increases expression EXP Dextran Sulfate results in increased expression of FAM229A mRNA CTD PMID:35093514 NCBI chr 4:129,384,983...129,385,749
Ensembl chr 4:129,384,983...129,385,749
JBrowse link
G Fam50b family with sequence similarity 50, member B increases expression EXP Dextran Sulfate results in increased expression of FAM50B mRNA CTD PMID:35093514 NCBI chr13:34,918,833...34,931,605
Ensembl chr13:34,918,833...34,931,606
JBrowse link
G Fam98b family with sequence similarity 98, member B increases expression EXP Dextran Sulfate results in increased expression of FAM98B mRNA CTD PMID:35093514 NCBI chr 2:117,080,150...117,102,021
Ensembl chr 2:117,080,220...117,102,021
JBrowse link
G Fau FAU ubiquitin like and ribosomal protein S30 fusion decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of FAU protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of FAU protein]
CTD PMID:32272095 NCBI chr19:6,107,977...6,109,554
Ensembl chr19:6,107,874...6,109,554
JBrowse link
G Fbln2 fibulin 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FBLN2 mRNA CTD PMID:29950665 NCBI chr 6:91,189,442...91,249,522
Ensembl chr 6:91,189,437...91,249,522
JBrowse link
G Fbln5 fibulin 5 multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FBLN5 mRNA
Dextran Sulfate results in decreased expression of FBLN5 mRNA
CTD PMID:29950665 PMID:35093514 NCBI chr12:101,712,820...101,785,541
Ensembl chr12:101,712,824...101,785,314
JBrowse link
G Fbn1 fibrillin 1 multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FBN1 mRNA; Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of FBN1 protein] CTD PMID:29950665 PMID:32272095 NCBI chr 2:125,142,514...125,348,417
Ensembl chr 2:125,142,514...125,349,913
JBrowse link
G Fbxo2 F-box protein 2 increases expression EXP Dextran Sulfate results in increased expression of FBXO2 mRNA CTD PMID:35093514 NCBI chr 4:148,244,605...148,250,874
Ensembl chr 4:148,245,078...148,250,881
JBrowse link
G Fcer1g Fc receptor, IgE, high affinity I, gamma polypeptide multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FCER1G mRNA CTD PMID:29950665 NCBI chr 1:171,057,141...171,061,918
Ensembl chr 1:171,057,141...171,061,934
JBrowse link
G Fcgr1 Fc receptor, IgG, high affinity I multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FCGR1 mRNA CTD PMID:29950665 NCBI chr 3:96,190,225...96,201,285
Ensembl chr 3:96,190,225...96,201,285
JBrowse link
G Fcgr2b Fc receptor, IgG, low affinity IIb multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FCGR2B mRNA CTD PMID:29950665 NCBI chr 1:170,786,186...170,804,141
Ensembl chr 1:170,786,186...170,804,116
JBrowse link
G Fcgr3 Fc receptor, IgG, low affinity III multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FCGR3 mRNA CTD PMID:29950665 NCBI chr 1:170,878,738...170,893,477
Ensembl chr 1:170,878,743...170,892,504
JBrowse link
G Fcgr4 Fc receptor, IgG, low affinity IV multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FCGR4 mRNA CTD PMID:29950665 NCBI chr 1:170,846,495...170,857,330
Ensembl chr 1:170,846,489...170,857,330
JBrowse link
G Fcsk fucose kinase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FCSK mRNA CTD PMID:29950665 NCBI chr 8:111,609,088...111,629,120
Ensembl chr 8:111,609,088...111,629,120
JBrowse link
G Fdx1 ferredoxin 1 multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of FDX1 protein] CTD PMID:32272095 NCBI chr 9:51,854,323...51,874,902
Ensembl chr 9:51,854,606...51,874,856
JBrowse link
G Fdxr ferredoxin reductase decreases expression EXP Dextran Sulfate results in decreased expression of FDXR mRNA CTD PMID:35093514 NCBI chr11:115,158,850...115,167,925
Ensembl chr11:115,158,850...115,167,876
JBrowse link
G Fermt3 fermitin family member 3 multiple interactions
increases expression
decreases expression
EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of FERMT3 protein; Erianin inhibits the reaction [Dextran Sulfate results in increased expression of FERMT3 protein]
Dextran Sulfate results in decreased expression of FERMT3 protein
CTD PMID:32272095 PMID:35999755 NCBI chr19:6,976,326...6,996,837
Ensembl chr19:6,976,326...6,996,837
JBrowse link
G Ffar2 free fatty acid receptor 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FFAR2 mRNA CTD PMID:29950665 NCBI chr 7:30,517,778...30,523,200
Ensembl chr 7:30,517,773...30,523,200
JBrowse link
G Ffar4 free fatty acid receptor 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FFAR4 mRNA CTD PMID:29950665 NCBI chr19:38,085,527...38,102,711
Ensembl chr19:38,085,519...38,102,711
JBrowse link
G Fgf15 fibroblast growth factor 15 multiple interactions EXP Dextran Sulfate results in increased expression of and results in increased secretion of FGF15 protein CTD PMID:27580383 NCBI chr 7:144,450,269...144,454,690
Ensembl chr 7:144,450,268...144,454,690
JBrowse link
G Fgf18 fibroblast growth factor 18 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FGF18 mRNA CTD PMID:29950665 NCBI chr11:33,066,970...33,097,400
Ensembl chr11:33,067,430...33,097,400
JBrowse link
G Fgf2 fibroblast growth factor 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FGF2 mRNA CTD PMID:29950665 NCBI chr 3:37,402,616...37,464,255
Ensembl chr 3:37,402,495...37,464,257
JBrowse link
G Fgf23 fibroblast growth factor 23 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FGF23 mRNA CTD PMID:29950665 NCBI chr 6:127,049,865...127,059,257
Ensembl chr 6:127,049,865...127,058,371
JBrowse link
G Fgf8 fibroblast growth factor 8 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FGF8 mRNA CTD PMID:29950665 NCBI chr19:45,724,930...45,731,380
Ensembl chr19:45,725,237...45,731,354
JBrowse link
G Fgf9 fibroblast growth factor 9 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FGF9 mRNA CTD PMID:29950665 NCBI chr14:58,308,543...58,350,311
Ensembl chr14:58,308,004...58,350,177
JBrowse link
G Fgfr1 fibroblast growth factor receptor 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FGFR1 mRNA CTD PMID:29950665 NCBI chr 8:26,008,808...26,067,819
Ensembl chr 8:26,003,670...26,065,734
JBrowse link
G Fgfr4 fibroblast growth factor receptor 4 increases expression EXP Dextran Sulfate results in increased expression of FGFR4 mRNA CTD PMID:27580383 NCBI chr13:55,300,631...55,316,572
Ensembl chr13:55,300,453...55,316,572
JBrowse link
G Fgl1 fibrinogen-like protein 1 increases expression EXP Dextran Sulfate results in increased expression of FGL1 protein CTD PMID:35999755 NCBI chr 8:41,644,471...41,671,015
Ensembl chr 8:41,644,471...41,668,193
JBrowse link
G Fhl1 four and a half LIM domains 1 multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of FHL1 protein CTD PMID:35999755 NCBI chr  X:55,776,569...55,838,704
Ensembl chr  X:55,777,147...55,838,706
JBrowse link
G Fhl2 four and a half LIM domains 2 decreases expression EXP Dextran Sulfate results in decreased expression of FHL2 mRNA CTD PMID:35093514 NCBI chr 1:43,162,233...43,237,501
Ensembl chr 1:43,162,234...43,236,144
JBrowse link
G Fhl3 four and a half LIM domains 3 multiple interactions
increases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in increased expression of FHL3 protein] CTD PMID:32272095 NCBI chr 4:124,589,750...124,602,404
Ensembl chr 4:124,594,494...124,602,404
JBrowse link
G Flna filamin, alpha multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of FLNA protein CTD PMID:35999755 NCBI chr  X:73,267,067...73,293,787
Ensembl chr  X:73,267,067...73,293,426
JBrowse link
G Flot2 flotillin 2 multiple interactions
increases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in increased expression of FLOT2 protein] CTD PMID:32272095 NCBI chr11:77,928,757...77,951,260
Ensembl chr11:77,928,757...77,951,260
JBrowse link
G Flt1 FMS-like tyrosine kinase 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FLT1 mRNA CTD PMID:29950665 NCBI chr 5:147,498,414...147,663,419
Ensembl chr 5:147,498,414...147,662,821
JBrowse link
G Flt4 FMS-like tyrosine kinase 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FLT4 mRNA CTD PMID:29950665 NCBI chr11:49,500,506...49,543,566
Ensembl chr11:49,500,090...49,543,566
JBrowse link
G Fmo1 flavin containing monooxygenase 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FMO1 mRNA CTD PMID:29950665 NCBI chr 1:162,657,130...162,694,170
Ensembl chr 1:162,657,130...162,694,179
JBrowse link
G Fmod fibromodulin multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FMOD mRNA CTD PMID:29950665 NCBI chr 1:133,964,992...133,976,018
Ensembl chr 1:133,964,992...133,976,015
JBrowse link
G Fn1 fibronectin 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FN1 mRNA CTD PMID:29950665 NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359
JBrowse link
G Fos FBJ osteosarcoma oncogene multiple interactions
increases expression
EXP Dextran Sulfate promotes the reaction [Capsaicin results in increased expression of FOS protein]; GRK6 mutant form promotes the reaction [Dextran Sulfate promotes the reaction [Capsaicin results in increased expression of FOS protein]]
Dextran Sulfate results in increased expression of FOS mRNA
CTD PMID:18687398 PMID:35093514 NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
JBrowse link
G Fosl1 fos-like antigen 1 increases expression EXP Dextran Sulfate results in increased expression of FOSL1 protein CTD PMID:20025956 NCBI chr19:5,497,726...5,505,966
Ensembl chr19:5,497,575...5,505,974
JBrowse link
G Foxa2 forkhead box A2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FOXA2 mRNA CTD PMID:29950665 NCBI chr 2:147,884,797...147,888,889
Ensembl chr 2:147,884,797...147,888,889
JBrowse link
G Foxa3 forkhead box A3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FOXA3 mRNA CTD PMID:29950665 NCBI chr 7:18,747,208...18,757,464
Ensembl chr 7:18,747,209...18,757,463
JBrowse link
G Foxo1 forkhead box O1 increases expression EXP Dextran Sulfate results in increased expression of FOXO1 mRNA; Dextran Sulfate results in increased expression of FOXO1 protein CTD PMID:35670535 NCBI chr 3:52,175,758...52,257,530
Ensembl chr 3:52,175,757...52,260,642
JBrowse link
G Foxo3 forkhead box O3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FOXO3 mRNA CTD PMID:29950665 NCBI chr10:42,057,841...42,152,691
Ensembl chr10:42,057,837...42,152,751
JBrowse link
G Foxo4 forkhead box O4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FOXO4 mRNA CTD PMID:29950665 NCBI chr  X:100,297,855...100,304,479
Ensembl chr  X:100,298,134...100,304,479
JBrowse link
G Foxp3 forkhead box P3 increases methylation
multiple interactions
increases expression
EXP
ISO
Dextran Sulfate results in increased methylation of FOXP3 gene
Chlorpyrifos inhibits the reaction [Dextran Sulfate results in increased expression of FOXP3 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Dextran Sulfate results in increased methylation of FOXP3 gene]
kappa-casein glycomacropeptide inhibits the reaction [Dextran Sulfate results in increased expression of FOXP3 mRNA]
CTD PMID:20881082 PMID:21858153 PMID:31807802 PMID:34998820 NCBI chr  X:7,445,915...7,461,482
Ensembl chr  X:7,439,883...7,461,484
JBrowse link
G Fpgt fucose-1-phosphate guanylyltransferase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FPGT mRNA CTD PMID:29950665 NCBI chr 3:154,790,552...154,799,024
Ensembl chr 3:154,790,555...154,799,040
JBrowse link
G Fpr-rs6 formyl peptide receptor, related sequence 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of FPR-RS6 mRNA CTD PMID:29950665 NCBI chr17:20,402,340...20,403,359
Ensembl chr17:20,402,340...20,403,359
JBrowse link
G Fpr1 formyl peptide receptor 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FPR1 mRNA CTD PMID:29950665 NCBI chr17:18,096,733...18,104,201
Ensembl chr17:18,096,733...18,104,202
JBrowse link
G Fpr2 formyl peptide receptor 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FPR2 mRNA CTD PMID:29950665 NCBI chr17:18,108,086...18,114,214
Ensembl chr17:18,108,086...18,114,214
JBrowse link
G Fpr3 formyl peptide receptor 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FPR3 mRNA CTD PMID:29950665 NCBI chr17:18,190,720...18,191,939
Ensembl chr17:18,108,114...18,191,939
JBrowse link
G Frat2 frequently rearranged in advanced T cell lymphomas 2 increases expression EXP Dextran Sulfate results in increased expression of FRAT2 mRNA CTD PMID:35093514 NCBI chr19:41,834,411...41,836,571
Ensembl chr19:41,834,411...41,836,571
JBrowse link
G Fshb follicle stimulating hormone beta decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of FSHB protein
gingerol inhibits the reaction [Dextran Sulfate results in decreased expression of FSHB protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in decreased expression of FSHB protein]
CTD PMID:28421826 NCBI chr 2:106,886,331...106,889,996
Ensembl chr 2:106,886,485...106,890,001
JBrowse link
G Fshr follicle stimulating hormone receptor multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FSHR mRNA CTD PMID:29950665 NCBI chr17:89,292,380...89,508,103
Ensembl chr17:89,292,380...89,508,103
JBrowse link
G Fst follistatin multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FST mRNA CTD PMID:29950665 NCBI chr13:114,588,798...114,595,522
Ensembl chr13:114,588,826...114,595,487
JBrowse link
G Fstl3 follistatin-like 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FSTL3 mRNA CTD PMID:29950665 NCBI chr10:79,613,108...79,618,464
Ensembl chr10:79,613,106...79,618,464
JBrowse link
G Fus fused in sarcoma increases expression EXP Dextran Sulfate results in increased expression of FUS mRNA CTD PMID:35093514 NCBI chr 7:127,565,276...127,581,204
Ensembl chr 7:127,566,629...127,584,873
JBrowse link
G Fxyd1 FXYD domain-containing ion transport regulator 1 multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FXYD1 mRNA
Dextran Sulfate results in decreased expression of FXYD1 mRNA
CTD PMID:29950665 PMID:35093514 NCBI chr 7:30,751,103...30,758,332
Ensembl chr 7:30,751,103...30,756,624
JBrowse link
G Fxyd3 FXYD domain-containing ion transport regulator 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FXYD3 mRNA CTD PMID:29950665 NCBI chr 7:30,769,960...30,776,122
Ensembl chr 7:30,767,597...30,776,129
JBrowse link
G Fxyd4 FXYD domain-containing ion transport regulator 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FXYD4 mRNA CTD PMID:29950665 NCBI chr 6:117,910,519...117,914,668
Ensembl chr 6:117,910,520...117,914,653
JBrowse link
G Fyn Fyn proto-oncogene multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FYN mRNA CTD PMID:29950665 NCBI chr10:39,245,735...39,441,377
Ensembl chr10:39,244,851...39,441,377
JBrowse link
G Fzd1 frizzled class receptor 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FZD1 mRNA CTD PMID:29950665 NCBI chr 5:4,803,839...4,808,216
Ensembl chr 5:4,803,839...4,808,035
JBrowse link
G Fzd4 frizzled class receptor 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FZD4 mRNA CTD PMID:29950665 NCBI chr 7:89,053,574...89,062,341
Ensembl chr 7:89,053,563...89,062,342
JBrowse link
G Fzd5 frizzled class receptor 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FZD5 mRNA CTD PMID:29950665 NCBI chr 1:64,769,717...64,776,907
Ensembl chr 1:64,769,717...64,776,910
JBrowse link
G Fzd6 frizzled class receptor 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FZD6 mRNA CTD PMID:29950665 NCBI chr15:38,869,673...38,901,587
Ensembl chr15:38,869,429...38,901,583
JBrowse link
G Fzd7 frizzled class receptor 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FZD7 mRNA CTD PMID:29950665 NCBI chr 1:59,521,306...59,526,114
Ensembl chr 1:59,521,583...59,526,114
JBrowse link
G Fzd8 frizzled class receptor 8 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FZD8 mRNA CTD PMID:29950665 NCBI chr18:9,212,856...9,216,201
Ensembl chr18:9,212,163...9,218,136
JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of G6PC1 mRNA CTD PMID:29950665 NCBI chr11:101,258,542...101,268,729
Ensembl chr11:101,258,387...101,268,729
JBrowse link
G Gabbr1 gamma-aminobutyric acid type B receptor subunit 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GABBR1 mRNA CTD PMID:29950665 NCBI chr17:37,356,888...37,385,197
Ensembl chr17:37,356,858...37,385,959
JBrowse link
G Gabra2 gamma-aminobutyric acid type A receptor subunit alpha 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GABRA2 mRNA CTD PMID:29950665 NCBI chr 5:71,115,735...71,253,192
Ensembl chr 5:71,114,940...71,253,192
JBrowse link
G Gabra5 gamma-aminobutyric acid type A receptor subunit alpha 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GABRA5 mRNA CTD PMID:29950665 NCBI chr 7:57,057,417...57,240,808
Ensembl chr 7:57,057,420...57,159,807
JBrowse link
G Gabrb2 gamma-aminobutyric acid type A receptor subunit beta 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GABRB2 mRNA CTD PMID:29950665 NCBI chr11:42,310,342...42,523,418
Ensembl chr11:42,310,584...42,519,855
JBrowse link
G Gabrd gamma-aminobutyric acid (GABA) A receptor, subunit delta multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GABRD mRNA CTD PMID:29950665 NCBI chr 4:155,469,437...155,482,528
Ensembl chr 4:155,469,437...155,482,569
JBrowse link
G Gad1 glutamate decarboxylase 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GAD1 mRNA CTD PMID:29950665 NCBI chr 2:70,392,109...70,432,358
Ensembl chr 2:70,383,416...70,432,358
JBrowse link
G Gale galactose-4-epimerase, UDP multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GALE mRNA CTD PMID:29950665 NCBI chr 4:135,690,550...135,695,489
Ensembl chr 4:135,691,038...135,695,489
JBrowse link
G Galk2 galactokinase 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GALK2 mRNA CTD PMID:29950665 NCBI chr 2:125,701,029...125,826,218
Ensembl chr 2:125,701,029...125,826,219
JBrowse link
G Galm galactose mutarotase increases expression EXP Dextran Sulfate results in increased expression of GALM mRNA CTD PMID:35093514 NCBI chr17:80,434,886...80,492,461
Ensembl chr17:80,434,900...80,492,530
JBrowse link
G Galnt10 polypeptide N-acetylgalactosaminyltransferase 10 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GALNT10 mRNA CTD PMID:29950665 NCBI chr11:57,536,268...57,678,327
Ensembl chr11:57,536,268...57,678,340
JBrowse link
G Galnt12 polypeptide N-acetylgalactosaminyltransferase 12 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GALNT12 mRNA CTD PMID:29950665 NCBI chr 4:47,091,894...47,123,058
Ensembl chr 4:47,091,909...47,123,070
JBrowse link
G Galnt15 polypeptide N-acetylgalactosaminyltransferase 15 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GALNT15 mRNA CTD PMID:29950665 NCBI chr14:31,750,739...31,784,161
Ensembl chr14:31,750,946...31,784,154
JBrowse link
G Galnt16 polypeptide N-acetylgalactosaminyltransferase 16 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GALNT16 mRNA CTD PMID:29950665 NCBI chr12:80,565,245...80,650,672
Ensembl chr12:80,565,051...80,677,746
JBrowse link
G Galnt18 polypeptide N-acetylgalactosaminyltransferase 18 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GALNT18 mRNA CTD PMID:29950665 NCBI chr 7:111,070,863...111,379,274
Ensembl chr 7:111,070,868...111,379,184
JBrowse link
G Galnt2 polypeptide N-acetylgalactosaminyltransferase 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GALNT2 mRNA CTD PMID:29950665 NCBI chr 8:124,958,133...125,072,461
Ensembl chr 8:124,958,130...125,072,463
JBrowse link
G Galnt4 polypeptide N-acetylgalactosaminyltransferase 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GALNT4 mRNA CTD PMID:29950665 NCBI chr10:98,943,997...98,949,109
Ensembl chr10:98,944,021...98,949,109
JBrowse link
G Galnt5 polypeptide N-acetylgalactosaminyltransferase 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GALNT5 mRNA CTD PMID:29950665 NCBI chr 2:57,887,832...57,931,039
Ensembl chr 2:57,887,896...57,935,872
JBrowse link
G Galnt6 polypeptide N-acetylgalactosaminyltransferase 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GALNT6 mRNA CTD PMID:29950665 NCBI chr15:100,587,796...100,627,257
Ensembl chr15:100,589,694...100,627,257
JBrowse link
G Galnt7 polypeptide N-acetylgalactosaminyltransferase 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GALNT7 mRNA CTD PMID:29950665 NCBI chr 8:57,976,859...58,106,089
Ensembl chr 8:57,976,862...58,106,066
JBrowse link
G Galntl6 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GALNTL6 mRNA CTD PMID:29950665 NCBI chr 8:58,225,523...59,366,213
Ensembl chr 8:58,227,086...59,365,674
JBrowse link
G Gar1 GAR1 ribonucleoprotein increases expression EXP Dextran Sulfate results in increased expression of GAR1 mRNA CTD PMID:35093514 NCBI chr 3:129,618,561...129,625,045
Ensembl chr 3:129,618,561...129,625,045
JBrowse link
G Gas8 growth arrest specific 8 increases expression EXP Dextran Sulfate results in increased expression of GAS8 mRNA CTD PMID:35093514 NCBI chr 8:124,245,630...124,263,394
Ensembl chr 8:124,245,573...124,263,389
JBrowse link
G Gast gastrin decreases response to substance
multiple interactions
EXP GAST protein modified form results in decreased susceptibility to Dextran Sulfate
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GAST mRNA
CTD PMID:16618411 PMID:29950665 NCBI chr11:100,225,233...100,227,823
Ensembl chr11:100,225,233...100,227,822
JBrowse link
G Gata2 GATA binding protein 2 multiple interactions EXP [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of GATA2 mRNA CTD PMID:26271895 NCBI chr 6:88,170,873...88,184,014
Ensembl chr 6:88,170,873...88,184,014
JBrowse link
G Gbp9 guanylate-binding protein 9 multiple interactions
increases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in increased expression of GBP9 protein] CTD PMID:32272095 NCBI chr 5:105,224,331...105,258,255
Ensembl chr 5:105,225,496...105,287,405
JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GCLC mRNA CTD PMID:29950665 NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767
JBrowse link
G Gclm glutamate-cysteine ligase, modifier subunit multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GCLM mRNA CTD PMID:29950665 NCBI chr 3:122,039,206...122,060,864
Ensembl chr 3:122,039,206...122,064,381
JBrowse link
G Gcnt3 glucosaminyl (N-acetyl) transferase 3, mucin type multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GCNT3 mRNA CTD PMID:29950665 NCBI chr 9:69,938,777...69,947,172
Ensembl chr 9:69,938,778...69,945,370
JBrowse link
G Gdi1 GDP dissociation inhibitor 1 multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of GDI1 protein CTD PMID:35999755 NCBI chr  X:73,348,618...73,355,473
Ensembl chr  X:73,348,604...73,355,468
JBrowse link
G Gfpt1 glutamine fructose-6-phosphate transaminase 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GFPT1 mRNA CTD PMID:29950665 NCBI chr 6:87,019,828...87,069,189
Ensembl chr 6:87,019,828...87,069,179
JBrowse link
G Gfpt2 glutamine fructose-6-phosphate transaminase 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GFPT2 mRNA CTD PMID:29950665 NCBI chr11:49,684,981...49,729,448
Ensembl chr11:49,685,005...49,729,440
JBrowse link
G Gfus GDP-L-fucose synthase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GFUS mRNA CTD PMID:29950665 NCBI chr15:75,796,532...75,801,613
Ensembl chr15:75,796,525...75,801,681
JBrowse link
G Gfy golgi-associated olfactory signaling regulator increases expression EXP Dextran Sulfate results in increased expression of GFY mRNA CTD PMID:35093514 NCBI chr 7:44,825,773...44,829,021
Ensembl chr 7:44,825,773...44,828,993
JBrowse link
G Ggct gamma-glutamyl cyclotransferase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GGCT mRNA CTD PMID:29950665 NCBI chr 6:54,962,080...54,969,947
Ensembl chr 6:54,959,565...54,969,935
JBrowse link
G Ggnbp1 gametogenetin binding protein 1 increases expression EXP Dextran Sulfate results in increased expression of GGNBP1 mRNA CTD PMID:35093514 NCBI chr17:27,237,009...27,255,352
Ensembl chr17:27,236,961...27,256,598
JBrowse link
G Gh growth hormone multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GH mRNA CTD PMID:29950665 NCBI chr11:106,191,087...106,194,529
Ensembl chr11:106,191,097...106,192,691
JBrowse link
G Ghrl ghrelin multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GHRL mRNA CTD PMID:29950665 NCBI chr 6:113,693,080...113,696,872
Ensembl chr 6:113,693,080...113,696,841
JBrowse link
G Glb1 galactosidase, beta 1 increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of GLB1 protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of GLB1 protein]
CTD PMID:32272095 NCBI chr 9:114,230,146...114,303,447
Ensembl chr 9:114,230,144...114,303,966
JBrowse link
G Glb1l2 galactosidase, beta 1-like 2 decreases expression EXP Dextran Sulfate results in decreased expression of GLB1L2 mRNA CTD PMID:35093514 NCBI chr 9:26,674,338...26,717,769
Ensembl chr 9:26,674,340...26,717,764
JBrowse link
G Gli1 GLI-Kruppel family member GLI1 decreases expression EXP Dextran Sulfate results in decreased expression of GLI1 mRNA CTD PMID:35093514 NCBI chr10:127,165,751...127,177,448
Ensembl chr10:127,165,751...127,177,843
JBrowse link
G Gli3 GLI-Kruppel family member GLI3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GLI3 mRNA CTD PMID:29950665 NCBI chr13:15,638,308...15,904,611
Ensembl chr13:15,637,820...15,904,611
JBrowse link
G Glp1r glucagon-like peptide 1 receptor multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GLP1R mRNA CTD PMID:29950665 NCBI chr17:31,120,841...31,155,484
Ensembl chr17:31,120,791...31,159,765
JBrowse link
G Gls glutaminase decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of GLS protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of GLS protein]
CTD PMID:32272095 NCBI chr 1:52,202,608...52,274,168
Ensembl chr 1:52,202,607...52,272,391
JBrowse link
G Gmds GDP-mannose 4, 6-dehydratase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GMDS mRNA CTD PMID:29950665 NCBI chr13:32,003,566...32,522,744
Ensembl chr13:32,003,562...32,522,723
JBrowse link
G Gna11 guanine nucleotide binding protein, alpha 11 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GNA11 mRNA CTD PMID:29950665 NCBI chr10:81,364,558...81,380,996
Ensembl chr10:81,364,558...81,381,024
JBrowse link
G Gna12 guanine nucleotide binding protein, alpha 12 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GNA12 mRNA CTD PMID:29950665 NCBI chr 5:140,745,699...140,816,186
Ensembl chr 5:140,744,163...140,816,186
JBrowse link
G Gna14 guanine nucleotide binding protein, alpha 14 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GNA14 mRNA CTD PMID:29950665 NCBI chr19:16,413,031...16,590,706
Ensembl chr19:16,413,126...16,588,184
JBrowse link
G Gna15 guanine nucleotide binding protein, alpha 15 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GNA15 mRNA CTD PMID:29950665 NCBI chr10:81,338,147...81,360,283
Ensembl chr10:81,338,140...81,360,059
JBrowse link
G Gnaz guanine nucleotide binding protein, alpha z subunit multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GNAZ mRNA CTD PMID:29950665 NCBI chr10:74,803,009...74,852,739
Ensembl chr10:74,803,009...74,852,739
JBrowse link
G Gnb3 guanine nucleotide binding protein (G protein), beta 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GNB3 mRNA CTD PMID:29950665 NCBI chr 6:124,811,203...124,817,238
Ensembl chr 6:124,811,203...124,817,238
JBrowse link
G Gne glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GNE mRNA CTD PMID:29950665 NCBI chr 4:44,034,075...44,084,177
Ensembl chr 4:44,034,075...44,084,177
JBrowse link
G Gng4 guanine nucleotide binding protein (G protein), gamma 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GNG4 mRNA CTD PMID:29950665 NCBI chr13:13,958,644...14,002,480
Ensembl chr13:13,958,644...14,002,481
JBrowse link
G Gng7 guanine nucleotide binding protein (G protein), gamma 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GNG7 mRNA CTD PMID:29950665 NCBI chr10:80,784,463...80,850,742
Ensembl chr10:80,784,458...80,850,779
JBrowse link
G Gng8 guanine nucleotide binding protein (G protein), gamma 8 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GNG8 mRNA CTD PMID:29950665 NCBI chr 7:16,625,687...16,629,361
Ensembl chr 7:16,625,711...16,629,361
JBrowse link
G Gngt2 guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GNGT2 mRNA CTD PMID:29950665 NCBI chr11:95,733,045...95,736,557
Ensembl chr11:95,728,042...95,736,560
JBrowse link
G Gnl1 guanine nucleotide binding protein-like 1 increases expression EXP Dextran Sulfate results in increased expression of GNL1 mRNA CTD PMID:35093514 NCBI chr17:36,290,847...36,300,354
Ensembl chr17:36,290,743...36,300,354
JBrowse link
G Gnpnat1 glucosamine-phosphate N-acetyltransferase 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GNPNAT1 mRNA CTD PMID:29950665 NCBI chr14:45,613,897...45,626,972
Ensembl chr14:45,613,791...45,642,370
JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1, soluble multiple interactions
increases activity
EXP Fatty Acids, Omega-3 inhibits the reaction [Dextran Sulfate results in increased activity of GOT1 protein] CTD PMID:30489199 NCBI chr19:43,488,191...43,514,743
Ensembl chr19:43,488,191...43,513,044
JBrowse link
G Gp1bb glycoprotein Ib, beta polypeptide increases expression EXP Dextran Sulfate results in increased expression of GP1BB mRNA CTD PMID:35093514 NCBI chr16:18,439,069...18,441,153
Ensembl chr16:18,439,067...18,441,153
JBrowse link
G Gp6 glycoprotein 6 platelet multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of GP6 protein CTD PMID:35999755 NCBI chr 7:4,365,852...4,400,849
Ensembl chr 7:4,366,964...4,400,743
JBrowse link
G Gpbar1 G protein-coupled bile acid receptor 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPBAR1 mRNA CTD PMID:29950665 NCBI chr 1:74,316,269...74,318,868
Ensembl chr 1:74,317,709...74,318,783
JBrowse link
G Gpc4 glypican 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPC4 mRNA CTD PMID:29950665 NCBI chr  X:51,139,884...51,253,800
Ensembl chr  X:51,141,898...51,254,129
JBrowse link
G Gpi1 glucose-6-phosphate isomerase 1 decreases expression EXP Dextran Sulfate results in decreased expression of GPI protein CTD PMID:35999755 NCBI chr 7:33,900,752...33,929,761
Ensembl chr 7:33,900,755...33,929,761
JBrowse link
G Gpnmb glycoprotein (transmembrane) nmb increases expression EXP Dextran Sulfate results in increased expression of GPNMB mRNA CTD PMID:23894361 NCBI chr 6:49,013,449...49,044,413
Ensembl chr 6:49,013,480...49,047,863
JBrowse link
G Gpr119 G-protein coupled receptor 119 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of GPR119 mRNA CTD PMID:29950665 NCBI chr  X:47,756,856...47,763,355
Ensembl chr  X:47,756,856...47,763,355
JBrowse link
G Gpr137b G protein-coupled receptor 137B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPR137B mRNA CTD PMID:29950665 NCBI chr13:13,528,035...13,568,250
Ensembl chr13:13,532,205...13,568,599
JBrowse link
G Gpr137b-ps G protein-coupled receptor 137B, pseudogene multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPR137B-PS mRNA CTD PMID:29950665 NCBI chr13:12,628,954...12,665,284
Ensembl chr13:12,630,627...12,665,175
Ensembl chr13:12,630,627...12,665,175
JBrowse link
G Gpr149 G protein-coupled receptor 149 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPR149 mRNA CTD PMID:29950665 NCBI chr 3:62,436,851...62,512,861
Ensembl chr 3:62,436,498...62,512,561
JBrowse link
G Gpr15 G protein-coupled receptor 15 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GPR15 mRNA CTD PMID:29950665 NCBI chr16:58,537,006...58,539,235
Ensembl chr16:58,537,796...58,539,433
JBrowse link
G Gpr152 G protein-coupled receptor 152 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GPR152 mRNA CTD PMID:29950665 NCBI chr19:4,189,798...4,195,740
Ensembl chr19:4,189,786...4,195,739
JBrowse link
G Gpr165 G protein-coupled receptor 165 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GPR165 mRNA CTD PMID:29950665 NCBI chr  X:95,757,074...95,762,994
Ensembl chr  X:95,757,047...95,765,464
JBrowse link
G Gpr17 G protein-coupled receptor 17 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GPR17 mRNA CTD PMID:29950665 NCBI chr18:32,076,052...32,082,925
Ensembl chr18:32,076,050...32,082,689
JBrowse link
G Gpr176 G protein-coupled receptor 176 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPR176 mRNA CTD PMID:29950665 NCBI chr 2:118,107,577...118,205,022
Ensembl chr 2:118,107,591...118,203,900
JBrowse link
G Gpr20 G protein-coupled receptor 20 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPR20 mRNA CTD PMID:29950665 NCBI chr15:73,560,346...73,579,354
Ensembl chr15:73,566,453...73,579,354
JBrowse link
G Gpr27 G protein-coupled receptor 27 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GPR27 mRNA CTD PMID:29950665 NCBI chr 6:99,669,328...99,672,027
Ensembl chr 6:99,669,640...99,672,027
JBrowse link
G Gpr37l1 G protein-coupled receptor 37-like 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GPR37L1 mRNA CTD PMID:29950665 NCBI chr 1:135,087,988...135,095,419
Ensembl chr 1:135,087,972...135,095,419
JBrowse link
G Gpr39 G protein-coupled receptor 39 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GPR39 mRNA CTD PMID:29950665 NCBI chr 1:125,604,725...125,804,132
Ensembl chr 1:125,604,732...125,801,599
JBrowse link
G Gpr4 G protein-coupled receptor 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPR4 mRNA CTD PMID:29950665 NCBI chr 7:18,946,463...18,958,101
Ensembl chr 7:18,946,463...18,958,099
JBrowse link
G Gpr50 G-protein-coupled receptor 50 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GPR50 mRNA CTD PMID:29950665 NCBI chr  X:70,707,273...70,712,863
Ensembl chr  X:70,707,273...70,712,863
JBrowse link
G Gpr68 G protein-coupled receptor 68 multiple interactions EXP [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GPR68 mRNA CTD PMID:28174749 NCBI chr12:100,842,941...100,874,457
Ensembl chr12:100,842,941...100,874,457
JBrowse link
G Gpr83 G protein-coupled receptor 83 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPR83 mRNA CTD PMID:29950665 NCBI chr 9:14,771,038...14,782,085
Ensembl chr 9:14,771,506...14,782,085
JBrowse link
G Gpr85 G protein-coupled receptor 85 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPR85 mRNA CTD PMID:29950665 NCBI chr 6:13,834,405...13,839,951
Ensembl chr 6:13,834,457...13,839,941
JBrowse link
G Gpr88 G-protein coupled receptor 88 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPR88 mRNA CTD PMID:29950665 NCBI chr 3:116,043,304...116,047,123
Ensembl chr 3:116,043,303...116,047,152
JBrowse link
G Gprc5b G protein-coupled receptor, family C, group 5, member B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPRC5B mRNA CTD PMID:29950665 NCBI chr 7:118,571,263...118,594,434
Ensembl chr 7:118,571,270...118,594,434
JBrowse link
G Gprc5d G protein-coupled receptor, family C, group 5, member D multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPRC5D mRNA CTD PMID:29950665 NCBI chr 6:135,082,989...135,095,281
Ensembl chr 6:135,082,989...135,095,281
JBrowse link
G Gpt glutamic pyruvic transaminase, soluble decreases activity EXP Dextran Sulfate results in decreased activity of GPT protein CTD PMID:30489199 NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
JBrowse link
G Gpt2 glutamic pyruvate transaminase (alanine aminotransferase) 2 decreases expression EXP Dextran Sulfate results in decreased expression of GPT2 mRNA CTD PMID:35093514 NCBI chr 8:86,219,090...86,255,531
Ensembl chr 8:86,219,205...86,254,189
JBrowse link
G Gpx3 glutathione peroxidase 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPX3 mRNA CTD PMID:29950665 NCBI chr11:54,793,680...54,801,213
Ensembl chr11:54,793,279...54,801,203
JBrowse link
G Gpx4 glutathione peroxidase 4 decreases activity
decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased activity of GPX4 protein
Dextran Sulfate results in decreased expression of GPX4 mRNA; Dextran Sulfate results in decreased expression of GPX4 protein
gingerenone A inhibits the reaction [Dextran Sulfate results in decreased expression of GPX4 mRNA]; gingerenone A inhibits the reaction [Dextran Sulfate results in decreased expression of GPX4 protein]
CTD PMID:36135333 NCBI chr10:79,883,000...79,892,273
Ensembl chr10:79,883,000...79,892,273
JBrowse link
G Gpx6 glutathione peroxidase 6 decreases expression EXP Dextran Sulfate results in decreased expression of GPX6 mRNA CTD PMID:35093514 NCBI chr13:21,479,635...21,503,795
Ensembl chr13:21,496,295...21,503,794
JBrowse link
G Gpx7 glutathione peroxidase 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPX7 mRNA CTD PMID:29950665 NCBI chr 4:108,257,414...108,263,910
Ensembl chr 4:108,257,587...108,264,158
JBrowse link
G Gpx8 glutathione peroxidase 8 (putative) multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPX8 mRNA CTD PMID:29950665 NCBI chr13:113,179,287...113,182,944
Ensembl chr13:113,179,287...113,182,944
JBrowse link
G Grb2 growth factor receptor bound protein 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GRB2 mRNA CTD PMID:29950665 NCBI chr11:115,534,871...115,599,423
Ensembl chr11:115,534,871...115,599,423
JBrowse link
G Grb7 growth factor receptor bound protein 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GRB7 mRNA CTD PMID:29950665 NCBI chr11:98,337,660...98,346,199
Ensembl chr11:98,337,220...98,346,199
JBrowse link
G Grem1 gremlin 1, DAN family BMP antagonist increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of GREM1 protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of GREM1 protein]
CTD PMID:32272095 NCBI chr 2:113,579,020...113,588,993
Ensembl chr 2:113,576,509...113,588,991
JBrowse link
G Grik4 glutamate receptor, ionotropic, kainate 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GRIK4 mRNA CTD PMID:29950665 NCBI chr 9:42,431,708...42,856,296
Ensembl chr 9:42,429,431...42,855,789
JBrowse link
G Grin2b glutamate receptor, ionotropic, NMDA2B (epsilon 2) multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GRIN2B mRNA CTD PMID:29950665 NCBI chr 6:135,690,219...136,150,658
Ensembl chr 6:135,690,231...136,150,509
JBrowse link
G Grin2d glutamate receptor, ionotropic, NMDA2D (epsilon 4) multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GRIN2D mRNA CTD PMID:29950665 NCBI chr 7:45,481,307...45,520,708
Ensembl chr 7:45,481,307...45,527,802
JBrowse link
G Grk3 G protein-coupled receptor kinase 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GRK3 mRNA CTD PMID:29950665 NCBI chr 5:113,058,344...113,163,518
Ensembl chr 5:113,058,348...113,163,657
JBrowse link
G Grk6 G protein-coupled receptor kinase 6 multiple interactions
decreases response to substance
EXP GRK6 mutant form promotes the reaction [Dextran Sulfate promotes the reaction [Capsaicin results in increased expression of FOS protein]]
GRK6 results in decreased susceptibility to Dextran Sulfate
CTD PMID:18687398 NCBI chr13:55,592,865...55,608,740
Ensembl chr13:55,592,885...55,608,740
JBrowse link
G Grm4 glutamate receptor, metabotropic 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GRM4 mRNA CTD PMID:29950665 NCBI chr17:27,641,361...27,732,800
Ensembl chr17:27,641,361...27,740,377
JBrowse link
G Grpr gastrin releasing peptide receptor multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GRPR mRNA CTD PMID:29950665 NCBI chr  X:162,296,900...162,332,732
Ensembl chr  X:162,296,900...162,332,673
JBrowse link
G Gsdmd gasdermin D multiple interactions
increases cleavage
EXP hydroxysafflor yellow A inhibits the reaction [Dextran Sulfate results in increased cleavage of GSDMD protein]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased cleavage of GSDMD protein] CTD PMID:37001609 NCBI chr15:75,733,990...75,739,257
Ensembl chr15:75,734,176...75,739,257
JBrowse link
G Gsn gelsolin multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GSN mRNA CTD PMID:29950665 NCBI chr 2:35,146,371...35,197,914
Ensembl chr 2:35,146,392...35,197,904
JBrowse link
G Gsr glutathione reductase multiple interactions
decreases activity
EXP Fatty Acids, Omega-3 inhibits the reaction [Dextran Sulfate results in decreased activity of GSR protein] CTD PMID:30489199 NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
JBrowse link
G Gss glutathione synthetase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GSS mRNA CTD PMID:29950665 NCBI chr 2:155,405,101...155,434,730
Ensembl chr 2:155,405,101...155,434,730
JBrowse link
G Gstk1 glutathione S-transferase kappa 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GSTK1 mRNA CTD PMID:29950665 NCBI chr 6:42,222,869...42,227,375
Ensembl chr 6:42,222,869...42,227,381
JBrowse link
G Gstm1 glutathione S-transferase, mu 1 decreases expression EXP Dextran Sulfate results in decreased expression of GSTM1 mRNA CTD PMID:35093514 NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
JBrowse link
G Gstm2 glutathione S-transferase, mu 2 decreases expression EXP Dextran Sulfate results in decreased expression of GSTM2 mRNA CTD PMID:35093514 NCBI chr 3:107,889,018...107,893,736
Ensembl chr 3:107,889,018...107,893,769
JBrowse link
G Gstm5 glutathione S-transferase, mu 5 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of GSTM3 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of GSTM3 protein]
CTD PMID:32272095 NCBI chr 3:107,803,240...107,806,002
Ensembl chr 3:107,803,137...107,806,002
JBrowse link
G Gsto1 glutathione S-transferase omega 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GSTO1 mRNA CTD PMID:29950665 NCBI chr19:47,843,412...47,853,229
Ensembl chr19:47,843,409...47,853,229
JBrowse link
G Gsto2 glutathione S-transferase omega 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GSTO2 mRNA CTD PMID:29950665 NCBI chr19:47,853,879...47,874,747
Ensembl chr19:47,853,973...47,874,763
JBrowse link
G Gstt2 glutathione S-transferase, theta 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GSTT2 mRNA CTD PMID:29950665 NCBI chr10:75,667,676...75,673,253
Ensembl chr10:75,666,948...75,673,258
JBrowse link
G Gstt3 glutathione S-transferase, theta 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GSTT3 mRNA CTD PMID:29950665 NCBI chr10:75,609,951...75,617,256
Ensembl chr10:75,609,949...75,617,248
JBrowse link
G Gtf2f1 general transcription factor IIF, polypeptide 1 increases expression EXP Dextran Sulfate results in increased expression of GTF2F1 mRNA CTD PMID:35093514 NCBI chr17:57,310,402...57,318,398
Ensembl chr17:57,310,405...57,318,288
JBrowse link
G Guca1a guanylate cyclase activator 1a (retina) multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GUCA1A mRNA CTD PMID:29950665 NCBI chr17:47,705,482...47,724,439
Ensembl chr17:47,705,483...47,711,509
JBrowse link
G Guca1b guanylate cyclase activator 1B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GUCA1B mRNA CTD PMID:29950665 NCBI chr17:47,692,526...47,703,892
Ensembl chr17:47,696,318...47,703,892
JBrowse link
G Guca2b guanylate cyclase activator 2b increases expression EXP Dextran Sulfate results in increased expression of GUCA2B protein CTD PMID:35999755 NCBI chr 4:119,513,798...119,516,142
Ensembl chr 4:119,513,804...119,516,151
JBrowse link
G Gucy2f guanylate cyclase 2f multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GUCY2F mRNA CTD PMID:29950665 NCBI chr  X:140,862,282...140,980,399
Ensembl chr  X:140,864,156...140,979,927
JBrowse link
G Guk1 guanylate kinase 1 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of GUK1 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of GUK1 protein]
CTD PMID:32272095 NCBI chr11:59,074,696...59,083,068
Ensembl chr11:59,074,701...59,083,069
JBrowse link
G Gulo gulonolactone (L-) oxidase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GULO mRNA CTD PMID:29950665 NCBI chr14:66,224,235...66,246,703
Ensembl chr14:66,224,235...66,246,656
JBrowse link
G Gzma granzyme A multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GZMA mRNA CTD PMID:29950665 NCBI chr13:113,230,358...113,237,515
Ensembl chr13:113,230,359...113,237,515
JBrowse link
G H1f10 H1.10 linker histone increases expression EXP Dextran Sulfate results in increased expression of H1F10 mRNA CTD PMID:35093514 NCBI chr 6:87,957,403...87,958,464
Ensembl chr 6:87,957,403...87,958,619
JBrowse link
G H2-Aa histocompatibility 2, class II antigen A, alpha increases expression EXP Dextran Sulfate results in increased expression of H2-AA mRNA CTD PMID:23894361 NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797
JBrowse link
G H2-Ab1 histocompatibility 2, class II antigen A, beta 1 increases expression EXP Dextran Sulfate results in increased expression of H2-AB1 mRNA CTD PMID:23894361 NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393
JBrowse link
G H2-DMa histocompatibility 2, class II, locus DMa increases expression EXP Dextran Sulfate results in increased expression of H2-DMA mRNA CTD PMID:23894361 NCBI chr17:34,338,667...34,358,075
Ensembl chr17:34,338,515...34,358,075
JBrowse link
G H2-DMb2 histocompatibility 2, class II, locus Mb2 increases expression EXP Dextran Sulfate results in increased expression of H2-DMB2 mRNA CTD PMID:23894361 NCBI chr17:34,362,203...34,370,527
Ensembl chr17:34,362,281...34,370,529
JBrowse link
G H2-Eb1 histocompatibility 2, class II antigen E beta increases expression EXP Dextran Sulfate results in increased expression of H2-EB1 mRNA CTD PMID:23894361 NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648
JBrowse link
G H2-Eb2 histocompatibility 2, class II antigen E beta2 increases expression EXP Dextran Sulfate results in increased expression of H2-EB2 mRNA CTD PMID:23894361 NCBI chr17:34,544,477...34,560,384
Ensembl chr17:34,544,639...34,560,386
JBrowse link
G H2-M11 histocompatibility 2, M region locus 11 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of H2-M11 mRNA CTD PMID:29950665 NCBI chr17:36,857,967...36,861,165
Ensembl chr17:36,857,967...36,860,142
JBrowse link
G H2-M3 histocompatibility 2, M region locus 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of H2-M3 mRNA CTD PMID:29950665 NCBI chr17:37,581,094...37,585,380
Ensembl chr17:37,581,111...37,585,375
JBrowse link
G H2-Ob histocompatibility 2, O region beta locus increases expression EXP Dextran Sulfate results in increased expression of H2-OB mRNA CTD PMID:23894361 NCBI chr17:34,457,879...34,464,882
Ensembl chr17:34,457,877...34,473,388
JBrowse link
G H2-Q8 histocompatibility 2, Q region locus 8 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of H2-Q8 mRNA CTD PMID:29950665 NCBI chr17:35,737,710...35,742,945 JBrowse link
G H2-T24 histocompatibility 2, T region locus 24 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of H2-T24 mRNA CTD PMID:29950665 NCBI chr17:36,314,363...36,331,689
Ensembl chr17:36,316,587...36,331,452
JBrowse link
G Hadh hydroxyacyl-Coenzyme A dehydrogenase decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of HADH protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of HADH protein]
CTD PMID:32272095 NCBI chr 3:131,027,068...131,065,750
Ensembl chr 3:131,027,068...131,065,750
JBrowse link
G Hadhb hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of HADHB mRNA CTD PMID:29950665 NCBI chr 5:30,360,251...30,389,591
Ensembl chr 5:30,360,246...30,389,591
JBrowse link
G Hba-a1 hemoglobin alpha, adult chain 1 increases expression EXP Dextran Sulfate results in increased expression of HBA-A1 mRNA CTD PMID:35093514 NCBI chr11:32,233,672...32,234,486
Ensembl chr11:32,233,511...32,234,465
JBrowse link
G Hbb-b1 hemoglobin, beta adult major chain increases expression EXP Dextran Sulfate results in increased expression of HBB-B1 mRNA CTD PMID:35093514
G Hbb-b2 hemoglobin, beta adult minor chain increases expression EXP Dextran Sulfate results in increased expression of HBB-B2 mRNA CTD PMID:35093514
G Hbb-bs hemoglobin, beta adult s chain increases expression EXP Dextran Sulfate results in increased expression of HBB-BS mRNA CTD PMID:35093514 NCBI chr 7:103,475,730...103,477,135
Ensembl chr 7:103,475,741...103,477,303
JBrowse link
G Hbb-bt hemoglobin, beta adult t chain increases expression EXP Dextran Sulfate results in increased expression of HBB-BT mRNA CTD PMID:35093514 NCBI chr 7:103,461,731...103,463,130
Ensembl chr 7:103,461,731...103,463,203
JBrowse link
G Hcn2 hyperpolarization-activated, cyclic nucleotide-gated K+ 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of HCN2 mRNA CTD PMID:29950665 NCBI chr10:79,552,468...79,571,942
Ensembl chr10:79,552,468...79,571,942
JBrowse link
G Hcn3 hyperpolarization-activated, cyclic nucleotide-gated K+ 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of HCN3 mRNA CTD PMID:29950665 NCBI chr 3:89,054,082...89,067,538
Ensembl chr 3:89,053,381...89,067,503
JBrowse link
G Hcn4 hyperpolarization-activated, cyclic nucleotide-gated K+ 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of HCN4 mRNA CTD PMID:29950665 NCBI chr 9:58,730,232...58,770,458
Ensembl chr 9:58,730,695...58,770,458
JBrowse link
G Hdgfl2 HDGF like 2 increases expression EXP Dextran Sulfate results in increased expression of HDGFL2 mRNA CTD PMID:35093514 NCBI chr17:56,386,661...56,407,605
Ensembl chr17:56,386,634...56,407,607
JBrowse link
G Heph hephaestin multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of HEPH mRNA CTD PMID:29950665 NCBI chr  X:95,499,042...95,618,091
Ensembl chr  X:95,498,965...95,618,091
JBrowse link
G Hes1 hes family bHLH transcription factor 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of HES1 mRNA CTD PMID:29950665 NCBI chr16:29,883,259...29,886,614
Ensembl chr16:29,883,202...29,886,614
JBrowse link
G Hif1a hypoxia inducible factor 1, alpha subunit increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of HIF1A protein
resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of HIF1A protein]
CTD PMID:26074695 NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
JBrowse link
G Hirip3 HIRA interacting protein 3 increases expression EXP Dextran Sulfate results in increased expression of HIRIP3 mRNA CTD PMID:35093514 NCBI chr 7:126,461,155...126,464,549
Ensembl chr 7:126,461,144...126,464,549
JBrowse link
G Hk1 hexokinase 1 increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of HK1 protein
hydroxysafflor yellow A inhibits the reaction [Dextran Sulfate results in increased expression of HK1 protein]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased expression of HK1 protein]
CTD PMID:37001609 NCBI chr10:62,104,634...62,215,699
Ensembl chr10:62,104,634...62,215,687
JBrowse link
G Hk3 hexokinase 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of HK3 mRNA CTD PMID:29950665 NCBI chr13:55,153,798...55,169,233
Ensembl chr13:55,153,798...55,169,198
JBrowse link
G Hmgb1 high mobility group box 1 multiple interactions EXP Dextran Sulfate results in increased expression of and results in increased secretion of HMGB1 protein; dihydrotanshinone I inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased secretion of HMGB1 protein] CTD PMID:29496522 NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of HMOX1 mRNA; asperuloside inhibits the reaction [Dextran Sulfate results in decreased expression of HMOX1 protein]; Cholecalciferol inhibits the reaction [Dextran Sulfate results in decreased expression of HMOX1 protein]; gingerenone A inhibits the reaction [Dextran Sulfate results in decreased expression of HMOX1 protein]; tussilagone inhibits the reaction [Dextran Sulfate results in decreased expression of HMOX1 mRNA]; tussilagone inhibits the reaction [Dextran Sulfate results in decreased expression of HMOX1 protein]
Dextran Sulfate results in decreased expression of HMOX1 mRNA; Dextran Sulfate results in decreased expression of HMOX1 protein
CTD PMID:29950665 PMID:30142311 PMID:33974900 PMID:36135333 NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
JBrowse link
G Hnf1a HNF1 homeobox A multiple interactions
increases expression
EXP 6-formylindolo(3,2-b)carbazole inhibits the reaction [Dextran Sulfate results in increased expression of HNF1A protein]; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of HNF1A mRNA CTD PMID:29680209 PMID:29950665 NCBI chr 5:115,087,039...115,109,121
Ensembl chr 5:115,087,039...115,109,153
JBrowse link
G Hnf1b HNF1 homeobox B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of HNF1B mRNA CTD PMID:29950665 NCBI chr11:83,741,035...83,796,743
Ensembl chr11:83,740,889...83,796,645
JBrowse link
G Hnf4a hepatic nuclear factor 4, alpha multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of HNF4A mRNA CTD PMID:29950665 NCBI chr 2:163,348,731...163,414,827
Ensembl chr 2:163,348,728...163,414,830
JBrowse link
G Hnf4g hepatocyte nuclear factor 4, gamma multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of HNF4G mRNA CTD PMID:29950665 NCBI chr 3:3,573,090...3,724,863
Ensembl chr 3:3,573,084...3,724,860
JBrowse link
G Hnrnpa0 heterogeneous nuclear ribonucleoprotein A0 increases expression EXP Dextran Sulfate results in increased expression of HNRNPA0 mRNA CTD PMID:35093514 NCBI chr13:58,273,693...58,276,370
Ensembl chr13:58,273,693...58,276,370
JBrowse link
G Hook2 hook microtubule tethering protein 2 increases expression EXP Dextran Sulfate results in increased expression of HOOK2 mRNA CTD PMID:35093514 NCBI chr 8:85,715,402...85,729,981
Ensembl chr 8:85,717,232...85,729,978
JBrowse link
G Hp haptoglobin multiple interactions
increases expression
EXP [Dextran Sulfate co-treated with bisphenol A] results in increased expression of HP protein; Chlorpyrifos promotes the reaction [Dextran Sulfate results in increased expression of HP protein] CTD PMID:31807802 PMID:35999755 NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804
JBrowse link
G Hpgd hydroxyprostaglandin dehydrogenase 15 (NAD) multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of HPGD mRNA CTD PMID:29950665 NCBI chr 8:56,747,587...56,774,081
Ensembl chr 8:56,747,620...56,774,078
JBrowse link
G Hpse heparanase multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of HPSE protein CTD PMID:35999755 NCBI chr 5:100,827,350...100,867,582
Ensembl chr 5:100,827,350...100,867,582
JBrowse link
G Hrh3 histamine receptor H3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of HRH3 mRNA CTD PMID:29950665 NCBI chr 2:179,741,258...179,746,264
Ensembl chr 2:179,741,258...179,746,281
JBrowse link
G Hsd11b1 hydroxysteroid 11-beta dehydrogenase 1 multiple interactions
increases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of HSD11B1 mRNA
Dextran Sulfate results in increased expression of HSD11B1 mRNA
CTD PMID:29950665 PMID:35093514 NCBI chr 1:192,903,917...192,946,345
Ensembl chr 1:192,903,942...192,946,383
JBrowse link
G Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of HSD11B2 mRNA CTD PMID:29950665 NCBI chr 8:106,245,378...106,250,620
Ensembl chr 8:106,245,387...106,250,620
JBrowse link
G Hsd17b1 hydroxysteroid (17-beta) dehydrogenase 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of HSD17B1 mRNA CTD PMID:29950665 NCBI chr11:100,968,792...100,972,014
Ensembl chr11:100,969,237...100,971,353
JBrowse link
G Hsd17b3 hydroxysteroid (17-beta) dehydrogenase 3 decreases expression EXP Dextran Sulfate results in decreased expression of HSD17B3 mRNA CTD PMID:35093514 NCBI chr13:64,206,088...64,237,076
Ensembl chr13:64,206,080...64,237,044
JBrowse link
G Hsd17b6 hydroxysteroid (17-beta) dehydrogenase 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of HSD17B6 mRNA CTD PMID:29950665 NCBI chr10:127,826,800...127,843,517
Ensembl chr10:127,826,805...127,843,480
JBrowse link
G Hsd3b1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 decreases expression EXP Dextran Sulfate results in decreased expression of HSD3B1 mRNA CTD PMID:35093514 NCBI chr 3:98,749,672...98,767,110
Ensembl chr 3:98,759,510...98,767,110
JBrowse link
G Hsd3b4 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of HSD3B4 mRNA CTD PMID:29950665 NCBI chr 3:98,406,387...98,417,895
Ensembl chr 3:98,406,387...98,417,830
JBrowse link
G Hsp90aa1 heat shock protein 90, alpha (cytosolic), class A member 1 increases expression
multiple interactions
ISO Dextran Sulfate results in increased expression of HSP90AA1 mRNA
celastrol inhibits the reaction [Dextran Sulfate results in increased expression of HSP90AA1 mRNA]
CTD PMID:32470352 NCBI chr12:110,657,470...110,662,829
Ensembl chr12:110,657,039...110,669,162
JBrowse link
G Hsp90ab1 heat shock protein 90 alpha (cytosolic), class B member 1 increases expression
multiple interactions
ISO Dextran Sulfate results in increased expression of HSP90AB1 protein
celastrol inhibits the reaction [Dextran Sulfate results in increased expression of HSP90AB1 protein]
CTD PMID:32470352 NCBI chr17:45,878,704...45,884,187
Ensembl chr17:45,878,701...45,884,197
JBrowse link
G Hspa1a heat shock protein 1A multiple interactions EXP [Benzo(a)pyrene co-treated with Dextran Sulfate] results in decreased expression of HSPA1A mRNA CTD PMID:26271895 NCBI chr17:35,188,335...35,191,132
Ensembl chr17:35,188,166...35,191,132
JBrowse link
G Hspa1b heat shock protein 1B multiple interactions EXP [Benzo(a)pyrene co-treated with Dextran Sulfate] results in decreased expression of HSPA1B mRNA CTD PMID:26271895 NCBI chr17:35,175,405...35,178,214
Ensembl chr17:35,175,412...35,178,214
JBrowse link
G Hspa8 heat shock protein 8 decreases expression EXP Dextran Sulfate results in decreased expression of HSPA8 protein CTD PMID:35999755 NCBI chr 9:40,712,572...40,716,498
Ensembl chr 9:40,712,280...40,721,383
JBrowse link
G Hspb1 heat shock protein 1 increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of HSPB1 mRNA
Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of HSPB1 mRNA]
CTD PMID:32033881 NCBI chr 5:135,916,773...135,918,417
Ensembl chr 5:135,916,773...135,918,417
JBrowse link
G Hspg2 perlecan (heparan sulfate proteoglycan 2) multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of HSPG2 mRNA CTD PMID:29950665 NCBI chr 4:137,196,062...137,297,941
Ensembl chr 4:137,196,080...137,297,941
JBrowse link
G Htr1b 5-hydroxytryptamine (serotonin) receptor 1B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of HTR1B mRNA CTD PMID:29950665 NCBI chr 9:81,510,344...81,515,885
Ensembl chr 9:81,510,344...81,515,881
JBrowse link
G Htr1d 5-hydroxytryptamine (serotonin) receptor 1D multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of HTR1D mRNA CTD PMID:29950665 NCBI chr 4:136,150,835...136,171,716
Ensembl chr 4:136,150,835...136,171,709
JBrowse link
G Htr4 5 hydroxytryptamine (serotonin) receptor 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of HTR4 mRNA CTD PMID:29950665 NCBI chr18:62,456,618...62,636,098
Ensembl chr18:62,457,275...62,629,648
JBrowse link
G Htr7 5-hydroxytryptamine (serotonin) receptor 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of HTR7 mRNA CTD PMID:29950665 NCBI chr19:35,935,815...36,035,533
Ensembl chr19:35,936,134...36,034,907
JBrowse link
G Htra1 HtrA serine peptidase 1 decreases expression EXP Dextran Sulfate results in decreased expression of HTRA1 mRNA CTD PMID:35093514 NCBI chr 7:130,537,933...130,587,388
Ensembl chr 7:130,537,841...130,587,390
JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions
increases expression
EXP 17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid inhibits the reaction [Dextran Sulfate results in increased expression of ICAM1 mRNA]; 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [Dextran Sulfate results in increased expression of ICAM1 mRNA]; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ICAM1 mRNA; Dexamethasone inhibits the reaction [Dextran Sulfate results in increased expression of ICAM1 mRNA]; flavokawain B inhibits the reaction [Dextran Sulfate results in increased expression of ICAM1 mRNA]; fraxinellone inhibits the reaction [Dextran Sulfate results in increased expression of ICAM1 mRNA]; notoginsenoside R1 inhibits the reaction [Dextran Sulfate results in increased expression of ICAM1 mRNA]; resolvin D1 inhibits the reaction [Dextran Sulfate results in increased expression of ICAM1 mRNA]; resolvin D2 inhibits the reaction [Dextran Sulfate results in increased expression of ICAM1 mRNA] CTD PMID:21724996 PMID:24038091 PMID:25448682 PMID:25472953 PMID:29950665 More... NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
JBrowse link
G Icam4 intercellular adhesion molecule 4, Landsteiner-Wiener blood group multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ICAM4 mRNA CTD PMID:29950665 NCBI chr 9:20,940,728...20,941,892
Ensembl chr 9:20,940,669...20,941,891
JBrowse link
G Icosl icos ligand multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ICOSL mRNA CTD PMID:29950665 NCBI chr10:77,904,921...77,915,359
Ensembl chr10:77,905,136...77,919,747
JBrowse link
G Idh1 isocitrate dehydrogenase 1 (NADP+), soluble decreases expression EXP Dextran Sulfate results in decreased expression of IDH1 mRNA CTD PMID:35093514 NCBI chr 1:65,197,775...65,225,638
Ensembl chr 1:65,197,775...65,225,659
JBrowse link
G Ido1 indoleamine 2,3-dioxygenase 1 increases expression EXP Dextran Sulfate results in increased expression of IDO1 mRNA CTD PMID:23894361 NCBI chr 8:25,074,148...25,086,987
Ensembl chr 8:25,074,152...25,087,025
JBrowse link
G Ier3 immediate early response 3 multiple interactions
increases expression
EXP Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of IER3 mRNA] CTD PMID:32033881 NCBI chr17:36,132,605...36,133,803
Ensembl chr17:36,132,576...36,133,815
JBrowse link
G Ifi204 interferon activated gene 204 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IFI204 mRNA CTD PMID:29950665 NCBI chr 1:173,574,859...173,594,606
Ensembl chr 1:173,574,859...173,594,509
JBrowse link
G Ifi205 interferon activated gene 205 increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of IFI205 mRNA; Dextran Sulfate results in increased expression of IFI205 protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of IFI205 protein]
CTD PMID:32272095 PMID:35093514 NCBI chr 1:173,839,549...173,859,617
Ensembl chr 1:173,839,564...173,859,376
JBrowse link
G Ifi211 interferon activated gene 211 increases expression EXP Dextran Sulfate results in increased expression of PYHIN1 mRNA CTD PMID:23894361 NCBI chr 1:173,723,907...173,740,650
Ensembl chr 1:173,723,911...173,740,612
JBrowse link
G Ifitm3 interferon induced transmembrane protein 3 multiple interactions
increases expression
EXP [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of IFITM3 mRNA; [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of IFITM3 protein; Erianin inhibits the reaction [Dextran Sulfate results in increased expression of IFITM3 protein] CTD PMID:26271895 PMID:32272095 NCBI chr 7:140,589,503...140,590,657
Ensembl chr 7:140,589,499...140,590,683
JBrowse link
G Ifna5 interferon alpha 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IFNA5 mRNA CTD PMID:29950665 NCBI chr 4:88,753,762...88,754,331
Ensembl chr 4:88,753,762...88,754,331
JBrowse link
G Ifnar2 interferon (alpha and beta) receptor 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IFNAR2 mRNA CTD PMID:29950665 NCBI chr16:91,166,517...91,202,477
Ensembl chr16:91,169,671...91,202,477
JBrowse link
G Ifng interferon gamma multiple interactions
increases secretion
increases expression
EXP 2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester inhibits the reaction [Dextran Sulfate results in increased expression of IFNG protein]; 5,7-dimethoxycoumarin inhibits the reaction [Dextran Sulfate results in increased expression of IFNG mRNA]; 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [Dextran Sulfate results in increased expression of IFNG protein]; [Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IFNG protein; [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IFNG protein; [Dextran Sulfate affects the susceptibility to CD14 protein] which affects the expression of IFNG mRNA; [IL17A protein affects the susceptibility to Dextran Sulfate] which affects the expression of IFNG protein; [TNFRSF8 protein affects the susceptibility to Dextran Sulfate] which affects the secretion of IFNG protein; [TNFSF8 protein affects the susceptibility to Dextran Sulfate] which affects the secretion of IFNG protein; ADAM17 protein affects the reaction [Dextran Sulfate results in increased expression of IFNG protein]; celastrol inhibits the reaction [Dextran Sulfate results in increased expression of IFNG protein]; Coumarins inhibits the reaction [Dextran Sulfate results in increased expression of IFNG protein]; Erianin inhibits the reaction [Dextran Sulfate results in increased expression of IFNG protein]; geraniol inhibits the reaction [Dextran Sulfate results in increased expression of IFNG protein]; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IFNG protein]; Lipopolysaccharides affects the reaction [Dextran Sulfate results in increased expression of IFNG mRNA]; MIF protein affects the reaction [Dextran Sulfate results in increased expression of IFNG mRNA]; notoginsenoside R1 inhibits the reaction [Dextran Sulfate results in increased expression of IFNG mRNA]; PNU-282987 inhibits the reaction [Dextran Sulfate results in increased expression of IFNG protein]; Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of IFNG mRNA]; Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of IFNG protein]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of IFNG protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased expression of IFNG protein]; Tetrachlorodibenzodioxin inhibits the reaction [Dextran Sulfate results in increased secretion of IFNG protein]
Dextran Sulfate results in increased expression of IFNG mRNA; Dextran Sulfate results in increased expression of IFNG protein
CTD PMID:12105854 PMID:19940103 PMID:20637373 PMID:21068411 PMID:21359540 More... NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
JBrowse link
G Ifnk interferon kappa multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IFNK mRNA CTD PMID:29950665 NCBI chr 4:35,152,055...35,154,019
Ensembl chr 4:35,152,056...35,154,005
JBrowse link
G Igf1 insulin-like growth factor 1 multiple interactions EXP [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IGF1 protein CTD PMID:19931517 NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
JBrowse link
G Igf2bp3 insulin-like growth factor 2 mRNA binding protein 3 multiple interactions EXP [Dextran Sulfate co-treated with azomethane] results in increased expression of IGF2BP3 protein; Berberine inhibits the reaction [[Dextran Sulfate co-treated with azomethane] results in increased expression of IGF2BP3 protein] CTD PMID:36822301 NCBI chr 6:49,062,152...49,200,225
Ensembl chr 6:49,062,157...49,191,891
JBrowse link
G Igfbp2 insulin-like growth factor binding protein 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IGFBP2 mRNA CTD PMID:29950665 NCBI chr 1:72,863,650...72,891,633
Ensembl chr 1:72,863,662...72,891,633
JBrowse link
G Igfbp4 insulin-like growth factor binding protein 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IGFBP4 mRNA CTD PMID:29950665 NCBI chr11:98,930,820...98,943,481
Ensembl chr11:98,932,070...98,945,218
JBrowse link
G Igfbp6 insulin-like growth factor binding protein 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IGFBP6 mRNA CTD PMID:29950665 NCBI chr15:102,052,621...102,057,947
Ensembl chr15:102,052,797...102,057,946
JBrowse link
G Igtp interferon gamma induced GTPase increases expression EXP Dextran Sulfate results in increased expression of IGTP mRNA CTD PMID:23894361 NCBI chr11:58,090,382...58,098,418
Ensembl chr11:58,090,382...58,098,417
JBrowse link
G Ihh Indian hedgehog multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IHH mRNA CTD PMID:29950665 NCBI chr 1:74,984,474...74,990,831
Ensembl chr 1:74,984,474...74,990,831
JBrowse link
G Iigp1 interferon inducible GTPase 1 increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of IIGP1 mRNA; Dextran Sulfate results in increased expression of IIGP1 protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of IIGP1 protein]
CTD PMID:23894361 PMID:32272095 NCBI chr18:60,506,688...60,525,706
Ensembl chr18:60,509,099...60,525,706
JBrowse link
G Ikbkb inhibitor of kappaB kinase beta multiple interactions
increases activity
increases expression
EXP 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Dextran Sulfate results in increased activity of IKBKB protein]; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IKBKB mRNA; notoginsenoside R1 inhibits the reaction [Dextran Sulfate results in increased expression of IKBKB protein modified form]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased activity of IKBKB protein] CTD PMID:20155626 PMID:25472953 PMID:29950665 NCBI chr 8:23,149,228...23,196,605
Ensembl chr 8:23,149,228...23,196,605
JBrowse link
G Ikbke inhibitor of kappaB kinase epsilon multiple interactions
increases phosphorylation
EXP GW 506033X inhibits the reaction [Dextran Sulfate results in increased phosphorylation of IKBKE protein] CTD PMID:27920257 NCBI chr 1:131,182,337...131,207,339
Ensembl chr 1:131,182,080...131,207,344
JBrowse link
G Ikzf3 IKAROS family zinc finger 3 increases expression EXP Dextran Sulfate results in increased expression of IKZF3 mRNA CTD PMID:23894361 NCBI chr11:98,355,436...98,437,157
Ensembl chr11:98,355,728...98,436,857
JBrowse link
G Il10 interleukin 10 multiple interactions
increases expression
decreases expression
EXP
ISO
2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester promotes the reaction [Dextran Sulfate results in increased expression of IL10 protein]; [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL10 protein; [TNFRSF8 protein affects the susceptibility to Dextran Sulfate] which affects the secretion of IL10 protein; [TNFSF8 protein affects the susceptibility to Dextran Sulfate] which affects the secretion of IL10 protein; asperuloside inhibits the reaction [Dextran Sulfate results in decreased expression of IL10 protein]; BCL6 protein inhibits the reaction [Dextran Sulfate results in decreased expression of and results in decreased secretion of IL10 protein]; biochanin A inhibits the reaction [Dextran Sulfate results in decreased expression of IL10 protein]; celastrol inhibits the reaction [Dextran Sulfate results in decreased expression of IL10 protein]; Chlorpyrifos inhibits the reaction [Dextran Sulfate results in increased expression of IL10 mRNA]; Cholecalciferol inhibits the reaction [Dextran Sulfate results in decreased expression of IL10 protein]; Coumarins inhibits the reaction [Dextran Sulfate results in decreased expression of IL10 protein]; Dextran Sulfate results in decreased expression of and results in decreased secretion of IL10 protein; flavokawain B inhibits the reaction [Dextran Sulfate results in decreased expression of IL10 mRNA]; geraniol inhibits the reaction [Dextran Sulfate results in increased expression of IL10 protein]; huanglian-jie-du decoction inhibits the reaction [Dextran Sulfate results in increased expression of IL10 mRNA]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in decreased expression of and results in decreased secretion of IL10 protein]]; IRF4 protein promotes the reaction [Dextran Sulfate results in decreased expression of and results in decreased secretion of IL10 protein]; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL10 protein]; Lipopolysaccharides affects the reaction [Dextran Sulfate results in increased expression of IL10 mRNA]; Nicotine inhibits the reaction [Dextran Sulfate results in decreased expression of IL10 protein]; Resveratrol inhibits the reaction [Dextran Sulfate results in decreased expression of IL10 protein]; Resveratrol promotes the reaction [Dextran Sulfate results in increased expression of IL10 mRNA]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in decreased expression of IL10 protein]; thiamet G promotes the reaction [Dextran Sulfate results in increased expression of IL10 mRNA]
Dextran Sulfate results in increased expression of IL10 mRNA; Dextran Sulfate results in increased expression of IL10 protein
kappa-casein glycomacropeptide inhibits the reaction [Dextran Sulfate results in increased expression of IL10 mRNA]
Dextran Sulfate results in decreased expression of IL10 mRNA; Dextran Sulfate results in decreased expression of IL10 protein
CTD PMID:20132809 PMID:20881082 PMID:21068411 PMID:21359540 PMID:21724996 More... NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
JBrowse link
G Il11 interleukin 11 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IL11 mRNA; Melatonin inhibits the reaction [Dextran Sulfate results in decreased expression of IL11 protein] CTD PMID:29950665 PMID:36265525 NCBI chr 7:4,775,372...4,785,877
Ensembl chr 7:4,775,372...4,785,858
JBrowse link
G Il11ra1 interleukin 11 receptor subunit alpha 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IL11RA1 mRNA CTD PMID:29950665 NCBI chr 4:41,760,443...41,769,473
Ensembl chr 4:41,699,989...41,769,474
JBrowse link
G Il12a interleukin 12a affects response to substance EXP IL12A protein affects the susceptibility to Dextran Sulfate CTD PMID:12940437 NCBI chr 3:68,597,977...68,605,881
Ensembl chr 3:68,597,977...68,605,880
JBrowse link
G Il12b interleukin 12b increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of IL12B mRNA
ligustilide inhibits the reaction [Dextran Sulfate results in increased expression of IL12B mRNA]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased expression of IL12B mRNA]
CTD PMID:33130971 NCBI chr11:44,290,890...44,305,504
Ensembl chr11:44,290,890...44,304,860
JBrowse link
G Il15 interleukin 15 increases response to substance
decreases expression
multiple interactions
EXP
ISO
IL15 protein results in increased susceptibility to Dextran Sulfate
Dextran Sulfate results in decreased expression of IL15 mRNA
Oligosaccharides inhibits the reaction [Dextran Sulfate results in decreased expression of IL15 mRNA]
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL15 mRNA
CTD PMID:16162679 PMID:16375993 PMID:29950665 NCBI chr 8:83,058,253...83,129,883
Ensembl chr 8:83,058,261...83,129,851
JBrowse link
G Il17a interleukin 17A multiple interactions
increases expression
affects response to substance
EXP
ISO
2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester inhibits the reaction [Dextran Sulfate results in increased expression of IL17A protein]; 5,7-dimethoxycoumarin inhibits the reaction [Dextran Sulfate results in increased expression of IL17A mRNA]; [IL17A protein affects the susceptibility to Dextran Sulfate] which affects the expression of IFNG protein; [IL17A protein affects the susceptibility to Dextran Sulfate] which affects the expression of IL1B protein; [IL17A protein affects the susceptibility to Dextran Sulfate] which affects the expression of IL6 protein; [IL17A protein affects the susceptibility to Dextran Sulfate] which affects the expression of TNF protein; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IL17A mRNA; [TNFRSF8 protein affects the susceptibility to Dextran Sulfate] which affects the secretion of IL17A protein; [TNFSF8 protein affects the susceptibility to Dextran Sulfate] which affects the secretion of IL17A protein; ADAM17 protein affects the reaction [Dextran Sulfate results in increased expression of IL17A protein]; AHR gene mutant form promotes the reaction [Dextran Sulfate results in increased expression of IL17A mRNA]; Benzo(a)pyrene inhibits the reaction [Dextran Sulfate results in increased expression of IL17A mRNA]; celastrol inhibits the reaction [Dextran Sulfate results in increased expression of IL17A protein]; geraniol inhibits the reaction [Dextran Sulfate results in increased expression of IL17A protein]; HU 211 inhibits the reaction [Dextran Sulfate results in increased expression of IL17A protein]; ligustilide inhibits the reaction [Dextran Sulfate results in increased expression of IL17A mRNA]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased expression of IL17A mRNA]; nitazoxanide inhibits the reaction [Dextran Sulfate results in increased expression of IL17A mRNA]; Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of IL17A mRNA]; Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of IL17A protein]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of IL17A protein]; TLR4 protein affects the reaction [HU 211 inhibits the reaction [Dextran Sulfate results in increased expression of IL17A protein]]
kappa-casein glycomacropeptide inhibits the reaction [Dextran Sulfate results in increased expression of IL17A mRNA]
Dextran Sulfate results in increased expression of IL17A mRNA; Dextran Sulfate results in increased expression of IL17A protein
CTD PMID:20881082 PMID:21068411 PMID:24384223 PMID:24548422 PMID:26074695 More... NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
JBrowse link
G Il18 interleukin 18 affects response to substance
increases expression
multiple interactions
increases secretion
EXP
ISO
IL18 protein affects the susceptibility to Dextran Sulfate
Dextran Sulfate results in increased expression of IL18 mRNA; Dextran Sulfate results in increased expression of IL18 protein
[Dextran Sulfate co-treated with Zearalenone] results in increased expression of IL18 mRNA; [Dextran Sulfate co-treated with Zearalenone] results in increased secretion of IL18 protein; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL18 mRNA; Dexamethasone inhibits the reaction [Dextran Sulfate results in increased expression of IL18 protein]; Dextran Sulfate inhibits the reaction [Zearalenone results in increased secretion of IL18 protein]; fraxinellone inhibits the reaction [Dextran Sulfate results in increased expression of IL18 protein]; hydroxysafflor yellow A inhibits the reaction [Dextran Sulfate results in increased secretion of IL18 protein]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased secretion of IL18 protein]; Zearalenone inhibits the reaction [Dextran Sulfate results in increased expression of IL18 mRNA]; Zearalenone inhibits the reaction [Dextran Sulfate results in increased secretion of IL18 protein]
celastrol inhibits the reaction [Dextran Sulfate results in increased expression of IL18 protein]; celastrol promotes the reaction [N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Dextran Sulfate results in increased expression of IL18 protein]]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Dextran Sulfate results in increased expression of IL18 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide promotes the reaction [celastrol inhibits the reaction [Dextran Sulfate results in increased expression of IL18 protein]]
CTD PMID:12940437 PMID:25448682 PMID:29950665 PMID:30270565 PMID:32470352 More... NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
JBrowse link
G Il18r1 interleukin 18 receptor 1 affects response to substance EXP IL18R1 protein affects the susceptibility to Dextran Sulfate CTD PMID:12940437 NCBI chr 1:40,504,712...40,540,014
Ensembl chr 1:40,504,712...40,540,014
JBrowse link
G Il18rap interleukin 18 receptor accessory protein multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IL18RAP mRNA CTD PMID:29950665 NCBI chr 1:40,554,548...40,590,867
Ensembl chr 1:40,554,522...40,590,865
JBrowse link
G Il19 interleukin 19 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IL19 mRNA CTD PMID:29950665 NCBI chr 1:130,860,393...130,873,194
Ensembl chr 1:130,860,393...130,867,852
JBrowse link
G Il1a interleukin 1 alpha increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of IL1A mRNA; Dextran Sulfate results in increased expression of IL1A protein
2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester inhibits the reaction [Dextran Sulfate results in increased expression of IL1A protein]; [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL1A protein; Melatonin inhibits the reaction [Dextran Sulfate results in increased expression of IL1A protein]; notoginsenoside R1 inhibits the reaction [Dextran Sulfate results in increased expression of IL1A mRNA]
CTD PMID:23894361 PMID:25472953 PMID:29672155 PMID:34273909 PMID:36265525 NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
JBrowse link
G Il1b interleukin 1 beta multiple interactions
increases expression
increases secretion
increases cleavage
ISO
EXP
[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL1B protein; banxia xiexin decoction inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; celastrol inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; celastrol promotes the reaction [N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]]; kappa-casein glycomacropeptide inhibits the reaction [Dextran Sulfate results in increased expression of IL1B mRNA]; Melatonin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL1B protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; palmatine inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]
17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; 2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; 3-methyladenine affects the reaction [[HU 308 co-treated with Dextran Sulfate] affects the expression of IL1B protein]; 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; 7-hydroxyl-1-methylindole-3-acetonitrile inhibits the reaction [Dextran Sulfate results in increased secretion of IL1B protein]; [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL1B protein; [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of IL1B protein; [Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of and results in increased secretion of IL1B protein; [Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA; [Dextran Sulfate co-treated with Zearalenone] results in increased secretion of IL1B protein; [HU 308 co-treated with Dextran Sulfate] affects the expression of IL1B protein; [IL17A protein affects the susceptibility to Dextran Sulfate] which affects the expression of IL1B protein; [Streptozocin co-treated with Dextran Sulfate] results in increased expression of IL1B protein; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IL1B mRNA; [TNFRSF8 protein affects the susceptibility to Dextran Sulfate] which affects the expression of IL1B protein; [TNFSF8 protein affects the susceptibility to Dextran Sulfate] which affects the expression of IL1B protein; ADAM17 protein affects the reaction [Dextran Sulfate results in increased expression of IL1B protein]; AHR gene mutant form promotes the reaction [Dextran Sulfate results in increased expression of IL1B mRNA]; anandamide inhibits the reaction [Serotonin promotes the reaction [Dextran Sulfate results in increased expression of IL1B protein]]; apigenin-6,8-di-C-glycopyranoside inhibits the reaction [Dextran Sulfate results in increased secretion of IL1B protein]; ATG5 protein affects the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein]]; BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased secretion of IL1B protein]; Benzo(a)pyrene inhibits the reaction [Dextran Sulfate results in increased expression of IL1B mRNA]; biochanin A inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; celastrol inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; CEP 33779 inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of IL1B protein]; CNR2 protein affects the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of and results in increased secretion of IL1B protein]; CNR2 protein affects the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA]; Coumarins inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; daphnetin inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; Dexamethasone inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; Dextran Sulfate results in increased expression of and results in increased secretion of IL1B protein; dihydrotanshinone I inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased secretion of IL1B protein]; dorsomorphin inhibits the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of IL1B protein]]; Erianin inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; flavokawain B inhibits the reaction [Dextran Sulfate results in increased expression of IL1B mRNA]; flavokawain B inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; fraxinellone inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; geraniol inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; gingerenone A inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; gingerol inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; glyceryl 2-arachidonate inhibits the reaction [Serotonin promotes the reaction [Dextran Sulfate results in increased expression of IL1B protein]]; GR 113808 inhibits the reaction [Serotonin promotes the reaction [Dextran Sulfate results in increased expression of IL1B protein]]; Granisetron inhibits the reaction [Serotonin promotes the reaction [Dextran Sulfate results in increased expression of IL1B protein]]; GW 506033X inhibits the reaction [Dextran Sulfate results in increased expression of IL1B mRNA]; HU 211 inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of and results in increased secretion of IL1B protein]; HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein]; hydroxysafflor yellow A inhibits the reaction [Dextran Sulfate results in increased cleavage of IL1B protein]; hydroxysafflor yellow A inhibits the reaction [Dextran Sulfate results in increased secretion of IL1B protein]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased secretion of IL1B protein]]; IRF4 protein promotes the reaction [Dextran Sulfate results in increased expression of IL1B mRNA]; isovitexin inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; ligustilide inhibits the reaction [Dextran Sulfate results in increased expression of IL1B mRNA]; ligustilide inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; mangiferin inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; Melatonin inhibits the reaction [Dextran Sulfate results in increased expression of IL1B mRNA]; Melatonin inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased cleavage of IL1B protein]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased expression of IL1B mRNA]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased secretion of IL1B protein]; Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of IL1B mRNA]; Nicotine inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; notoginsenoside R1 inhibits the reaction [Dextran Sulfate results in increased expression of IL1B mRNA]; oxymatrine inhibits the reaction [Dextran Sulfate results in increased expression of IL1B mRNA]; phenethyl isothiocyanate inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; Plant Extracts inhibits the reaction [Dextran Sulfate results in increased expression of IL1B mRNA]; Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of IL1B mRNA]; Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; Quercetin promotes the reaction [Dextran Sulfate results in increased expression of IL1B protein]; resolvin D1 inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; resolvin D2 inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of IL1B mRNA]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; Rutin inhibits the reaction [Dextran Sulfate results in increased expression of IL1B mRNA]; Rutin inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; Serotonin promotes the reaction [Dextran Sulfate results in increased expression of IL1B protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased secretion of IL1B protein]; thiamet G promotes the reaction [Dextran Sulfate results in increased expression of IL1B mRNA]; TLR4 protein affects the reaction [HU 211 inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]]; Zearalenone inhibits the reaction [Dextran Sulfate results in increased secretion of IL1B protein]
Dextran Sulfate results in increased expression of IL1B mRNA; Dextran Sulfate results in increased expression of IL1B protein
CTD PMID:15652231 PMID:16774945 PMID:19028472 PMID:19285099 PMID:19645018 More... NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
JBrowse link
G Il1r1 interleukin 1 receptor, type I multiple interactions
increases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IL1R1 mRNA; Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of IL1R1 mRNA] CTD PMID:29950665 PMID:32033881 NCBI chr 1:40,261,651...40,355,361
Ensembl chr 1:40,264,240...40,356,417
JBrowse link
G Il1r2 interleukin 1 receptor, type II multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IL1R2 mRNA CTD PMID:29950665 NCBI chr 1:40,123,872...40,164,390
Ensembl chr 1:40,113,239...40,164,391
JBrowse link
G Il1rn interleukin 1 receptor antagonist multiple interactions EXP [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL1RN mRNA; [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL1RN protein; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL1RN mRNA]; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL1RN protein] CTD PMID:25026504 NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
JBrowse link
G Il2 interleukin 2 increases expression
multiple interactions
decreases expression
EXP Dextran Sulfate results in increased expression of IL2 mRNA
5,7-dimethoxycoumarin inhibits the reaction [Dextran Sulfate results in increased expression of IL2 mRNA]; [TNFRSF8 protein affects the susceptibility to Dextran Sulfate] which affects the secretion of IL2 protein; [TNFSF8 protein affects the susceptibility to Dextran Sulfate] which affects the secretion of IL2 protein; Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of IL2 protein]; notoginsenoside R1 inhibits the reaction [Dextran Sulfate results in increased expression of IL2 mRNA]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in decreased expression of IL2 protein]
CTD PMID:21068411 PMID:25472953 PMID:32272095 PMID:35889507 NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
JBrowse link
G Il20ra interleukin 20 receptor, alpha multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IL20RA mRNA CTD PMID:29950665 NCBI chr10:19,587,421...19,635,801
Ensembl chr10:19,588,318...19,635,801
JBrowse link
G Il20rb interleukin 20 receptor beta multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IL20RB mRNA CTD PMID:29950665 NCBI chr 9:100,339,772...100,368,526
Ensembl chr 9:100,339,772...100,368,841
JBrowse link
G Il22b interleukin 22B increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of IL22 mRNA
[Azoxymethane co-treated with Dextran Sulfate] results in increased secretion of IL22 protein; Benzo(a)pyrene inhibits the reaction [Dextran Sulfate results in increased expression of IL22 mRNA]; Dronabinol inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased secretion of IL22 protein]
CTD PMID:27920257 PMID:32942172 PMID:34998820 PMID:37385329 NCBI chr10:118,125,534...118,130,943
Ensembl chr10:118,125,534...118,130,943
JBrowse link
G Il22ra1 interleukin 22 receptor, alpha 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL22RA1 mRNA CTD PMID:29950665 NCBI chr 4:135,455,470...135,482,694
Ensembl chr 4:135,455,483...135,479,451
JBrowse link
G Il22ra2 interleukin 22 receptor, alpha 2 decreases expression EXP Dextran Sulfate results in decreased expression of IL22RA2 mRNA CTD PMID:27920257 NCBI chr10:19,497,776...19,510,429
Ensembl chr10:19,497,746...19,510,429
JBrowse link
G Il23a interleukin 23, alpha subunit p19 increases expression
multiple interactions
EXP
ISO
Dextran Sulfate results in increased expression of IL23A protein
celastrol inhibits the reaction [Dextran Sulfate results in increased expression of IL23A protein]; Melatonin inhibits the reaction [Dextran Sulfate results in increased expression of IL23A protein]
Dextran Sulfate results in increased expression of IL23A mRNA
kappa-casein glycomacropeptide inhibits the reaction [Dextran Sulfate results in increased expression of IL23A mRNA]
CTD PMID:20881082 PMID:24384223 PMID:36265525 NCBI chr10:128,132,009...128,133,953
Ensembl chr10:128,132,008...128,134,621
JBrowse link
G Il27ra interleukin 27 receptor, alpha decreases response to substance EXP IL27RA protein results in decreased susceptibility to Dextran Sulfate CTD PMID:16306766 NCBI chr 8:84,756,915...84,769,250
Ensembl chr 8:84,756,923...84,769,218
JBrowse link
G Il2rg interleukin 2 receptor, gamma chain increases expression EXP Dextran Sulfate results in increased expression of IL2RG mRNA CTD PMID:23894361 NCBI chr  X:100,307,991...100,311,861
Ensembl chr  X:100,307,984...100,311,861
JBrowse link
G Il33 interleukin 33 increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of IL33 mRNA
flavokawain B inhibits the reaction [Dextran Sulfate results in increased expression of IL33 mRNA]
CTD PMID:38583725 NCBI chr19:29,902,513...29,938,118
Ensembl chr19:29,902,514...29,938,118
JBrowse link
G Il3ra interleukin 3 receptor, alpha chain multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IL3RA mRNA CTD PMID:29950665 NCBI chr14:8,114,270...8,123,851
Ensembl chr14:8,113,752...8,123,488
JBrowse link
G Il4 interleukin 4 decreases expression
multiple interactions
increases expression
EXP
ISO
Dextran Sulfate results in decreased expression of IL4 mRNA
[TNFRSF8 protein affects the susceptibility to Dextran Sulfate] which affects the secretion of IL4 protein; [TNFSF8 protein affects the susceptibility to Dextran Sulfate] which affects the secretion of IL4 protein; MIF protein affects the reaction [Dextran Sulfate results in decreased expression of IL4 mRNA]
Dextran Sulfate results in increased expression of IL4 protein
CTD PMID:12105854 PMID:21068411 PMID:25777935 PMID:28438436 NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
JBrowse link
G Il4ra interleukin 4 receptor, alpha multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IL4RA mRNA CTD PMID:29950665 NCBI chr 7:125,151,443...125,178,646
Ensembl chr 7:125,151,292...125,178,646
JBrowse link
G Il6 interleukin 6 multiple interactions
increases expression
affects expression
increases secretion
EXP
ISO
(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; 2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; 4-methylesculetin inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; 7-hydroxyl-1-methylindole-3-acetonitrile inhibits the reaction [Dextran Sulfate results in increased secretion of IL6 protein]; [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL6 mRNA; [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL6 protein; [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of IL6 protein; [Dextran Sulfate co-treated with Lipopolysaccharides] results in increased secretion of IL6 protein; [IL17A protein affects the susceptibility to Dextran Sulfate] which affects the expression of IL6 protein; [RASSF1 gene mutant form results in increased susceptibility to Dextran Sulfate] which results in increased secretion of IL6 protein; [Streptozocin co-treated with Dextran Sulfate] results in increased expression of IL6 protein; [TNFRSF8 protein affects the susceptibility to Dextran Sulfate] which affects the expression of IL6 protein; [TNFSF8 protein affects the susceptibility to Dextran Sulfate] which affects the expression of IL6 protein; ADAM17 protein affects the reaction [Dextran Sulfate results in increased expression of IL6 protein]; AHR gene mutant form promotes the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; anandamide inhibits the reaction [Serotonin promotes the reaction [Dextran Sulfate results in increased expression of IL6 protein]]; apigenin-6,8-di-C-glycopyranoside inhibits the reaction [Dextran Sulfate results in increased secretion of IL6 protein]; asperuloside inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased secretion of IL6 protein]; Benzo(a)pyrene inhibits the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; Benzo(a)pyrene inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; Butylated Hydroxyanisole affects the reaction [Dextran Sulfate affects the expression of IL6 protein]; celastrol inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; CEP 33779 inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of IL6 protein]; Cholecalciferol inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; Coumarins inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; daphnetin inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; Dexamethasone inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; Dextran Sulfate affects the reaction [TLR4 protein affects the expression of IL6 protein]; Dextran Sulfate inhibits the reaction [[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of IL6 protein]; Dextran Sulfate inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; Dextran Sulfate inhibits the reaction [Polymyxin B results in decreased expression of IL6 protein]; Dextran Sulfate results in increased expression of and results in increased secretion of IL6 protein; dihydrotanshinone I inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased secretion of IL6 protein]; DUSP1 protein affects the reaction [Butylated Hydroxyanisole affects the reaction [Dextran Sulfate affects the expression of IL6 protein]]; DUSP1 protein affects the reaction [Resveratrol affects the reaction [Dextran Sulfate affects the expression of IL6 protein]]; EIF2AK2 protein affects the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; Erianin inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; Fenofibrate promotes the reaction [Dextran Sulfate results in increased expression of IL6 protein]; flavokawain B inhibits the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; flavokawain B inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; fraxinellone inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; geraniol inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; gingerenone A inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; glyceryl 2-arachidonate inhibits the reaction [Serotonin promotes the reaction [Dextran Sulfate results in increased expression of IL6 protein]]; GR 113808 inhibits the reaction [Serotonin promotes the reaction [Dextran Sulfate results in increased expression of IL6 protein]]; Granisetron inhibits the reaction [Serotonin promotes the reaction [Dextran Sulfate results in increased expression of IL6 protein]]; GW 506033X inhibits the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; HU 211 inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; huanglian-jie-du decoction inhibits the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; hydroxysafflor yellow A inhibits the reaction [Dextran Sulfate results in increased secretion of IL6 protein]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased secretion of IL6 protein]]; IRF4 protein promotes the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL6 mRNA]; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL6 protein]; ligustilide inhibits the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; ligustilide inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; Lipopolysaccharides affects the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; Lipopolysaccharides promotes the reaction [Dextran Sulfate results in increased expression of IL6 protein]; Melatonin inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased secretion of IL6 protein]; Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; NFE2L2 protein affects the reaction [Butylated Hydroxyanisole affects the reaction [Dextran Sulfate affects the expression of IL6 protein]]; NFE2L2 protein affects the reaction [Resveratrol affects the reaction [Dextran Sulfate affects the expression of IL6 protein]]; Nicotine inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; nitazoxanide inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased secretion of IL6 protein]; nitazoxanide inhibits the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; notoginsenoside R1 inhibits the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; notoginsenoside R1 inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; oxymatrine inhibits the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; Plant Extracts inhibits the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; PNU-282987 inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; Polymyxin B inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; Resveratrol affects the reaction [Dextran Sulfate affects the expression of IL6 protein]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; Rutin inhibits the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; SB 203580 inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; Serotonin promotes the reaction [Dextran Sulfate results in increased expression of IL6 protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased secretion of IL6 protein]; thiamet G promotes the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; TLR4 protein affects the reaction [Dextran Sulfate results in increased expression of IL6 protein]; TLR4 protein affects the reaction [HU 211 inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]]; tussilagone inhibits the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; tussilagone inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]
banxia xiexin decoction inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; celastrol inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; celastrol promotes the reaction [N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]]; kappa-casein glycomacropeptide inhibits the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; palmatine inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]
Dextran Sulfate results in increased expression of IL6 mRNA; Dextran Sulfate results in increased expression of IL6 protein
CTD PMID:15652231 PMID:16774945 PMID:19285099 PMID:19940103 PMID:20079348 More... NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
JBrowse link
G Il6st interleukin 6 signal transducer multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IL6ST mRNA CTD PMID:29950665 NCBI chr13:112,600,604...112,643,394
Ensembl chr13:112,600,604...112,646,620
JBrowse link
G Il7r interleukin 7 receptor multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IL7R mRNA CTD PMID:29950665 NCBI chr15:9,505,880...9,530,270
Ensembl chr15:9,505,874...9,530,262
JBrowse link
G Ilk integrin linked kinase decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of ILK protein
[Dextran Sulfate co-treated with bisphenol A] results in decreased expression of ILK protein
CTD PMID:35999755 NCBI chr 7:105,385,797...105,392,132
Ensembl chr 7:105,385,799...105,392,132
JBrowse link
G Inhba inhibin beta-A multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of INHBA mRNA CTD PMID:29950665 NCBI chr13:16,178,841...16,206,194
Ensembl chr13:16,186,436...16,206,206
JBrowse link
G Inhbb inhibin beta-B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of INHBB mRNA CTD PMID:29950665 NCBI chr 1:119,343,193...119,349,978
Ensembl chr 1:119,343,195...119,349,978
JBrowse link
G Ino80b INO80 complex subunit B increases expression EXP Dextran Sulfate results in increased expression of INO80B mRNA CTD PMID:35093514 NCBI chr 6:83,098,746...83,102,100
Ensembl chr 6:83,098,746...83,102,412
JBrowse link
G Inpp5d inositol polyphosphate-5-phosphatase D multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of INPP5D mRNA CTD PMID:29950665 NCBI chr 1:87,548,034...87,648,232
Ensembl chr 1:87,548,034...87,648,229
JBrowse link
G Insl5 insulin-like 5 multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of INSL5 mRNA; Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of INSL5 protein] CTD PMID:29950665 PMID:32272095 NCBI chr 4:102,875,069...102,884,468
Ensembl chr 4:102,875,069...102,884,039
JBrowse link
G Iqank1 IQ motif and ankyrin repeat containing 1 increases expression EXP Dextran Sulfate results in increased expression of IQANK1 mRNA CTD PMID:35093514 NCBI chr15:75,881,320...75,918,830
Ensembl chr15:75,881,737...75,918,830
JBrowse link
G Iqcd IQ motif containing D increases expression EXP Dextran Sulfate results in increased expression of IQCD mRNA CTD PMID:35093514 NCBI chr 5:120,724,829...120,745,185
Ensembl chr 5:120,727,081...120,745,183
JBrowse link
G Irag1 inositol 1,4,5-triphosphate receptor associated 1 multiple interactions
increases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in increased expression of IRAG1 protein] CTD PMID:32272095 NCBI chr 7:110,467,464...110,582,116
Ensembl chr 7:110,467,473...110,581,668
JBrowse link
G Irak1 interleukin-1 receptor-associated kinase 1 multiple interactions EXP [Azoxymethane co-treated with Dextran Sulfate] results in increased phosphorylation of IRAK1 protein CTD PMID:34273909 NCBI chr  X:73,057,520...73,067,527
Ensembl chr  X:73,057,520...73,067,524
JBrowse link
G Irak2 interleukin-1 receptor-associated kinase 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IRAK2 mRNA CTD PMID:29950665 NCBI chr 6:113,615,428...113,671,987
Ensembl chr 6:113,615,428...113,671,987
JBrowse link
G Irak4 interleukin-1 receptor-associated kinase 4 multiple interactions EXP [Azoxymethane co-treated with Dextran Sulfate] results in increased phosphorylation of IRAK4 protein CTD PMID:34273909 NCBI chr15:94,441,495...94,466,198
Ensembl chr15:94,441,524...94,479,696
JBrowse link
G Irf4 interferon regulatory factor 4 multiple interactions EXP IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in decreased expression of and results in decreased secretion of IL10 protein]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in decreased expression of ARG1 mRNA]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in decreased expression of ARG1 protein]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in decreased expression of MRC1 mRNA]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in decreased expression of MRC1 protein]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased secretion of IL1B protein]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased secretion of IL6 protein]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased secretion of TNF protein]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of CD86 mRNA]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of CD86 protein]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 mRNA]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 protein]]; IRF4 protein promotes the reaction [Dextran Sulfate results in decreased expression of and results in decreased secretion of IL10 protein]; IRF4 protein promotes the reaction [Dextran Sulfate results in decreased expression of ARG1 mRNA]; IRF4 protein promotes the reaction [Dextran Sulfate results in decreased expression of ARG1 protein]; IRF4 protein promotes the reaction [Dextran Sulfate results in decreased expression of MRC1 mRNA]; IRF4 protein promotes the reaction [Dextran Sulfate results in decreased expression of MRC1 protein]; IRF4 protein promotes the reaction [Dextran Sulfate results in increased expression of CD86 mRNA]; IRF4 protein promotes the reaction [Dextran Sulfate results in increased expression of CD86 protein]; IRF4 protein promotes the reaction [Dextran Sulfate results in increased expression of IL1B mRNA]; IRF4 protein promotes the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; IRF4 protein promotes the reaction [Dextran Sulfate results in increased expression of NOS2 mRNA]; IRF4 protein promotes the reaction [Dextran Sulfate results in increased expression of NOS2 protein]; IRF4 protein promotes the reaction [Dextran Sulfate results in increased expression of TNF mRNA] CTD PMID:38164749 NCBI chr13:30,933,191...30,950,965
Ensembl chr13:30,933,209...30,950,959
JBrowse link
G Irgm2 immunity-related GTPase family M member 2 increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of IRGM2 protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of IRGM2 protein]
CTD PMID:32272095 NCBI chr11:58,105,803...58,113,609
Ensembl chr11:58,090,444...58,113,608
JBrowse link
G Irs1 insulin receptor substrate 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IRS1 mRNA CTD PMID:29950665 NCBI chr 1:82,210,826...82,269,160
Ensembl chr 1:82,210,822...82,269,137
JBrowse link
G Irx6 Iroquois homeobox 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IRX6 mRNA CTD PMID:29950665 NCBI chr 8:93,400,917...93,407,584
Ensembl chr 8:93,400,916...93,407,584
JBrowse link
G Itga10 integrin, alpha 10 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ITGA10 mRNA CTD PMID:29950665 NCBI chr 3:96,552,900...96,571,835
Ensembl chr 3:96,552,900...96,571,835
JBrowse link
G Itga2b integrin alpha 2b multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ITGA2B mRNA CTD PMID:29950665 NCBI chr11:102,344,134...102,360,570
Ensembl chr11:102,344,123...102,360,948
JBrowse link
G Itga4 integrin alpha 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ITGA4 mRNA CTD PMID:29950665 NCBI chr 2:79,084,767...79,163,458
Ensembl chr 2:79,085,770...79,163,467
JBrowse link
G Itga5 integrin alpha 5 (fibronectin receptor alpha) multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ITGA5 mRNA CTD PMID:29950665 NCBI chr15:103,252,713...103,275,218
Ensembl chr15:103,252,713...103,275,190
JBrowse link
G Itga6 integrin alpha 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ITGA6 mRNA CTD PMID:29950665 NCBI chr 2:71,617,236...71,688,761
Ensembl chr 2:71,575,960...71,688,760
JBrowse link
G Itgal integrin alpha L multiple interactions
increases expression
EXP 17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid inhibits the reaction [Dextran Sulfate results in increased expression of ITGAL mRNA]; resolvin D1 inhibits the reaction [Dextran Sulfate results in increased expression of ITGAL mRNA]; resolvin D2 inhibits the reaction [Dextran Sulfate results in increased expression of ITGAL mRNA] CTD PMID:21724996 NCBI chr 7:126,895,404...126,934,309
Ensembl chr 7:126,895,432...126,934,310
JBrowse link
G Itgb1 integrin beta 1 (fibronectin receptor beta) multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ITGB1 mRNA CTD PMID:29950665 NCBI chr 8:129,412,135...129,460,060
Ensembl chr 8:129,412,135...129,459,681
JBrowse link
G Itgb2 integrin beta 2 multiple interactions
increases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ITGB2 mRNA; Erianin inhibits the reaction [Dextran Sulfate results in increased expression of ITGB2 protein] CTD PMID:29950665 PMID:32272095 NCBI chr10:77,366,164...77,401,542
Ensembl chr10:77,366,086...77,401,542
JBrowse link
G Itgb3 integrin beta 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ITGB3 mRNA CTD PMID:29950665 NCBI chr11:104,498,826...104,561,302
Ensembl chr11:104,498,826...104,561,302
JBrowse link
G Itgb6 integrin beta 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ITGB6 mRNA CTD PMID:29950665 NCBI chr 2:60,428,636...60,553,005
Ensembl chr 2:60,428,636...60,552,987
JBrowse link
G Itgb8 integrin beta 8 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ITGB8 mRNA CTD PMID:29950665 NCBI chr12:119,121,757...119,202,891
Ensembl chr12:119,121,757...119,202,537
JBrowse link
G Itih1 inter-alpha trypsin inhibitor, heavy chain 1 increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of ITIH1 protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of ITIH1 protein]
CTD PMID:32272095 NCBI chr14:30,651,137...30,665,246
Ensembl chr14:30,651,137...30,665,246
JBrowse link
G Itih3 inter-alpha trypsin inhibitor, heavy chain 3 multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in increased expression of ITIH3 protein CTD PMID:35999755 NCBI chr14:30,630,529...30,645,748
Ensembl chr14:30,630,529...30,645,717
JBrowse link
G Itih4 inter alpha-trypsin inhibitor, heavy chain 4 increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of ITIH4 protein
[Dextran Sulfate co-treated with bisphenol A] results in increased expression of ITIH4 protein; Erianin inhibits the reaction [Dextran Sulfate results in increased expression of ITIH4 protein]
CTD PMID:32272095 PMID:35999755 NCBI chr14:30,608,433...30,623,943
Ensembl chr14:30,608,433...30,624,310
JBrowse link
G Itih5 inter-alpha-trypsin inhibitor, heavy chain 5 decreases expression EXP Dextran Sulfate results in decreased expression of ITIH5 mRNA CTD PMID:35093514 NCBI chr 2:10,158,354...10,261,340
Ensembl chr 2:10,158,382...10,261,340
JBrowse link
G Itpka inositol 1,4,5-trisphosphate 3-kinase A multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ITPKA mRNA CTD PMID:29950665 NCBI chr 2:119,572,818...119,581,734
Ensembl chr 2:119,572,818...119,581,744
JBrowse link
G Itpr3 inositol 1,4,5-triphosphate receptor 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ITPR3 mRNA CTD PMID:29950665 NCBI chr17:27,275,976...27,341,197
Ensembl chr17:27,276,278...27,341,197
JBrowse link
G Jak2 Janus kinase 2 multiple interactions
increases phosphorylation
EXP BCL6 protein inhibits the reaction [Dextran Sulfate results in increased phosphorylation of JAK2 protein]; Dextran Sulfate results in increased expression of and results in increased phosphorylation of JAK2 protein; Erianin inhibits the reaction [Dextran Sulfate results in increased phosphorylation of JAK2 protein]; nitazoxanide inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased phosphorylation of JAK2 protein]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased phosphorylation of JAK2 protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased phosphorylation of JAK2 protein]; thiamet G promotes the reaction [Dextran Sulfate results in increased phosphorylation of JAK2 protein] CTD PMID:32272095 PMID:38164749 PMID:38437956 PMID:38663798 NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
JBrowse link
G Jam2 junction adhesion molecule 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of JAM2 mRNA CTD PMID:29950665 NCBI chr16:84,571,011...84,623,268
Ensembl chr16:84,571,011...84,622,816
JBrowse link
G Jam3 junction adhesion molecule 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of JAM3 mRNA CTD PMID:29950665 NCBI chr 9:27,008,680...27,066,739
Ensembl chr 9:27,008,680...27,066,717
JBrowse link
G Jaml junction adhesion molecule like multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of JAML mRNA CTD PMID:29950665 NCBI chr 9:44,990,451...45,019,829
Ensembl chr 9:44,990,481...45,019,832
JBrowse link
G Jchain immunoglobulin joining chain decreases expression EXP Dextran Sulfate results in decreased expression of JCHAIN mRNA CTD PMID:35093514 NCBI chr 5:88,667,663...88,675,667
Ensembl chr 5:88,667,668...88,675,750
JBrowse link
G Josd2 Josephin domain containing 2 increases expression EXP Dextran Sulfate results in increased expression of JOSD2 mRNA CTD PMID:35093514 NCBI chr 7:44,117,404...44,121,082
Ensembl chr 7:44,117,404...44,121,086
JBrowse link
G Jun jun proto-oncogene multiple interactions EXP Dextran Sulfate results in increased expression of and affects the localization of JUN protein; ligustilide inhibits the reaction [Dextran Sulfate results in increased expression of and affects the localization of JUN protein]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased expression of and affects the localization of JUN protein] CTD PMID:33130971 NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
JBrowse link
G Kalrn kalirin, RhoGEF kinase decreases expression EXP Dextran Sulfate results in decreased expression of KALRN protein CTD PMID:35999755 NCBI chr16:33,789,443...34,393,647
Ensembl chr16:33,789,443...34,393,902
JBrowse link
G Kash5 KASH domain containing 5 increases expression EXP Dextran Sulfate results in increased expression of KASH5 mRNA CTD PMID:35093514 NCBI chr 7:44,833,043...44,854,344
Ensembl chr 7:44,833,048...44,854,316
JBrowse link
G Kcnab1 potassium voltage-gated channel, shaker-related subfamily, beta member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of KCNAB1 mRNA CTD PMID:29950665 NCBI chr 3:64,856,636...65,285,643
Ensembl chr 3:64,856,617...65,285,644
JBrowse link
G Kcne3 potassium voltage-gated channel, Isk-related subfamily, gene 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of KCNE3 mRNA CTD PMID:29950665 NCBI chr 7:99,825,714...99,834,076
Ensembl chr 7:99,825,709...99,834,076
JBrowse link
G Kcnh2 potassium voltage-gated channel, subfamily H (eag-related), member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of KCNH2 mRNA CTD PMID:29950665 NCBI chr 5:24,524,583...24,556,671
Ensembl chr 5:24,524,587...24,556,602
JBrowse link
G Kcnj9 potassium inwardly-rectifying channel, subfamily J, member 9 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of KCNJ9 mRNA CTD PMID:29950665 NCBI chr 1:172,148,075...172,156,889
Ensembl chr 1:172,148,068...172,156,885
JBrowse link
G Kcnk4 potassium channel, subfamily K, member 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of KCNK4 mRNA CTD PMID:29950665 NCBI chr19:6,903,030...6,912,261
Ensembl chr19:6,901,334...6,911,883
JBrowse link
G Kcnk5 potassium channel, subfamily K, member 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of KCNK5 mRNA CTD PMID:29950665 NCBI chr14:20,190,125...20,231,850
Ensembl chr14:20,190,125...20,231,877
JBrowse link
G Khdc1a KH domain containing 1A increases expression EXP Dextran Sulfate results in increased expression of KHDC1A mRNA CTD PMID:23894361 NCBI chr 1:21,419,901...21,422,423
Ensembl chr 1:21,419,865...21,422,424
JBrowse link
G Kiss1 KiSS-1 metastasis-suppressor multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of KISS1 mRNA CTD PMID:29950665 NCBI chr 1:133,249,625...133,257,460
Ensembl chr 1:133,237,565...133,257,460
Ensembl chr 1:133,237,565...133,257,460
JBrowse link
G Kit KIT proto-oncogene receptor tyrosine kinase multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of KIT mRNA
Dextran Sulfate results in decreased expression of KIT mRNA
CTD PMID:29950665 PMID:35093514 NCBI chr 5:75,735,647...75,817,382
Ensembl chr 5:75,735,576...75,817,382
JBrowse link
G Kitl kit ligand multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of KITL mRNA CTD PMID:29950665 NCBI chr10:99,851,477...99,936,278
Ensembl chr10:99,851,492...99,936,278
JBrowse link
G Klb klotho beta multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of KLB mRNA CTD PMID:29950665 NCBI chr 5:65,505,754...65,544,300
Ensembl chr 5:65,505,657...65,541,350
JBrowse link
G Klc3 kinesin light chain 3 increases expression EXP Dextran Sulfate results in increased expression of KLC3 mRNA CTD PMID:35093514 NCBI chr 7:19,128,365...19,138,101
Ensembl chr 7:19,128,362...19,138,029
JBrowse link
G Klk1 kallikrein 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of KLK1 mRNA CTD PMID:29950665 NCBI chr 7:43,874,784...43,879,046
Ensembl chr 7:43,874,784...43,879,042
JBrowse link
G Klk1b21 kallikrein 1-related peptidase b21 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of KLK1B21 mRNA CTD PMID:29950665 NCBI chr 7:43,654,040...43,756,007
Ensembl chr 7:43,751,752...43,756,007
JBrowse link
G Klk1b22 kallikrein 1-related peptidase b22 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of KLK1B22 mRNA CTD PMID:29950665 NCBI chr 7:43,762,097...43,766,346
Ensembl chr 7:43,762,097...43,766,346
JBrowse link
G Klk1b24 kallikrein 1-related peptidase b24 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of KLK1B24 mRNA CTD PMID:29950665 NCBI chr 7:43,837,658...43,841,879
Ensembl chr 7:43,837,660...43,841,879
JBrowse link
G Klk1b26 kallikrein 1-related petidase b26 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of KLK1B26 mRNA CTD PMID:29950665 NCBI chr 7:43,662,102...43,666,393
Ensembl chr 7:43,661,592...43,666,392
JBrowse link
G Klk1b27 kallikrein 1-related peptidase b27 decreases expression EXP Dextran Sulfate results in decreased expression of KLK1B27 mRNA CTD PMID:35093514 NCBI chr 7:43,701,714...43,706,136
Ensembl chr 7:43,701,714...43,706,136
JBrowse link
G Klk1b3 kallikrein 1-related peptidase b3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of KLK1B3 mRNA CTD PMID:29950665 NCBI chr 7:43,847,615...43,851,775
Ensembl chr 7:43,847,615...43,851,776
JBrowse link
G Klk1b4 kallikrein 1-related pepidase b4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of KLK1B4 mRNA CTD PMID:29950665 NCBI chr 7:43,856,857...43,861,178
Ensembl chr 7:43,856,859...43,861,178
JBrowse link
G Klk1b5 kallikrein 1-related peptidase b5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of KLK1B5 mRNA CTD PMID:29950665 NCBI chr 7:43,865,898...43,870,127
Ensembl chr 7:43,865,369...43,870,127
JBrowse link
G Klk1b8 kallikrein 1-related peptidase b8 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of KLK1B8 mRNA CTD PMID:29950665 NCBI chr 7:43,600,090...43,604,368
Ensembl chr 7:43,600,088...43,604,365
JBrowse link
G Klra4 killer cell lectin-like receptor, subfamily A, member 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of KLRA4 mRNA CTD PMID:29950665 NCBI chr 6:130,020,693...130,044,242
Ensembl chr 6:130,020,694...130,044,234
JBrowse link
G Kpna1 karyopherin subunit alpha 1 increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of KPNA1 protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of KPNA1 protein]
CTD PMID:32272095 NCBI chr16:35,803,693...35,859,479
Ensembl chr16:35,799,120...35,857,501
JBrowse link
G Kras Kirsten rat sarcoma viral oncogene homolog multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of KRAS mRNA; Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of KRAS protein] CTD PMID:29950665 PMID:32272095 NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965
JBrowse link
G Krt16 keratin 16 decreases expression EXP Dextran Sulfate results in decreased expression of KRT16 protein CTD PMID:35999755 NCBI chr11:100,136,917...100,139,728
Ensembl chr11:100,136,917...100,139,728
JBrowse link
G L1cam L1 cell adhesion molecule multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of L1CAM mRNA
Dextran Sulfate results in decreased expression of L1CAM protein
CTD PMID:29950665 PMID:35999755 NCBI chr  X:72,897,384...72,924,843
Ensembl chr  X:72,897,384...72,939,711
JBrowse link
G Lama5 laminin, alpha 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LAMA5 mRNA CTD PMID:29950665 NCBI chr 2:179,818,166...179,867,652
Ensembl chr 2:179,818,166...179,867,652
JBrowse link
G Lamb2 laminin, beta 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LAMB2 mRNA CTD PMID:29950665 NCBI chr 9:108,357,080...108,367,729
Ensembl chr 9:108,356,935...108,367,729
JBrowse link
G Lamb3 laminin, beta 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of LAMB3 mRNA CTD PMID:29950665 NCBI chr 1:192,976,661...193,026,186
Ensembl chr 1:192,890,007...193,026,186
JBrowse link
G Lamc1 laminin, gamma 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LAMC1 mRNA CTD PMID:29950665 NCBI chr 1:153,094,668...153,208,532
Ensembl chr 1:153,094,668...153,208,532
JBrowse link
G Lamc3 laminin gamma 3 decreases expression EXP Dextran Sulfate results in decreased expression of LAMC3 mRNA CTD PMID:35093514 NCBI chr 2:31,777,293...31,839,095
Ensembl chr 2:31,777,303...31,836,551
JBrowse link
G Laptm5 lysosomal-associated protein transmembrane 5 increases expression EXP Dextran Sulfate results in increased expression of LAPTM5 mRNA CTD PMID:23894361 NCBI chr 4:130,640,627...130,663,459
Ensembl chr 4:130,640,436...130,663,452
JBrowse link
G Larp1 La ribonucleoprotein 1, translational regulator decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of LARP1 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of LARP1 protein]
CTD PMID:32272095 NCBI chr11:57,899,711...57,952,860
Ensembl chr11:57,899,890...57,952,860
JBrowse link
G Lasp1 LIM and SH3 protein 1 multiple interactions
decreases expression
EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of LASP1 protein
Dextran Sulfate results in decreased expression of LASP1 protein
CTD PMID:35999755 NCBI chr11:97,689,748...97,729,591
Ensembl chr11:97,689,826...97,729,590
JBrowse link
G Lat2 linker for activation of T cells family, member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LAT2 mRNA CTD PMID:29950665 NCBI chr 5:134,628,957...134,648,637
Ensembl chr 5:134,628,876...134,643,879
JBrowse link
G Layn layilin decreases expression EXP Dextran Sulfate results in decreased expression of LAYN protein CTD PMID:35999755 NCBI chr 9:50,966,323...50,988,501
Ensembl chr 9:50,965,940...50,988,394
JBrowse link
G Lcn2 lipocalin 2 increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of LCN2 mRNA
AHR gene mutant form promotes the reaction [Dextran Sulfate results in increased expression of LCN2 mRNA]
CTD PMID:23894361 PMID:36519841 NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
JBrowse link
G Lct lactase decreases activity
multiple interactions
EXP Dextran Sulfate results in decreased activity of LCT protein
Fatty Acids, Omega-3 inhibits the reaction [Dextran Sulfate results in decreased activity of LCT protein]
CTD PMID:30489199 NCBI chr 1:128,212,493...128,256,055
Ensembl chr 1:128,212,493...128,256,055
JBrowse link
G Ldha lactate dehydrogenase A decreases expression EXP Dextran Sulfate results in decreased expression of LDHA protein CTD PMID:35999755 NCBI chr 7:46,491,698...46,505,051
Ensembl chr 7:46,490,899...46,505,051
JBrowse link
G Ldhal6b lactate dehydrogenase A-like 6B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of LDHAL6B mRNA CTD PMID:29950665 NCBI chr17:5,467,598...5,469,042
Ensembl chr17:5,467,598...5,469,042
JBrowse link
G Ldhb lactate dehydrogenase B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LDHB mRNA CTD PMID:29950665 NCBI chr 6:142,435,975...142,453,683
Ensembl chr 6:142,435,975...142,453,683
JBrowse link
G Ldhc lactate dehydrogenase C increases activity
multiple interactions
EXP Dextran Sulfate results in increased activity of LDHC protein
gingerol inhibits the reaction [Dextran Sulfate results in increased activity of LDHC protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased activity of LDHC protein]
CTD PMID:28421826 NCBI chr 7:46,510,687...46,527,571
Ensembl chr 7:46,510,627...46,527,566
JBrowse link
G Lef1 lymphoid enhancer binding factor 1 multiple interactions EXP [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of LEF1 mRNA; [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of LEF1 protein; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of LEF1 mRNA]; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of LEF1 protein] CTD PMID:31715269 NCBI chr 3:130,903,972...131,018,006
Ensembl chr 3:130,904,120...131,018,005
JBrowse link
G Leng1 leukocyte receptor cluster (LRC) member 1 increases expression EXP Dextran Sulfate results in increased expression of LENG1 mRNA CTD PMID:35093514 NCBI chr 7:3,663,106...3,668,839
Ensembl chr 7:3,663,097...3,668,839
JBrowse link
G Lep leptin multiple interactions EXP [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of LEP mRNA; [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of LEP protein CTD PMID:19931517 NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
JBrowse link
G Lgr4 leucine-rich repeat-containing G protein-coupled receptor 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of LGR4 mRNA CTD PMID:29950665 NCBI chr 2:109,747,919...109,844,602
Ensembl chr 2:109,747,992...109,844,602
JBrowse link
G Lgr6 leucine-rich repeat-containing G protein-coupled receptor 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LGR6 mRNA CTD PMID:29950665 NCBI chr 1:134,911,038...135,033,112
Ensembl chr 1:134,911,039...135,033,014
JBrowse link
G Lhb luteinizing hormone beta decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of LHB protein
gingerol inhibits the reaction [Dextran Sulfate results in decreased expression of LHB protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in decreased expression of LHB protein]
CTD PMID:28421826 NCBI chr 7:45,070,370...45,071,278
Ensembl chr 7:45,070,244...45,071,321
JBrowse link
G Lhcgr luteinizing hormone/choriogonadotropin receptor multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of LHCGR mRNA
Dextran Sulfate results in decreased expression of LHCGR mRNA
CTD PMID:29950665 PMID:35093514 NCBI chr17:89,023,812...89,099,487
Ensembl chr17:89,023,909...89,099,418
JBrowse link
G Limk1 LIM domain kinase 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LIMK1 mRNA CTD PMID:29950665 NCBI chr 5:134,684,893...134,718,713
Ensembl chr 5:134,684,893...134,717,452
JBrowse link
G Lims1 LIM and senescent cell antigen-like domains 1 decreases expression EXP Dextran Sulfate results in decreased expression of LIMS1 protein CTD PMID:35999755 NCBI chr10:58,159,164...58,260,513
Ensembl chr10:58,159,288...58,260,513
JBrowse link
G Lmnb2 lamin B2 increases expression EXP Dextran Sulfate results in increased expression of LMNB2 mRNA CTD PMID:35093514 NCBI chr10:80,737,197...80,754,079
Ensembl chr10:80,737,037...80,754,079
JBrowse link
G Lox lysyl oxidase multiple interactions
increases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LOX mRNA; Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of LOX mRNA] CTD PMID:29950665 PMID:32033881 PMID:35093514 NCBI chr18:52,649,132...52,662,939
Ensembl chr18:52,649,139...52,662,939
JBrowse link
G Loxl1 lysyl oxidase-like 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LOXL1 mRNA CTD PMID:29950665 NCBI chr 9:58,195,006...58,220,495
Ensembl chr 9:58,195,021...58,220,469
JBrowse link
G Lpar2 lysophosphatidic acid receptor 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LPAR2 mRNA CTD PMID:29950665 NCBI chr 8:70,275,215...70,283,752
Ensembl chr 8:70,275,079...70,283,752
JBrowse link
G Lpar3 lysophosphatidic acid receptor 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of LPAR3 mRNA CTD PMID:29950665 NCBI chr 3:145,926,716...145,991,969
Ensembl chr 3:145,926,718...145,991,941
JBrowse link
G Lpar4 lysophosphatidic acid receptor 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LPAR4 mRNA CTD PMID:29950665 NCBI chr  X:105,964,231...105,977,505
Ensembl chr  X:105,964,231...105,977,506
JBrowse link
G Lrg1 leucine-rich alpha-2-glycoprotein 1 increases expression EXP Dextran Sulfate results in increased expression of LRG1 mRNA CTD PMID:23894361 PMID:35093514 NCBI chr17:56,426,678...56,428,946
Ensembl chr17:56,426,678...56,429,001
JBrowse link
G Lrp1 low density lipoprotein receptor-related protein 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of LRP1 mRNA CTD PMID:29950665 NCBI chr10:127,374,026...127,457,158
Ensembl chr10:127,374,030...127,457,017
JBrowse link
G Lrp2 low density lipoprotein receptor-related protein 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LRP2 mRNA CTD PMID:29950665 NCBI chr 2:69,254,679...69,416,373
Ensembl chr 2:69,254,684...69,416,409
JBrowse link
G Lrp5 low density lipoprotein receptor-related protein 5 multiple interactions EXP [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of LRP5 mRNA; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of LRP5 mRNA] CTD PMID:31715269 NCBI chr19:3,634,825...3,736,574
Ensembl chr19:3,634,828...3,736,564
JBrowse link
G Lrrc61 leucine rich repeat containing 61 increases expression EXP Dextran Sulfate results in increased expression of LRRC61 mRNA CTD PMID:35093514 NCBI chr 6:48,531,732...48,547,656
Ensembl chr 6:48,531,730...48,547,656
JBrowse link
G Lsm4 LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated increases expression EXP Dextran Sulfate results in increased expression of LSM4 mRNA CTD PMID:35093514 NCBI chr 8:71,124,663...71,131,402
Ensembl chr 8:71,125,898...71,131,402
JBrowse link
G Lta lymphotoxin A increases expression EXP Dextran Sulfate results in increased expression of LTA mRNA CTD PMID:20079348 NCBI chr17:35,422,141...35,424,568
Ensembl chr17:35,422,141...35,424,327
JBrowse link
G Lta4h leukotriene A4 hydrolase multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of LTA4H protein CTD PMID:35999755 NCBI chr10:93,289,258...93,320,758
Ensembl chr10:93,289,273...93,320,737
JBrowse link
G Ltb4r1 leukotriene B4 receptor 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LTB4R1 mRNA CTD PMID:29950665 NCBI chr14:56,002,154...56,005,951
Ensembl chr14:56,003,419...56,005,951
JBrowse link
G Ltbp3 latent transforming growth factor beta binding protein 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LTBP3 mRNA CTD PMID:29950665 NCBI chr19:5,790,928...5,808,564
Ensembl chr19:5,790,932...5,808,560
JBrowse link
G Ltbp4 latent transforming growth factor beta binding protein 4 multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LTBP4 mRNA
Dextran Sulfate results in decreased expression of LTBP4 mRNA
CTD PMID:29950665 PMID:35093514 NCBI chr 7:27,004,566...27,039,142
Ensembl chr 7:27,004,561...27,037,117
JBrowse link
G Ltf lactotransferrin decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of LTF protein
[Dextran Sulfate co-treated with bisphenol A] results in increased expression of LTF protein
CTD PMID:35999755 NCBI chr 9:110,848,360...110,871,834
Ensembl chr 9:110,848,339...110,871,835
JBrowse link
G Ly6d lymphocyte antigen 6 family member D decreases expression EXP Dextran Sulfate results in decreased expression of LY6D mRNA CTD PMID:35093514 NCBI chr15:74,633,905...74,635,416
Ensembl chr15:74,633,905...74,635,469
JBrowse link
G Ly6e lymphocyte antigen 6 family member E decreases expression EXP Dextran Sulfate results in decreased expression of LY6E mRNA CTD PMID:35093514 NCBI chr15:74,826,874...74,831,753
Ensembl chr15:74,826,900...74,831,752
JBrowse link
G Ly86 lymphocyte antigen 86 increases expression EXP Dextran Sulfate results in increased expression of LY86 mRNA CTD PMID:23894361 NCBI chr13:37,529,276...37,603,012
Ensembl chr13:37,529,184...37,603,012
JBrowse link
G Lyz2 lysozyme 2 increases expression EXP Dextran Sulfate results in increased expression of LYZ2 mRNA CTD PMID:23894361 NCBI chr10:117,113,446...117,118,177
Ensembl chr10:117,113,236...117,118,226
JBrowse link
G Maff v-maf musculoaponeurotic fibrosarcoma oncogene family, protein F (avian) increases expression EXP Dextran Sulfate results in increased expression of MAFF mRNA CTD PMID:35093514 NCBI chr15:79,230,813...79,243,278
Ensembl chr15:79,230,821...79,243,276
JBrowse link
G Mag myelin-associated glycoprotein multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MAG mRNA CTD PMID:29950665 NCBI chr 7:30,598,600...30,614,347
Ensembl chr 7:30,598,601...30,614,298
JBrowse link
G Manf mesencephalic astrocyte-derived neurotrophic factor decreases expression EXP Dextran Sulfate results in decreased expression of MANF protein CTD PMID:35999755 NCBI chr 9:106,765,952...106,769,137
Ensembl chr 9:106,715,511...106,769,178
JBrowse link
G Maoa monoamine oxidase A multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MAOA mRNA CTD PMID:29950665 NCBI chr  X:16,485,937...16,554,051
Ensembl chr  X:16,485,937...16,554,057
JBrowse link
G Map1lc3b microtubule-associated protein 1 light chain 3 beta multiple interactions EXP 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[Dextran Sulfate co-treated with alpinetin] results in increased expression of and results in increased lipidation of MAP1LC3B protein]; [Dextran Sulfate co-treated with 6-formylindolo(3,2-b)carbazole] results in increased expression of and results in increased lipidation of MAP1LC3B protein; [Dextran Sulfate co-treated with alpinetin] results in increased expression of and results in increased lipidation of MAP1LC3B protein; Leucine inhibits the reaction [[Dextran Sulfate co-treated with alpinetin] results in increased expression of and results in increased lipidation of MAP1LC3B protein] CTD PMID:31676321 NCBI chr 8:122,317,177...122,325,499
Ensembl chr 8:122,317,100...122,325,499
JBrowse link
G Map3k7 mitogen-activated protein kinase kinase kinase 7 increases phosphorylation
multiple interactions
EXP Dextran Sulfate results in increased phosphorylation of MAP3K7 protein
flavokawain B inhibits the reaction [Dextran Sulfate results in increased phosphorylation of MAP3K7 protein]
CTD PMID:38583725 NCBI chr 4:31,963,659...32,023,470
Ensembl chr 4:31,964,097...32,023,467
JBrowse link
G Mapk1 mitogen-activated protein kinase 1 multiple interactions
increases activity
increases phosphorylation
EXP
ISO
3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Dextran Sulfate results in increased activity of MAPK1 protein]; 5,7-dimethoxycoumarin inhibits the reaction [Dextran Sulfate results in increased phosphorylation of MAPK1 protein]; [Azoxymethane co-treated with Dextran Sulfate] results in increased phosphorylation of MAPK1 protein; Resveratrol inhibits the reaction [Dextran Sulfate results in increased activity of MAPK1 protein]
banxia xiexin decoction inhibits the reaction [Dextran Sulfate results in increased phosphorylation of MAPK1 protein]; palmatine inhibits the reaction [Dextran Sulfate results in increased phosphorylation of MAPK1 protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased phosphorylation of MAPK1 protein]
CTD PMID:19931517 PMID:20155626 PMID:35889507 PMID:36806191 NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
JBrowse link
G Mapk10 mitogen-activated protein kinase 10 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MAPK10 mRNA CTD PMID:29950665 NCBI chr 5:103,056,413...103,359,200
Ensembl chr 5:103,055,814...103,359,200
JBrowse link
G Mapk3 mitogen-activated protein kinase 3 multiple interactions
increases activity
increases phosphorylation
EXP
ISO
3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Dextran Sulfate results in increased activity of MAPK3 protein]; 5,7-dimethoxycoumarin inhibits the reaction [Dextran Sulfate results in increased phosphorylation of MAPK3 protein]; [Azoxymethane co-treated with Dextran Sulfate] results in increased phosphorylation of MAPK3 protein; Resveratrol inhibits the reaction [Dextran Sulfate results in increased activity of MAPK3 protein]
banxia xiexin decoction inhibits the reaction [Dextran Sulfate results in increased phosphorylation of MAPK3 protein]; palmatine inhibits the reaction [Dextran Sulfate results in increased phosphorylation of MAPK3 protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased phosphorylation of MAPK3 protein]
CTD PMID:19931517 PMID:20155626 PMID:35889507 PMID:36806191 NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
JBrowse link
G Mapre1 microtubule-associated protein, RP/EB family, member 1 decreases expression EXP Dextran Sulfate results in decreased expression of MAPRE1 protein CTD PMID:35999755 NCBI chr 2:153,583,131...153,615,237
Ensembl chr 2:153,583,194...153,615,230
JBrowse link
G Masp1 MBL associated serine protease 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MASP1 mRNA CTD PMID:29950665 NCBI chr16:23,261,778...23,340,127
Ensembl chr16:23,268,167...23,339,565
JBrowse link
G Matn4 matrilin 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MATN4 mRNA CTD PMID:29950665 NCBI chr 2:164,231,313...164,247,080
Ensembl chr 2:164,231,313...164,247,080
JBrowse link
G Mavs mitochondrial antiviral signaling protein multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of MAVS protein] CTD PMID:32272095 NCBI chr 2:131,075,445...131,089,945
Ensembl chr 2:131,075,983...131,089,945
JBrowse link
G Mbd3 methyl-CpG binding domain protein 3 increases expression EXP Dextran Sulfate results in increased expression of MBD3 mRNA CTD PMID:35093514 NCBI chr10:80,228,373...80,235,365
Ensembl chr10:80,228,373...80,235,384
JBrowse link
G Mc4r melanocortin 4 receptor multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MC4R mRNA CTD PMID:29950665 NCBI chr18:66,990,776...66,993,558
Ensembl chr18:66,990,775...66,993,577
JBrowse link
G Mcm3 minichromosome maintenance complex component 3 increases expression EXP Dextran Sulfate results in increased expression of MCM3 protein CTD PMID:20025956 NCBI chr 1:20,873,188...20,890,536
Ensembl chr 1:20,873,192...20,890,536
JBrowse link
G Mcpt1 mast cell protease 1 increases expression EXP Dextran Sulfate results in increased expression of MCPT1 mRNA CTD PMID:23894361 NCBI chr14:56,255,421...56,257,848
Ensembl chr14:56,255,428...56,257,841
JBrowse link
G Mcpt2 mast cell protease 2 increases expression EXP Dextran Sulfate results in increased expression of MCPT2 mRNA CTD PMID:23894361 NCBI chr14:56,259,041...56,282,092
Ensembl chr14:56,279,498...56,282,099
JBrowse link
G Mdh1 malate dehydrogenase 1, NAD (soluble) decreases expression EXP Dextran Sulfate results in decreased expression of MDH1 protein CTD PMID:35999755 NCBI chr11:21,506,692...21,521,934
Ensembl chr11:21,506,692...21,522,367
JBrowse link
G Mdk midkine multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MDK mRNA CTD PMID:29950665 NCBI chr 2:91,760,149...91,762,348
Ensembl chr 2:91,760,150...91,762,642
JBrowse link
G Me1 malic enzyme 1, NADP(+)-dependent, cytosolic multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of ME1 protein CTD PMID:35999755 NCBI chr 9:86,463,416...86,577,967
Ensembl chr 9:86,463,424...86,578,006
JBrowse link
G Mep1a meprin 1 alpha multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MEP1A mRNA CTD PMID:29950665 NCBI chr17:43,785,215...43,815,034
Ensembl chr17:43,785,215...43,813,703
JBrowse link
G Mep1b meprin 1 beta multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MEP1B mRNA CTD PMID:29950665 NCBI chr18:21,205,401...21,233,256
Ensembl chr18:21,194,980...21,233,256
JBrowse link
G Mesp1 mesoderm posterior 1 increases expression EXP Dextran Sulfate results in increased expression of MESP1 mRNA CTD PMID:35093514 NCBI chr 7:79,441,989...79,443,338
Ensembl chr 7:79,441,989...79,443,536
JBrowse link
G Mfap4 microfibrillar-associated protein 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MFAP4 mRNA CTD PMID:29950665 NCBI chr11:61,376,257...61,379,536
Ensembl chr11:61,376,257...61,379,726
JBrowse link
G Mfap5 microfibrillar associated protein 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MFAP5 mRNA CTD PMID:29950665 NCBI chr 6:122,490,543...122,506,249
Ensembl chr 6:122,482,804...122,506,249
JBrowse link
G Mfge8 milk fat globule EGF and factor V/VIII domain containing multiple interactions EXP [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of MFGE8 mRNA CTD PMID:26271895 NCBI chr 7:78,783,516...78,798,808
Ensembl chr 7:78,783,516...78,798,808
JBrowse link
G Mfsd2a MFSD2 lysolipid transporter A, lysophospholipid increases expression
decreases expression
EXP Dextran Sulfate results in increased expression of MFSD2A mRNA
Dextran Sulfate results in decreased expression of MFSD2A mRNA
CTD PMID:23894361 PMID:35093514 NCBI chr 4:122,840,643...122,855,844
Ensembl chr 4:122,840,643...122,854,981
JBrowse link
G Mgp matrix Gla protein multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MGP mRNA CTD PMID:29950665 NCBI chr 6:136,849,433...136,852,821
Ensembl chr 6:136,849,433...136,852,821
JBrowse link
G Mgst2 microsomal glutathione S-transferase 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MGST2 mRNA CTD PMID:29950665 NCBI chr 3:51,544,179...51,590,096
Ensembl chr 3:51,567,781...51,590,098
JBrowse link
G Mgst3 microsomal glutathione S-transferase 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MGST3 mRNA CTD PMID:29950665 NCBI chr 1:167,199,535...167,221,410
Ensembl chr 1:167,199,535...167,221,410
JBrowse link
G Mif macrophage migration inhibitory factor (glycosylation-inhibiting factor) increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of MIF mRNA
MIF protein affects the reaction [Dextran Sulfate results in decreased expression of IL4 mRNA]; MIF protein affects the reaction [Dextran Sulfate results in increased expression of IFNG mRNA]; MIF protein affects the reaction [Dextran Sulfate results in increased expression of MMP13 mRNA]; MIF protein affects the reaction [Dextran Sulfate results in increased expression of TNF mRNA]
CTD PMID:12105854 NCBI chr10:75,695,187...75,696,111
Ensembl chr10:75,695,187...75,696,074
JBrowse link
G Miox myo-inositol oxygenase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MIOX mRNA CTD PMID:29950665 NCBI chr15:89,218,676...89,221,210
Ensembl chr15:89,218,601...89,221,218
JBrowse link
G Mki67 antigen identified by monoclonal antibody Ki 67 multiple interactions
decreases expression
ISO
EXP
[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein; Melatonin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein]
[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein; [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of MKI67 protein; berberrubine inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of MKI67 protein]; biochanin A inhibits the reaction [Dextran Sulfate results in decreased expression of MKI67 protein]
CTD PMID:19028472 PMID:34273909 PMID:37871880 PMID:38648921 NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090
JBrowse link
G Mlkl mixed lineage kinase domain-like increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of MLKL protein
dihydrotanshinone I inhibits the reaction [Dextran Sulfate results in increased expression of MLKL protein]
CTD PMID:29496522 NCBI chr 8:112,037,879...112,065,081
Ensembl chr 8:112,038,429...112,064,809
JBrowse link
G Mme membrane metallo endopeptidase multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MME mRNA
Dextran Sulfate results in decreased expression of MME mRNA
CTD PMID:29950665 PMID:35093514 NCBI chr 3:63,202,632...63,291,134
Ensembl chr 3:63,148,958...63,293,451
JBrowse link
G Mmp10 matrix metallopeptidase 10 increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of MMP10 mRNA
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MMP10 mRNA
CTD PMID:20824662 PMID:29950665 NCBI chr 9:7,502,343...7,510,243
Ensembl chr 9:7,502,353...7,510,241
JBrowse link
G Mmp12 matrix metallopeptidase 12 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MMP12 mRNA CTD PMID:29950665 NCBI chr 9:7,344,397...7,360,461
Ensembl chr 9:7,344,381...7,369,499
JBrowse link
G Mmp13 matrix metallopeptidase 13 multiple interactions
increases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MMP13 mRNA; MIF protein affects the reaction [Dextran Sulfate results in increased expression of MMP13 mRNA]; Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of MMP13 mRNA] CTD PMID:12105854 PMID:19285099 PMID:20824662 PMID:23894361 PMID:29950665 NCBI chr 9:7,272,514...7,283,333
Ensembl chr 9:7,272,514...7,283,331
JBrowse link
G Mmp14 matrix metallopeptidase 14 (membrane-inserted) multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MMP14 mRNA CTD PMID:29950665 NCBI chr14:54,669,055...54,679,913
Ensembl chr14:54,669,069...54,682,821
JBrowse link
G Mmp15 matrix metallopeptidase 15 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MMP15 mRNA CTD PMID:29950665 NCBI chr 8:96,078,924...96,100,921
Ensembl chr 8:96,078,896...96,101,708
JBrowse link
G Mmp19 matrix metallopeptidase 19 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MMP19 mRNA CTD PMID:29950665 NCBI chr10:128,626,779...128,636,696
Ensembl chr10:128,626,779...128,636,693
JBrowse link
G Mmp2 matrix metallopeptidase 2 increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of MMP2 mRNA; Dextran Sulfate results in increased expression of MMP2 protein
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MMP2 mRNA; Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of MMP2 mRNA]; Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of MMP2 protein]
CTD PMID:19285099 PMID:29950665 NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
JBrowse link
G Mmp23 matrix metallopeptidase 23 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MMP23 mRNA CTD PMID:29950665 NCBI chr 4:155,735,111...155,738,982
Ensembl chr 4:155,735,112...155,737,841
JBrowse link
G Mmp3 matrix metallopeptidase 3 multiple interactions
increases expression
EXP Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of MMP3 mRNA]; Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of MMP3 mRNA] CTD PMID:19285099 PMID:20824662 PMID:32033881 NCBI chr 9:7,445,845...7,455,975
Ensembl chr 9:7,445,822...7,455,975
JBrowse link
G Mmp7 matrix metallopeptidase 7 multiple interactions EXP [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of MMP7 mRNA; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of MMP7 mRNA] CTD PMID:31715269 NCBI chr 9:7,692,095...7,699,587
Ensembl chr 9:7,692,091...7,699,587
JBrowse link
G Mmp8 matrix metallopeptidase 8 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MMP8 mRNA CTD PMID:29950665 NCBI chr 9:7,558,430...7,568,487
Ensembl chr 9:7,558,457...7,568,486
JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions
increases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MMP9 mRNA; apigenin-6,8-di-C-glycopyranoside inhibits the reaction [Dextran Sulfate results in increased expression of MMP9 protein]; mangiferin inhibits the reaction [Dextran Sulfate results in increased expression of MMP9 protein]; Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of MMP9 mRNA]; Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of MMP9 protein]; Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of MMP9 mRNA]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased expression of MMP9 protein]
Dextran Sulfate results in increased expression of MMP9 mRNA; Dextran Sulfate results in increased expression of MMP9 protein
CTD PMID:19285099 PMID:27125760 PMID:29950665 PMID:30972795 PMID:32033881 NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
JBrowse link
G Mmut methylmalonyl-Coenzyme A mutase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MMUT mRNA CTD PMID:29950665 NCBI chr17:41,245,576...41,272,880
Ensembl chr17:41,245,576...41,272,879
JBrowse link
G Mndal myeloid nuclear differentiation antigen like multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MNDAL mRNA CTD PMID:29950665 NCBI chr 1:173,684,786...173,708,038
Ensembl chr 1:173,676,692...173,708,447
JBrowse link
G Mns1 meiosis-specific nuclear structural protein 1 increases expression EXP Dextran Sulfate results in increased expression of MNS1 mRNA CTD PMID:35093514 NCBI chr 9:72,345,276...72,366,036
Ensembl chr 9:72,345,293...72,369,307
JBrowse link
G Morn2 MORN repeat containing 2 increases expression EXP Dextran Sulfate results in increased expression of MORN2 mRNA CTD PMID:35093514 NCBI chr17:80,597,626...80,613,130
Ensembl chr17:80,597,632...80,604,905
JBrowse link
G Mpeg1 macrophage expressed gene 1 increases expression EXP Dextran Sulfate results in increased expression of MPEG1 mRNA CTD PMID:23894361 NCBI chr19:12,438,134...12,442,649
Ensembl chr19:12,438,143...12,442,649
JBrowse link
G Mpi mannose phosphate isomerase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MPI mRNA CTD PMID:29950665 NCBI chr 9:57,448,744...57,460,095
Ensembl chr 9:57,451,539...57,460,046
JBrowse link
G Mpig6b megakaryocyte and platelet inhibitory receptor G6b decreases expression EXP Dextran Sulfate results in decreased expression of MPIG6B protein CTD PMID:35999755 NCBI chr17:35,281,669...35,285,761
Ensembl chr17:35,281,669...35,285,160
JBrowse link
G Mpo myeloperoxidase multiple interactions
increases expression
increases activity
increases secretion
ISO
EXP
Capsaicin inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; celastrol inhibits the reaction [Dextran Sulfate results in increased expression of MPO protein]; kappa-casein glycomacropeptide inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; lafutidine inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Dextran Sulfate results in increased expression of MPO protein]; Oligosaccharides inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; Olmesartan Medoxomil inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; Rosiglitazone inhibits the reaction [Dextran Sulfate results in increased expression of MPO protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; zileuton inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]
(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; 17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpinetin inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]]; 4-methylesculetin inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; [APC protein affects the susceptibility to Dextran Sulfate] which affects the activity of MPO protein; [Dextran Sulfate co-treated with Zearalenone] results in increased secretion of MPO protein; [Probenecid binds to Dextrans] inhibits the reaction [Dextran Sulfate results in increased secretion of MPO protein]; [RASSF1 gene mutant form results in increased susceptibility to Dextran Sulfate] which results in increased activity of MPO protein; [Streptozocin co-treated with Dextran Sulfate] results in increased activity of MPO protein; alpinetin inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; apigenin-6,8-di-C-glycopyranoside inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; asperuloside inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; biochanin A inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; celastrol inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; Cholecalciferol inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; CNR2 gene mutant form promotes the reaction [Dextran Sulfate results in increased secretion of MPO protein]; Coumarins inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; Dexamethasone inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; dihydrotanshinone I inhibits the reaction [Dextran Sulfate results in increased expression of MPO protein]; fraxinellone inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; geraniol inhibits the reaction [Dextran Sulfate results in increased expression of MPO protein]; gingerol inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; glyceryl 2-arachidonate inhibits the reaction [Serotonin promotes the reaction [Dextran Sulfate results in increased activity of MPO protein]]; GR 113808 inhibits the reaction [Serotonin promotes the reaction [Dextran Sulfate results in increased activity of MPO protein]]; Granisetron inhibits the reaction [Serotonin promotes the reaction [Dextran Sulfate results in increased activity of MPO protein]]; HU 211 inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; hydroxysafflor yellow A inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; icilin inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; isovitexin inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; Leucine inhibits the reaction [alpinetin inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]]; ligustilide inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; mangiferin inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; monotropein inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; morphiceptin analog inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Dextran Sulfate results in increased expression of MPO protein]; nitazoxanide inhibits the reaction [Dextran Sulfate results in increased secretion of MPO protein]; notoginsenoside R1 inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; Plant Extracts inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; PNU-282987 inhibits the reaction [Dextran Sulfate results in increased expression of MPO protein]; Qingdai compound inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; resolvin D1 inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; resolvin D2 inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; resorcinol inhibits the reaction [[APC protein affects the susceptibility to Dextran Sulfate] which affects the activity of MPO protein]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; SB 203580 inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; Serotonin promotes the reaction [Dextran Sulfate results in increased activity of MPO protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; TLR4 protein affects the reaction [HU 211 inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]]; Tropisetron inhibits the reaction [Dextran Sulfate results in increased expression of MPO protein]; tussilagone inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]; Zearalenone inhibits the reaction [Dextran Sulfate results in increased secretion of MPO protein]
CTD PMID:11766996 PMID:15339030 PMID:15573930 PMID:16375993 PMID:20637373 More... NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
JBrowse link
G Mrc1 mannose receptor, C type 1 multiple interactions
decreases expression
EXP [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MRC1 mRNA; [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MRC1 protein; BCL6 protein inhibits the reaction [Dextran Sulfate results in decreased expression of MRC1 mRNA]; BCL6 protein inhibits the reaction [Dextran Sulfate results in decreased expression of MRC1 protein]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in decreased expression of MRC1 mRNA]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in decreased expression of MRC1 protein]]; IRF4 protein promotes the reaction [Dextran Sulfate results in decreased expression of MRC1 mRNA]; IRF4 protein promotes the reaction [Dextran Sulfate results in decreased expression of MRC1 protein]; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MRC1 mRNA]; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MRC1 protein]
Dextran Sulfate results in decreased expression of MRC1 mRNA; Dextran Sulfate results in decreased expression of MRC1 protein
CTD PMID:25026504 PMID:38164749 NCBI chr 2:14,234,225...14,336,834
Ensembl chr 2:14,234,203...14,336,868
JBrowse link
G Mrgprb4 MAS-related GPR, member B4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MRGPRB4 mRNA CTD PMID:29950665 NCBI chr 7:47,847,961...47,848,926
Ensembl chr 7:47,847,818...47,849,036
JBrowse link
G Mrpl20 mitochondrial ribosomal protein L20 increases expression EXP Dextran Sulfate results in increased expression of MRPL20 mRNA CTD PMID:35093514 NCBI chr 4:155,887,335...155,893,288
Ensembl chr 4:155,887,335...155,894,432
JBrowse link
G Ms4a1 membrane-spanning 4-domains, subfamily A, member 1 increases expression EXP Dextran Sulfate results in increased expression of MS4A1 mRNA CTD PMID:23894361 NCBI chr19:11,227,043...11,243,513
Ensembl chr19:11,227,039...11,243,605
JBrowse link
G Msmo1 methylsterol monoxygenase 1 decreases expression EXP Dextran Sulfate results in decreased expression of MSMO1 mRNA CTD PMID:35093514 NCBI chr 8:65,171,157...65,186,822
Ensembl chr 8:65,171,173...65,186,826
JBrowse link
G Msn moesin multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MSN mRNA CTD PMID:29950665 NCBI chr  X:95,139,651...95,212,159
Ensembl chr  X:95,139,648...95,212,158
JBrowse link
G mt-Nd6 NADH dehydrogenase 6, mitochondrial increases expression EXP Dextran Sulfate results in increased expression of ND6 mRNA CTD PMID:23894361 NCBI chr MT:13,552...14,070
Ensembl chr MT:13,552...14,070
JBrowse link
G Mt1 metallothionein 1 multiple interactions
increases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MT1 mRNA
Dextran Sulfate results in increased expression of MT1 mRNA
CTD PMID:29950665 PMID:35093514 NCBI chr 8:94,905,214...94,906,955
Ensembl chr 8:94,905,710...94,906,955
JBrowse link
G Mt2 metallothionein 2 increases expression EXP Dextran Sulfate results in increased expression of MT2 mRNA CTD PMID:35093514 NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196
JBrowse link
G Mtnr1a melatonin receptor 1A multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MTNR1A mRNA CTD PMID:29950665 NCBI chr 8:45,522,144...45,542,270
Ensembl chr 8:45,522,174...45,541,543
JBrowse link
G Mtnr1b melatonin receptor 1B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MTNR1B mRNA CTD PMID:29950665 NCBI chr 9:15,773,910...15,785,852
Ensembl chr 9:15,735,824...15,785,852
JBrowse link
G Mtor mechanistic target of rapamycin kinase increases expression
multiple interactions
decreases phosphorylation
increases phosphorylation
EXP
ISO
Dextran Sulfate results in increased expression of MTOR protein
biochanin A inhibits the reaction [Dextran Sulfate results in increased phosphorylation of MTOR protein]; CNR2 protein affects the reaction [Dextran Sulfate results in decreased phosphorylation of MTOR protein]; Nicotine promotes the reaction [Dextran Sulfate results in decreased phosphorylation of MTOR protein]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of MTOR protein]
dorsomorphin inhibits the reaction [Nicotine promotes the reaction [Dextran Sulfate results in decreased phosphorylation of MTOR protein]]; Nicotine promotes the reaction [Dextran Sulfate results in decreased phosphorylation of MTOR protein]
Dextran Sulfate results in increased expression of MTOR protein modified form
celastrol inhibits the reaction [Dextran Sulfate results in increased expression of MTOR protein modified form]
CTD PMID:26074695 PMID:27611972 PMID:31926917 PMID:32470352 PMID:38648921 NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
JBrowse link
G Mtpn myotrophin decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of MTPN protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of MTPN protein]
CTD PMID:32272095 NCBI chr 6:35,485,759...35,516,823
Ensembl chr 6:35,485,841...35,516,823
JBrowse link
G Muc13 mucin 13, epithelial transmembrane multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MUC13 mRNA CTD PMID:29950665 NCBI chr16:33,614,407...33,640,299
Ensembl chr16:33,614,407...33,640,304
JBrowse link
G Muc2 mucin 2 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of MUC2 mRNA; Dextran Sulfate results in decreased expression of MUC2 protein
biochanin A inhibits the reaction [Dextran Sulfate results in decreased expression of MUC2 protein]
CTD PMID:37385329 PMID:38648921 NCBI chr 7:141,276,583...141,308,428
Ensembl chr 7:141,276,583...141,308,430
JBrowse link
G Muc4 mucin 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MUC4 mRNA CTD PMID:29950665 NCBI chr16:32,555,089...32,602,786
Ensembl chr16:32,555,015...32,602,754
JBrowse link
G Musk muscle, skeletal, receptor tyrosine kinase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MUSK mRNA CTD PMID:29950665 NCBI chr 4:58,285,742...58,377,848
Ensembl chr 4:58,285,962...58,374,303
JBrowse link
G Mybpc1 myosin binding protein C, slow-type multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MYBPC1 mRNA CTD PMID:29950665 NCBI chr10:88,354,141...88,441,051
Ensembl chr10:88,354,141...88,441,014
JBrowse link
G Mybpc2 myosin binding protein C, fast-type multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MYBPC2 mRNA CTD PMID:29950665 NCBI chr 7:44,151,123...44,174,093
Ensembl chr 7:44,151,123...44,174,080
JBrowse link
G Mybpc3 myosin binding protein C, cardiac multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MYBPC3 mRNA CTD PMID:29950665 NCBI chr 2:90,948,459...90,966,862
Ensembl chr 2:90,948,489...90,966,861
JBrowse link
G Myc myelocytomatosis oncogene multiple interactions EXP [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of MYC mRNA; [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of MYC protein; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of MYC mRNA]; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of MYC protein] CTD PMID:31715269 NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
JBrowse link
G Myd88 myeloid differentiation primary response gene 88 multiple interactions EXP Dextran Sulfate promotes the reaction [TLR2 protein binds to MYD88 protein]; flavokawain B inhibits the reaction [Dextran Sulfate promotes the reaction [TLR2 protein binds to MYD88 protein]] CTD PMID:38583725 NCBI chr 9:119,165,000...119,169,084
Ensembl chr 9:119,165,000...119,170,477
JBrowse link
G Myh8 myosin, heavy polypeptide 8, skeletal muscle, perinatal multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MYH8 mRNA CTD PMID:29950665 NCBI chr11:67,167,950...67,199,460
Ensembl chr11:67,167,950...67,199,460
JBrowse link
G Myh9 myosin, heavy polypeptide 9, non-muscle decreases expression EXP Dextran Sulfate results in decreased expression of MYH9 protein CTD PMID:35999755 NCBI chr15:77,644,788...77,726,315
Ensembl chr15:77,644,787...77,726,375
JBrowse link
G Myl1 myosin, light polypeptide 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MYL1 mRNA CTD PMID:29950665 NCBI chr 1:66,963,454...66,987,091
Ensembl chr 1:66,963,454...66,984,563
JBrowse link
G Myl3 myosin, light polypeptide 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MYL3 mRNA CTD PMID:29950665 NCBI chr 9:110,592,746...110,598,870
Ensembl chr 9:110,570,929...110,598,866
JBrowse link
G Myl4 myosin, light polypeptide 4 increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of MYL4 protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of MYL4 protein]
CTD PMID:32272095 NCBI chr11:104,427,604...104,478,041
Ensembl chr11:104,441,489...104,486,579
JBrowse link
G Myl6 myosin, light polypeptide 6, alkali, smooth muscle and non-muscle decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of MYL6 protein
[Dextran Sulfate co-treated with bisphenol A] results in decreased expression of MYL6 protein
CTD PMID:35999755 NCBI chr10:128,326,728...128,329,755
Ensembl chr10:128,326,729...128,330,014
JBrowse link
G Myl7 myosin, light polypeptide 7, regulatory increases expression EXP Dextran Sulfate results in increased expression of MYL7 mRNA CTD PMID:23894361 NCBI chr11:5,846,637...5,848,782
Ensembl chr11:5,846,637...5,848,782
JBrowse link
G Myl9 myosin, light polypeptide 9, regulatory decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of MYL9 protein
[Dextran Sulfate co-treated with bisphenol A] results in decreased expression of MYL9 protein
CTD PMID:35999755 NCBI chr 2:156,617,373...156,623,578
Ensembl chr 2:156,617,340...156,623,578
JBrowse link
G Mylk2 myosin, light polypeptide kinase 2, skeletal muscle multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MYLK2 mRNA CTD PMID:29950665 NCBI chr 2:152,753,265...152,764,985
Ensembl chr 2:152,753,272...152,764,988
JBrowse link
G Myo1b myosin IB multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of MYO1B protein] CTD PMID:32272095 NCBI chr 1:51,788,915...51,955,143
Ensembl chr 1:51,788,924...51,955,230
JBrowse link
G Myo5b myosin VB decreases expression EXP Dextran Sulfate results in decreased expression of MYO5B mRNA CTD PMID:37385329 NCBI chr18:74,575,435...74,905,769
Ensembl chr18:74,574,007...74,904,564
JBrowse link
G Myo7a myosin VIIA multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MYO7A mRNA CTD PMID:29950665 NCBI chr 7:97,700,261...97,768,730
Ensembl chr 7:97,700,267...97,768,731
JBrowse link
G N4bp3 NEDD4 binding protein 3 increases expression EXP Dextran Sulfate results in increased expression of N4BP3 mRNA CTD PMID:35093514 NCBI chr11:51,533,908...51,541,664
Ensembl chr11:51,533,890...51,541,669
JBrowse link
G Nalcn sodium leak channel, non-selective multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of NALCN mRNA CTD PMID:29950665 NCBI chr14:123,514,046...123,864,846
Ensembl chr14:123,514,046...123,864,556
JBrowse link
G Nans N-acetylneuraminic acid synthase (sialic acid synthase) multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of NANS mRNA CTD PMID:29950665 NCBI chr 4:46,489,319...46,503,439
Ensembl chr 4:46,489,248...46,503,632
JBrowse link
G Napepld N-acyl phosphatidylethanolamine phospholipase D decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of NAPEPLD protein
GR 113808 inhibits the reaction [Serotonin promotes the reaction [Dextran Sulfate results in decreased expression of NAPEPLD protein]]; Granisetron inhibits the reaction [Serotonin promotes the reaction [Dextran Sulfate results in decreased expression of NAPEPLD protein]]; Serotonin promotes the reaction [Dextran Sulfate results in decreased expression of NAPEPLD protein]
CTD PMID:30611738 NCBI chr 5:21,867,899...21,906,620
Ensembl chr 5:21,867,899...21,906,394
JBrowse link
G Nat2 N-acetyltransferase 2 (arylamine N-acetyltransferase) multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of NAT2 mRNA CTD PMID:29950665 NCBI chr 8:67,947,527...67,955,296
Ensembl chr 8:67,947,510...67,955,236
JBrowse link
G Nat3 N-acetyltransferase 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of NAT3 mRNA CTD PMID:29950665 NCBI chr 8:67,976,506...68,001,279
Ensembl chr 8:67,976,506...68,001,279
JBrowse link
G Ncan neurocan multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NCAN mRNA CTD PMID:29950665 NCBI chr 8:70,545,735...70,573,494
Ensembl chr 8:70,545,735...70,573,523
JBrowse link
G Nceh1 neutral cholesterol ester hydrolase 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of NCEH1 mRNA CTD PMID:29950665 NCBI chr 3:27,237,153...27,299,112
Ensembl chr 3:27,237,114...27,338,757
JBrowse link
G Nckipsd NCK interacting protein with SH3 domain multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NCKIPSD mRNA CTD PMID:29950665 NCBI chr 9:108,685,515...108,696,044
Ensembl chr 9:108,685,567...108,696,043
JBrowse link
G Ncor2 nuclear receptor co-repressor 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of NCOR2 mRNA CTD PMID:29950665 NCBI chr 5:125,094,217...125,256,302
Ensembl chr 5:125,094,217...125,256,283
JBrowse link
G Ndrg2 N-myc downstream regulated gene 2 multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of NDRG2 protein] CTD PMID:32272095 NCBI chr14:52,142,738...52,151,463
Ensembl chr14:52,142,728...52,151,615
JBrowse link
G Ndufaf3 NADH:ubiquinone oxidoreductase complex assembly factor 3 increases expression EXP Dextran Sulfate results in increased expression of NDUFAF3 mRNA CTD PMID:35093514 NCBI chr 9:108,442,786...108,444,635
Ensembl chr 9:108,442,736...108,444,633
JBrowse link
G Neb nebulin multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NEB mRNA CTD PMID:29950665 NCBI chr 2:52,026,652...52,228,810
Ensembl chr 2:52,026,659...52,268,486
JBrowse link
G Nedd4 neural precursor cell expressed, developmentally down-regulated 4 multiple interactions EXP [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of NEDD4 mRNA CTD PMID:26271895 NCBI chr 9:72,569,613...72,657,133
Ensembl chr 9:72,569,628...72,657,134
JBrowse link
G Neurod1 neurogenic differentiation 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of NEUROD1 mRNA CTD PMID:29950665 NCBI chr 2:79,282,981...79,286,980
Ensembl chr 2:79,282,865...79,287,095
JBrowse link
G Nfat5 nuclear factor of activated T cells 5 increases activity
decreases expression
EXP Dextran Sulfate results in increased activity of NFAT5 protein
Dextran Sulfate results in decreased expression of NFAT5 mRNA
CTD PMID:27920257 PMID:35093514 NCBI chr 8:108,020,072...108,106,149
Ensembl chr 8:108,020,102...108,106,149
JBrowse link
G Nfe2l2 nuclear factor, erythroid derived 2, like 2 affects response to substance
decreases expression
multiple interactions
EXP NFE2L2 affects the susceptibility to Dextran Sulfate
Dextran Sulfate results in decreased expression of NFE2L2 mRNA; Dextran Sulfate results in decreased expression of NFE2L2 protein
[asperuloside co-treated with Dextran Sulfate] results in increased expression of NFE2L2 protein; [Cholecalciferol co-treated with Dextran Sulfate] results in increased expression of NFE2L2 protein; gingerenone A inhibits the reaction [Dextran Sulfate results in decreased expression of NFE2L2 protein]; NFE2L2 protein affects the reaction [Butylated Hydroxyanisole affects the reaction [Dextran Sulfate affects the expression of IL6 protein]]; NFE2L2 protein affects the reaction [Butylated Hydroxyanisole affects the reaction [Dextran Sulfate affects the expression of TNF protein]]; NFE2L2 protein affects the reaction [Butylated Hydroxyanisole inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein]]; NFE2L2 protein affects the reaction [Resveratrol affects the reaction [Dextran Sulfate affects the expression of IL6 protein]]; NFE2L2 protein affects the reaction [Resveratrol affects the reaction [Dextran Sulfate affects the expression of TNF protein]]; NFE2L2 protein affects the reaction [Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein]]; NFE2L2 protein affects the susceptibility to [Azoxymethane co-treated with Dextran Sulfate]; NFE2L2 results in decreased susceptibility to [Dextran Sulfate co-treated with Azoxymethane]; Qingdai compound inhibits the reaction [Dextran Sulfate results in decreased expression of NFE2L2 mRNA]; tussilagone inhibits the reaction [Dextran Sulfate results in decreased expression of NFE2L2 protein]
CTD PMID:20404090 PMID:23056183 PMID:23261717 PMID:30142311 PMID:30844440 More... NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
JBrowse link
G Nfkb1 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 multiple interactions
affects localization
ISO
EXP
[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of NFKB1 protein; Melatonin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of NFKB1 protein]
monotropein inhibits the reaction [Dextran Sulfate affects the localization of NFKB1 protein]
CTD PMID:19028472 PMID:23261679 NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308
JBrowse link
G Nfkbia nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha multiple interactions
increases expression
increases phosphorylation
decreases expression
EXP
ISO
17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid inhibits the reaction [Dextran Sulfate results in increased expression of NFKBIA mRNA]; Dextran Sulfate results in increased phosphorylation of and results in increased degradation of NFKBIA protein; Erianin inhibits the reaction [Dextran Sulfate results in increased phosphorylation of NFKBIA protein]; flavokawain B inhibits the reaction [Dextran Sulfate results in decreased expression of NFKBIA protein]; geraniol inhibits the reaction [Dextran Sulfate results in increased phosphorylation of NFKBIA protein]; monotropein inhibits the reaction [Dextran Sulfate results in increased phosphorylation of NFKBIA protein]; notoginsenoside R1 inhibits the reaction [Dextran Sulfate results in increased phosphorylation of NFKBIA protein]; resolvin D1 inhibits the reaction [Dextran Sulfate results in increased expression of NFKBIA mRNA]; resolvin D2 inhibits the reaction [Dextran Sulfate results in increased expression of NFKBIA mRNA]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased phosphorylation of NFKBIA protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased phosphorylation of NFKBIA protein]
banxia xiexin decoction inhibits the reaction [Dextran Sulfate results in increased phosphorylation of NFKBIA protein]; palmatine inhibits the reaction [Dextran Sulfate results in increased phosphorylation of NFKBIA protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased phosphorylation of NFKBIA protein]
CTD PMID:19940103 PMID:21724996 PMID:23261679 PMID:25472953 PMID:26190278 More... NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
JBrowse link
G Nfkbil1 nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor like 1 increases expression EXP Dextran Sulfate results in increased expression of NFKBIL1 mRNA CTD PMID:35093514 NCBI chr17:35,439,151...35,455,457
Ensembl chr17:35,439,151...35,454,768
JBrowse link
G Ngp neutrophilic granule protein increases expression
multiple interactions
decreases expression
EXP Dextran Sulfate results in increased expression of NGP protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of NGP protein]
Dextran Sulfate results in decreased expression of NGP protein
CTD PMID:32272095 PMID:35999755 NCBI chr 9:110,248,876...110,252,080
Ensembl chr 9:110,248,815...110,252,080
JBrowse link
G Niban1 niban apoptosis regulator 1 decreases expression EXP Dextran Sulfate results in decreased expression of NIBAN1 mRNA CTD PMID:35093514 NCBI chr 1:151,447,215...151,597,690
Ensembl chr 1:151,446,937...151,597,690
JBrowse link
G Nid2 nidogen 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NID2 mRNA CTD PMID:29950665 NCBI chr14:19,801,325...19,861,855
Ensembl chr14:19,801,333...19,861,855
JBrowse link
G Nkd1 naked cuticle 1 multiple interactions EXP [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of NKD1 mRNA; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of NKD1 mRNA] CTD PMID:31715269 NCBI chr 8:89,247,961...89,321,515
Ensembl chr 8:89,247,982...89,321,512
JBrowse link
G Nkx2-2 NK2 homeobox 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of NKX2-2 mRNA CTD PMID:29950665 NCBI chr 2:146,967,909...147,037,270
Ensembl chr 2:147,019,466...147,036,163
JBrowse link
G Nlgn1 neuroligin 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NLGN1 mRNA CTD PMID:29950665 NCBI chr 3:25,475,972...26,387,504
Ensembl chr 3:25,480,379...26,386,609
JBrowse link
G Nlgn3 neuroligin 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NLGN3 mRNA CTD PMID:29950665 NCBI chr  X:100,342,785...100,364,956
Ensembl chr  X:100,342,774...100,369,569
JBrowse link
G Nln neurolysin (metallopeptidase M3 family) decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of NLN protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of NLN protein]
CTD PMID:32272095 NCBI chr13:104,159,558...104,246,170
Ensembl chr13:104,159,565...104,246,122
JBrowse link
G Nlrc5 NLR family, CARD domain containing 5 increases expression EXP Dextran Sulfate results in increased expression of NLRC5 mRNA CTD PMID:23894361 NCBI chr 8:95,160,963...95,253,900
Ensembl chr 8:95,160,984...95,253,900
JBrowse link
G Nlrp1a NLR family, pyrin domain containing 1A multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NLRP1A mRNA CTD PMID:29950665 NCBI chr11:70,982,023...71,035,780
Ensembl chr11:70,983,062...71,035,530
JBrowse link
G Nlrp3 NLR family, pyrin domain containing 3 increases expression
multiple interactions
EXP
ISO
Dextran Sulfate results in increased expression of NLRP3 mRNA; Dextran Sulfate results in increased expression of NLRP3 protein
[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of NLRP3 protein; [Dextran Sulfate co-treated with Zearalenone] results in increased expression of NLRP3 mRNA; [Dextran Sulfate co-treated with Zearalenone] results in increased expression of NLRP3 protein; [HU 308 co-treated with Dextran Sulfate] affects the expression of NLRP3 protein; CNR2 protein affects the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of NLRP3 protein]; Dextran Sulfate inhibits the reaction [Zearalenone results in increased expression of NLRP3 mRNA]; hydroxysafflor yellow A inhibits the reaction [Dextran Sulfate results in increased expression of NLRP3 protein]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased expression of NLRP3 protein]; Zearalenone inhibits the reaction [Dextran Sulfate results in increased expression of NLRP3 mRNA]; Zearalenone inhibits the reaction [Dextran Sulfate results in increased expression of NLRP3 protein]
celastrol inhibits the reaction [Dextran Sulfate results in increased expression of NLRP3 mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Dextran Sulfate results in increased expression of NLRP3 mRNA]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide promotes the reaction [celastrol inhibits the reaction [Dextran Sulfate results in increased expression of NLRP3 mRNA]]
CTD PMID:27611972 PMID:30270565 PMID:32470352 PMID:37001609 NCBI chr11:59,432,395...59,457,781
Ensembl chr11:59,432,394...59,457,782
JBrowse link
G Nmb neuromedin B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NMB mRNA CTD PMID:29950665 NCBI chr 7:80,551,975...80,554,810
Ensembl chr 7:80,551,975...80,554,824
JBrowse link
G Nme1 NME/NM23 nucleoside diphosphate kinase 1 decreases expression EXP Dextran Sulfate results in decreased expression of NME1 protein CTD PMID:35999755 NCBI chr11:93,849,751...93,859,341
Ensembl chr11:93,847,805...93,859,347
JBrowse link
G Nme2 NME/NM23 nucleoside diphosphate kinase 2 decreases expression EXP Dextran Sulfate results in decreased expression of NME2 protein CTD PMID:35999755 NCBI chr11:93,840,640...93,847,082
Ensembl chr11:93,840,640...93,847,085
JBrowse link
G Nmur2 neuromedin U receptor 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of NMUR2 mRNA CTD PMID:29950665 NCBI chr11:55,915,816...55,931,813
Ensembl chr11:55,915,813...55,931,836
JBrowse link
G Nos2 nitric oxide synthase 2, inducible multiple interactions
affects response to substance
increases expression
increases activity
EXP 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 protein]; 7-hydroxyl-1-methylindole-3-acetonitrile inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 protein]; [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with Dextran Sulfate] results in increased expression of NOS2 protein; [Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NOS2 mRNA; [Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NOS2 protein; [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of NOS2 mRNA; apigenin-6,8-di-C-glycopyranoside inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 protein]; BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 mRNA]; BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 protein]; Dexamethasone inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 mRNA]; dihydrotanshinone I inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 protein]; EIF2AK2 protein affects the reaction [Dextran Sulfate results in increased expression of NOS2 mRNA]; fraxinellone inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 mRNA]; geraniol inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 protein]; GW 506033X inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 mRNA]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 mRNA]]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 protein]]; IRF4 protein promotes the reaction [Dextran Sulfate results in increased expression of NOS2 mRNA]; IRF4 protein promotes the reaction [Dextran Sulfate results in increased expression of NOS2 protein]; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NOS2 mRNA]; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NOS2 protein]; ligustilide inhibits the reaction [Dextran Sulfate results in increased activity of NOS2 protein]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased activity of NOS2 protein]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 protein]; Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 mRNA]; Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 protein]; monotropein inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 protein]; notoginsenoside R1 inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 mRNA]; Plant Extracts inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 protein]; Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 mRNA]; RELA protein affects the reaction [Dextran Sulfate results in increased expression of NOS2 mRNA]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 mRNA]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 protein]; thiamet G promotes the reaction [Dextran Sulfate results in increased expression of NOS2 mRNA]; tussilagone inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 mRNA]; tussilagone inhibits the reaction [Dextran Sulfate results in increased expression of NOS2 protein]; Ursodeoxycholic Acid inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of NOS2 mRNA]
NOS2 protein affects the susceptibility to Dextran Sulfate
Dextran Sulfate results in increased expression of NOS2 mRNA; Dextran Sulfate results in increased expression of NOS2 protein
CTD PMID:15459021 PMID:15652231 PMID:16049979 PMID:17438113 PMID:17449036 More... NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
JBrowse link
G Nos3 nitric oxide synthase 3, endothelial cell multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NOS3 mRNA CTD PMID:29950665 NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
JBrowse link
G Notum notum palmitoleoyl-protein carboxylesterase multiple interactions EXP [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of NOTUM mRNA; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of NOTUM mRNA] CTD PMID:31715269 NCBI chr11:120,544,614...120,552,019
Ensembl chr11:120,544,614...120,552,001
JBrowse link
G Nox4 NADPH oxidase 4 increases expression EXP Dextran Sulfate results in increased expression of NOX4 mRNA; Dextran Sulfate results in increased expression of NOX4 protein CTD PMID:36281492 NCBI chr 7:86,893,638...87,047,918
Ensembl chr 7:86,895,304...87,047,918
JBrowse link
G Npl N-acetylneuraminate pyruvate lyase increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of NPL protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of NPL protein]
CTD PMID:32272095 NCBI chr 1:153,378,762...153,425,460
Ensembl chr 1:153,378,761...153,425,791
JBrowse link
G Nptx1 neuronal pentraxin 1 multiple interactions EXP [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of NPTX1 mRNA CTD PMID:26271895 NCBI chr11:119,429,545...119,438,646
Ensembl chr11:119,429,545...119,438,579
JBrowse link
G Npy neuropeptide Y multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NPY mRNA CTD PMID:29950665 NCBI chr 6:49,799,690...49,806,487
Ensembl chr 6:49,799,690...49,806,487
JBrowse link
G Npy1r neuropeptide Y receptor Y1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NPY1R mRNA CTD PMID:29950665 NCBI chr 8:67,149,595...67,159,452
Ensembl chr 8:67,149,844...67,159,444
JBrowse link
G Npy2r neuropeptide Y receptor Y2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of NPY2R mRNA CTD PMID:29950665 NCBI chr 3:82,445,688...82,455,404
Ensembl chr 3:82,445,690...82,455,391
JBrowse link
G Nqo1 NAD(P)H dehydrogenase, quinone 1 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of NQO1 mRNA; Dextran Sulfate results in decreased expression of NQO1 protein
gingerenone A inhibits the reaction [Dextran Sulfate results in decreased expression of NQO1 protein]
CTD PMID:36135333 NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
JBrowse link
G Nr1h4 nuclear receptor subfamily 1, group H, member 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of NR1H4 mRNA CTD PMID:29950665 NCBI chr10:89,290,096...89,369,484
Ensembl chr10:89,290,096...89,369,447
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of NR1I2 mRNA CTD PMID:29950665 NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
JBrowse link
G Nr5a2 nuclear receptor subfamily 5, group A, member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of NR5A2 mRNA CTD PMID:29950665 NCBI chr 1:136,770,300...136,888,186
Ensembl chr 1:136,770,309...136,888,186
JBrowse link
G Nrk Nik related kinase decreases expression EXP Dextran Sulfate results in decreased expression of NRK mRNA CTD PMID:35093514 NCBI chr  X:137,814,980...137,911,281
Ensembl chr  X:137,815,179...137,911,281
JBrowse link
G Nrp1 neuropilin 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NRP1 mRNA CTD PMID:29950665 NCBI chr 8:129,085,553...129,231,957
Ensembl chr 8:129,085,085...129,229,844
JBrowse link
G Ntng1 netrin G1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NTNG1 mRNA CTD PMID:29950665 NCBI chr 3:109,687,366...110,057,291
Ensembl chr 3:109,687,356...110,051,327
JBrowse link
G Nts neurotensin multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of NTS mRNA CTD PMID:29950665 NCBI chr10:102,317,617...102,326,294
Ensembl chr10:102,317,617...102,326,347
JBrowse link
G Nucb1 nucleobindin 1 multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of NUCB1 protein CTD PMID:35999755 NCBI chr 7:45,142,300...45,159,813
Ensembl chr 7:45,139,882...45,159,830
JBrowse link
G Nudc nudC nuclear distribution protein increases expression EXP Dextran Sulfate results in increased expression of NUDC mRNA CTD PMID:35093514 NCBI chr 4:133,259,853...133,273,338
Ensembl chr 4:133,259,853...133,273,307
JBrowse link
G Nudt16 nudix hydrolase 16 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of NUDT16 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of NUDT16 protein]
CTD PMID:32272095 NCBI chr 9:105,006,531...105,010,332
Ensembl chr 9:105,006,102...105,009,023
JBrowse link
G Nup205 nucleoporin 205 multiple interactions
increases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in increased expression of NUP205 protein] CTD PMID:32272095 NCBI chr 6:35,154,551...35,224,534
Ensembl chr 6:35,154,356...35,224,531
JBrowse link
G Nupr2 nuclear protein transcriptional regulator 2 increases expression EXP Dextran Sulfate results in increased expression of NUPR2 mRNA CTD PMID:35093514 NCBI chr 5:129,937,381...129,942,629
Ensembl chr 5:129,937,381...129,942,630
JBrowse link
G Obp1a odorant binding protein IA multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in increased expression of OBP1A protein CTD PMID:35999755 NCBI chr  X:77,129,111...77,134,980
Ensembl chr  X:77,129,111...77,134,980
JBrowse link
G Ocln occludin decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of OCLN mRNA; Dextran Sulfate results in decreased expression of OCLN protein
7-hydroxyl-1-methylindole-3-acetonitrile inhibits the reaction [Dextran Sulfate results in decreased expression of OCLN protein]; [Dietary Fats co-treated with Dextran Sulfate] results in increased expression of OCLN protein; biochanin A inhibits the reaction [Dextran Sulfate results in decreased expression of OCLN protein]; daphnetin inhibits the reaction [Dextran Sulfate results in decreased expression of OCLN protein]; HU 211 inhibits the reaction [Dextran Sulfate results in decreased expression of OCLN mRNA]; hydroxysafflor yellow A inhibits the reaction [Dextran Sulfate results in decreased expression of OCLN protein]; nitazoxanide inhibits the reaction [Dextran Sulfate results in decreased expression of OCLN protein]; obeticholic acid promotes the reaction [[Dietary Fats co-treated with Dextran Sulfate] results in increased expression of OCLN protein]
CTD PMID:23261717 PMID:27995407 PMID:35439472 PMID:35670535 PMID:36281492 More... NCBI chr13:100,633,012...100,689,226
Ensembl chr13:100,633,015...100,689,226
JBrowse link
G Oga O-GlcNAcase multiple interactions
decreases expression
EXP Resveratrol inhibits the reaction [Dextran Sulfate results in decreased expression of OGA protein]; thiamet G inhibits the reaction [Dextran Sulfate results in decreased expression of OGA protein] CTD PMID:38437956 NCBI chr19:45,738,698...45,772,274
Ensembl chr19:45,738,698...45,772,276
JBrowse link
G Ogt O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase) multiple interactions
increases expression
EXP Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of OGT protein]; thiamet G inhibits the reaction [Dextran Sulfate results in increased expression of OGT protein] CTD PMID:38437956 NCBI chr  X:100,683,617...100,727,957
Ensembl chr  X:100,683,666...100,727,957
JBrowse link
G Olfr100 olfactory receptor 100 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OLFR100 mRNA CTD PMID:29950665
G Opn1mw opsin 1 (cone pigments), medium-wave-sensitive (color blindness, deutan) multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OPN1MW mRNA CTD PMID:29950665 NCBI chr  X:73,171,072...73,194,362
Ensembl chr  X:73,171,070...73,194,366
JBrowse link
G Oprd1 opioid receptor, delta 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OPRD1 mRNA CTD PMID:29950665 NCBI chr 4:131,834,980...131,872,042
Ensembl chr 4:131,838,037...131,871,797
JBrowse link
G Oprk1 opioid receptor, kappa 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OPRK1 mRNA CTD PMID:29950665 NCBI chr 1:5,658,673...5,676,357
Ensembl chr 1:5,658,689...5,676,354
JBrowse link
G Or10ad1 olfactory receptor family 10 subfamily AD member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR10AD1 mRNA CTD PMID:29950665 NCBI chr15:98,100,192...98,118,937
Ensembl chr15:98,104,852...98,118,937
JBrowse link
G Or10ag57 olfactory receptor family 10 subfamily AG member 57 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR10AG57 mRNA CTD PMID:29950665 NCBI chr 2:87,218,051...87,219,031
Ensembl chr 2:87,216,193...87,222,274
JBrowse link
G Or10al6 olfactory receptor family 10 subfamily AL member 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR10AL6 mRNA CTD PMID:29950665 NCBI chr17:38,079,533...38,083,511
Ensembl chr17:38,079,498...38,084,640
JBrowse link
G Or10b1 olfactory receptor family 10 subfamily B member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR10B1 mRNA CTD PMID:29950665 NCBI chr10:78,334,017...78,357,117
Ensembl chr10:78,353,262...78,356,400
JBrowse link
G Or10d5 olfactory receptor family 10 subfamily D member 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR10D5 mRNA CTD PMID:29950665 NCBI chr 9:39,861,133...39,862,065
Ensembl chr 9:39,859,427...39,863,342
JBrowse link
G Or10h28 olfactory receptor family 10 subfamily H member 28 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR10H28 mRNA CTD PMID:29950665 NCBI chr17:33,487,700...33,488,650
Ensembl chr17:33,483,650...33,494,618
JBrowse link
G Or10j3 olfactory receptor family 10 subfamily J member 3B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR10J3 mRNA CTD PMID:29950665 NCBI chr 1:173,030,925...173,031,866
Ensembl chr 1:173,025,375...173,033,903
JBrowse link
G Or10v5 olfactory receptor family 10 subfamily V member 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR10V5 mRNA CTD PMID:29950665 NCBI chr19:11,805,441...11,806,388
Ensembl chr19:11,804,167...11,816,583
JBrowse link
G Or11a4 olfactory receptor family 11 subfamily A member 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR11A4 mRNA CTD PMID:29950665 NCBI chr17:37,535,982...37,537,032
Ensembl chr17:37,531,037...37,537,564
JBrowse link
G Or11g7 olfactory receptor family 11 subfamily G member 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR11G7 mRNA CTD PMID:29950665 NCBI chr14:50,690,511...50,693,135
Ensembl chr14:50,683,002...50,694,390
JBrowse link
G Or11m3 olfactory receptor family 11 subfamily M member 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR11M3 mRNA CTD PMID:29950665 NCBI chr15:98,390,281...98,397,312
Ensembl chr15:98,390,283...98,400,518
JBrowse link
G Or11n2 olfactory receptor family 11 subfamily N member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR11N2 mRNA CTD PMID:29950665 NCBI chr  X:48,974,346...48,975,278
Ensembl chr  X:48,971,868...48,980,360
JBrowse link
G Or12j3 olfactory receptor family 12 subfamily J member 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR12J3 mRNA CTD PMID:29950665 NCBI chr 7:139,952,598...139,953,521
Ensembl chr 7:139,951,785...139,956,244
JBrowse link
G Or12k5 olfactory receptor family 12 subfamily K member 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR12K5 mRNA CTD PMID:29950665 NCBI chr 2:36,894,632...36,895,624
Ensembl chr 2:36,892,175...36,899,347
JBrowse link
G Or12k7 olfactory receptor family 12 subfamily K member 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR12K7 mRNA CTD PMID:29950665 NCBI chr 2:36,958,319...36,959,272
Ensembl chr 2:36,955,758...36,959,663
JBrowse link
G Or13a17 olfactory receptor family 13 subfamily A member 17 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR13A17 mRNA CTD PMID:29950665 NCBI chr 7:140,270,797...140,271,832
Ensembl chr 7:140,261,864...140,276,758
JBrowse link
G Or13a18 olfactory receptor family 13 subfamily A member 18 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR13A18 mRNA CTD PMID:29950665 NCBI chr 7:140,181,253...140,191,037
Ensembl chr 7:140,181,182...140,197,591
JBrowse link
G Or13a20 olfactory receptor family 13 subfamily A member 20 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR13A20 mRNA CTD PMID:29950665 NCBI chr 7:140,226,365...140,232,832
Ensembl chr 7:140,226,365...140,232,998
JBrowse link
G Or13a24 olfactory receptor family 13 subfamily A member 24 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR13A24 mRNA CTD PMID:29950665 NCBI chr 7:140,154,068...140,155,000
Ensembl chr 7:140,147,799...140,155,706
JBrowse link
G Or13c25 olfactory receptor family 13 subfamily C member 25 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR13C25 mRNA CTD PMID:29950665 NCBI chr 4:52,910,833...52,911,792
Ensembl chr 4:52,910,207...52,919,178
JBrowse link
G Or13l2 olfactory receptor family 13 subfamily L member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR13L2 mRNA CTD PMID:29950665 NCBI chr 3:97,317,533...97,318,495
Ensembl chr 3:97,314,766...97,329,336
JBrowse link
G Or13p3 olfactory receptor family 13 subfamily P member 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR13P3 mRNA CTD PMID:29950665 NCBI chr 4:118,566,606...118,567,544
Ensembl chr 4:118,560,720...118,570,635
JBrowse link
G Or13p5 olfactory receptor family 13 subfamily P member 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR13P5 mRNA CTD PMID:29950665 NCBI chr 4:118,591,728...118,592,675
Ensembl chr 4:118,589,372...118,594,103
JBrowse link
G Or14j10 olfactory receptor family 14 subfamily J member 10 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR14J10 mRNA CTD PMID:29950665 NCBI chr17:37,934,559...37,935,524
Ensembl chr17:37,931,468...37,938,090
JBrowse link
G Or14j7 olfactory receptor family 14 subfamily J member 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR14J7 mRNA CTD PMID:29950665 NCBI chr17:38,234,459...38,235,385
Ensembl chr17:38,231,439...38,237,692
JBrowse link
G Or1ad1 olfactory receptor family 1 subfamily AD member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR1AD1 mRNA CTD PMID:29950665 NCBI chr11:50,875,530...50,876,453
Ensembl chr11:50,872,794...50,877,420
JBrowse link
G Or1b1 olfactory receptor family 1 subfamily B member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR1B1 mRNA CTD PMID:29950665 NCBI chr 2:36,994,707...36,995,660
Ensembl chr 2:36,991,718...37,007,922
JBrowse link
G Or1e1f olfactory receptor family 1 subfamily E member 1F multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR1E1F mRNA CTD PMID:29950665 NCBI chr11:73,855,436...73,856,383
Ensembl chr11:73,851,643...73,858,638
JBrowse link
G Or1e26 olfactory receptor family 1 subfamily E member 26 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR1E26 mRNA CTD PMID:29950665 NCBI chr11:73,479,624...73,480,562
Ensembl chr11:73,479,128...73,483,834
JBrowse link
G Or1f19 olfactory receptor family 1 subfamily F member 19 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR1F19 mRNA CTD PMID:29950665 NCBI chr16:3,410,262...3,411,203
Ensembl chr16:3,408,906...3,417,187
JBrowse link
G Or1j10 olfactory receptor family 1 subfamily J member 10 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR1J10 mRNA CTD PMID:29950665 NCBI chr 2:36,266,790...36,267,710
Ensembl chr 2:36,263,531...36,272,445
JBrowse link
G Or1j13 olfactory receptor family 1 subfamily J member 13 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR1J13 mRNA CTD PMID:29950665 NCBI chr 2:36,369,199...36,370,140
Ensembl chr 2:36,363,733...36,372,480
JBrowse link
G Or1j15 olfactory receptor family 1 subfamily J member 15 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR1J15 mRNA CTD PMID:29950665 NCBI chr 2:36,458,612...36,459,541
Ensembl chr 2:36,456,674...36,466,190
JBrowse link
G Or1m1 olfactory receptor family 1 subfamily M member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR1M1 mRNA CTD PMID:29950665 NCBI chr 9:18,665,988...18,666,929
Ensembl chr 9:18,662,803...18,675,292
JBrowse link
G Or1o2 olfactory receptor family 1 subfamily O member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR1O2 mRNA CTD PMID:29950665 NCBI chr17:37,542,327...37,543,259
Ensembl chr17:37,541,854...37,548,221
JBrowse link
G Or1q1 olfactory receptor family 1 subfamily Q member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR1Q1 mRNA CTD PMID:29950665 NCBI chr 2:36,886,824...36,887,750
Ensembl chr 2:36,883,839...36,891,859
JBrowse link
G Or1r1 olfactory receptor family 1 subfamily JRmember 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of OR1R1 mRNA CTD PMID:29950665 NCBI chr11:73,874,488...73,875,432
Ensembl chr11:73,870,793...73,881,233
JBrowse link
G Or1s2 olfactory receptor family 1 subfamily S member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR1S2 mRNA CTD PMID:29950665 NCBI chr19:13,757,912...13,758,978
Ensembl chr19:13,755,242...13,760,284
JBrowse link
G Or2a54 olfactory receptor family 2 subfamily A member 54 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR2A54 mRNA CTD PMID:29950665 NCBI chr 6:43,092,678...43,093,610
Ensembl chr 6:43,083,303...43,094,737
JBrowse link
G Or2a57 olfactory receptor family 2 subfamily A member 57 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR2A57 mRNA CTD PMID:29950665 NCBI chr 6:43,212,544...43,213,509
Ensembl chr 6:43,208,463...43,213,893
JBrowse link
G Or2ad1 olfactory receptor family 2 subfamily AD member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR2AD1 mRNA CTD PMID:29950665 NCBI chr13:21,326,281...21,327,225
Ensembl chr13:21,326,052...21,330,037
JBrowse link
G Or2ag17 olfactory receptor family 2 subfamily AG member 17 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR2AG17 mRNA CTD PMID:29950665 NCBI chr 7:106,389,256...106,390,206
Ensembl chr 7:106,387,170...106,392,405
JBrowse link
G Or2ag2b olfactory receptor family 2 subfamily AG member 2B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR2AG2 mRNA CTD PMID:29950665 NCBI chr 7:106,413,336...106,419,916
Ensembl chr 7:106,413,336...106,420,679
JBrowse link
G Or2aj5 olfactory receptor family 2 subfamily AJ member 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR2AJ5 mRNA CTD PMID:29950665 NCBI chr16:19,424,475...19,425,416
Ensembl chr16:19,424,446...19,430,632
JBrowse link
G Or2ak4 olfactory receptor family 2 subfamily AK member 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of OR2AK4 mRNA CTD PMID:29950665 NCBI chr11:58,642,356...58,650,292
Ensembl chr11:58,643,560...58,650,497
JBrowse link
G Or2av9 olfactory receptor family 2 subfamily AV member 9 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR2AV9 mRNA CTD PMID:29950665 NCBI chr11:58,380,545...58,383,325
Ensembl chr11:58,378,776...58,383,381
JBrowse link
G Or2b4 olfactory receptor family 2 subfamily B member 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR2B4 mRNA CTD PMID:29950665 NCBI chr17:38,115,960...38,117,081
Ensembl chr17:38,110,779...38,119,508
JBrowse link
G Or2b7 olfactory receptor family 2 subfamily B member 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR2B7 mRNA CTD PMID:29950665 NCBI chr13:21,739,210...21,740,190
Ensembl chr13:21,738,064...21,744,063
JBrowse link
G Or2d2b olfactory receptor family 2 subfamily D member 2B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of OR2D2B mRNA CTD PMID:29950665 NCBI chr 7:106,705,119...106,706,066
Ensembl chr 7:106,702,955...106,709,576
JBrowse link
G Or2d3b olfactory receptor family 2 subfamily D member 3B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR2D3B mRNA CTD PMID:29950665 NCBI chr 7:106,507,332...106,514,330
Ensembl chr 7:106,507,208...106,515,472
JBrowse link
G Or2f2 olfactory receptor family 2 subfamily F member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR2F2 mRNA CTD PMID:29950665 NCBI chr 6:42,766,975...42,767,928
Ensembl chr 6:42,762,027...42,768,553
JBrowse link
G Or2g1 olfactory receptor family 2 subfamily G member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR2G1 mRNA CTD PMID:29950665 NCBI chr17:38,106,337...38,107,266
Ensembl chr17:38,104,420...38,109,025
JBrowse link
G Or2l13 olfactory receptor family 2 subfamily L member 13 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR2L13 mRNA CTD PMID:29950665 NCBI chr16:19,305,590...19,306,528
Ensembl chr16:19,302,444...19,308,632
JBrowse link
G Or2l13b olfactory receptor family 2 subfamily L member 13B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR2L13B mRNA CTD PMID:29950665 NCBI chr16:19,348,730...19,349,668
Ensembl chr16:19,348,024...19,354,305
JBrowse link
G Or2o1 olfactory receptor family 2 subfamily O member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR2O1 mRNA CTD PMID:29950665 NCBI chr11:49,050,843...49,051,781
Ensembl chr11:49,045,204...49,053,681
JBrowse link
G Or2r11 olfactory receptor family 2 subfamily R member 11 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR2R11 mRNA CTD PMID:29950665 NCBI chr 6:42,437,010...42,437,951
Ensembl chr 6:42,436,913...42,442,130
JBrowse link
G Or2r3 olfactory receptor family 2 subfamily R member 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR2R3 mRNA CTD PMID:29950665 NCBI chr 6:42,448,169...42,449,110
Ensembl chr 6:42,444,949...42,453,269
JBrowse link
G Or2t26 olfactory receptor family 2 subfamily T member 26 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR2T26 mRNA CTD PMID:29950665 NCBI chr11:49,039,086...49,040,039
Ensembl chr11:49,033,101...49,041,280
JBrowse link
G Or2t43 olfactory receptor family 2 subfamily T member 43 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR2T43 mRNA CTD PMID:29950665 NCBI chr11:58,456,682...58,461,394
Ensembl chr11:58,456,682...58,461,379
JBrowse link
G Or2t48 olfactory receptor family 2 subfamily T member 48 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR2T48 mRNA CTD PMID:29950665 NCBI chr11:58,419,755...58,425,651
Ensembl chr11:58,418,012...58,425,662
JBrowse link
G Or2v1 olfactory receptor family 2 subfamily V member 1 increases expression EXP Dextran Sulfate results in increased expression of OR2V1 mRNA CTD PMID:23894361 NCBI chr11:49,025,000...49,026,214
Ensembl chr11:48,941,560...49,026,214
JBrowse link
G Or2v2 olfactory receptor family 2 subfamily V member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR2V2 mRNA CTD PMID:29950665 NCBI chr11:49,003,604...49,004,584
Ensembl chr11:49,000,809...49,005,701
JBrowse link
G Or2w4 olfactory receptor family 2 subfamily W member 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR2W4 mRNA CTD PMID:29950665 NCBI chr13:21,795,190...21,796,174
Ensembl chr13:21,795,148...21,798,192
JBrowse link
G Or2y14 olfactory receptor family 2 subfamily Y member 14 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR2Y14 mRNA CTD PMID:29950665 NCBI chr11:49,404,445...49,405,478
Ensembl chr11:49,397,551...49,408,172
JBrowse link
G Or2y15 olfactory receptor family 2 subfamily Y member 15 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR2Y15 mRNA CTD PMID:29950665 NCBI chr11:49,350,508...49,351,443
Ensembl chr11:49,346,170...49,354,828
JBrowse link
G Or2y1g olfactory receptor family 2 subfamily Y member 1G multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR2Y1G mRNA CTD PMID:29950665 NCBI chr11:49,154,700...49,183,186
Ensembl chr11:49,169,131...49,173,596
JBrowse link
G Or2z8 olfactory receptor family 2 subfamily Z member 8 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR2Z8 mRNA CTD PMID:29950665 NCBI chr 8:72,811,504...72,812,519
Ensembl chr 8:72,795,062...72,814,474
JBrowse link
G Or2z9 olfactory receptor family 2 subfamily Z member 9 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR2Z9 mRNA CTD PMID:29950665 NCBI chr 8:72,853,606...72,854,550
Ensembl chr 8:72,837,021...72,856,928
JBrowse link
G Or3a1d olfactory receptor family 3 subfamily A member 1D multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR3A1D mRNA CTD PMID:29950665 NCBI chr11:74,237,450...74,238,498
Ensembl chr11:74,235,955...74,243,476
JBrowse link
G Or3a4 olfactory receptor family 3 subfamily A member 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR3A4 mRNA CTD PMID:29950665 NCBI chr11:73,944,602...73,945,604
Ensembl chr11:73,943,953...73,947,441
JBrowse link
G Or4b1b olfactory receptor family 4 subfamily B member 1B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR4B1B mRNA CTD PMID:29950665 NCBI chr 2:90,111,991...90,112,917
Ensembl chr 2:90,110,607...90,123,185
JBrowse link
G Or4b1d olfactory receptor family 4 subfamily B member 1D multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR4B1D mRNA CTD PMID:29950665 NCBI chr 2:89,968,425...89,980,334
Ensembl chr 2:89,966,617...89,972,640
JBrowse link
G Or4c10b olfactory receptor family 4 subfamily C member 10B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR4C10B mRNA CTD PMID:29950665 NCBI chr 2:89,709,708...89,712,147
Ensembl chr 2:89,708,781...89,713,370
JBrowse link
G Or4c112 olfactory receptor family 4 subfamily C member 112 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR4C112 mRNA CTD PMID:29950665 NCBI chr 2:88,853,339...88,854,443
Ensembl chr 2:88,851,680...88,862,409
JBrowse link
G Or4c113 olfactory receptor family 4 subfamily C member 113 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR4C113 mRNA CTD PMID:29950665 NCBI chr 2:88,884,833...88,885,768
Ensembl chr 2:88,882,640...88,891,531
JBrowse link
G Or4c117 olfactory receptor family 4 subfamily C member 117 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR4C117 mRNA CTD PMID:29950665 NCBI chr 2:88,955,138...88,956,073
Ensembl chr 2:88,953,229...88,963,398
JBrowse link
G Or4c121 olfactory receptor family 4 subfamily C member 121 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of OR4C121 mRNA CTD PMID:29950665 NCBI chr 2:89,023,444...89,024,376
Ensembl chr 2:89,019,183...89,030,392
JBrowse link
G Or4c123 olfactory receptor family 4 subfamily C member 123 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR4C123 mRNA CTD PMID:29950665 NCBI chr 2:89,126,695...89,127,612
Ensembl chr 2:89,126,695...89,127,612
JBrowse link
G Or4c124 olfactory receptor family 4 subfamily C member 124 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR4C124 mRNA CTD PMID:29950665 NCBI chr 2:89,155,587...89,156,522
Ensembl chr 2:89,155,333...89,160,019
JBrowse link
G Or4c127 olfactory receptor family 4 subfamily C member 127 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR4C127 mRNA CTD PMID:29950665 NCBI chr 2:89,832,752...89,833,666
Ensembl chr 2:89,830,489...89,838,635
JBrowse link
G Or4c15 olfactory receptor family 4 subfamily C member 15 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR4C15 mRNA CTD PMID:29950665 NCBI chr 2:88,759,722...88,764,870
Ensembl chr 2:88,757,220...88,768,455
JBrowse link
G Or4c58 olfactory receptor family 4 subfamily C member 58 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR4C58 mRNA CTD PMID:29950665 NCBI chr 2:89,674,410...89,675,315
Ensembl chr 2:89,672,137...89,678,549
JBrowse link
G Or4e2 olfactory receptor family 4 subfamily E member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR4E2 mRNA CTD PMID:29950665 NCBI chr14:52,687,850...52,688,859
Ensembl chr14:52,680,447...52,690,031
JBrowse link
G Or4e5 olfactory receptor family 4 subfamily E member 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of OR4E5 mRNA CTD PMID:29950665 NCBI chr14:52,727,392...52,733,152
Ensembl chr14:52,726,248...52,733,206
JBrowse link
G Or4f14d olfactory receptor family 4 subfamily F member 14D multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR4F14D mRNA CTD PMID:29950665 NCBI chr 2:111,960,216...111,961,160
Ensembl chr 2:111,957,341...111,965,322
JBrowse link
G Or4f15 olfactory receptor family 4 subfamily F member 15 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR4F15 mRNA CTD PMID:29950665 NCBI chr 2:111,813,479...111,814,441
Ensembl chr 2:111,810,202...111,820,626
JBrowse link
G Or4f58 olfactory receptor family 4 subfamily F member 58 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR4F58 mRNA CTD PMID:29950665 NCBI chr 2:111,851,259...111,852,197
Ensembl chr 2:111,850,001...111,854,757
JBrowse link
G Or4g17 olfactory receptor family 4 subfamily G member 17 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR4G17 mRNA CTD PMID:29950665 NCBI chr 2:111,209,347...111,210,282
Ensembl chr 2:111,205,867...111,210,958
JBrowse link
G Or4k36 olfactory receptor family 4 subfamily K member 36 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR4K36 mRNA CTD PMID:29950665 NCBI chr 2:111,144,295...111,204,476
Ensembl chr 2:111,144,362...111,156,348
JBrowse link
G Or4k44 olfactory receptor family 4 subfamily K member 44 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR4K44 mRNA CTD PMID:29950665 NCBI chr 2:111,367,694...111,368,632
Ensembl chr 2:111,366,875...111,370,636
JBrowse link
G Or4n5 olfactory receptor family 4 subfamily N member 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR4N5 mRNA CTD PMID:29950665 NCBI chr14:50,131,715...50,139,398
Ensembl chr14:50,131,715...50,139,456
JBrowse link
G Or4p22 olfactory receptor family 4 subfamily P member 22 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR4P22 mRNA CTD PMID:29950665 NCBI chr 2:88,317,078...88,318,013
Ensembl chr 2:88,313,942...88,319,628
JBrowse link
G Or4q3 olfactory receptor family 4 subfamily Q member 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR4Q3 mRNA CTD PMID:29950665 NCBI chr14:50,582,833...50,583,897
Ensembl chr14:50,580,069...50,586,329
JBrowse link
G Or4z4 olfactory receptor family 4 subfamily Z member 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR4Z4 mRNA CTD PMID:29950665 NCBI chr19:12,076,066...12,077,001
Ensembl chr19:12,075,370...12,080,698
JBrowse link
G Or51a25 olfactory receptor family 51 subfamily A member 25 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR51A25 mRNA CTD PMID:29950665 NCBI chr 7:102,372,739...102,373,695
Ensembl chr 7:102,372,414...102,376,698
JBrowse link
G Or51a39 olfactory receptor family 51 subfamily A member 39 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of OR51A39 mRNA CTD PMID:29950665 NCBI chr 7:102,362,662...102,363,618
Ensembl chr 7:102,361,358...102,368,277
JBrowse link
G Or51a7 olfactory receptor family 51 subfamily A member 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR51A7 mRNA CTD PMID:29950665 NCBI chr 7:102,614,309...102,615,247
Ensembl chr 7:102,611,867...102,624,367
JBrowse link
G Or51a8 olfactory receptor family 51 subfamily A member 8 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR51A8 mRNA CTD PMID:29950665 NCBI chr 7:102,549,549...102,550,593
Ensembl chr 7:102,543,784...102,550,917
JBrowse link
G Or51aa2 olfactory receptor family 51 subfamily AA member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR51AA2 mRNA CTD PMID:29950665 NCBI chr 7:103,187,468...103,188,439
Ensembl chr 7:103,186,429...103,191,924
JBrowse link
G Or51aa5 olfactory receptor family 51 subfamily AA member 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR51AA5 mRNA CTD PMID:29950665 NCBI chr 7:103,166,618...103,167,589
Ensembl chr 7:103,165,672...103,170,053
JBrowse link
G Or51b6 olfactory receptor family 51 subfamily B member 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR51B6 mRNA CTD PMID:29950665 NCBI chr 7:103,555,549...103,556,654
Ensembl chr 7:103,552,694...103,557,857
JBrowse link
G Or51d1 olfactory receptor family 51 subfamily D member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR51D1 mRNA CTD PMID:29950665 NCBI chr 7:102,347,423...102,348,479
Ensembl chr 7:102,345,117...102,349,914
JBrowse link
G Or51e2 olfactory receptor family 51 subfamily E member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR51E2 mRNA CTD PMID:29950665 NCBI chr 7:102,389,928...102,408,678
Ensembl chr 7:102,387,718...102,408,678
JBrowse link
G Or51g1 olfactory receptor family 51 subfamily G member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR51G1 mRNA CTD PMID:29950665 NCBI chr 7:102,633,428...102,634,369
Ensembl chr 7:102,630,815...102,638,531
JBrowse link
G Or51g2 olfactory receptor family 51 subfamily G member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR51G2 mRNA CTD PMID:29950665 NCBI chr 7:102,622,259...102,623,197
Ensembl chr 7:102,620,387...102,625,150
JBrowse link
G Or51m1 olfactory receptor family 51 subfamily M member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR51M1 mRNA CTD PMID:29950665 NCBI chr 7:103,564,269...103,579,873
Ensembl chr 7:103,578,032...103,578,991
JBrowse link
G Or51q1c olfactory receptor family 51 subfamily Q member 1C multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR51Q1C mRNA CTD PMID:29950665 NCBI chr 7:103,652,466...103,653,431
Ensembl chr 7:103,647,953...103,653,564
JBrowse link
G Or51v14 olfactory receptor family 51 subfamily V member 14 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR51V14 mRNA CTD PMID:29950665 NCBI chr 7:103,260,617...103,261,558
Ensembl chr 7:103,254,102...103,261,741
JBrowse link
G Or52ae7 olfactory receptor family 52 subfamily AE member 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of OR52AE7 mRNA CTD PMID:29950665 NCBI chr 7:103,119,248...103,120,198
Ensembl chr 7:103,119,084...103,120,565
JBrowse link
G Or52b1 olfactory receptor family 52 subfamily B member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR52B1 mRNA CTD PMID:29950665 NCBI chr 7:104,978,424...104,979,485
Ensembl chr 7:104,977,432...104,983,311
JBrowse link
G Or52e8 olfactory receptor family 52 subfamily E member 8 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR52E8 mRNA CTD PMID:29950665 NCBI chr 7:104,621,683...104,625,202
Ensembl chr 7:104,622,103...104,628,333
JBrowse link
G Or52x1 olfactory receptor family 52 subfamily X member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR52X1 mRNA CTD PMID:29950665 NCBI chr 7:104,852,595...104,853,548
Ensembl chr 7:104,851,065...104,856,692
JBrowse link
G Or5ac25 olfactory receptor family 5 subfamily AC member 25 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR5AC25 mRNA CTD PMID:29950665 NCBI chr16:59,181,587...59,182,603
Ensembl chr16:59,181,523...59,184,356
Ensembl chr16:59,181,523...59,184,356
JBrowse link
G Or5af1 olfactory receptor family 5 subfamily AF member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR5AF1 mRNA CTD PMID:29950665 NCBI chr11:58,721,982...58,722,908
Ensembl chr11:58,720,063...58,725,606
JBrowse link
G Or5aq6 olfactory receptor family 5 subfamily AQ member 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR5AQ6 mRNA CTD PMID:29950665 NCBI chr 2:86,922,801...86,930,230
Ensembl chr 2:86,921,539...86,926,352
JBrowse link
G Or5aq7 olfactory receptor family 5 subfamily AQ member 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR5AQ7 mRNA CTD PMID:29950665 NCBI chr 2:86,937,791...86,938,729
Ensembl chr 2:86,934,922...86,944,911
JBrowse link
G Or5b112 olfactory receptor family 5 subfamily B member 112 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR5B112 mRNA CTD PMID:29950665 NCBI chr19:13,319,124...13,321,692
Ensembl chr19:13,316,226...13,320,936
JBrowse link
G Or5b123 olfactory receptor family 5 subfamily B member 123 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR5B123 mRNA CTD PMID:29950665 NCBI chr19:13,596,528...13,597,475
Ensembl chr19:13,594,739...13,600,436
JBrowse link
G Or5b12b olfactory receptor family 5 subfamily B member 12B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR5B12B mRNA CTD PMID:29950665 NCBI chr19:12,861,247...12,862,191
Ensembl chr19:12,861,219...12,862,219
JBrowse link
G Or5b94 olfactory receptor family 5 subfamily B member 94 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR5B94 mRNA CTD PMID:29950665 NCBI chr19:12,651,543...12,652,607
Ensembl chr19:12,647,803...12,654,641
JBrowse link
G Or5c1 olfactory receptor family 5 subfamily C member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR5C1 mRNA CTD PMID:29950665 NCBI chr 2:37,221,761...37,222,744
Ensembl chr 2:37,216,527...37,222,784
JBrowse link
G Or5d36 olfactory receptor family 5 subfamily D member 36 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR5D36 mRNA CTD PMID:29950665 NCBI chr 2:87,900,709...87,901,751
Ensembl chr 2:87,900,161...87,902,174
JBrowse link
G Or5d41 olfactory receptor family 5 subfamily D member 41 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR5D41 mRNA CTD PMID:29950665 NCBI chr 2:88,054,424...88,055,374
Ensembl chr 2:88,052,442...88,058,678
JBrowse link
G Or5d47 olfactory receptor family 5 subfamily D member 47 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR5D47 mRNA CTD PMID:29950665 NCBI chr 2:87,804,051...87,805,007
Ensembl chr 2:87,804,051...87,805,007
JBrowse link
G Or5e1 olfactory receptor family 5 subfamily E member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR5E1 mRNA CTD PMID:29950665 NCBI chr 7:108,354,065...108,354,994
Ensembl chr 7:108,350,180...108,356,007
JBrowse link
G Or5g27 olfactory receptor family 5 subfamily G member 27 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR5G27 mRNA CTD PMID:29950665 NCBI chr 2:85,409,559...85,410,626
Ensembl chr 2:85,409,559...85,410,626
JBrowse link
G Or5h19 olfactory receptor family 5 subfamily H member 19 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR5H19 mRNA CTD PMID:29950665 NCBI chr16:58,856,143...58,860,112
Ensembl chr16:58,855,926...58,860,130
JBrowse link
G Or5h22 olfactory receptor family 5 subfamily H member 22 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of OR5H22 mRNA CTD PMID:29950665 NCBI chr16:58,894,518...58,895,441
Ensembl chr16:58,887,503...58,898,368
JBrowse link
G Or5h26 olfactory receptor family 5 subfamily H member 26 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR5H26 mRNA CTD PMID:29950665 NCBI chr16:58,987,575...58,992,475
Ensembl chr16:58,987,010...58,990,817
JBrowse link
G Or5h27 olfactory receptor family 5 subfamily H member 27, pseudogene 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OLFR197 mRNA CTD PMID:29950665 NCBI chr16:59,005,919...59,006,844
Ensembl chr16:59,005,582...59,010,291
JBrowse link
G Or5k3 olfactory receptor family 5 subfamily K member 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR5K3 mRNA CTD PMID:29950665 NCBI chr16:58,969,215...58,970,141
Ensembl chr16:58,967,409...58,971,140
JBrowse link
G Or5m13b olfactory receptor family 5 subfamily M member 13B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR5M13B mRNA CTD PMID:29950665 NCBI chr 2:85,753,614...85,754,537
Ensembl chr 2:85,751,902...85,754,967
JBrowse link
G Or5m5 olfactory receptor family 5 subfamily M member 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR5M5 mRNA CTD PMID:29950665 NCBI chr 2:85,809,656...85,815,142
Ensembl chr 2:85,809,620...85,818,638
JBrowse link
G Or5p51 olfactory receptor family 5 subfamily P member 51 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR5P51 mRNA CTD PMID:29950665 NCBI chr 7:107,443,994...107,444,938
Ensembl chr 7:107,442,112...107,446,697
JBrowse link
G Or5p56 olfactory receptor family 5 subfamily P member 56 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR5P56 mRNA CTD PMID:29950665 NCBI chr 7:107,589,574...107,590,506
Ensembl chr 7:107,585,900...107,591,930
JBrowse link
G Or5p58 olfactory receptor family 5 subfamily P member 58 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR5P58 mRNA CTD PMID:29950665 NCBI chr 7:107,693,804...107,694,775
Ensembl chr 7:107,692,206...107,696,793
JBrowse link
G Or5p59 olfactory receptor family 5 subfamily P member 59 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR5P59 mRNA CTD PMID:29950665 NCBI chr 7:107,702,518...107,703,465
Ensembl chr 7:107,700,056...107,705,151
JBrowse link
G Or5p6 olfactory receptor family 5 subfamily P member 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR5P6 mRNA CTD PMID:29950665 NCBI chr 7:107,630,502...107,633,174
Ensembl chr 7:107,629,172...107,633,196
JBrowse link
G Or5p60 olfactory receptor family 5 subfamily P member 60 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR5P60 mRNA CTD PMID:29950665 NCBI chr 7:107,723,503...107,724,468
Ensembl chr 7:107,719,898...107,726,656
JBrowse link
G Or5p76 olfactory receptor family 5 subfamily P member 76 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR5P76 mRNA CTD PMID:29950665 NCBI chr 7:108,122,211...108,123,155
Ensembl chr 7:108,120,032...108,124,272
JBrowse link
G Or5w11 olfactory receptor family 5 subfamily W member 11 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR5W11 mRNA CTD PMID:29950665 NCBI chr 2:87,458,809...87,459,738
Ensembl chr 2:87,457,448...87,460,547
JBrowse link
G Or5w18 olfactory receptor family 5 subfamily W member 18 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR5W18 mRNA CTD PMID:29950665 NCBI chr 2:87,632,735...87,633,679
Ensembl chr 2:87,630,936...87,634,618
JBrowse link
G Or5w20 olfactory receptor family 5 subfamily W member 20 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR5W20 mRNA CTD PMID:29950665 NCBI chr 2:87,726,521...87,727,477
Ensembl chr 2:87,725,306...87,728,654
JBrowse link
G Or5w22 olfactory receptor family 5 subfamily W member 22 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR5W22 mRNA CTD PMID:29950665 NCBI chr 2:87,362,379...87,363,302
Ensembl chr 2:87,362,140...87,363,397
JBrowse link
G Or6b13 olfactory receptor family 6 subfamily B member 13 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR6B13 mRNA CTD PMID:29950665 NCBI chr 7:139,781,299...139,785,192
Ensembl chr 7:139,778,412...139,785,877
JBrowse link
G Or6b3 olfactory receptor family 6 subfamily B member 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR6B3 mRNA CTD PMID:29950665 NCBI chr 1:92,438,770...92,446,237
Ensembl chr 1:92,434,088...92,446,383
JBrowse link
G Or6b9 olfactory receptor family 6 subfamily B member 9 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR6B9 mRNA CTD PMID:29950665 NCBI chr 7:106,555,191...106,556,141
Ensembl chr 7:106,552,458...106,563,144
JBrowse link
G Or6c1b olfactory receptor family 6 subfamily C member 1B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR6C1B mRNA CTD PMID:29950665 NCBI chr10:129,272,683...129,273,621
Ensembl chr10:129,263,175...129,274,949
JBrowse link
G Or6c2 olfactory receptor family 6 subfamily C member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR6C2 mRNA CTD PMID:29950665 NCBI chr10:129,362,098...129,363,036
Ensembl chr10:129,357,661...129,364,222
JBrowse link
G Or6c211 olfactory receptor family 6 subfamily C member 211 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR6C211 mRNA CTD PMID:29950665 NCBI chr10:129,505,430...129,506,386
Ensembl chr10:129,502,858...129,509,734
JBrowse link
G Or6c216 olfactory receptor family 6 subfamily C member 216 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR6C216 mRNA CTD PMID:29950665 NCBI chr10:129,677,977...129,678,909
Ensembl chr10:129,677,287...129,681,963
JBrowse link
G Or6c217 olfactory receptor family 6 subfamily C member 217 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR6C217 mRNA CTD PMID:29950665 NCBI chr10:129,737,645...129,738,595
Ensembl chr10:129,736,439...129,741,736
JBrowse link
G Or6c3 olfactory receptor family 6 subfamily C member 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR6C3 mRNA CTD PMID:29950665 NCBI chr10:129,308,563...129,309,498
Ensembl chr10:129,306,867...129,312,487
JBrowse link
G Or6c66 olfactory receptor family 6 subfamily C member 66 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR6C66 mRNA CTD PMID:29950665 NCBI chr10:129,460,993...129,461,928
Ensembl chr10:129,458,484...129,463,803
JBrowse link
G Or6c68 olfactory receptor family 6 subfamily C member 68 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of OR6C68 mRNA CTD PMID:29950665 NCBI chr10:129,157,494...129,158,432
Ensembl chr10:129,153,986...129,160,010
JBrowse link
G Or6c74 olfactory receptor family 6 subfamily C member 74 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR6C74 mRNA CTD PMID:29950665 NCBI chr10:129,869,497...129,870,429
Ensembl chr10:129,866,217...129,870,940
JBrowse link
G Or6c8 olfactory receptor family 6 subfamily C member 8 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR6C8 mRNA CTD PMID:29950665 NCBI chr10:128,914,901...128,915,830
Ensembl chr10:128,910,694...128,918,779
JBrowse link
G Or6f2 olfactory receptor family 6 subfamily F member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR6F2 mRNA CTD PMID:29950665 NCBI chr 7:139,756,017...139,756,970
Ensembl chr 7:139,753,130...139,758,671
JBrowse link
G Or6k4 olfactory receptor family 6 subfamily K member 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR6K4 mRNA CTD PMID:29950665 NCBI chr 1:173,964,312...173,965,259
Ensembl chr 1:173,959,083...173,965,823
JBrowse link
G Or6k6 olfactory receptor family 6 subfamily K member 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR6K6 mRNA CTD PMID:29950665 NCBI chr 1:173,944,657...173,945,580
Ensembl chr 1:173,940,777...173,948,728
JBrowse link
G Or6n2 olfactory receptor family 6 subfamily N member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR6N2 mRNA CTD PMID:29950665 NCBI chr 1:173,896,866...173,897,819
Ensembl chr 1:173,894,171...173,899,839
JBrowse link
G Or7e174 olfactory receptor family 7 subfamily E member 174 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR7E174 mRNA CTD PMID:29950665 NCBI chr 9:20,009,922...20,012,986
Ensembl chr 9:20,009,922...20,016,050
JBrowse link
G Or7e178 olfactory receptor family 7 subfamily E member 178 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR7E178 mRNA CTD PMID:29950665 NCBI chr 9:20,223,391...20,247,389
Ensembl chr 9:20,223,448...20,247,390
JBrowse link
G Or7g18 olfactory receptor family 7 subfamily G member 18 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR7G18 mRNA CTD PMID:29950665 NCBI chr 9:18,786,256...18,787,572
Ensembl chr 9:18,785,989...18,789,665
JBrowse link
G Or7g25 olfactory receptor family 7 subfamily G member 25 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR7G25 mRNA CTD PMID:29950665 NCBI chr 9:19,159,653...19,160,759
Ensembl chr 9:19,154,252...19,163,283
JBrowse link
G Or7g29 olfactory receptor family 7 subfamily G member 29 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR7G29 mRNA CTD PMID:29950665 NCBI chr 9:19,286,237...19,287,175
Ensembl chr 9:19,284,964...19,289,965
JBrowse link
G Or8b1 olfactory receptor family 8 subfamily B member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR8B1 mRNA CTD PMID:29950665 NCBI chr 9:38,399,327...38,400,262
Ensembl chr 9:38,398,381...38,402,856
JBrowse link
G Or8b12 olfactory receptor family 8 subfamily B member 12 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of OR8B12 mRNA CTD PMID:29950665 NCBI chr 9:37,656,596...37,658,402
Ensembl chr 9:37,656,402...37,659,890
JBrowse link
G Or8b12b olfactory receptor family 8 subfamily B member 12B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR8B12B mRNA CTD PMID:29950665 NCBI chr 9:37,683,933...37,684,936
Ensembl chr 9:37,683,153...37,685,755
JBrowse link
G Or8b12i olfactory receptor family 8 subfamily B member 12I multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR8B12I mRNA CTD PMID:29950665 NCBI chr 9:20,081,930...20,082,865
Ensembl chr 9:20,079,829...20,085,353
JBrowse link
G Or8b1c olfactory receptor family 8 subfamily B member 1C multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR8B1C mRNA CTD PMID:29950665 NCBI chr 9:38,384,045...38,384,977
Ensembl chr 9:38,382,403...38,388,309
JBrowse link
G Or8b42 olfactory receptor family 8 subfamily B member 42 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR8B42 mRNA CTD PMID:29950665 NCBI chr 9:38,341,580...38,342,515
Ensembl chr 9:38,340,751...38,343,978
JBrowse link
G Or8b44 olfactory receptor family 8 subfamily B member 44 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR8B44 mRNA CTD PMID:29950665 NCBI chr 9:38,409,967...38,410,899
Ensembl chr 9:38,407,097...38,411,178
JBrowse link
G Or8b46 olfactory receptor family 8 subfamily B member 46 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR8B46 mRNA CTD PMID:29950665 NCBI chr 9:38,449,178...38,451,125
Ensembl chr 9:38,449,145...38,452,116
JBrowse link
G Or8b50 olfactory receptor family 8 subfamily B member 50 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR8B50 mRNA CTD PMID:29950665 NCBI chr 9:38,517,763...38,518,713
Ensembl chr 9:38,516,398...38,522,274
JBrowse link
G Or8d23 olfactory receptor family 8 subfamily D member 23 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR8D23 mRNA CTD PMID:29950665 NCBI chr 9:38,841,469...38,842,395
Ensembl chr 9:38,841,105...38,842,692
JBrowse link
G Or8d2b olfactory receptor family 8 subfamily D member 2D multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR8D2B mRNA CTD PMID:29950665 NCBI chr 9:38,788,474...38,789,400
Ensembl chr 9:38,788,422...38,789,472
JBrowse link
G Or8g18 olfactory receptor family 8 subfamily G member 18 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR8G18 mRNA CTD PMID:29950665 NCBI chr 9:39,148,783...39,149,727
Ensembl chr 9:39,145,708...39,161,290
JBrowse link
G Or8g2 olfactory receptor family 8 subfamily G member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR8G2 mRNA CTD PMID:29950665 NCBI chr 9:39,821,101...39,822,024
Ensembl chr 9:39,818,632...39,824,028
JBrowse link
G Or8g28 olfactory receptor family 8 subfamily G member 28 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of OR8G28 mRNA CTD PMID:29950665 NCBI chr 9:39,169,016...39,169,975
Ensembl chr 9:39,168,165...39,188,114
JBrowse link
G Or8g30 olfactory receptor family 8 subfamily G member 30 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR8G30 mRNA CTD PMID:29950665 NCBI chr 9:39,229,943...39,230,908
Ensembl chr 9:39,227,008...39,237,341
JBrowse link
G Or8g32 olfactory receptor family 8 subfamily G member 32 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR8G32 mRNA CTD PMID:29950665 NCBI chr 9:39,305,089...39,306,033
Ensembl chr 9:39,298,706...39,306,929
JBrowse link
G Or8g34 olfactory receptor family 8 subfamily G member 34 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR8G34 mRNA CTD PMID:29950665 NCBI chr 9:39,372,729...39,373,673
Ensembl chr 9:39,367,997...39,375,921
JBrowse link
G Or8g50 olfactory receptor family 8 subfamily G member 50 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR8G50 mRNA CTD PMID:29950665 NCBI chr 9:39,648,113...39,649,051
Ensembl chr 9:39,642,274...39,649,752
JBrowse link
G Or8g54 olfactory receptor family 8 subfamily G member 54 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR8G54 mRNA CTD PMID:29950665 NCBI chr 9:39,706,673...39,707,608
Ensembl chr 9:39,702,241...39,707,931
JBrowse link
G Or8k17 olfactory receptor family 8 subfamily K member 17 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR8K17 mRNA CTD PMID:29950665 NCBI chr 2:86,066,215...86,067,177
Ensembl chr 2:86,064,295...86,070,633
JBrowse link
G Or8k28 olfactory receptor family 8 subfamily K member 28 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR8K28 mRNA CTD PMID:29950665 NCBI chr 2:86,285,672...86,286,613
Ensembl chr 2:86,285,672...86,286,613
JBrowse link
G Or9a4 olfactory receptor family 9 subfamily A member 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR9A4 mRNA CTD PMID:29950665 NCBI chr 6:40,546,086...40,549,438
Ensembl chr 6:40,546,421...40,551,277
JBrowse link
G Or9g4 olfactory receptor family 9 subfamily G member 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR9G4 mRNA CTD PMID:29950665 NCBI chr 2:85,504,555...85,509,085
Ensembl chr 2:85,504,001...85,509,111
JBrowse link
G Or9i1b olfactory receptor family 9 subfamily I member 1B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR9I1B mRNA CTD PMID:29950665 NCBI chr19:13,896,386...13,897,336
Ensembl chr19:13,890,894...13,899,230
JBrowse link
G Or9s13 olfactory receptor family 9 subfamily S member 13 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of OR9S13 mRNA CTD PMID:29950665 NCBI chr 1:92,547,603...92,548,723
Ensembl chr 1:92,545,510...92,551,134
JBrowse link
G Or9s14 olfactory receptor family 9 subfamily S member 14 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OR9S14 mRNA CTD PMID:29950665 NCBI chr 1:92,535,561...92,536,529
Ensembl chr 1:92,533,504...92,542,528
JBrowse link
G Osm oncostatin M multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OSM mRNA CTD PMID:29950665 NCBI chr11:4,186,831...4,191,027
Ensembl chr11:4,186,420...4,191,026
JBrowse link
G Osmr oncostatin M receptor multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OSMR mRNA CTD PMID:29950665 NCBI chr15:6,843,049...6,904,434
Ensembl chr15:6,843,058...6,904,450
JBrowse link
G Ovgp1 oviductal glycoprotein 1 multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of OVGP1 protein CTD PMID:35999755 NCBI chr 3:105,881,118...105,894,739
Ensembl chr 3:105,881,027...105,894,739
JBrowse link
G Oxtr oxytocin receptor decreases expression EXP Dextran Sulfate results in decreased expression of OXTR mRNA CTD PMID:35093514 NCBI chr 6:112,450,646...112,467,800
Ensembl chr 6:112,450,644...112,466,904
JBrowse link
G P2rx5 purinergic receptor P2X, ligand-gated ion channel, 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of P2RX5 mRNA CTD PMID:29950665 NCBI chr11:73,029,164...73,063,509
Ensembl chr11:73,051,247...73,063,511
JBrowse link
G P2rx7 purinergic receptor P2X, ligand-gated ion channel, 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of P2RX7 mRNA CTD PMID:29950665 NCBI chr 5:122,781,990...122,830,399
Ensembl chr 5:122,781,974...122,829,495
JBrowse link
G P2ry4 pyrimidinergic receptor P2Y, G-protein coupled, 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of P2RY4 mRNA CTD PMID:29950665 NCBI chr  X:99,631,964...99,638,533
Ensembl chr  X:99,633,760...99,638,475
JBrowse link
G P2ry6 pyrimidinergic receptor P2Y, G-protein coupled, 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of P2RY6 mRNA CTD PMID:29950665 NCBI chr 7:100,586,837...100,628,528
Ensembl chr 7:100,586,837...100,623,856
JBrowse link
G P3h3 prolyl 3-hydroxylase 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of P3H3 mRNA CTD PMID:29950665 NCBI chr 6:124,818,052...124,834,680
Ensembl chr 6:124,818,052...124,834,715
JBrowse link
G P4hb prolyl 4-hydroxylase, beta polypeptide multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of P4HB mRNA
Dextran Sulfate results in decreased expression of P4HB protein
CTD PMID:29950665 PMID:35999755 NCBI chr11:120,451,124...120,464,079
Ensembl chr11:120,451,124...120,464,079
JBrowse link
G Pabpn1 poly(A) binding protein, nuclear 1 increases expression EXP Dextran Sulfate results in increased expression of PABPN1 mRNA CTD PMID:35093514 NCBI chr14:55,131,600...55,136,384
Ensembl chr14:55,129,957...55,135,626
JBrowse link
G Pag1 phosphoprotein associated with glycosphingolipid microdomains 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PAG1 mRNA CTD PMID:29950665 NCBI chr 3:9,752,539...9,898,744
Ensembl chr 3:9,752,539...9,898,739
JBrowse link
G Pak4 p21 (RAC1) activated kinase 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PAK4 mRNA CTD PMID:29950665 NCBI chr 7:28,258,244...28,297,609
Ensembl chr 7:28,258,244...28,297,610
JBrowse link
G Pank1 pantothenate kinase 1 decreases expression EXP Dextran Sulfate results in decreased expression of PANK1 mRNA CTD PMID:35093514 NCBI chr19:34,784,335...34,862,420
Ensembl chr19:34,784,340...34,856,855
JBrowse link
G Paox polyamine oxidase (exo-N4-amino) multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PAOX mRNA CTD PMID:29950665 NCBI chr 7:139,693,182...139,714,249
Ensembl chr 7:139,695,712...139,717,137
JBrowse link
G Pappa pregnancy-associated plasma protein A multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PAPPA mRNA CTD PMID:29950665 NCBI chr 4:65,041,993...65,276,776
Ensembl chr 4:65,042,411...65,275,746
JBrowse link
G Papss2 3'-phosphoadenosine 5'-phosphosulfate synthase 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PAPSS2 mRNA CTD PMID:29950665 NCBI chr19:32,573,072...32,644,587
Ensembl chr19:32,573,190...32,644,587
JBrowse link
G Parp1 poly (ADP-ribose) polymerase family, member 1 increases cleavage
multiple interactions
EXP Dextran Sulfate results in increased cleavage of PARP1 protein
[Camptothecin co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased cleavage of PARP1 protein; [Plant Extracts co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased cleavage of PARP1 protein; Plant Extracts inhibits the reaction [Dextran Sulfate results in increased cleavage of PARP1 protein]
CTD PMID:21989142 PMID:25449198 NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
JBrowse link
G Parvb parvin, beta multiple interactions
decreases expression
EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of PARVB protein
Dextran Sulfate results in decreased expression of PARVB protein
CTD PMID:35999755 NCBI chr15:84,116,244...84,199,890
Ensembl chr15:84,116,244...84,199,889
JBrowse link
G Pawr PRKC, apoptosis, WT1, regulator multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of PAWR protein] CTD PMID:32272095 NCBI chr10:108,168,050...108,250,708
Ensembl chr10:108,167,982...108,250,101
JBrowse link
G Pax4 paired box 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PAX4 mRNA CTD PMID:29950665 NCBI chr 6:28,442,333...28,449,339
Ensembl chr 6:28,442,333...28,449,352
JBrowse link
G Pax6 paired box 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PAX6 mRNA CTD PMID:29950665 NCBI chr 2:105,499,241...105,528,755
Ensembl chr 2:105,499,245...105,527,709
JBrowse link
G Pccb propionyl Coenzyme A carboxylase, beta polypeptide multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PCCB mRNA CTD PMID:29950665 NCBI chr 9:100,864,085...100,916,993
Ensembl chr 9:100,864,085...100,916,951
JBrowse link
G Pcdhgb1 protocadherin gamma subfamily B, 1 decreases expression EXP Dextran Sulfate results in decreased expression of PCDHGB1 mRNA CTD PMID:35093514 NCBI chr18:37,813,325...37,974,923
Ensembl chr18:37,813,286...37,974,923
JBrowse link
G Pcna proliferating cell nuclear antigen multiple interactions
decreases expression
EXP
ISO
[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PCNA protein; [Streptozocin co-treated with Dextran Sulfate] results in increased expression of PCNA protein; biochanin A inhibits the reaction [Dextran Sulfate results in decreased expression of PCNA protein]; Ursodeoxycholic Acid inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PCNA protein]
[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PCNA protein; Melatonin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PCNA protein]
CTD PMID:17438113 PMID:19028472 PMID:34964214 PMID:38648921 NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
JBrowse link
G Pcnp PEST proteolytic signal containing nuclear protein multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of PCNP protein] CTD PMID:32272095 NCBI chr16:55,835,870...55,851,590
Ensembl chr16:55,827,608...55,850,102
JBrowse link
G Pcolce procollagen C-endopeptidase enhancer protein multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PCOLCE mRNA
Dextran Sulfate results in decreased expression of PCOLCE mRNA
CTD PMID:29950665 PMID:35093514 NCBI chr 5:137,603,369...137,609,666
Ensembl chr 5:137,603,365...137,612,046
JBrowse link
G Pcp4l1 Purkinje cell protein 4-like 1 decreases expression EXP Dextran Sulfate results in decreased expression of PCP4L1 mRNA CTD PMID:35093514 NCBI chr 1:171,000,833...171,023,837
Ensembl chr 1:171,000,831...171,023,837
JBrowse link
G Pdap1 PDGFA associated protein 1 increases expression EXP Dextran Sulfate results in increased expression of PDAP1 mRNA CTD PMID:35093514 NCBI chr 5:145,065,580...145,076,835
Ensembl chr 5:145,065,579...145,077,048
JBrowse link
G Pdcd4 programmed cell death 4 multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of PDCD4 protein] CTD PMID:32272095 NCBI chr19:53,880,662...53,926,024
Ensembl chr19:53,880,662...53,918,291
JBrowse link
G Pde10a phosphodiesterase 10A multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PDE10A mRNA CTD PMID:29950665 NCBI chr17:8,742,719...9,205,480
Ensembl chr17:8,744,204...9,205,480
JBrowse link
G Pde1a phosphodiesterase 1A, calmodulin-dependent multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PDE1A mRNA CTD PMID:29950665 NCBI chr 2:79,664,797...80,026,862
Ensembl chr 2:79,664,797...79,959,802
JBrowse link
G Pde1c phosphodiesterase 1C multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PDE1C mRNA CTD PMID:29950665 NCBI chr 6:56,046,783...56,629,590
Ensembl chr 6:56,046,789...56,629,472
JBrowse link
G Pde2a phosphodiesterase 2A, cGMP-stimulated multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PDE2A mRNA; Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of PDE2A protein] CTD PMID:29950665 PMID:32272095 NCBI chr 7:101,070,905...101,162,026
Ensembl chr 7:101,060,093...101,162,026
Ensembl chr 7:101,060,093...101,162,026
JBrowse link
G Pde3a phosphodiesterase 3A, cGMP inhibited multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PDE3A mRNA CTD PMID:29950665 NCBI chr 6:141,194,995...141,452,588
Ensembl chr 6:141,194,995...141,453,174
JBrowse link
G Pde4a phosphodiesterase 4A, cAMP specific multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PDE4A mRNA CTD PMID:29950665 NCBI chr 9:21,076,998...21,124,544
Ensembl chr 9:21,073,005...21,124,544
JBrowse link
G Pde4b phosphodiesterase 4B, cAMP specific multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PDE4B mRNA; PDE4B protein affects the reaction [APC protein affects the susceptibility to Dextran Sulfate] CTD PMID:29950665 PMID:30188895 NCBI chr 4:101,944,529...102,464,459
Ensembl chr 4:101,944,740...102,464,456
JBrowse link
G Pde7a phosphodiesterase 7A multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PDE7A mRNA CTD PMID:29950665 NCBI chr 3:19,277,272...19,365,486
Ensembl chr 3:19,277,272...19,365,486
JBrowse link
G Pde7b phosphodiesterase 7B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PDE7B mRNA CTD PMID:29950665 NCBI chr10:20,272,798...20,600,824
Ensembl chr10:20,273,750...20,600,824
JBrowse link
G Pdgfb platelet derived growth factor, B polypeptide multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PDGFB mRNA CTD PMID:29950665 NCBI chr15:79,880,066...79,899,178
Ensembl chr15:79,880,075...79,899,178
JBrowse link
G Pdgfra platelet derived growth factor receptor, alpha polypeptide multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PDGFRA mRNA CTD PMID:29950665 NCBI chr 5:75,311,988...75,358,867
Ensembl chr 5:75,312,953...75,358,876
JBrowse link
G Pdgfrb platelet derived growth factor receptor, beta polypeptide multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PDGFRB mRNA CTD PMID:29950665 NCBI chr18:61,178,194...61,218,139
Ensembl chr18:61,178,222...61,218,133
JBrowse link
G Pdia3 protein disulfide isomerase associated 3 decreases expression EXP Dextran Sulfate results in decreased expression of PDIA3 protein CTD PMID:35999755 NCBI chr 2:121,244,383...121,269,168
Ensembl chr 2:121,244,256...121,269,168
JBrowse link
G Pdyn prodynorphin multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PDYN mRNA CTD PMID:29950665 NCBI chr 2:129,528,469...129,541,858
Ensembl chr 2:129,528,485...129,541,764
JBrowse link
G Pdzk1ip1 PDZK1 interacting protein 1 increases expression EXP Dextran Sulfate results in increased expression of PDZK1IP1 mRNA CTD PMID:35093514 NCBI chr 4:114,945,905...114,951,091
Ensembl chr 4:114,945,905...114,951,096
JBrowse link
G Pecam1 platelet/endothelial cell adhesion molecule 1 multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of PECAM1 protein CTD PMID:35999755 NCBI chr11:106,545,039...106,606,107
Ensembl chr11:106,545,043...106,641,454
JBrowse link
G Pf4 platelet factor 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PF4 mRNA CTD PMID:29950665 NCBI chr 5:90,920,362...90,921,242
Ensembl chr 5:90,920,294...90,921,242
JBrowse link
G Pfn1 profilin 1 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of PFN1 protein
[Dextran Sulfate co-treated with bisphenol A] results in decreased expression of PFN1 protein
CTD PMID:35999755 NCBI chr11:70,542,670...70,547,625
Ensembl chr11:70,542,676...70,545,470
JBrowse link
G Pfn3 profilin 3 increases expression EXP Dextran Sulfate results in increased expression of PFN3 mRNA CTD PMID:35093514 NCBI chr13:55,562,501...55,563,045
Ensembl chr13:55,562,501...55,563,045
JBrowse link
G Pgam1 phosphoglycerate mutase 1 decreases expression EXP Dextran Sulfate results in decreased expression of PGAM1 protein CTD PMID:35999755 NCBI chr19:41,900,310...41,907,104
Ensembl chr19:41,900,362...41,907,099
JBrowse link
G Pgam2 phosphoglycerate mutase 2 decreases expression EXP Dextran Sulfate results in decreased expression of PGAM2 protein CTD PMID:35999755 NCBI chr11:5,751,637...5,753,796
Ensembl chr11:5,751,640...5,753,733
JBrowse link
G Pgf placental growth factor decreases expression
multiple interactions
ISO Dextran Sulfate results in decreased expression of PGF mRNA
Oligosaccharides inhibits the reaction [Dextran Sulfate results in decreased expression of PGF mRNA]
CTD PMID:16375993 NCBI chr12:85,213,413...85,224,087
Ensembl chr12:85,213,409...85,224,564
JBrowse link
G Pgk1 phosphoglycerate kinase 1 decreases expression EXP Dextran Sulfate results in decreased expression of PGK1 protein CTD PMID:35999755 NCBI chr  X:105,230,706...105,247,305
Ensembl chr  X:105,230,706...105,247,305
JBrowse link
G Pgls 6-phosphogluconolactonase decreases expression EXP Dextran Sulfate results in decreased expression of PGLS protein CTD PMID:35999755 NCBI chr 8:72,044,828...72,048,911
Ensembl chr 8:72,044,820...72,053,736
JBrowse link
G Pgm1 phosphoglucomutase 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PGM1 mRNA CTD PMID:29950665 NCBI chr 4:99,786,648...99,844,491
Ensembl chr 4:99,786,611...99,844,491
JBrowse link
G Pgm2 phosphoglucomutase 2 decreases expression EXP Dextran Sulfate results in decreased expression of PGM2 protein CTD PMID:35999755 NCBI chr 5:64,250,258...64,285,698
Ensembl chr 5:64,250,293...64,285,694
JBrowse link
G Pgm3 phosphoglucomutase 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PGM3 mRNA CTD PMID:29950665 NCBI chr 9:86,423,997...86,453,927
Ensembl chr 9:86,436,430...86,453,895
JBrowse link
G Pgp phosphoglycolate phosphatase increases expression EXP Dextran Sulfate results in increased expression of PGP mRNA CTD PMID:35093514 NCBI chr17:24,689,400...24,692,084
Ensembl chr17:24,689,366...24,692,084
JBrowse link
G Phex phosphate regulating endopeptidase homolog, X-linked increases expression EXP Dextran Sulfate results in increased expression of PHEX protein CTD PMID:20025956 NCBI chr  X:155,945,071...156,198,282
Ensembl chr  X:155,945,071...156,198,308
JBrowse link
G Phka1 phosphorylase kinase alpha 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PHKA1 mRNA CTD PMID:29950665 NCBI chr  X:101,557,581...101,687,907
Ensembl chr  X:101,557,581...101,687,852
JBrowse link
G Phkb phosphorylase kinase beta multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PHKB mRNA CTD PMID:29950665 NCBI chr 8:86,567,489...86,790,883
Ensembl chr 8:86,567,588...86,788,005
JBrowse link
G Pik3ap1 phosphoinositide-3-kinase adaptor protein 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PIK3AP1 mRNA CTD PMID:29950665 NCBI chr19:41,260,980...41,373,541
Ensembl chr19:41,260,816...41,373,541
JBrowse link
G Pik3ca phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PIK3CA mRNA CTD PMID:29950665 NCBI chr 3:32,451,203...32,520,256
Ensembl chr 3:32,451,820...32,522,635
JBrowse link
G Pik3r5 phosphoinositide-3-kinase regulatory subunit 5 increases expression EXP Dextran Sulfate results in increased expression of PIK3R5 protein CTD PMID:20025956 NCBI chr11:68,322,951...68,388,675
Ensembl chr11:68,322,947...68,388,675
JBrowse link
G Pkdcc protein kinase domain containing, cytoplasmic decreases expression EXP Dextran Sulfate results in decreased expression of PKDCC mRNA CTD PMID:35093514 NCBI chr17:83,522,708...83,532,496
Ensembl chr17:83,522,721...83,532,499
JBrowse link
G Pklr pyruvate kinase liver and red blood cell multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PKLR mRNA CTD PMID:29950665 NCBI chr 3:89,043,429...89,054,122
Ensembl chr 3:89,043,449...89,054,091
JBrowse link
G Pkp2 plakophilin 2 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of PKP2 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of PKP2 protein]
CTD PMID:32272095 NCBI chr16:16,031,209...16,090,576
Ensembl chr16:16,031,182...16,090,576
JBrowse link
G Pla2g10 phospholipase A2, group X multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PLA2G10 mRNA CTD PMID:29950665 NCBI chr16:13,532,921...13,548,863
Ensembl chr16:13,532,921...13,548,847
JBrowse link
G Pla2g12a phospholipase A2, group XIIA multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PLA2G12A mRNA CTD PMID:29950665 NCBI chr 3:129,672,255...129,689,474
Ensembl chr 3:129,672,255...129,689,474
JBrowse link
G Pla2g12b phospholipase A2, group XIIB multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PLA2G12B mRNA CTD PMID:29950665 NCBI chr10:59,239,242...59,257,798
Ensembl chr10:59,239,482...59,257,798
JBrowse link
G Pla2g2a phospholipase A2, group IIA (platelets, synovial fluid) increases expression EXP Dextran Sulfate results in increased expression of PLA2G2A mRNA CTD PMID:23894361 NCBI chr 4:138,559,168...138,562,500
Ensembl chr 4:138,559,171...138,562,497
JBrowse link
G Pla2g2c phospholipase A2, group IIC multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PLA2G2C mRNA CTD PMID:29950665 NCBI chr 4:138,452,636...138,471,886
Ensembl chr 4:138,452,103...138,473,443
JBrowse link
G Pla2g2e phospholipase A2, group IIE multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PLA2G2E mRNA CTD PMID:29950665 NCBI chr 4:138,605,253...138,610,125
Ensembl chr 4:138,605,253...138,610,128
JBrowse link
G Pla2g2f phospholipase A2, group IIF multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PLA2G2F mRNA CTD PMID:29950665 NCBI chr 4:138,477,842...138,484,932
Ensembl chr 4:138,477,844...138,484,937
JBrowse link
G Pla2g4a phospholipase A2, group IVA (cytosolic, calcium-dependent) multiple interactions
increases phosphorylation
EXP tussilagone inhibits the reaction [Dextran Sulfate results in increased phosphorylation of PLA2G4A protein] CTD PMID:30142311 NCBI chr 1:149,705,369...149,837,041
Ensembl chr 1:149,705,369...149,837,041
JBrowse link
G Pla2g4c phospholipase A2, group IVC (cytosolic, calcium-independent) multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of PLA2G4C protein] CTD PMID:32272095 NCBI chr 7:13,045,432...13,094,597
Ensembl chr 7:13,058,580...13,094,597
JBrowse link
G Pla2g4f phospholipase A2, group IVF multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PLA2G4F mRNA CTD PMID:29950665 NCBI chr 2:120,130,433...120,144,646
Ensembl chr 2:120,130,438...120,144,646
JBrowse link
G Plat plasminogen activator, tissue multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PLAT mRNA CTD PMID:29950665 NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860
JBrowse link
G Plau plasminogen activator, urokinase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PLAU mRNA CTD PMID:29950665 NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
JBrowse link
G Plaur plasminogen activator, urokinase receptor multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PLAUR mRNA CTD PMID:29950665 NCBI chr 7:24,161,857...24,175,393
Ensembl chr 7:24,161,909...24,175,393
JBrowse link
G Plcb2 phospholipase C, beta 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PLCB2 mRNA CTD PMID:29950665 NCBI chr 2:118,535,484...118,559,140
Ensembl chr 2:118,537,998...118,558,919
JBrowse link
G Plcb4 phospholipase C, beta 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PLCB4 mRNA CTD PMID:29950665 NCBI chr 2:135,500,523...135,856,522
Ensembl chr 2:135,500,931...135,856,513
JBrowse link
G Plce1 phospholipase C, epsilon 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PLCE1 mRNA CTD PMID:29950665 NCBI chr19:38,469,438...38,773,549
Ensembl chr19:38,469,557...38,773,474
JBrowse link
G Pld3 phospholipase D family member 3 decreases expression EXP Dextran Sulfate results in decreased expression of PLD3 mRNA CTD PMID:35093514 NCBI chr 7:27,231,090...27,252,511
Ensembl chr 7:27,231,425...27,252,643
JBrowse link
G Plek pleckstrin multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PLEK mRNA CTD PMID:29950665 NCBI chr11:16,921,206...16,958,718
Ensembl chr11:16,921,206...17,002,381
JBrowse link
G Plg plasminogen multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PLG mRNA CTD PMID:29950665 NCBI chr17:12,597,496...12,638,271
Ensembl chr17:12,597,495...12,638,272
JBrowse link
G Plod2 procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PLOD2 mRNA CTD PMID:29950665 NCBI chr 9:92,421,828...92,490,481
Ensembl chr 9:92,424,276...92,490,481
JBrowse link
G Pls1 plastin 1 (I-isoform) decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of PLS1 protein
[Dextran Sulfate co-treated with bisphenol A] results in decreased expression of PLS1 protein
CTD PMID:35999755 NCBI chr 9:95,634,695...95,727,359
Ensembl chr 9:95,634,695...95,727,364
JBrowse link
G Pltp phospholipid transfer protein decreases expression EXP Dextran Sulfate results in decreased expression of PLTP mRNA CTD PMID:35093514 NCBI chr 2:164,681,441...164,699,564
Ensembl chr 2:164,681,438...164,699,631
JBrowse link
G Plxna1 plexin A1 decreases expression EXP Dextran Sulfate results in decreased expression of PLXNA1 mRNA CTD PMID:35093514 NCBI chr 6:89,293,295...89,339,595
Ensembl chr 6:89,293,296...89,339,602
JBrowse link
G Plxnc1 plexin C1 decreases expression EXP Dextran Sulfate results in decreased expression of PLXNC1 mRNA CTD PMID:35093514 NCBI chr10:94,626,728...94,780,875
Ensembl chr10:94,626,728...94,780,697
JBrowse link
G Plxnd1 plexin D1 decreases expression EXP Dextran Sulfate results in decreased expression of PLXND1 mRNA CTD PMID:35093514 NCBI chr 6:115,931,772...115,972,300
Ensembl chr 6:115,931,772...115,971,966
JBrowse link
G Pmel premelanosome protein multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of PMEL protein CTD PMID:35999755 NCBI chr10:128,531,757...128,555,993
Ensembl chr10:128,540,064...128,556,107
JBrowse link
G Pmm2 phosphomannomutase 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PMM2 mRNA CTD PMID:29950665 NCBI chr16:8,455,467...8,475,472
Ensembl chr16:8,455,538...8,480,331
JBrowse link
G Pnliprp1 pancreatic lipase related protein 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PNLIPRP1 mRNA CTD PMID:29950665 NCBI chr19:58,717,319...58,732,601
Ensembl chr19:58,717,319...58,732,601
JBrowse link
G Pnp2 purine-nucleoside phosphorylase 2 decreases expression EXP Dextran Sulfate results in decreased expression of PNP2 mRNA CTD PMID:35093514 NCBI chr14:51,193,598...51,202,206
Ensembl chr14:51,193,449...51,202,206
JBrowse link
G Pnpt1 polyribonucleotide nucleotidyltransferase 1 multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of PNPT1 protein] CTD PMID:32272095 NCBI chr11:29,080,236...29,112,010
Ensembl chr11:29,080,744...29,111,828
JBrowse link
G Podxl podocalyxin-like decreases expression EXP Dextran Sulfate results in decreased expression of PODXL mRNA CTD PMID:35093514 NCBI chr 6:31,496,428...31,540,872
Ensembl chr 6:31,496,423...31,540,916
JBrowse link
G Pon3 paraoxonase 3 decreases expression EXP Dextran Sulfate results in decreased expression of PON3 mRNA CTD PMID:35093514 NCBI chr 6:5,216,253...5,256,236
Ensembl chr 6:5,220,852...5,256,286
JBrowse link
G Postn periostin, osteoblast specific factor multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of POSTN protein] CTD PMID:32272095 NCBI chr 3:54,266,688...54,298,462
Ensembl chr 3:54,268,530...54,298,458
JBrowse link
G Ppara peroxisome proliferator activated receptor alpha multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PPARA mRNA CTD PMID:29950665 NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
JBrowse link
G Ppard peroxisome proliferator activator receptor delta multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PPARD mRNA CTD PMID:29950665 NCBI chr17:28,451,715...28,520,446
Ensembl chr17:28,451,674...28,520,448
JBrowse link
G Pparg peroxisome proliferator activated receptor gamma increases expression
multiple interactions
affects localization
EXP Dextran Sulfate results in increased expression of PPARG protein
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PPARG mRNA; ligustilide inhibits the reaction [Dextran Sulfate affects the localization of PPARG protein]; Mesalamine inhibits the reaction [Dextran Sulfate affects the localization of PPARG protein]
CTD PMID:23261717 PMID:29950665 PMID:33130971 NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
JBrowse link
G Ppargc1a peroxisome proliferative activated receptor, gamma, coactivator 1 alpha decreases expression
multiple interactions
ISO Dextran Sulfate results in decreased expression of PPARGC1A protein
Hesperidin inhibits the reaction [Dextran Sulfate results in decreased expression of PPARGC1A protein]
CTD PMID:30811821 NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068
JBrowse link
G Ppia peptidylprolyl isomerase A decreases expression EXP Dextran Sulfate results in decreased expression of PPIA protein CTD PMID:35999755 NCBI chr11:6,365,867...6,369,817
Ensembl chr11:6,365,443...6,369,817
JBrowse link
G Ppih peptidyl prolyl isomerase H multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of PPIH protein] CTD PMID:32272095 NCBI chr 4:119,157,207...119,177,720
Ensembl chr 4:119,157,207...119,177,743
JBrowse link
G Ppp1cc protein phosphatase 1 catalytic subunit gamma increases expression EXP Dextran Sulfate results in increased expression of PPP1CC mRNA CTD PMID:35093514 NCBI chr 5:122,296,338...122,313,336
Ensembl chr 5:122,296,341...122,313,336
JBrowse link
G Ppp1ccb protein phosphatase 1 catalytic subunit gamma B decreases expression EXP Dextran Sulfate results in decreased expression of PPP1CCB mRNA CTD PMID:35093514 NCBI chr 7:119,339,133...119,341,467
Ensembl chr 7:119,339,351...119,340,322
Ensembl chr 7:119,339,351...119,340,322
JBrowse link
G Ppp1r14a protein phosphatase 1, regulatory inhibitor subunit 14A increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of PPP1R14A protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of PPP1R14A protein]
CTD PMID:32272095 NCBI chr 7:28,988,732...28,992,817
Ensembl chr 7:28,988,733...28,993,226
JBrowse link
G Ppp1r1b protein phosphatase 1, regulatory inhibitor subunit 1B multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of PPP1R1B protein] CTD PMID:32272095 NCBI chr11:98,239,232...98,248,622
Ensembl chr11:98,239,230...98,248,622
JBrowse link
G Ppp3cc protein phosphatase 3, catalytic subunit, gamma isoform multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PPP3CC mRNA CTD PMID:29950665 NCBI chr14:70,455,314...70,526,979
Ensembl chr14:70,455,314...70,526,920
JBrowse link
G Ppy pancreatic polypeptide multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PPY mRNA CTD PMID:29950665 NCBI chr11:101,990,757...101,992,145
Ensembl chr11:101,990,756...101,992,145
JBrowse link
G Prdx1 peroxiredoxin 1 decreases expression EXP Dextran Sulfate results in decreased expression of PRDX1 protein CTD PMID:35999755 NCBI chr 4:116,542,796...116,557,196
Ensembl chr 4:116,542,741...116,558,019
JBrowse link
G Prkaa1 protein kinase, AMP-activated, alpha 1 catalytic subunit decreases phosphorylation
multiple interactions
EXP Dextran Sulfate results in decreased phosphorylation of PRKAA1 protein
biochanin A inhibits the reaction [Dextran Sulfate results in decreased phosphorylation of PRKAA1 protein]
CTD PMID:38648921 NCBI chr15:5,172,641...5,211,380
Ensembl chr15:5,173,343...5,211,380
JBrowse link
G Prkacb protein kinase, cAMP dependent, catalytic, beta multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PRKACB mRNA CTD PMID:29950665 NCBI chr 3:146,435,334...146,518,691
Ensembl chr 3:146,435,329...146,518,745
JBrowse link
G Prkag2 protein kinase, AMP-activated, gamma 2 non-catalytic subunit multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PRKAG2 mRNA CTD PMID:29950665 NCBI chr 5:25,067,733...25,311,576
Ensembl chr 5:25,067,742...25,305,640
JBrowse link
G Prkca protein kinase C, alpha multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PRKCA mRNA CTD PMID:29950665 NCBI chr11:107,824,213...108,237,360
Ensembl chr11:107,824,213...108,234,754
JBrowse link
G Prkcb protein kinase C, beta multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PRKCB mRNA CTD PMID:29950665 NCBI chr 7:121,888,327...122,233,625
Ensembl chr 7:121,887,974...122,233,625
JBrowse link
G Prkcq protein kinase C, theta multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PRKCQ mRNA CTD PMID:29950665 NCBI chr 2:11,176,922...11,306,033
Ensembl chr 2:11,176,919...11,306,033
JBrowse link
G Prkg2 protein kinase, cGMP-dependent, type II multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PRKG2 mRNA CTD PMID:29950665 NCBI chr 5:99,077,632...99,185,042
Ensembl chr 5:99,077,632...99,185,210
JBrowse link
G Prl2c3 prolactin family 2, subfamily c, member 3 increases expression EXP Dextran Sulfate results in increased expression of PRL2C3 protein CTD PMID:20025956 NCBI chr13:12,805,705...12,814,982
Ensembl chr13:12,805,705...12,814,968
JBrowse link
G Prl3b1 prolactin family 3, subfamily b, member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PRL3B1 mRNA CTD PMID:29950665 NCBI chr13:27,426,413...27,433,666
Ensembl chr13:27,425,830...27,433,666
JBrowse link
G Prl3d1 prolactin family 3, subfamily d, member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PRL3D1 mRNA CTD PMID:29950665 NCBI chr13:27,278,172...27,284,243
Ensembl chr13:27,278,173...27,284,241
JBrowse link
G Prl6a1 prolactin family 6, subfamily a, member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PRL6A1 mRNA CTD PMID:29950665 NCBI chr13:27,496,598...27,503,237
Ensembl chr13:27,496,610...27,503,235
JBrowse link
G Prlr prolactin receptor multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PRLR mRNA
Dextran Sulfate results in decreased expression of PRLR mRNA
CTD PMID:29950665 PMID:35093514 NCBI chr15:10,177,324...10,349,276
Ensembl chr15:10,177,324...10,349,266
JBrowse link
G Prm3 protamine 3 increases expression EXP Dextran Sulfate results in increased expression of PRM3 mRNA CTD PMID:35093514 NCBI chr16:10,608,372...10,608,778
Ensembl chr16:10,608,369...10,608,778
JBrowse link
G Proc protein C multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PROC mRNA CTD PMID:29950665 NCBI chr18:32,256,179...32,272,623
Ensembl chr18:32,256,179...32,272,623
JBrowse link
G Pros1 protein S (alpha) multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PROS1 mRNA CTD PMID:29950665 NCBI chr16:62,674,670...62,749,709
Ensembl chr16:62,674,670...62,749,709
JBrowse link
G Prox1 prospero homeobox 1 multiple interactions EXP [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of PROX1 mRNA CTD PMID:26271895 NCBI chr 1:189,850,232...189,903,024
Ensembl chr 1:189,850,232...189,902,911
JBrowse link
G Prpf38b PRP38 pre-mRNA processing factor 38 (yeast) domain containing B increases expression EXP Dextran Sulfate results in increased expression of PRPF38B mRNA CTD PMID:35093514 NCBI chr 3:108,810,121...108,819,055
Ensembl chr 3:108,810,121...108,819,043
JBrowse link
G Prrc1 proline-rich coiled-coil 1 multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of PRRC1 protein] CTD PMID:32272095 NCBI chr18:57,487,805...57,526,028
Ensembl chr18:57,487,813...57,526,028
JBrowse link
G Prrc2c proline-rich coiled-coil 2C multiple interactions EXP [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of PRRC2C mRNA CTD PMID:26271895 NCBI chr 1:162,499,354...162,568,125
Ensembl chr 1:162,498,294...162,568,125
JBrowse link
G Prss2 serine protease 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PRSS2 mRNA CTD PMID:29950665 NCBI chr 6:41,498,710...41,502,013
Ensembl chr 6:41,498,721...41,502,013
JBrowse link
G Prxl2b peroxiredoxin like 2B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PRXL2B mRNA CTD PMID:29950665 NCBI chr 4:154,980,884...154,983,522
Ensembl chr 4:154,979,961...154,983,592
JBrowse link
G Psen1 presenilin 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PSEN1 mRNA CTD PMID:29950665 NCBI chr12:83,734,926...83,781,869
Ensembl chr12:83,734,926...83,781,973
JBrowse link
G Psmb8 proteasome (prosome, macropain) subunit, beta type 8 (large multifunctional peptidase 7) increases expression EXP Dextran Sulfate results in increased expression of PSMB8 mRNA CTD PMID:23894361 NCBI chr17:34,417,169...34,420,428
Ensembl chr17:34,416,695...34,420,428
JBrowse link
G Pstpip1 proline-serine-threonine phosphatase-interacting protein 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PSTPIP1 mRNA CTD PMID:29950665 NCBI chr 9:55,985,729...56,036,174
Ensembl chr 9:55,997,246...56,036,172
JBrowse link
G Ptafr platelet-activating factor receptor multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PTAFR mRNA CTD PMID:29950665 NCBI chr 4:132,291,378...132,309,994
Ensembl chr 4:132,291,378...132,309,994
JBrowse link
G Pten phosphatase and tensin homolog multiple interactions EXP [APC protein affects the susceptibility to Dextran Sulfate] which results in increased chemical synthesis of PTEN protein modified form; resorcinol inhibits the reaction [[APC protein affects the susceptibility to Dextran Sulfate] which results in increased chemical synthesis of PTEN protein modified form] CTD PMID:26262998 NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560
JBrowse link
G Ptgdr2 prostaglandin D2 receptor 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PTGDR2 mRNA CTD PMID:29950665 NCBI chr19:10,901,883...10,919,875
Ensembl chr19:10,914,524...10,919,875
JBrowse link
G Ptgds prostaglandin D2 synthase (brain) multiple interactions
decreases expression
increases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PTGDS mRNA; Fatty Acids, Omega-3 inhibits the reaction [Dextran Sulfate results in increased expression of PTGDS protein]
Dextran Sulfate results in decreased expression of PTGDS protein
CTD PMID:29950665 PMID:30489199 PMID:35999755 NCBI chr 2:25,356,723...25,360,080
Ensembl chr 2:25,356,721...25,360,058
JBrowse link
G Ptger2 prostaglandin E receptor 2 (subtype EP2) multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PTGER2 mRNA CTD PMID:29950665 NCBI chr14:45,225,568...45,241,277
Ensembl chr14:45,225,652...45,241,277
JBrowse link
G Ptger3 prostaglandin E receptor 3 (subtype EP3) multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PTGER3 mRNA CTD PMID:29950665 NCBI chr 3:157,272,459...157,350,392
Ensembl chr 3:157,272,529...157,351,525
JBrowse link
G Ptger4 prostaglandin E receptor 4 (subtype EP4) multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PTGER4 mRNA CTD PMID:29950665 NCBI chr15:5,262,880...5,273,668
Ensembl chr15:5,236,142...5,273,668
JBrowse link
G Ptges prostaglandin E synthase multiple interactions
increases expression
ISO
EXP
resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of PTGES protein]
7-hydroxyl-1-methylindole-3-acetonitrile inhibits the reaction [Dextran Sulfate results in increased expression of PTGES protein]; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PTGES mRNA; Fatty Acids, Omega-3 inhibits the reaction [Dextran Sulfate results in increased expression of PTGES protein]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased expression of PTGES protein]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of PTGES protein]
CTD PMID:19228061 PMID:20132809 PMID:29950665 PMID:30489199 PMID:36543318 NCBI chr 2:30,779,483...30,793,309
Ensembl chr 2:30,779,483...30,819,875
JBrowse link
G Ptges3 prostaglandin E synthase 3 decreases expression EXP Dextran Sulfate results in decreased expression of PTGES3 protein CTD PMID:35999755 NCBI chr10:127,894,851...127,913,123
Ensembl chr10:127,894,823...127,913,141
JBrowse link
G Ptgfr prostaglandin F receptor multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PTGFR mRNA CTD PMID:29950665 NCBI chr 3:151,504,247...151,543,165
Ensembl chr 3:151,502,139...151,543,267
JBrowse link
G Ptgir prostaglandin I receptor (IP) multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PTGIR mRNA CTD PMID:29950665 NCBI chr 7:16,640,442...16,644,828
Ensembl chr 7:16,640,415...16,644,830
JBrowse link
G Ptgis prostaglandin I2 (prostacyclin) synthase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PTGIS mRNA CTD PMID:29950665 NCBI chr 2:167,045,114...167,095,069
Ensembl chr 2:167,033,725...167,082,524
JBrowse link
G Ptgr1 prostaglandin reductase 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PTGR1 mRNA CTD PMID:29950665 NCBI chr 4:58,965,590...58,987,131
Ensembl chr 4:58,965,439...58,987,119
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
increases expression
EXP
ISO
[2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with Dextran Sulfate] results in increased expression of PTGS2 protein; [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PTGS2 mRNA; [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PTGS2 protein; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PTGS2 mRNA; AHR gene mutant form promotes the reaction [Dextran Sulfate results in increased expression of PTGS2 mRNA]; apigenin-6,8-di-C-glycopyranoside inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein]; Butylated Hydroxyanisole inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein]; Dexamethasone inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 mRNA]; dihydrotanshinone I inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein]; DUSP1 protein affects the reaction [Butylated Hydroxyanisole inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein]]; DUSP1 protein affects the reaction [Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein]]; Fatty Acids, Omega-3 inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein]; fraxinellone inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 mRNA]; geraniol inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 mRNA]; geraniol inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein]; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PTGS2 mRNA]; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PTGS2 protein]; monotropein inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein]; NFE2L2 protein affects the reaction [Butylated Hydroxyanisole inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein]]; NFE2L2 protein affects the reaction [Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein]]; notoginsenoside R1 inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 mRNA]; Plant Extracts inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein]; Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 mRNA]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 mRNA]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein]; Rutin inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 mRNA]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein]; thiamet G promotes the reaction [Dextran Sulfate results in increased expression of PTGS2 mRNA]; thiamet G promotes the reaction [Dextran Sulfate results in increased expression of PTGS2 protein]; tussilagone inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 mRNA]; tussilagone inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein]
resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein]
Dextran Sulfate results in increased expression of PTGS2 mRNA; Dextran Sulfate results in increased expression of PTGS2 protein
CTD PMID:15459021 PMID:15652231 PMID:16049979 PMID:17438113 PMID:19228061 More... NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
JBrowse link
G Pth1r parathyroid hormone 1 receptor multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PTH1R mRNA CTD PMID:29950665 NCBI chr 9:110,551,132...110,576,213
Ensembl chr 9:110,551,153...110,576,213
JBrowse link
G Pthlh parathyroid hormone-like peptide multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PTHLH mRNA CTD PMID:29950665 NCBI chr 6:147,153,607...147,165,511
Ensembl chr 6:147,153,599...147,165,681
JBrowse link
G Ptn pleiotrophin decreases expression EXP Dextran Sulfate results in decreased expression of PTN mRNA CTD PMID:35093514 NCBI chr 6:36,691,863...36,787,114
Ensembl chr 6:36,691,864...36,787,155
JBrowse link
G Ptprc protein tyrosine phosphatase receptor type C increases expression EXP Dextran Sulfate results in increased expression of PTPRC mRNA CTD PMID:23894361 NCBI chr 1:137,990,601...138,103,491
Ensembl chr 1:137,990,599...138,103,446
JBrowse link
G Ptprh protein tyrosine phosphatase receptor type H decreases expression EXP Dextran Sulfate results in decreased expression of PTPRH mRNA CTD PMID:37385329 NCBI chr 7:4,551,607...4,607,040
Ensembl chr 7:4,551,611...4,607,040
JBrowse link
G Ptprm protein tyrosine phosphatase receptor type M decreases expression EXP Dextran Sulfate results in decreased expression of PTPRM protein CTD PMID:35999755 NCBI chr17:66,973,843...67,661,486
Ensembl chr17:66,973,942...67,661,452
JBrowse link
G Ptpru protein tyrosine phosphatase receptor type U multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PTPRU mRNA CTD PMID:29950665 NCBI chr 4:131,495,768...131,565,617
Ensembl chr 4:131,495,768...131,565,599
JBrowse link
G Ptprv protein tyrosine phosphatase receptor type V decreases expression EXP Dextran Sulfate results in decreased expression of PTPRV mRNA CTD PMID:35093514 NCBI chr 1:135,036,236...135,060,313
Ensembl chr 1:135,036,235...135,060,332
JBrowse link
G Pycard PYD and CARD domain containing increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of PYCARD mRNA; Dextran Sulfate results in increased expression of PYCARD protein
[Dextran Sulfate co-treated with Zearalenone] results in increased expression of PYCARD mRNA; [Dextran Sulfate co-treated with Zearalenone] results in increased expression of PYCARD protein; [Streptozocin co-treated with Dextran Sulfate] results in increased expression of PYCARD protein; Zearalenone inhibits the reaction [Dextran Sulfate results in increased expression of PYCARD mRNA]; Zearalenone inhibits the reaction [Dextran Sulfate results in increased expression of PYCARD protein]
CTD PMID:30270565 PMID:34964214 NCBI chr 7:127,590,545...127,593,039
Ensembl chr 7:127,588,880...127,593,039
JBrowse link
G Pygb brain glycogen phosphorylase multiple interactions
decreases expression
EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of PYGB protein
Dextran Sulfate results in decreased expression of PYGB protein
CTD PMID:35999755 NCBI chr 2:150,628,716...150,673,668
Ensembl chr 2:150,628,655...150,673,678
JBrowse link
G Pygl liver glycogen phosphorylase decreases expression EXP Dextran Sulfate results in decreased expression of PYGL protein CTD PMID:35999755 NCBI chr12:70,237,589...70,274,457
Ensembl chr12:70,237,585...70,278,262
JBrowse link
G Pyy peptide YY multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PYY mRNA CTD PMID:29950665 NCBI chr11:101,997,502...101,998,658
Ensembl chr11:101,997,502...101,998,658
JBrowse link
G R3hcc1 R3H domain and coiled-coil containing 1 increases expression EXP Dextran Sulfate results in increased expression of R3HCC1 mRNA CTD PMID:35093514 NCBI chr14:69,934,753...69,952,258
Ensembl chr14:69,934,756...69,945,033
JBrowse link
G Rab11b RAB11B, member RAS oncogene family decreases expression EXP Dextran Sulfate results in decreased expression of RAB11B protein CTD PMID:35999755 NCBI chr17:33,961,458...33,979,460
Ensembl chr17:33,961,458...33,979,504
JBrowse link
G Rab1b RAB1B, member RAS oncogene family multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of RAB1B protein] CTD PMID:32272095 NCBI chr19:5,149,235...5,157,024
Ensembl chr19:5,149,233...5,157,100
JBrowse link
G Rab21 RAB21, member RAS oncogene family multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of RAB21 protein CTD PMID:35999755 NCBI chr10:115,125,767...115,151,540
Ensembl chr10:115,122,989...115,151,499
JBrowse link
G Rab27a RAB27A, member RAS oncogene family decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of RAB27A protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of RAB27A protein]
CTD PMID:32272095 NCBI chr 9:72,952,092...73,004,905
Ensembl chr 9:72,952,136...73,004,911
JBrowse link
G Rab27b RAB27B, member RAS oncogene family multiple interactions
decreases expression
EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of RAB27B protein; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of RAB27B mRNA
Dextran Sulfate results in decreased expression of RAB27B protein
CTD PMID:29950665 PMID:35999755 NCBI chr18:70,112,202...70,274,704
Ensembl chr18:70,112,202...70,274,676
JBrowse link
G Rab39b RAB39B, member RAS oncogene family multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of RAB39B protein CTD PMID:35999755 NCBI chr  X:74,615,651...74,621,837
Ensembl chr  X:74,615,652...74,621,837
JBrowse link
G Rac3 Rac family small GTPase 3 multiple interactions EXP [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of RAC3 mRNA; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of RAC3 mRNA] CTD PMID:31715269 NCBI chr11:120,612,294...120,614,795
Ensembl chr11:120,612,296...120,614,795
JBrowse link
G Ramp1 receptor (calcitonin) activity modifying protein 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RAMP1 mRNA CTD PMID:29950665 NCBI chr 1:91,107,544...91,152,918
Ensembl chr 1:91,107,544...91,152,918
JBrowse link
G Ramp2 receptor (calcitonin) activity modifying protein 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RAMP2 mRNA CTD PMID:29950665 NCBI chr11:101,137,160...101,139,076
Ensembl chr11:101,136,854...101,150,372
JBrowse link
G Ramp3 receptor (calcitonin) activity modifying protein 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RAMP3 mRNA CTD PMID:29950665 NCBI chr11:6,608,507...6,627,478
Ensembl chr11:6,608,521...6,627,475
JBrowse link
G Rap1b RAS related protein 1b decreases expression EXP Dextran Sulfate results in decreased expression of RAP1B protein CTD PMID:35999755 NCBI chr10:117,650,502...117,681,879
Ensembl chr10:117,649,776...117,681,940
JBrowse link
G Rapgef4 Rap guanine nucleotide exchange factor (GEF) 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RAPGEF4 mRNA CTD PMID:29950665 NCBI chr 2:71,811,559...72,087,818
Ensembl chr 2:71,811,584...72,087,818
JBrowse link
G Rarg retinoic acid receptor, gamma multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RARG mRNA CTD PMID:29950665 NCBI chr15:102,143,373...102,165,891
Ensembl chr15:102,143,373...102,165,952
JBrowse link
G Rarres1 retinoic acid receptor responder (tazarotene induced) 1 decreases expression EXP Dextran Sulfate results in decreased expression of RARRES1 mRNA CTD PMID:35093514 NCBI chr 3:67,386,219...67,422,856
Ensembl chr 3:67,386,305...67,422,856
JBrowse link
G Rasgrp3 RAS, guanyl releasing protein 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RASGRP3 mRNA CTD PMID:29950665 NCBI chr17:75,742,849...75,836,049
Ensembl chr17:75,742,891...75,836,049
JBrowse link
G Rassf1 Ras association (RalGDS/AF-6) domain family member 1 increases response to substance
multiple interactions
EXP RASSF1 gene mutant form results in increased susceptibility to Dextran Sulfate
[RASSF1 gene mutant form results in increased susceptibility to Dextran Sulfate] which results in decreased activity of STK4 protein; [RASSF1 gene mutant form results in increased susceptibility to Dextran Sulfate] which results in increased activity of MPO protein; [RASSF1 gene mutant form results in increased susceptibility to Dextran Sulfate] which results in increased expression of BAX mRNA; [RASSF1 gene mutant form results in increased susceptibility to Dextran Sulfate] which results in increased expression of BAX protein; [RASSF1 gene mutant form results in increased susceptibility to Dextran Sulfate] which results in increased phosphorylation of and affects the localization of YAP1 protein; [RASSF1 gene mutant form results in increased susceptibility to Dextran Sulfate] which results in increased secretion of CCL2 protein; [RASSF1 gene mutant form results in increased susceptibility to Dextran Sulfate] which results in increased secretion of IL6 protein
CTD PMID:24146755 NCBI chr 9:107,428,752...107,439,460
Ensembl chr 9:107,428,754...107,439,466
JBrowse link
G Rbm12b2 RNA binding motif protein 12 B2 decreases expression EXP Dextran Sulfate results in decreased expression of RBM12B2 mRNA CTD PMID:35093514 NCBI chr 4:12,089,370...12,105,618
Ensembl chr 4:12,089,439...12,096,243
JBrowse link
G Rbp4 retinol binding protein 4, plasma multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of RBP4 protein CTD PMID:35999755 NCBI chr19:38,105,068...38,113,769
Ensembl chr19:38,105,077...38,113,729
JBrowse link
G Rcbtb2 regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2 increases expression EXP Dextran Sulfate results in increased expression of RCBTB2 mRNA CTD PMID:35093514 NCBI chr14:73,376,185...73,421,495
Ensembl chr14:73,360,477...73,445,283
JBrowse link
G Rdx radixin decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of RDX protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of RDX protein]
CTD PMID:32272095 NCBI chr 9:51,958,450...52,000,038
Ensembl chr 9:51,958,473...52,011,763
JBrowse link
G Reg1 regenerating islet-derived 1 multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in increased expression of REG1 protein CTD PMID:35999755 NCBI chr 6:78,402,966...78,405,651
Ensembl chr 6:78,399,694...78,405,650
JBrowse link
G Reg3b regenerating islet-derived 3 beta increases expression EXP Dextran Sulfate results in increased expression of REG3B mRNA CTD PMID:23894361 NCBI chr 6:78,347,868...78,350,449
Ensembl chr 6:78,347,640...78,350,449
JBrowse link
G Reg3g regenerating islet-derived 3 gamma increases expression EXP Dextran Sulfate results in increased expression of REG3G mRNA CTD PMID:23894361 NCBI chr 6:78,443,252...78,445,857
Ensembl chr 6:78,443,252...78,445,855
JBrowse link
G Rela v-rel reticuloendotheliosis viral oncogene homolog A (avian) multiple interactions
increases activity
affects localization
increases phosphorylation
increases expression
EXP
ISO
17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid inhibits the reaction [Dextran Sulfate results in increased activity of RELA protein]; 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [Dextran Sulfate results in increased phosphorylation of RELA protein]; 7-hydroxyl-1-methylindole-3-acetonitrile inhibits the reaction [Dextran Sulfate results in increased phosphorylation of RELA protein]; [Azoxymethane co-treated with Dextran Sulfate] affects the localization of and results in increased phosphorylation of RELA protein; [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of RELA protein; [Streptozocin co-treated with Dextran Sulfate] results in increased phosphorylation of RELA protein; apigenin-6,8-di-C-glycopyranoside inhibits the reaction [Dextran Sulfate results in increased expression of RELA protein]; asperuloside inhibits the reaction [Dextran Sulfate results in increased phosphorylation of RELA protein]; Aspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] affects the localization of and results in increased phosphorylation of RELA protein]; Camptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] affects the localization of and results in increased phosphorylation of RELA protein]; Cholecalciferol inhibits the reaction [Dextran Sulfate results in increased phosphorylation of RELA protein]; Dextran Sulfate results in decreased expression of and results in increased phosphorylation of RELA protein; Dextran Sulfate results in increased activity of and results in increased phosphorylation of RELA protein; Dextran Sulfate results in increased expression of and affects the localization of and results in increased activity of RELA protein; Dextran Sulfate results in increased expression of and affects the localization of RELA protein; Dextran Sulfate results in increased phosphorylation of and affects the localization of RELA protein; EIF2AK2 protein affects the reaction [Dextran Sulfate results in increased phosphorylation of RELA protein]; Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of and results in increased phosphorylation of RELA protein]; flavokawain B inhibits the reaction [Dextran Sulfate results in increased phosphorylation of RELA protein]; geraniol inhibits the reaction [Dextran Sulfate results in increased expression of and affects the localization of and results in increased activity of RELA protein]; GW 506033X inhibits the reaction [Dextran Sulfate results in increased phosphorylation of RELA protein]; ligustilide inhibits the reaction [Dextran Sulfate results in increased expression of and affects the localization of RELA protein]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased phosphorylation of RELA protein]; monotropein inhibits the reaction [Dextran Sulfate affects the localization of RELA protein]; notoginsenoside R1 inhibits the reaction [Dextran Sulfate results in increased expression of RELA protein modified form]; Plant Extracts inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] affects the localization of and results in increased phosphorylation of RELA protein]; Plant Extracts inhibits the reaction [Dextran Sulfate results in increased activity of and results in increased phosphorylation of RELA protein]; RELA protein affects the reaction [Dextran Sulfate results in increased expression of NOS2 mRNA]; resolvin D1 inhibits the reaction [Dextran Sulfate results in increased activity of RELA protein]; resolvin D2 inhibits the reaction [Dextran Sulfate results in increased activity of RELA protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased expression of RELA protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased phosphorylation of RELA protein]; tussilagone inhibits the reaction [Dextran Sulfate results in increased expression of RELA protein]
Dextran Sulfate results in increased expression of RELA protein; Dextran Sulfate results in increased expression of RELA protein modified form
banxia xiexin decoction inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased phosphorylation of RELA protein]; Dextran Sulfate results in increased expression of and results in increased phosphorylation of RELA protein; palmatine inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased phosphorylation of RELA protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased phosphorylation of RELA protein]
CTD PMID:21724996 PMID:23261679 PMID:24038091 PMID:25449198 PMID:25472953 More... NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
JBrowse link
G Renbp renin binding protein multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RENBP mRNA CTD PMID:29950665 NCBI chr  X:72,965,727...72,974,408
Ensembl chr  X:72,965,727...72,974,456
JBrowse link
G Retnlb resistin like beta increases expression EXP Dextran Sulfate results in increased expression of RETNLB mRNA CTD PMID:23894361 NCBI chr16:48,637,219...48,639,255
Ensembl chr16:48,637,219...48,639,255
JBrowse link
G Retnlg resistin like gamma multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in increased expression of RETNLG protein CTD PMID:35999755 NCBI chr16:48,692,971...48,694,861
Ensembl chr16:48,692,984...48,694,859
JBrowse link
G Retsat retinol saturase (all trans retinol 13,14 reductase) multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of RETSAT mRNA CTD PMID:29950665 NCBI chr 6:72,575,585...72,584,471
Ensembl chr 6:72,575,458...72,585,408
JBrowse link
G Rgr retinal G protein coupled receptor multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RGR mRNA CTD PMID:29950665 NCBI chr14:36,756,866...36,770,971
Ensembl chr14:36,756,866...36,770,921
JBrowse link
G Rgs19 regulator of G-protein signaling 19 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RGS19 mRNA CTD PMID:29950665 NCBI chr 2:181,330,212...181,336,330
Ensembl chr 2:181,330,212...181,335,770
JBrowse link
G Rgs7 regulator of G protein signaling 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RGS7 mRNA CTD PMID:29950665 NCBI chr 1:174,886,642...175,320,287
Ensembl chr 1:174,886,653...175,320,066
JBrowse link
G Rhbg Rhesus blood group-associated B glycoprotein multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of RHBG mRNA
Dextran Sulfate results in decreased expression of RHBG mRNA
CTD PMID:29950665 PMID:35093514 NCBI chr 3:88,150,181...88,162,046
Ensembl chr 3:88,150,181...88,162,016
JBrowse link
G Rhoj ras homolog family member J multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RHOJ mRNA CTD PMID:29950665 NCBI chr12:75,355,087...75,448,229
Ensembl chr12:75,355,096...75,448,230
JBrowse link
G Rida reactive intermediate imine deaminase A homolog decreases expression EXP Dextran Sulfate results in decreased expression of RIDA protein CTD PMID:35999755 NCBI chr15:34,484,168...34,495,392
Ensembl chr15:34,484,167...34,495,401
JBrowse link
G Ripk1 receptor (TNFRSF)-interacting serine-threonine kinase 1 multiple interactions
increases expression
EXP dihydrotanshinone I inhibits the reaction [Dextran Sulfate results in increased expression of RIPK1 protein] CTD PMID:29496522 NCBI chr13:34,181,072...34,219,153
Ensembl chr13:34,186,346...34,221,130
JBrowse link
G Ripk3 receptor-interacting serine-threonine kinase 3 increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of RIPK3 protein
dihydrotanshinone I inhibits the reaction [Dextran Sulfate results in increased expression of RIPK3 protein]
CTD PMID:29496522 NCBI chr14:56,022,452...56,026,314
Ensembl chr14:56,022,452...56,026,322
JBrowse link
G Rnf213 ring finger protein 213 decreases expression EXP Dextran Sulfate results in decreased expression of RNF213 mRNA CTD PMID:35093514 NCBI chr11:119,280,778...119,378,245
Ensembl chr11:119,283,926...119,378,244
JBrowse link
G Rorc RAR-related orphan receptor gamma increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of RORC mRNA; Dextran Sulfate results in increased expression of RORC mRNA alternative form
Chlorpyrifos inhibits the reaction [Dextran Sulfate results in increased expression of RORC mRNA alternative form]; Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of RORC mRNA]
CTD PMID:31737179 PMID:31807802 NCBI chr 3:94,280,106...94,305,583
Ensembl chr 3:94,280,101...94,305,583
JBrowse link
G Rpl39l ribosomal protein L39-like increases expression EXP Dextran Sulfate results in increased expression of RPL39L mRNA CTD PMID:35093514 NCBI chr16:9,988,061...9,992,775
Ensembl chr16:9,988,090...9,992,775
JBrowse link
G Rpl41 ribosomal protein L41 increases expression EXP Dextran Sulfate results in increased expression of RPL41 mRNA CTD PMID:35093514 NCBI chr10:128,383,979...128,385,037
Ensembl chr10:128,383,983...128,385,174
JBrowse link
G Rps14 ribosomal protein S14 increases expression EXP Dextran Sulfate results in increased expression of RPS14 mRNA CTD PMID:35093514 NCBI chr18:60,907,668...60,911,618
Ensembl chr18:60,880,170...60,911,618
JBrowse link
G Rps15 ribosomal protein S15 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of RPS15 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of RPS15 protein]
CTD PMID:32272095 NCBI chr10:80,128,265...80,129,948
Ensembl chr10:80,128,287...80,129,948
JBrowse link
G Rps15a ribosomal protein S15A decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of RPS15A protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of RPS15A protein]
CTD PMID:32272095 NCBI chr 7:117,703,597...117,715,370
Ensembl chr 7:117,703,595...117,715,411
JBrowse link
G Rps29 ribosomal protein S29 increases expression EXP Dextran Sulfate results in increased expression of RPS29 mRNA CTD PMID:35093514 NCBI chr12:69,204,495...69,205,891
Ensembl chr12:69,204,496...69,205,960
JBrowse link
G Rps6 ribosomal protein S6 multiple interactions
increases phosphorylation
EXP 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpinetin inhibits the reaction [Dextran Sulfate results in increased phosphorylation of RPS6 protein]]; [Azoxymethane co-treated with Dextran Sulfate] results in increased phosphorylation of RPS6 protein; alpinetin inhibits the reaction [Dextran Sulfate results in increased phosphorylation of RPS6 protein] CTD PMID:19931517 PMID:31676321 NCBI chr 4:86,772,336...86,775,604
Ensembl chr 4:86,772,897...86,775,649
JBrowse link
G Rps6kb1 ribosomal protein S6 kinase, polypeptide 1 multiple interactions
increases phosphorylation
decreases phosphorylation
EXP
ISO
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpinetin inhibits the reaction [Dextran Sulfate results in increased phosphorylation of RPS6KB1 protein]]; alpinetin inhibits the reaction [Dextran Sulfate results in increased phosphorylation of RPS6KB1 protein]; CNR2 protein affects the reaction [Dextran Sulfate results in decreased phosphorylation of RPS6KB1 protein]; Nicotine promotes the reaction [Dextran Sulfate results in decreased phosphorylation of RPS6KB1 protein]
dorsomorphin inhibits the reaction [Nicotine promotes the reaction [Dextran Sulfate results in decreased phosphorylation of RPS6KB1 protein]]; Nicotine promotes the reaction [Dextran Sulfate results in decreased phosphorylation of RPS6KB1 protein]
CTD PMID:27611972 PMID:31676321 PMID:31926917 NCBI chr11:86,389,695...86,435,711
Ensembl chr11:86,389,697...86,435,631
JBrowse link
G Rras2 related RAS viral (r-ras) oncogene 2 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of RRAS2 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of RRAS2 protein]
CTD PMID:32272095 NCBI chr 7:113,646,017...113,717,016
Ensembl chr 7:113,646,017...113,717,016
JBrowse link
G Rrbp1 ribosome binding protein 1 increases expression EXP Dextran Sulfate results in increased expression of RRBP1 mRNA CTD PMID:35093514 NCBI chr 2:143,789,315...143,853,216
Ensembl chr 2:143,789,315...143,853,183
JBrowse link
G Rrp1 ribosomal RNA processing 1 increases expression EXP Dextran Sulfate results in increased expression of RRP1 mRNA CTD PMID:35093514 NCBI chr10:78,236,196...78,248,877
Ensembl chr10:78,236,218...78,248,877
JBrowse link
G Rsph1 radial spoke head 1 homolog (Chlamydomonas) increases expression EXP Dextran Sulfate results in increased expression of RSPH1 mRNA CTD PMID:35093514 NCBI chr17:31,473,993...31,496,270
Ensembl chr17:31,473,993...31,496,357
JBrowse link
G Rsu1 Ras suppressor protein 1 decreases expression EXP Dextran Sulfate results in decreased expression of RSU1 protein CTD PMID:35999755 NCBI chr 2:13,081,778...13,276,116
Ensembl chr 2:13,081,632...13,276,226
JBrowse link
G Rxfp1 relaxin/insulin-like family peptide receptor 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RXFP1 mRNA CTD PMID:29950665 NCBI chr 3:79,548,910...79,645,258
Ensembl chr 3:79,548,918...79,645,187
JBrowse link
G Rxfp4 relaxin family peptide receptor 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RXFP4 mRNA CTD PMID:29950665 NCBI chr 3:88,559,081...88,560,489
Ensembl chr 3:88,559,205...88,560,449
JBrowse link
G Rxra retinoid X receptor alpha multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of RXRA mRNA CTD PMID:29950665 NCBI chr 2:27,566,457...27,653,331
Ensembl chr 2:27,566,452...27,652,969
JBrowse link
G Ryr1 ryanodine receptor 1, skeletal muscle multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RYR1 mRNA CTD PMID:29950665 NCBI chr 7:28,702,765...28,824,599
Ensembl chr 7:28,702,769...28,824,604
JBrowse link
G S100a11 S100 calcium binding protein A11 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of S100A11 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of S100A11 protein]
CTD PMID:32272095 NCBI chr 3:93,427,803...93,433,595
Ensembl chr 3:93,427,795...93,433,594
JBrowse link
G S100a4 S100 calcium binding protein A4 multiple interactions
increases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in increased expression of S100A4 protein] CTD PMID:32272095 NCBI chr 3:90,511,077...90,513,349
Ensembl chr 3:90,511,078...90,513,352
JBrowse link
G S100a8 S100 calcium binding protein A8 (calgranulin A) increases expression EXP Dextran Sulfate results in increased expression of S100A8 mRNA CTD PMID:20824662 NCBI chr 3:90,576,378...90,577,341
Ensembl chr 3:90,576,285...90,577,342
JBrowse link
G S100a9 S100 calcium binding protein A9 (calgranulin B) increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of S100A9 protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of S100A9 protein]
CTD PMID:32272095 NCBI chr 3:90,599,937...90,603,028
Ensembl chr 3:90,599,939...90,603,028
JBrowse link
G S100g S100 calcium binding protein G multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of S100G mRNA CTD PMID:29950665 NCBI chr  X:161,744,988...161,747,595
Ensembl chr  X:161,744,988...161,747,595
JBrowse link
G S1pr2 sphingosine-1-phosphate receptor 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of S1PR2 mRNA CTD PMID:29950665 NCBI chr 9:20,877,248...20,888,089
Ensembl chr 9:20,873,657...20,888,077
JBrowse link
G Saa1 serum amyloid A 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SAA1 mRNA CTD PMID:29950665 NCBI chr 7:46,389,921...46,392,404
Ensembl chr 7:46,389,921...46,392,404
JBrowse link
G Saa2 serum amyloid A 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SAA2 mRNA CTD PMID:29950665 NCBI chr 7:46,401,257...46,403,737
Ensembl chr 7:46,401,214...46,403,737
JBrowse link
G Saa3 serum amyloid A 3 increases expression EXP Dextran Sulfate results in increased expression of SAA3 mRNA CTD PMID:23894361 NCBI chr 7:46,361,422...46,365,100
Ensembl chr 7:46,361,422...46,365,124
JBrowse link
G Safb scaffold attachment factor B increases expression EXP Dextran Sulfate results in increased expression of SAFB mRNA CTD PMID:35093514 NCBI chr17:56,891,982...56,913,294
Ensembl chr17:56,891,825...56,913,294
JBrowse link
G Safb2 scaffold attachment factor B2 increases expression EXP Dextran Sulfate results in increased expression of SAFB2 mRNA CTD PMID:35093514 NCBI chr17:56,867,971...56,891,673
Ensembl chr17:56,867,965...56,891,585
JBrowse link
G Sap30 sin3 associated polypeptide increases expression EXP Dextran Sulfate results in increased expression of SAP30 mRNA CTD PMID:35093514 NCBI chr 8:57,935,740...57,940,874
Ensembl chr 8:57,935,741...57,940,894
JBrowse link
G Sardh sarcosine dehydrogenase decreases expression EXP Dextran Sulfate results in decreased expression of SARDH mRNA CTD PMID:35093514 NCBI chr 2:27,078,405...27,138,344
Ensembl chr 2:27,078,405...27,138,349
JBrowse link
G Sarnp SAP domain containing ribonucleoprotein decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of SARNP protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of SARNP protein]
CTD PMID:32272095 NCBI chr10:128,657,633...128,713,507
Ensembl chr10:128,653,202...128,713,498
JBrowse link
G Sart1 squamous cell carcinoma antigen recognized by T cells 1 increases expression EXP Dextran Sulfate results in increased expression of SART1 mRNA CTD PMID:35093514 NCBI chr19:5,427,551...5,438,731
Ensembl chr19:5,427,551...5,438,731
JBrowse link
G Sc5d sterol-C5-desaturase decreases expression EXP Dextran Sulfate results in decreased expression of SC5D mRNA CTD PMID:35093514 NCBI chr 9:42,162,888...42,175,607
Ensembl chr 9:42,162,891...42,175,552
JBrowse link
G Scamp1 secretory carrier membrane protein 1 multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of SCAMP1 protein] CTD PMID:32272095 NCBI chr13:94,337,818...94,422,339
Ensembl chr13:94,337,818...94,422,365
JBrowse link
G Scd1 stearoyl-Coenzyme A desaturase 1 decreases expression EXP Dextran Sulfate results in decreased expression of SCD1 mRNA CTD PMID:35093514 NCBI chr19:44,382,889...44,396,148
Ensembl chr19:44,382,894...44,396,318
JBrowse link
G Scd2 stearoyl-Coenzyme A desaturase 2 decreases expression EXP Dextran Sulfate results in decreased expression of SCD2 mRNA CTD PMID:35093514 NCBI chr19:44,282,115...44,295,303
Ensembl chr19:44,282,113...44,295,303
JBrowse link
G Scgb1a1 secretoglobin, family 1A, member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SCGB1A1 mRNA CTD PMID:29950665 NCBI chr19:9,061,006...9,065,320
Ensembl chr19:9,061,000...9,065,322
JBrowse link
G Scgb3a1 secretoglobin, family 3A, member 1 increases expression EXP Dextran Sulfate results in increased expression of SCGB3A1 mRNA CTD PMID:35093514 NCBI chr11:49,554,422...49,555,945
Ensembl chr11:49,554,437...49,555,945
JBrowse link
G Scin scinderin multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SCIN mRNA CTD PMID:29950665 NCBI chr12:40,109,768...40,184,227
Ensembl chr12:40,109,768...40,184,227
JBrowse link
G Scnn1a sodium channel, nonvoltage-gated 1 alpha multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SCNN1A mRNA CTD PMID:29950665 NCBI chr 6:125,286,657...125,321,906
Ensembl chr 6:125,297,622...125,321,906
JBrowse link
G Scnn1b sodium channel, nonvoltage-gated 1 beta multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SCNN1B mRNA CTD PMID:29950665 NCBI chr 7:121,464,261...121,517,951
Ensembl chr 7:121,464,261...121,517,737
JBrowse link
G Sct secretin multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SCT mRNA CTD PMID:29950665 NCBI chr 7:140,858,243...140,859,082
Ensembl chr 7:140,858,243...140,859,046
JBrowse link
G Sdc3 syndecan 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SDC3 mRNA CTD PMID:29950665 NCBI chr 4:130,519,855...130,553,629
Ensembl chr 4:130,519,848...130,553,630
JBrowse link
G Sec62 SEC62 homolog, preprotein translocation multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of SEC62 protein] CTD PMID:32272095 NCBI chr 3:30,847,025...30,875,412
Ensembl chr 3:30,847,024...30,875,412
JBrowse link
G Selp selectin, platelet multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SELP mRNA CTD PMID:29950665 NCBI chr 1:163,942,833...163,977,595
Ensembl chr 1:163,942,833...163,977,595
JBrowse link
G Serpina1b serine (or cysteine) preptidase inhibitor, clade A, member 1B multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of SERPINA1B protein CTD PMID:35999755 NCBI chr12:103,694,415...103,704,448
Ensembl chr12:103,694,415...103,796,632
JBrowse link
G Serpina1e serine (or cysteine) peptidase inhibitor, clade A, member 1E multiple interactions
increases expression
EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of SERPINA1E protein
Dextran Sulfate results in increased expression of SERPINA1E protein
CTD PMID:35999755 NCBI chr12:103,913,190...103,923,156
Ensembl chr12:103,913,190...103,925,234
JBrowse link
G Serpina3f serine (or cysteine) peptidase inhibitor, clade A, member 3F increases expression EXP Dextran Sulfate results in increased expression of SERPINA3F mRNA CTD PMID:23894361 NCBI chr12:104,180,803...104,187,388
Ensembl chr12:104,180,803...104,187,388
JBrowse link
G Serpina3n serine (or cysteine) peptidase inhibitor, clade A, member 3N increases expression EXP Dextran Sulfate results in increased expression of SERPINA3N mRNA CTD PMID:23894361 PMID:35093514 NCBI chr12:104,372,967...104,380,588
Ensembl chr12:104,372,988...104,380,588
JBrowse link
G Serpina5 serine (or cysteine) peptidase inhibitor, clade A, member 5 multiple interactions ISO Dextran Sulfate affects the reaction [SEMG2 protein binds to SERPINA5 protein] CTD PMID:17253189 NCBI chr12:104,065,572...104,072,397
Ensembl chr12:104,067,372...104,072,396
JBrowse link
G Serpinb1a serine (or cysteine) peptidase inhibitor, clade B, member 1a decreases expression EXP Dextran Sulfate results in decreased expression of SERPINB1A protein CTD PMID:35999755 NCBI chr13:33,026,075...33,037,189
Ensembl chr13:33,026,075...33,035,168
JBrowse link
G Serpine1 serine (or cysteine) peptidase inhibitor, clade E, member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SERPINE1 mRNA CTD PMID:29950665 NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
JBrowse link
G Serping1 serine (or cysteine) peptidase inhibitor, clade G, member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SERPING1 mRNA CTD PMID:29950665 NCBI chr 2:84,595,704...84,605,748
Ensembl chr 2:84,595,731...84,605,788
JBrowse link
G Sf3a2 splicing factor 3a, subunit 2 multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of SF3A2 protein] CTD PMID:32272095 NCBI chr10:80,634,569...80,640,756
Ensembl chr10:80,634,032...80,640,758
JBrowse link
G Sgk2 serum/glucocorticoid regulated kinase 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SGK2 mRNA CTD PMID:29950665 NCBI chr 2:162,829,249...162,856,059
Ensembl chr 2:162,829,250...162,856,047
JBrowse link
G Sgms2 sphingomyelin synthase 2 increases expression EXP Dextran Sulfate results in increased expression of SGMS2 mRNA CTD PMID:25035112 NCBI chr 3:131,112,634...131,197,204
Ensembl chr 3:131,112,634...131,197,172
JBrowse link
G Sgpp2 sphingosine-1-phosphate phosphatase 2 multiple interactions
increases expression
ISO Hesperidin inhibits the reaction [Dextran Sulfate results in increased expression of SGPP2 mRNA] CTD PMID:30811821 NCBI chr 1:78,286,186...78,396,926
Ensembl chr 1:78,286,982...78,396,926
JBrowse link
G Sh3bgrl SH3-binding domain glutamic acid-rich protein like decreases expression EXP Dextran Sulfate results in decreased expression of SH3BGRL protein CTD PMID:35999755 NCBI chr  X:108,139,013...108,206,073
Ensembl chr  X:108,138,971...108,241,479
JBrowse link
G Sh3bgrl3 SH3 domain binding glutamic acid-rich protein-like 3 decreases expression EXP Dextran Sulfate results in decreased expression of SH3BGRL3 protein CTD PMID:35999755 NCBI chr 4:133,854,717...133,856,044
Ensembl chr 4:133,854,717...133,856,100
JBrowse link
G Sh3gl2 SH3-domain GRB2-like 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SH3GL2 mRNA CTD PMID:29950665 NCBI chr 4:85,123,663...85,307,617
Ensembl chr 4:85,123,363...85,557,432
JBrowse link
G Sh3kbp1 SH3-domain kinase binding protein 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SH3KBP1 mRNA CTD PMID:29950665 NCBI chr  X:158,409,888...158,758,916
Ensembl chr  X:158,410,268...158,761,065
JBrowse link
G Shmt1 serine hydroxymethyltransferase 1 (soluble) decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of SHMT1 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of SHMT1 protein]
CTD PMID:32272095 NCBI chr11:60,679,723...60,702,062
Ensembl chr11:60,678,930...60,702,544
JBrowse link
G Siae sialic acid acetylesterase decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of SIAE protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of SIAE protein]
CTD PMID:32272095 NCBI chr 9:37,525,117...37,559,554
Ensembl chr 9:37,466,994...37,560,951
JBrowse link
G Sipa1 signal-induced proliferation associated gene 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SIPA1 mRNA CTD PMID:29950665 NCBI chr19:5,701,211...5,713,758
Ensembl chr19:5,701,213...5,713,735
JBrowse link
G Sirt1 sirtuin 1 multiple interactions
decreases expression
EXP ADAM17 protein affects the reaction [Dextran Sulfate results in decreased expression of SIRT1 mRNA]; resveratrol inhibits the reaction [Dextran Sulfate results in decreased expression of SIRT1 mRNA]; resveratrol inhibits the reaction [Dextran Sulfate results in decreased expression of SIRT1 protein]
Dextran Sulfate results in decreased expression of SIRT1 mRNA; Dextran Sulfate results in decreased expression of SIRT1 protein
CTD PMID:19940103 PMID:24548422 NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483
JBrowse link
G Slc10a1 solute carrier family 10 (sodium/bile acid cotransporter family), member 1 decreases expression EXP Dextran Sulfate results in decreased expression of SLC10A1 mRNA; Dextran Sulfate results in decreased expression of SLC10A1 protein CTD PMID:27580383 NCBI chr12:80,999,959...81,015,479
Ensembl chr12:80,999,957...81,015,479
JBrowse link
G Slc10a2 solute carrier family 10, member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC10A2 mRNA CTD PMID:29950665 NCBI chr 8:5,133,219...5,155,287
Ensembl chr 8:5,133,219...5,155,351
JBrowse link
G Slc10a6 solute carrier family 10 (sodium/bile acid cotransporter family), member 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC10A6 mRNA CTD PMID:29950665 NCBI chr 5:103,753,583...103,777,152
Ensembl chr 5:103,753,577...103,777,269
JBrowse link
G Slc11a1 solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC11A1 mRNA CTD PMID:29950665 NCBI chr 1:74,414,318...74,429,974
Ensembl chr 1:74,414,354...74,425,221
JBrowse link
G Slc12a4 solute carrier family 12, member 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC12A4 mRNA CTD PMID:29950665 NCBI chr 8:106,670,222...106,692,781
Ensembl chr 8:106,670,222...106,692,729
JBrowse link
G Slc12a7 solute carrier family 12, member 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC12A7 mRNA CTD PMID:29950665 NCBI chr13:73,881,172...73,964,873
Ensembl chr13:73,881,213...73,964,873
JBrowse link
G Slc13a1 solute carrier family 13 (sodium/sulfate symporters), member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC13A1 mRNA CTD PMID:29950665 NCBI chr 6:24,088,282...24,168,118
Ensembl chr 6:24,088,282...24,168,091
JBrowse link
G Slc13a2 solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC13A2 mRNA CTD PMID:29950665 NCBI chr11:78,288,102...78,313,107
Ensembl chr11:78,287,913...78,313,043
JBrowse link
G Slc13a5 solute carrier family 13 (sodium-dependent citrate transporter), member 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC13A5 mRNA CTD PMID:29950665 NCBI chr11:72,132,816...72,158,092
Ensembl chr11:72,132,815...72,158,048
JBrowse link
G Slc15a1 solute carrier family 15 (oligopeptide transporter), member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC15A1 mRNA CTD PMID:29950665 NCBI chr14:121,697,033...121,742,666
Ensembl chr14:121,697,033...121,742,664
JBrowse link
G Slc15a4 solute carrier family 15, member 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC15A4 mRNA CTD PMID:29950665 NCBI chr 5:127,668,795...127,710,356
Ensembl chr 5:127,672,728...127,709,961
JBrowse link
G Slc16a3 solute carrier family 16 (monocarboxylic acid transporters), member 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC16A3 mRNA CTD PMID:29950665 NCBI chr11:120,839,310...120,849,826
Ensembl chr11:120,839,306...120,851,694
JBrowse link
G Slc16a8 solute carrier family 16 (monocarboxylic acid transporters), member 8 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC16A8 mRNA CTD PMID:29950665 NCBI chr15:79,135,216...79,139,619
Ensembl chr15:79,135,214...79,138,961
JBrowse link
G Slc17a5 solute carrier family 17 (anion/sugar transporter), member 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC17A5 mRNA CTD PMID:29950665 NCBI chr 9:78,443,769...78,495,346
Ensembl chr 9:78,443,770...78,495,323
JBrowse link
G Slc17a6 solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC17A6 mRNA CTD PMID:29950665 NCBI chr 7:51,271,578...51,320,874
Ensembl chr 7:51,271,754...51,320,867
JBrowse link
G Slc17a8 solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC17A8 mRNA CTD PMID:29950665 NCBI chr10:89,409,882...89,457,111
Ensembl chr10:89,409,882...89,457,115
JBrowse link
G Slc18a1 solute carrier family 18 (vesicular monoamine), member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC18A1 mRNA CTD PMID:29950665 NCBI chr 8:69,490,360...69,547,951
Ensembl chr 8:69,490,363...69,541,887
JBrowse link
G Slc1a2 solute carrier family 1 (glial high affinity glutamate transporter), member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC1A2 mRNA CTD PMID:29950665 NCBI chr 2:102,488,584...102,621,129
Ensembl chr 2:102,489,004...102,621,129
JBrowse link
G Slc1a5 solute carrier family 1 (neutral amino acid transporter), member 5 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of SLC1A5 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of SLC1A5 protein]
CTD PMID:32272095 NCBI chr 7:16,515,259...16,532,199
Ensembl chr 7:16,515,265...16,532,199
JBrowse link
G Slc1a6 solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC1A6 mRNA CTD PMID:29950665 NCBI chr10:78,615,923...78,650,659
Ensembl chr10:78,616,330...78,650,599
JBrowse link
G Slc1a7 solute carrier family 1 (glutamate transporter), member 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC1A7 mRNA CTD PMID:29950665 NCBI chr 4:107,825,603...107,870,726
Ensembl chr 4:107,825,529...107,870,729
JBrowse link
G Slc22a1 solute carrier family 22 (organic cation transporter), member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC22A1 mRNA CTD PMID:29950665 NCBI chr17:12,867,761...12,894,725
Ensembl chr17:12,867,756...12,894,716
JBrowse link
G Slc22a18 solute carrier family 22 (organic cation transporter), member 18 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC22A18 mRNA CTD PMID:29950665 NCBI chr 7:143,027,502...143,053,071
Ensembl chr 7:143,027,473...143,053,071
JBrowse link
G Slc22a21 solute carrier family 22 (organic cation transporter), member 21 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC22A21 mRNA CTD PMID:29950665 NCBI chr11:53,840,780...53,871,159
Ensembl chr11:53,840,791...53,871,158
JBrowse link
G Slc22a3 solute carrier family 22 (organic cation transporter), member 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC22A3 mRNA CTD PMID:29950665 NCBI chr17:12,638,859...12,726,591
Ensembl chr17:12,637,847...12,726,591
JBrowse link
G Slc22a4 solute carrier family 22 (organic cation transporter), member 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of SLC22A4 mRNA CTD PMID:29950665 NCBI chr11:53,873,941...53,920,866
Ensembl chr11:53,873,949...53,918,916
JBrowse link
G Slc22a5 solute carrier family 22 (organic cation transporter), member 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC22A5 mRNA CTD PMID:29950665 NCBI chr11:53,755,368...53,782,609
Ensembl chr11:53,755,368...53,782,486
JBrowse link
G Slc22a8 solute carrier family 22 (organic anion transporter), member 8 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC22A8 mRNA CTD PMID:29950665 NCBI chr19:8,568,576...8,589,199
Ensembl chr19:8,568,618...8,589,199
JBrowse link
G Slc25a10 solute carrier family 25 (mitochondrial carrier, dicarboxylate transporter), member 10 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC25A10 mRNA CTD PMID:29950665 NCBI chr11:120,382,663...120,391,987
Ensembl chr11:120,382,666...120,390,013
JBrowse link
G Slc25a28 solute carrier family 25, member 28 increases expression EXP Dextran Sulfate results in increased expression of SLC25A28 mRNA CTD PMID:35093514 NCBI chr19:43,652,240...43,663,320
Ensembl chr19:43,652,240...43,663,320
JBrowse link
G Slc25a4 solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC25A4 mRNA CTD PMID:29950665 NCBI chr 8:46,660,205...46,664,099
Ensembl chr 8:46,659,834...46,664,321
JBrowse link
G Slc26a1 solute carrier family 26 (sulfate transporter), member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC26A1 mRNA CTD PMID:29950665 NCBI chr 5:108,817,744...108,826,246
Ensembl chr 5:108,817,744...108,823,435
JBrowse link
G Slc26a2 solute carrier family 26 (sulfate transporter), member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC26A2 mRNA CTD PMID:29950665 NCBI chr18:61,329,926...61,344,668
Ensembl chr18:61,325,991...61,344,684
JBrowse link
G Slc26a3 solute carrier family 26, member 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC26A3 mRNA CTD PMID:29950665 NCBI chr12:31,483,141...31,523,921
Ensembl chr12:31,440,870...31,523,916
JBrowse link
G Slc26a7 solute carrier family 26, member 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC26A7 mRNA CTD PMID:29950665 NCBI chr 4:14,502,430...14,621,946
Ensembl chr 4:14,502,430...14,621,805
JBrowse link
G Slc26a9 solute carrier family 26, member 9 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC26A9 mRNA CTD PMID:29950665 NCBI chr 1:131,671,760...131,699,242
Ensembl chr 1:131,671,760...131,699,242
JBrowse link
G Slc27a1 solute carrier family 27 (fatty acid transporter), member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC27A1 mRNA CTD PMID:29950665 NCBI chr 8:72,021,372...72,039,951
Ensembl chr 8:72,021,526...72,039,946
JBrowse link
G Slc27a4 solute carrier family 27 (fatty acid transporter), member 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC27A4 mRNA CTD PMID:29950665 NCBI chr 2:29,692,646...29,707,534
Ensembl chr 2:29,692,646...29,707,534
JBrowse link
G Slc28a3 solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC28A3 mRNA CTD PMID:29950665 NCBI chr13:58,701,121...58,758,691
Ensembl chr13:58,693,213...58,758,691
JBrowse link
G Slc29a2 solute carrier family 29 (nucleoside transporters), member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC29A2 mRNA CTD PMID:29950665 NCBI chr19:5,069,085...5,082,000
Ensembl chr19:5,073,888...5,082,000
JBrowse link
G Slc2a1 solute carrier family 2 (facilitated glucose transporter), member 1 increases expression EXP Dextran Sulfate results in increased expression of SLC2A1 protein CTD PMID:20025956 NCBI chr 4:118,966,001...118,994,527
Ensembl chr 4:118,965,908...118,995,180
JBrowse link
G Slc2a12 solute carrier family 2 (facilitated glucose transporter), member 12 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC2A12 mRNA CTD PMID:29950665 NCBI chr10:22,488,821...22,579,779
Ensembl chr10:22,520,910...22,580,184
JBrowse link
G Slc2a3 solute carrier family 2 (facilitated glucose transporter), member 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC2A3 mRNA CTD PMID:29950665 NCBI chr 6:122,704,783...122,779,149
Ensembl chr 6:122,704,768...122,778,599
JBrowse link
G Slc30a1 solute carrier family 30 (zinc transporter), member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC30A1 mRNA CTD PMID:29950665 NCBI chr 1:191,638,810...191,645,359
Ensembl chr 1:191,638,879...191,645,359
JBrowse link
G Slc30a2 solute carrier family 30 (zinc transporter), member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC30A2 mRNA CTD PMID:29950665 NCBI chr 4:134,070,357...134,081,795
Ensembl chr 4:134,070,492...134,081,795
JBrowse link
G Slc34a2 solute carrier family 34 (sodium phosphate), member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC34A2 mRNA CTD PMID:29950665 NCBI chr 5:53,206,695...53,229,006
Ensembl chr 5:53,195,423...53,229,006
JBrowse link
G Slc35a1 solute carrier family 35 (CMP-sialic acid transporter), member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC35A1 mRNA CTD PMID:29950665 NCBI chr 4:34,663,257...34,688,113
Ensembl chr 4:34,663,257...34,687,438
JBrowse link
G Slc35a3 solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC35A3 mRNA CTD PMID:29950665 NCBI chr 3:116,463,118...116,506,366
Ensembl chr 3:116,463,119...116,506,480
JBrowse link
G Slc35d1 solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC35D1 mRNA CTD PMID:29950665 NCBI chr 4:103,027,846...103,078,208
Ensembl chr 4:103,027,846...103,072,361
JBrowse link
G Slc35d2 solute carrier family 35, member D2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC35D2 mRNA CTD PMID:29950665 NCBI chr13:64,244,122...64,277,195
Ensembl chr13:64,244,122...64,277,182
JBrowse link
G Slc36a1 solute carrier family 36 (proton/amino acid symporter), member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC36A1 mRNA CTD PMID:29950665 NCBI chr11:55,095,148...55,127,156
Ensembl chr11:55,095,176...55,127,156
JBrowse link
G Slc38a1 solute carrier family 38, member 1 decreases expression EXP Dextran Sulfate results in decreased expression of SLC38A1 mRNA CTD PMID:35093514 NCBI chr15:96,469,299...96,541,396
Ensembl chr15:96,469,299...96,540,794
JBrowse link
G Slc38a2 solute carrier family 38, member 2 increases expression EXP Dextran Sulfate results in increased expression of SLC38A2 mRNA CTD PMID:27920257 NCBI chr15:96,585,267...96,597,609
Ensembl chr15:96,585,273...96,597,611
JBrowse link
G Slc39a10 solute carrier family 39 (zinc transporter), member 10 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC39A10 mRNA CTD PMID:29950665 NCBI chr 1:46,846,704...46,964,952
Ensembl chr 1:46,846,704...46,932,012
JBrowse link
G Slc39a14 solute carrier family 39 (zinc transporter), member 14 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC39A14 mRNA CTD PMID:29950665 NCBI chr14:70,540,916...70,588,873
Ensembl chr14:70,540,918...70,588,874
JBrowse link
G Slc39a4 solute carrier family 39 (zinc transporter), member 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC39A4 mRNA CTD PMID:29950665 NCBI chr15:76,496,583...76,501,579
Ensembl chr15:76,496,583...76,501,584
JBrowse link
G Slc39a5 solute carrier family 39 (metal ion transporter), member 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC39A5 mRNA CTD PMID:29950665 NCBI chr10:128,231,796...128,237,145
Ensembl chr10:128,231,800...128,237,098
JBrowse link
G Slc39a6 solute carrier family 39 (metal ion transporter), member 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC39A6 mRNA CTD PMID:29950665 NCBI chr18:24,712,938...24,736,874
Ensembl chr18:24,712,938...24,736,874
JBrowse link
G Slc39a8 solute carrier family 39 (metal ion transporter), member 8 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC39A8 mRNA CTD PMID:29950665 NCBI chr 3:135,522,644...135,594,333
Ensembl chr 3:135,531,040...135,594,333
JBrowse link
G Slc3a1 solute carrier family 3, member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC3A1 mRNA CTD PMID:29950665 NCBI chr17:85,335,775...85,371,669
Ensembl chr17:85,335,804...85,371,664
JBrowse link
G Slc40a1 solute carrier family 40 (iron-regulated transporter), member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC40A1 mRNA CTD PMID:29950665 NCBI chr 1:45,947,230...45,965,690
Ensembl chr 1:45,947,228...45,965,683
JBrowse link
G Slc44a3 solute carrier family 44, member 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC44A3 mRNA CTD PMID:29950665 NCBI chr 3:121,253,177...121,325,993
Ensembl chr 3:121,253,177...121,326,053
JBrowse link
G Slc44a4 solute carrier family 44, member 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC44A4 mRNA CTD PMID:29950665 NCBI chr17:35,133,200...35,149,412
Ensembl chr17:35,133,442...35,149,412
JBrowse link
G Slc46a1 solute carrier family 46, member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC46A1 mRNA CTD PMID:29950665 NCBI chr11:78,356,527...78,362,771
Ensembl chr11:78,356,523...78,362,885
JBrowse link
G Slc47a1 solute carrier family 47, member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC47A1 mRNA CTD PMID:29950665 NCBI chr11:61,234,226...61,269,668
Ensembl chr11:61,234,227...61,269,171
JBrowse link
G Slc47a2 solute carrier family 47, member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC47A2 mRNA CTD PMID:29950665 NCBI chr11:61,192,453...61,233,686
Ensembl chr11:61,192,457...61,233,686
JBrowse link
G Slc4a1 solute carrier family 4 (anion exchanger), member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC4A1 mRNA CTD PMID:29950665 NCBI chr11:102,239,646...102,256,107
Ensembl chr11:102,239,650...102,257,029
JBrowse link
G Slc4a2 solute carrier family 4 (anion exchanger), member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC4A2 mRNA CTD PMID:29950665 NCBI chr 5:24,628,834...24,645,945
Ensembl chr 5:24,628,835...24,645,948
JBrowse link
G Slc4a7 solute carrier family 4, sodium bicarbonate cotransporter, member 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC4A7 mRNA CTD PMID:29950665 NCBI chr14:7,669,819...7,766,808
Ensembl chr14:7,669,823...7,767,484
JBrowse link
G Slc51a solute carrier family 51, alpha subunit multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC51A mRNA CTD PMID:29950665 NCBI chr16:32,294,396...32,306,697
Ensembl chr16:32,293,322...32,306,697
JBrowse link
G Slc51b solute carrier family 51, beta subunit multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC51B mRNA CTD PMID:29950665 NCBI chr 9:65,320,035...65,330,055
Ensembl chr 9:65,319,996...65,330,237
JBrowse link
G Slc52a2 solute carrier protein 52, member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC52A2 mRNA CTD PMID:29950665 NCBI chr15:76,422,994...76,432,078
Ensembl chr15:76,423,032...76,428,808
JBrowse link
G Slc5a1 solute carrier family 5 (sodium/glucose cotransporter), member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC5A1 mRNA CTD PMID:29950665 NCBI chr 5:33,261,563...33,320,043
Ensembl chr 5:33,261,563...33,320,214
JBrowse link
G Slc5a11 solute carrier family 5 (sodium/glucose cotransporter), member 11 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC5A11 mRNA CTD PMID:29950665 NCBI chr 7:122,813,817...122,873,612
Ensembl chr 7:122,814,003...122,872,476
JBrowse link
G Slc5a3 solute carrier family 5 (inositol transporters), member 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of SLC5A3 mRNA CTD PMID:29950665 NCBI chr16:91,855,210...91,884,361
Ensembl chr16:91,855,210...91,884,361
JBrowse link
G Slc5a8 solute carrier family 5 (iodide transporter), member 8 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC5A8 mRNA CTD PMID:29950665 NCBI chr10:88,721,854...88,765,377
Ensembl chr10:88,721,854...88,765,377
JBrowse link
G Slc5a9 solute carrier family 5 (sodium/glucose cotransporter), member 9 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC5A9 mRNA CTD PMID:29950665 NCBI chr 4:111,732,571...111,759,993
Ensembl chr 4:111,732,572...111,760,115
JBrowse link
G Slc6a11 solute carrier family 6 (neurotransmitter transporter, GABA), member 11 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC6A11 mRNA CTD PMID:29950665 NCBI chr 6:114,108,202...114,226,847
Ensembl chr 6:114,108,202...114,226,913
JBrowse link
G Slc6a12 solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC6A12 mRNA CTD PMID:29950665 NCBI chr 6:121,319,533...121,342,732
Ensembl chr 6:121,320,035...121,342,734
JBrowse link
G Slc6a14 solute carrier family 6 (neurotransmitter transporter), member 14 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC6A14 mRNA CTD PMID:29950665 NCBI chr  X:21,581,139...21,608,597
Ensembl chr  X:21,581,135...21,608,594
JBrowse link
G Slc6a19 solute carrier family 6 (neurotransmitter transporter), member 19 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC6A19 mRNA CTD PMID:29950665 NCBI chr13:73,827,864...73,848,899
Ensembl chr13:73,827,864...73,852,984
JBrowse link
G Slc6a2 solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC6A2 mRNA CTD PMID:29950665 NCBI chr 8:93,687,100...93,728,295
Ensembl chr 8:93,686,707...93,728,295
JBrowse link
G Slc6a3 solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC6A3 mRNA CTD PMID:29950665 NCBI chr13:73,684,270...73,726,791
Ensembl chr13:73,684,866...73,726,791
JBrowse link
G Slc6a6 solute carrier family 6 (neurotransmitter transporter, taurine), member 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC6A6 mRNA CTD PMID:29950665 NCBI chr 6:91,661,031...91,736,044
Ensembl chr 6:91,661,034...91,736,047
JBrowse link
G Slc7a5 solute carrier family 7 (cationic amino acid transporter, y+ system), member 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC7A5 mRNA CTD PMID:29950665 NCBI chr 8:122,607,885...122,634,425
Ensembl chr 8:122,607,889...122,634,433
JBrowse link
G Slc7a6 solute carrier family 7 (cationic amino acid transporter, y+ system), member 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC7A6 mRNA CTD PMID:29950665 NCBI chr 8:106,894,718...106,925,346
Ensembl chr 8:106,895,489...106,925,338
JBrowse link
G Slc7a9 solute carrier family 7 (cationic amino acid transporter, y+ system), member 9 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC7A9 mRNA CTD PMID:29950665 NCBI chr 7:35,148,152...35,165,459
Ensembl chr 7:35,148,221...35,165,461
JBrowse link
G Slc8a1 solute carrier family 8 (sodium/calcium exchanger), member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC8A1 mRNA CTD PMID:29950665 NCBI chr17:81,680,534...82,045,816
Ensembl chr17:81,680,534...82,045,806
JBrowse link
G Slc8a3 solute carrier family 8 (sodium/calcium exchanger), member 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC8A3 mRNA CTD PMID:29950665 NCBI chr12:81,244,686...81,380,506
Ensembl chr12:81,244,689...81,379,954
JBrowse link
G Slc9a2 solute carrier family 9 (sodium/hydrogen exchanger), member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC9A2 mRNA CTD PMID:29950665 NCBI chr 1:40,720,872...40,808,045
Ensembl chr 1:40,719,734...40,808,433
JBrowse link
G Slc9a3 solute carrier family 9 (sodium/hydrogen exchanger), member 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC9A3 mRNA CTD PMID:29950665 NCBI chr13:74,234,374...74,317,561
Ensembl chr13:74,269,576...74,317,561
JBrowse link
G Slc9a7 solute carrier family 9 (sodium/hydrogen exchanger), member 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC9A7 mRNA CTD PMID:29950665 NCBI chr  X:19,965,090...20,158,274
Ensembl chr  X:19,971,993...20,158,046
JBrowse link
G Slco1a1 solute carrier organic anion transporter family, member 1a1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLCO1A1 mRNA CTD PMID:29950665 NCBI chr 6:141,853,007...141,892,688
Ensembl chr 6:141,853,008...141,892,688
JBrowse link
G Slco1a4 solute carrier organic anion transporter family, member 1a4 multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLCO1A4 mRNA
Dextran Sulfate results in decreased expression of SLCO1A4 mRNA
CTD PMID:29950665 PMID:35093514 NCBI chr 6:141,751,164...141,802,011
Ensembl chr 6:141,751,166...141,801,925
JBrowse link
G Slco1a6 solute carrier organic anion transporter family, member 1a6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLCO1A6 mRNA CTD PMID:29950665 NCBI chr 6:142,031,487...142,131,903
Ensembl chr 6:142,031,487...142,154,247
JBrowse link
G Slco2b1 solute carrier organic anion transporter family, member 2b1 multiple interactions
increases expression
EXP
ISO
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLCO2B1 mRNA
Dextran Sulfate results in increased expression of SLCO2B1 mRNA; Dextran Sulfate results in increased expression of SLCO2B1 protein
Rifampin inhibits the reaction [Dextran Sulfate results in increased expression of SLCO2B1 mRNA]
CTD PMID:29950665 PMID:38423481 NCBI chr 7:99,307,011...99,360,547
Ensembl chr 7:99,307,011...99,360,547
JBrowse link
G Slco3a1 solute carrier organic anion transporter family, member 3a1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLCO3A1 mRNA CTD PMID:29950665 NCBI chr 7:73,925,166...74,204,528
Ensembl chr 7:73,925,167...74,204,528
JBrowse link
G Smo smoothened, frizzled class receptor multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SMO mRNA CTD PMID:29950665 NCBI chr 6:29,735,480...29,761,359
Ensembl chr 6:29,735,502...29,761,364
JBrowse link
G Smox spermine oxidase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SMOX mRNA CTD PMID:29950665 NCBI chr 2:131,333,624...131,367,103
Ensembl chr 2:131,333,416...131,367,842
JBrowse link
G Smpd2 sphingomyelin phosphodiesterase 2, neutral decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of SMPD2 mRNA
Fenofibrate promotes the reaction [Dextran Sulfate results in decreased expression of SMPD2 mRNA]
CTD PMID:25035112 NCBI chr10:41,363,168...41,366,410
Ensembl chr10:41,361,638...41,366,365
JBrowse link
G Smpd4 sphingomyelin phosphodiesterase 4 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of SMPD4 mRNA
Fenofibrate promotes the reaction [Dextran Sulfate results in decreased expression of SMPD4 mRNA]
CTD PMID:25035112 NCBI chr16:17,437,218...17,462,694
Ensembl chr16:17,437,218...17,462,692
JBrowse link
G Snai1 snail family zinc finger 1 multiple interactions EXP [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SNAI1 protein CTD PMID:34273909 NCBI chr 2:167,380,115...167,384,734
Ensembl chr 2:167,380,115...167,384,734
JBrowse link
G Snord118 small nucleolar RNA, C/D box 118 increases expression EXP Dextran Sulfate results in increased expression of SNORD118 mRNA CTD PMID:23894361 NCBI chr11:68,964,252...68,964,388
Ensembl chr11:68,964,253...68,964,387
JBrowse link
G Snx9 sorting nexin 9 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of SNX9 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of SNX9 protein]
CTD PMID:32272095 NCBI chr17:5,891,599...5,982,231
Ensembl chr17:5,891,604...5,982,229
JBrowse link
G Sox4 SRY (sex determining region Y)-box 4 multiple interactions EXP [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of SOX4 mRNA CTD PMID:26271895 NCBI chr13:29,132,902...29,137,682
Ensembl chr13:29,132,902...29,137,696
JBrowse link
G Sox9 SRY (sex determining region Y)-box 9 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SOX9 mRNA CTD PMID:29950665 NCBI chr11:112,673,036...112,678,583
Ensembl chr11:112,673,050...112,678,586
JBrowse link
G Sparc secreted acidic cysteine rich glycoprotein multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SPARC mRNA CTD PMID:29950665 NCBI chr11:55,284,985...55,310,906
Ensembl chr11:55,285,326...55,314,009
JBrowse link
G Sphk1 sphingosine kinase 1 multiple interactions
increases expression
EXP
ISO
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SPHK1 mRNA
Hesperidin inhibits the reaction [Dextran Sulfate results in increased expression of SPHK1 protein]
CTD PMID:29950665 PMID:30811821 NCBI chr11:116,421,662...116,427,502
Ensembl chr11:116,421,751...116,427,501
JBrowse link
G Spn sialophorin multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SPN mRNA CTD PMID:29950665 NCBI chr 7:126,731,404...126,743,785
Ensembl chr 7:126,731,404...126,736,995
JBrowse link
G Spp1 secreted phosphoprotein 1 multiple interactions
increases expression
decreases expression
EXP Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of SPP1 mRNA]
Dextran Sulfate results in decreased expression of SPP1 protein
CTD PMID:32033881 PMID:35999755 NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
JBrowse link
G Sprr1a small proline-rich protein 1A increases expression EXP Dextran Sulfate results in increased expression of SPRR1A mRNA CTD PMID:23894361 NCBI chr 3:92,391,261...92,393,188
Ensembl chr 3:92,391,259...92,393,202
JBrowse link
G Sptbn1 spectrin beta, non-erythrocytic 1 decreases expression EXP Dextran Sulfate results in decreased expression of SPTBN1 protein CTD PMID:35999755 NCBI chr11:30,049,395...30,218,384
Ensembl chr11:30,049,395...30,218,175
JBrowse link
G Sqstm1 sequestosome 1 multiple interactions
decreases expression
increases expression
EXP
ISO
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[Dextran Sulfate co-treated with alpinetin] results in decreased expression of SQSTM1 protein]; [Dextran Sulfate co-treated with 6-formylindolo(3,2-b)carbazole] results in decreased expression of SQSTM1 protein; [Dextran Sulfate co-treated with alpinetin] results in decreased expression of SQSTM1 protein; [Dextran Sulfate co-treated with Lipopolysaccharides] results in decreased expression of SQSTM1 protein; [HU 308 co-treated with Dextran Sulfate] affects the expression of SQSTM1 protein; biochanin A inhibits the reaction [Dextran Sulfate results in increased expression of SQSTM1 protein]; CNR2 protein affects the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in decreased expression of SQSTM1 protein]; HU 308 promotes the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in decreased expression of SQSTM1 protein]; Leucine inhibits the reaction [[Dextran Sulfate co-treated with alpinetin] results in decreased expression of SQSTM1 protein]; Nicotine promotes the reaction [Dextran Sulfate results in decreased expression of SQSTM1 protein]
dorsomorphin inhibits the reaction [Nicotine promotes the reaction [Dextran Sulfate results in decreased expression of SQSTM1 protein]]; Nicotine promotes the reaction [Dextran Sulfate results in decreased expression of SQSTM1 protein]
CTD PMID:27611972 PMID:31676321 PMID:31926917 PMID:38648921 NCBI chr11:50,090,979...50,105,303
Ensembl chr11:50,090,193...50,101,654
JBrowse link
G Srd5a2 steroid 5 alpha-reductase 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SRD5A2 mRNA CTD PMID:29950665 NCBI chr17:74,321,886...74,354,855
Ensembl chr17:74,323,950...74,354,911
JBrowse link
G Srgap3 SLIT-ROBO Rho GTPase activating protein 3 multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SRGAP3 mRNA
Dextran Sulfate results in decreased expression of SRGAP3 mRNA
CTD PMID:29950665 PMID:35093514 NCBI chr 6:112,694,932...112,924,466
Ensembl chr 6:112,694,932...112,924,227
JBrowse link
G Srp9 signal recognition particle 9 multiple interactions
increases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in increased expression of SRP9 protein] CTD PMID:32272095 NCBI chr 1:181,952,302...181,959,980
Ensembl chr 1:181,952,302...181,959,972
JBrowse link
G Srsf4 serine and arginine-rich splicing factor 4 increases expression EXP Dextran Sulfate results in increased expression of SRSF4 mRNA CTD PMID:35093514 NCBI chr 4:131,600,841...131,629,036
Ensembl chr 4:131,600,928...131,629,017
JBrowse link
G Sstr1 somatostatin receptor 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SSTR1 mRNA CTD PMID:29950665 NCBI chr12:58,258,524...58,262,822
Ensembl chr12:58,258,558...58,260,673
JBrowse link
G St3gal3 ST3 beta-galactoside alpha-2,3-sialyltransferase 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of ST3GAL3 mRNA CTD PMID:29950665 NCBI chr 4:117,789,349...117,992,169
Ensembl chr 4:117,789,351...117,992,111
JBrowse link
G St3gal6 ST3 beta-galactoside alpha-2,3-sialyltransferase 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ST3GAL6 mRNA CTD PMID:29950665 NCBI chr16:58,290,105...58,344,614
Ensembl chr16:58,288,488...58,344,606
JBrowse link
G Star steroidogenic acute regulatory protein decreases expression EXP Dextran Sulfate results in decreased expression of STAR mRNA CTD PMID:35093514 NCBI chr 8:26,298,502...26,306,010
Ensembl chr 8:26,296,583...26,306,010
JBrowse link
G Stard5 StAR related lipid transfer domain containing 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of STARD5 mRNA CTD PMID:29950665 NCBI chr 7:83,281,225...83,291,536
Ensembl chr 7:83,281,167...83,302,335
JBrowse link
G Stat1 signal transducer and activator of transcription 1 multiple interactions
increases phosphorylation
EXP Qingdai compound inhibits the reaction [Dextran Sulfate results in increased phosphorylation of STAT1 protein] CTD PMID:31737179 NCBI chr 1:52,158,588...52,201,024
Ensembl chr 1:52,158,599...52,201,024
JBrowse link
G Stat3 signal transducer and activator of transcription 3 multiple interactions
increases expression
increases phosphorylation
ISO
EXP
[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of STAT3 protein; Melatonin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of STAT3 protein]
3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Dextran Sulfate results in increased phosphorylation of and results in increased activity of STAT3 protein]; 7-hydroxyl-1-methylindole-3-acetonitrile inhibits the reaction [Dextran Sulfate results in increased phosphorylation of STAT3 protein]; [Azoxymethane co-treated with Dextran Sulfate] results in increased phosphorylation of STAT3 protein; [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of and results in increased phosphorylation of STAT3 protein; BCL6 protein inhibits the reaction [Dextran Sulfate results in increased phosphorylation of STAT3 protein]; CEP 33779 inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of and results in increased phosphorylation of STAT3 protein]; Dextran Sulfate results in increased expression of and results in increased phosphorylation of STAT3 protein; Dextran Sulfate results in increased phosphorylation of and results in increased activity of STAT3 protein; Erianin inhibits the reaction [Dextran Sulfate results in increased phosphorylation of STAT3 protein]; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased phosphorylation of STAT3 protein]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased phosphorylation of STAT3 protein]; nitazoxanide inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased phosphorylation of STAT3 protein]; Qingdai compound inhibits the reaction [Dextran Sulfate results in increased phosphorylation of STAT3 protein]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of STAT3 protein]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased phosphorylation of and results in increased activity of STAT3 protein]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased phosphorylation of STAT3 protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased phosphorylation of STAT3 protein]; thiamet G promotes the reaction [Dextran Sulfate results in increased phosphorylation of STAT3 protein]
CTD PMID:19028472 PMID:20155626 PMID:22334590 PMID:25026504 PMID:26074695 More... NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
JBrowse link
G Steap1 six transmembrane epithelial antigen of the prostate 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of STEAP1 mRNA CTD PMID:29950665 NCBI chr 5:5,786,322...5,799,317
Ensembl chr 5:5,786,317...5,799,326
JBrowse link
G Steap2 six transmembrane epithelial antigen of prostate 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of STEAP2 mRNA CTD PMID:29950665 NCBI chr 5:5,714,829...5,744,649
Ensembl chr 5:5,714,829...5,744,578
JBrowse link
G Stim1 stromal interaction molecule 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of STIM1 mRNA CTD PMID:29950665 NCBI chr 7:101,909,279...102,086,525
Ensembl chr 7:101,917,013...102,086,526
JBrowse link
G Stip1 stress-induced phosphoprotein 1 decreases expression EXP Dextran Sulfate results in decreased expression of STIP1 protein CTD PMID:35999755 NCBI chr19:6,998,064...7,017,394
Ensembl chr19:6,998,070...7,017,335
JBrowse link
G Stk4 serine/threonine kinase 4 multiple interactions EXP [RASSF1 gene mutant form results in increased susceptibility to Dextran Sulfate] which results in decreased activity of STK4 protein CTD PMID:24146755 NCBI chr 2:163,916,033...163,997,444
Ensembl chr 2:163,912,242...163,997,444
JBrowse link
G Stx1a syntaxin 1A (brain) multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of STX1A mRNA CTD PMID:29950665 NCBI chr 5:135,051,473...135,079,954
Ensembl chr 5:135,052,336...135,079,954
JBrowse link
G Sub1 SUB1 homolog, transcriptional regulator multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of SUB1 protein] CTD PMID:32272095 NCBI chr15:11,981,422...11,996,091
Ensembl chr15:11,981,425...11,997,069
JBrowse link
G Suclg2 succinate-Coenzyme A ligase, GDP-forming, beta subunit multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SUCLG2 mRNA CTD PMID:29950665 NCBI chr 6:95,449,992...95,695,799
Ensembl chr 6:95,449,990...95,695,781
JBrowse link
G Sult1a1 sulfotransferase family 1A, phenol-preferring, member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SULT1A1 mRNA CTD PMID:29950665 NCBI chr 7:126,272,042...126,289,615
Ensembl chr 7:126,272,037...126,275,604
JBrowse link
G Sult1b1 sulfotransferase family 1B, member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SULT1B1 mRNA CTD PMID:29950665 NCBI chr 5:87,661,186...87,686,054
Ensembl chr 5:87,661,198...87,686,054
JBrowse link
G Sult1c2 sulfotransferase family, cytosolic, 1C, member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SULT1C2 mRNA CTD PMID:29950665 NCBI chr17:54,136,665...54,152,986
Ensembl chr17:54,136,665...54,153,367
JBrowse link
G Sult1e1 sulfotransferase family 1E, member 1 decreases expression EXP Dextran Sulfate results in decreased expression of SULT1E1 mRNA CTD PMID:35093514 NCBI chr 5:87,723,827...87,739,470
Ensembl chr 5:87,723,828...87,739,453
JBrowse link
G Suox sulfite oxidase decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of SUOX protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of SUOX protein]
CTD PMID:32272095 NCBI chr10:128,505,756...128,509,787
Ensembl chr10:128,505,763...128,509,942
JBrowse link
G Suv39h1 suppressor of variegation 3-9 1 multiple interactions
increases expression
EXP 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpinetin inhibits the reaction [Dextran Sulfate results in increased expression of SUV39H1 protein]]; alpinetin inhibits the reaction [Dextran Sulfate results in increased expression of SUV39H1 protein] CTD PMID:31676321 NCBI chr  X:7,927,401...7,940,994
Ensembl chr  X:7,927,410...7,940,999
JBrowse link
G Svil supervillin decreases expression EXP Dextran Sulfate results in decreased expression of SVIL mRNA CTD PMID:35093514 NCBI chr18:4,920,497...5,119,290
Ensembl chr18:4,920,540...5,119,299
JBrowse link
G Taar4 trace amine-associated receptor 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TAAR4 mRNA CTD PMID:29950665 NCBI chr10:23,836,392...23,837,435
Ensembl chr10:23,836,392...23,837,435
JBrowse link
G Taar5 trace amine-associated receptor 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TAAR5 mRNA CTD PMID:29950665 NCBI chr10:23,846,604...23,847,617
Ensembl chr10:23,846,604...23,847,617
JBrowse link
G Taar7b trace amine-associated receptor 7B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TAAR7B mRNA CTD PMID:29950665 NCBI chr10:23,875,837...23,876,913
Ensembl chr10:23,875,837...23,876,913
JBrowse link
G Taar7f trace amine-associated receptor 7F multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TAAR7F mRNA CTD PMID:29950665 NCBI chr10:23,925,408...23,926,484
Ensembl chr10:23,925,408...23,926,484
JBrowse link
G Tac1 tachykinin 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TAC1 mRNA CTD PMID:29950665 NCBI chr 6:7,555,061...7,562,978
Ensembl chr 6:7,554,879...7,565,834
JBrowse link
G Tacr1 tachykinin receptor 1 affects response to substance
multiple interactions
EXP TACR1 protein affects the susceptibility to Dextran Sulfate
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TACR1 mRNA
CTD PMID:20889569 PMID:29950665 NCBI chr 6:82,378,990...82,537,085
Ensembl chr 6:82,379,315...82,537,085
JBrowse link
G Tacr2 tachykinin receptor 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TACR2 mRNA CTD PMID:29950665 NCBI chr10:62,088,217...62,101,769
Ensembl chr10:62,088,217...62,101,769
JBrowse link
G Taf15 TATA-box binding protein associated factor 15 increases expression EXP Dextran Sulfate results in increased expression of TAF15 mRNA CTD PMID:35093514 NCBI chr11:83,363,897...83,397,569
Ensembl chr11:83,363,912...83,397,569
JBrowse link
G Tagap T cell activation Rho GTPase activating protein multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TAGAP mRNA CTD PMID:29950665 NCBI chr17:8,144,832...8,153,729
Ensembl chr17:8,144,832...8,153,729
JBrowse link
G Tagln transgelin multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of TAGLN protein CTD PMID:35999755 NCBI chr 9:45,840,926...45,847,356
Ensembl chr 9:45,840,917...45,847,356
JBrowse link
G Tagln2 transgelin 2 multiple interactions
decreases expression
EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of TAGLN2 protein
Dextran Sulfate results in decreased expression of TAGLN2 protein
CTD PMID:35999755 NCBI chr 1:172,327,813...172,334,942
Ensembl chr 1:172,327,614...172,334,947
JBrowse link
G Tap1 transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of TAP1 mRNA
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TAP1 mRNA
CTD PMID:23894361 PMID:29950665 NCBI chr17:34,406,530...34,416,199
Ensembl chr17:34,406,527...34,416,199
JBrowse link
G Tas1r2 taste receptor, type 1, member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of TAS1R2 mRNA CTD PMID:29950665 NCBI chr 4:139,380,849...139,397,591
Ensembl chr 4:139,380,849...139,397,591
JBrowse link
G Tas1r3 taste receptor, type 1, member 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TAS1R3 mRNA CTD PMID:29950665 NCBI chr 4:155,943,725...155,947,810
Ensembl chr 4:155,943,725...155,947,819
JBrowse link
G Tas2r103 taste receptor, type 2, member 103 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TAS2R103 mRNA CTD PMID:29950665 NCBI chr 6:133,013,126...133,014,064
Ensembl chr 6:133,013,126...133,014,064
JBrowse link
G Tas2r109 taste receptor, type 2, member 109 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TAS2R109 mRNA CTD PMID:29950665 NCBI chr 6:132,956,978...132,957,928
Ensembl chr 6:132,956,978...132,957,928
JBrowse link
G Tas2r118 taste receptor, type 2, member 118 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TAS2R118 mRNA CTD PMID:29950665 NCBI chr 6:23,969,160...23,970,059
Ensembl chr 6:23,969,160...23,970,059
JBrowse link
G Tas2r131 taste receptor, type 2, member 131 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TAS2R131 mRNA CTD PMID:29950665 NCBI chr 6:132,933,875...132,934,807
Ensembl chr 6:132,933,847...132,934,882
JBrowse link
G Tas2r137 taste receptor, type 2, member 137 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TAS2R137 mRNA CTD PMID:29950665 NCBI chr 6:40,468,172...40,469,173
Ensembl chr 6:40,468,167...40,469,239
JBrowse link
G Tbc1d15 TBC1 domain family, member 15 multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of TBC1D15 protein] CTD PMID:32272095 NCBI chr10:115,031,459...115,087,343
Ensembl chr10:115,033,777...115,087,372
JBrowse link
G Tbcc tubulin-specific chaperone C increases expression EXP Dextran Sulfate results in increased expression of TBCC mRNA CTD PMID:35093514 NCBI chr17:47,201,547...47,203,389
Ensembl chr17:47,201,610...47,202,773
JBrowse link
G Tbx21 T-box 21 multiple interactions
increases expression
EXP Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of TBX21 mRNA] CTD PMID:31737179 NCBI chr11:96,988,833...97,006,157
Ensembl chr11:96,988,897...97,006,157
JBrowse link
G Tbxas1 thromboxane A synthase 1, platelet multiple interactions
increases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TBXAS1 mRNA
Dextran Sulfate results in increased expression of TBXAS1 protein
CTD PMID:29950665 PMID:30489199 NCBI chr 6:38,817,897...39,061,524
Ensembl chr 6:38,852,338...39,061,519
JBrowse link
G Tcaf1 TRPM8 channel-associated factor 1 decreases expression EXP Dextran Sulfate results in decreased expression of TCAF1 mRNA CTD PMID:35093514 NCBI chr 6:42,644,933...42,687,065
Ensembl chr 6:42,644,936...42,687,022
JBrowse link
G Tcaf2 TRPM8 channel-associated factor 2 increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of TCAF2 protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of TCAF2 protein]
CTD PMID:32272095 NCBI chr 6:42,599,950...42,622,134
Ensembl chr 6:42,599,950...42,622,188
JBrowse link
G Tcap titin-cap multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TCAP mRNA CTD PMID:29950665 NCBI chr11:98,274,637...98,275,779
Ensembl chr11:98,274,637...98,275,779
JBrowse link
G Tcf7 transcription factor 7, T cell specific multiple interactions EXP [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of TCF7 mRNA; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of TCF7 mRNA] CTD PMID:31715269 NCBI chr11:52,137,347...52,174,211
Ensembl chr11:52,143,198...52,174,158
JBrowse link
G Tchp trichoplein, keratin filament binding increases expression EXP Dextran Sulfate results in increased expression of TCHP mRNA CTD PMID:35093514 NCBI chr 5:114,845,813...114,860,388
Ensembl chr 5:114,845,821...114,860,388
JBrowse link
G Tff3 trefoil factor 3, intestinal increases expression EXP Dextran Sulfate results in increased expression of TFF3 mRNA CTD PMID:31807802 NCBI chr17:31,344,280...31,348,585
Ensembl chr17:31,344,280...31,348,620
JBrowse link
G Tfrc transferrin receptor increases expression EXP Dextran Sulfate results in increased expression of TFRC protein CTD PMID:20025956 NCBI chr16:32,427,714...32,451,612
Ensembl chr16:32,427,738...32,451,612
JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions
increases expression
decreases expression
EXP
ISO
[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TGFB1 protein; [Dietary Fats co-treated with Dextran Sulfate] results in increased expression of TGFB1 protein; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TGFB1 protein]; obeticholic acid inhibits the reaction [[Dietary Fats co-treated with Dextran Sulfate] results in increased expression of TGFB1 protein]; Resveratrol inhibits the reaction [Dextran Sulfate results in decreased expression of TGFB1 protein]
Dextran Sulfate results in increased expression of TGFB1 mRNA
kappa-casein glycomacropeptide inhibits the reaction [Dextran Sulfate results in increased expression of TGFB1 mRNA]
CTD PMID:20881082 PMID:25026504 PMID:26074695 PMID:35439472 NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
JBrowse link
G Tgfb3 transforming growth factor, beta 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TGFB3 mRNA CTD PMID:29950665 NCBI chr12:86,103,517...86,125,815
Ensembl chr12:86,103,519...86,125,815
JBrowse link
G Tgtp1 T cell specific GTPase 1 increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of TGTP1 mRNA; Dextran Sulfate results in increased expression of TGTP1 protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of TGTP1 protein]
CTD PMID:23894361 PMID:32272095 NCBI chr11:48,876,156...48,883,073
Ensembl chr11:48,876,154...48,884,999
JBrowse link
G Thbd thrombomodulin multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of THBD mRNA
Dextran Sulfate results in decreased expression of THBD mRNA
CTD PMID:29950665 PMID:35093514 NCBI chr 2:148,246,391...148,250,108
Ensembl chr 2:148,246,386...148,250,108
JBrowse link
G Thbs1 thrombospondin 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of THBS1 mRNA CTD PMID:29950665 NCBI chr 2:117,942,357...117,957,614
Ensembl chr 2:117,942,357...117,957,614
JBrowse link
G Thbs4 thrombospondin 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of THBS4 mRNA CTD PMID:29950665 NCBI chr13:92,888,094...92,931,326
Ensembl chr13:92,888,098...92,931,326
JBrowse link
G Thy1 thymus cell antigen 1, theta increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of THY1 protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of THY1 protein]
CTD PMID:32272095 NCBI chr 9:43,954,681...43,959,876
Ensembl chr 9:43,954,681...43,959,876
JBrowse link
G Timp1 tissue inhibitor of metalloproteinase 1 multiple interactions
increases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TIMP1 mRNA; Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of TIMP1 mRNA] CTD PMID:29950665 PMID:32033881 NCBI chr  X:20,736,524...20,740,972
Ensembl chr  X:20,736,405...20,740,974
JBrowse link
G Timp2 tissue inhibitor of metalloproteinase 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TIMP2 mRNA CTD PMID:29950665 NCBI chr11:118,191,887...118,246,237
Ensembl chr11:118,191,887...118,246,566
JBrowse link
G Timp3 tissue inhibitor of metalloproteinase 3 multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TIMP3 mRNA; ADAM17 protein affects the reaction [Dextran Sulfate results in decreased expression of TIMP3 mRNA]; Resveratrol inhibits the reaction [Dextran Sulfate results in decreased expression of TIMP3 mRNA] CTD PMID:24548422 PMID:29950665 NCBI chr10:86,136,276...86,185,369
Ensembl chr10:86,136,236...86,185,370
JBrowse link
G Tjp1 tight junction protein 1 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of TJP1 mRNA; Dextran Sulfate results in decreased expression of TJP1 protein
[Dietary Fats co-treated with Dextran Sulfate] results in increased expression of TJP1 protein; biochanin A inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 protein]; daphnetin inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 protein]; HU 211 inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 mRNA]; nitazoxanide inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 protein]; obeticholic acid promotes the reaction [[Dietary Fats co-treated with Dextran Sulfate] results in increased expression of TJP1 protein]
CTD PMID:27995407 PMID:35439472 PMID:35670535 PMID:36281492 PMID:37209277 More... NCBI chr 7:64,945,913...65,177,629
Ensembl chr 7:64,945,913...65,177,529
JBrowse link
G Tk1 thymidine kinase 1 multiple interactions EXP [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TK1 mRNA; alfacalcidol inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TK1 mRNA] CTD PMID:17893519 NCBI chr11:117,706,345...117,716,913
Ensembl chr11:117,706,352...117,716,918
JBrowse link
G Tkt transketolase decreases expression EXP Dextran Sulfate results in decreased expression of TKT mRNA CTD PMID:35093514 NCBI chr14:30,271,088...30,296,681
Ensembl chr14:30,270,316...30,296,677
JBrowse link
G Tll1 tolloid-like multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TLL1 mRNA CTD PMID:29950665 NCBI chr 8:64,466,132...64,659,043
Ensembl chr 8:64,467,965...64,659,305
JBrowse link
G Tln1 talin 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TLN1 mRNA CTD PMID:29950665 NCBI chr 4:43,531,513...43,562,583
Ensembl chr 4:43,531,519...43,562,691
JBrowse link
G Tlr2 toll-like receptor 2 multiple interactions EXP Dextran Sulfate promotes the reaction [TLR2 protein binds to MYD88 protein]; flavokawain B inhibits the reaction [Dextran Sulfate promotes the reaction [TLR2 protein binds to MYD88 protein]] CTD PMID:38583725 NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions
increases expression
affects response to substance
EXP 7-hydroxyl-1-methylindole-3-acetonitrile inhibits the reaction [Dextran Sulfate results in increased expression of TLR4 protein]; [Dietary Fats co-treated with Dextran Sulfate] results in increased expression of TLR4 protein; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TLR4 mRNA; Dextran Sulfate affects the reaction [TLR4 protein affects the expression of IL6 protein]; Dextran Sulfate affects the reaction [TLR4 protein affects the expression of TNF protein]; Erianin inhibits the reaction [Dextran Sulfate results in increased expression of TLR4 protein]; Lipopolysaccharides inhibits the reaction [Dextran Sulfate results in increased expression of TLR4 protein]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased expression of TLR4 protein]; obeticholic acid inhibits the reaction [[Dietary Fats co-treated with Dextran Sulfate] results in increased expression of TLR4 protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased expression of TLR4 protein]; TLR4 protein affects the reaction [Dextran Sulfate results in increased expression of CSF2 protein]; TLR4 protein affects the reaction [Dextran Sulfate results in increased expression of IL6 protein]; TLR4 protein affects the reaction [Dextran Sulfate results in increased expression of TNF protein]; TLR4 protein affects the reaction [HU 211 inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein]]; TLR4 protein affects the reaction [HU 211 inhibits the reaction [Dextran Sulfate results in increased expression of IL17A protein]]; TLR4 protein affects the reaction [HU 211 inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein]]; TLR4 protein affects the reaction [HU 211 inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]]; TLR4 protein affects the reaction [HU 211 inhibits the reaction [Dextran Sulfate results in increased expression of TNF mRNA]]; TLR4 protein affects the reaction [HU 211 inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]]
TLR4 protein affects the susceptibility to Dextran Sulfate
CTD PMID:21359540 PMID:27995407 PMID:29950665 PMID:31442584 PMID:32272095 More... NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
JBrowse link
G Tlr7 toll-like receptor 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TLR7 mRNA CTD PMID:29950665 NCBI chr  X:166,086,376...166,113,570
Ensembl chr  X:166,087,925...166,113,554
JBrowse link
G Tmem109 transmembrane protein 109 multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of TMEM109 protein] CTD PMID:32272095 NCBI chr19:10,848,021...10,859,107
Ensembl chr19:10,848,024...10,859,365
JBrowse link
G Tmem164 transmembrane protein 164 decreases expression EXP Dextran Sulfate results in decreased expression of TMEM164 mRNA CTD PMID:35093514 NCBI chr  X:141,463,343...141,626,490
Ensembl chr  X:141,464,402...141,626,490
JBrowse link
G Tmem191 transmembrane protein 191 increases expression EXP Dextran Sulfate results in increased expression of TMEM191C mRNA CTD PMID:35093514 NCBI chr16:17,094,164...17,096,525
Ensembl chr16:17,093,941...17,101,093
JBrowse link
G Tmem252 transmembrane protein 252 increases expression EXP Dextran Sulfate results in increased expression of TMEM252 mRNA CTD PMID:35093514 NCBI chr19:24,651,372...24,657,025
Ensembl chr19:24,651,372...24,659,597
JBrowse link
G Tmsb4x thymosin, beta 4, X chromosome decreases expression EXP Dextran Sulfate results in decreased expression of TMSB4X protein CTD PMID:35999755 NCBI chr  X:165,990,089...165,996,475
Ensembl chr  X:165,990,089...165,992,311
JBrowse link
G Tmt1b thiol methyltransferase 1B multiple interactions
increases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in increased expression of TMT1B protein] CTD PMID:32272095 NCBI chr10:128,794,146...128,796,857
Ensembl chr10:128,794,143...128,796,857
JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases secretion
increases expression
affects expression
EXP
ISO
(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; 17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; 2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl ester inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; 7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; [Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TNF protein; [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TNF mRNA; [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TNF protein; [Dextran Sulfate co-treated with Lipopolysaccharides] results in increased secretion of TNF protein; [IL17A protein affects the susceptibility to Dextran Sulfate] which affects the expression of TNF protein; [Serotonin co-treated with Dextran Sulfate] results in increased expression of TNF protein; [TNFRSF8 protein affects the susceptibility to Dextran Sulfate] which affects the expression of TNF protein; [TNFSF8 protein affects the susceptibility to Dextran Sulfate] which affects the expression of TNF protein; ADAM17 protein affects the reaction [Dextran Sulfate results in increased expression of TNF protein]; anandamide inhibits the reaction [[Serotonin co-treated with Dextran Sulfate] results in increased expression of TNF protein]; apigenin-6,8-di-C-glycopyranoside inhibits the reaction [Dextran Sulfate results in increased secretion of TNF protein]; asperuloside inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased secretion of TNF protein]; biochanin A inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; bisphenol A promotes the reaction [Dextran Sulfate results in increased expression of TNF protein]; Butylated Hydroxyanisole affects the reaction [Dextran Sulfate affects the expression of TNF protein]; Butylated Hydroxytoluene inhibits the reaction [Dextran Sulfate promotes the reaction [Ascorbic Acid promotes the reaction [Quartz results in increased secretion of TNF protein]]]; Butylated Hydroxytoluene inhibits the reaction [Dextran Sulfate promotes the reaction [Quartz results in increased secretion of TNF protein]]; CD14 protein inhibits the reaction [Dextran Sulfate results in increased expression of TNF mRNA]; celastrol inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; celastrol promotes the reaction [Dextran Sulfate results in increased expression of TNF protein]; Chlorpyrifos promotes the reaction [Dextran Sulfate results in increased expression of TNF mRNA]; Cholecalciferol inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; Coumarins inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; daphnetin inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; Dexamethasone inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; Dextran Sulfate affects the reaction [TLR4 protein affects the expression of TNF protein]; Dextran Sulfate inhibits the reaction [[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of TNF protein]; Dextran Sulfate inhibits the reaction [Polymyxin B results in decreased expression of TNF protein]; Dextran Sulfate promotes the reaction [Ascorbic Acid promotes the reaction [Quartz results in increased secretion of TNF protein]]; Dextran Sulfate promotes the reaction [Quartz results in increased secretion of TNF protein]; Dextran Sulfate results in increased expression of and results in increased secretion of TNF protein; dihydrotanshinone I inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased secretion of TNF protein]; DUSP1 protein affects the reaction [Butylated Hydroxyanisole affects the reaction [Dextran Sulfate affects the expression of TNF protein]]; DUSP1 protein affects the reaction [Resveratrol affects the reaction [Dextran Sulfate affects the expression of TNF protein]]; Erianin inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; Fatty Acids, Omega-3 inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; Fenofibrate promotes the reaction [Dextran Sulfate results in increased expression of TNF protein]; flavokawain B inhibits the reaction [Dextran Sulfate results in increased expression of TNF mRNA]; fraxinellone inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; geraniol inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; gingerenone A inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; gingerol inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; glyceryl 2-arachidonate inhibits the reaction [[Serotonin co-treated with Dextran Sulfate] results in increased expression of TNF protein]; HU 211 inhibits the reaction [Dextran Sulfate results in increased expression of TNF mRNA]; HU 211 inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; hydroxysafflor yellow A inhibits the reaction [Dextran Sulfate results in increased secretion of TNF protein]; IRF4 protein inhibits the reaction [BCL6 protein inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased secretion of TNF protein]]; IRF4 protein promotes the reaction [Dextran Sulfate results in increased expression of TNF mRNA]; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TNF protein]; isovitexin inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; ligustilide inhibits the reaction [Dextran Sulfate results in increased expression of TNF mRNA]; ligustilide inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; Lipopolysaccharides promotes the reaction [Dextran Sulfate results in increased expression of TNF protein]; mangiferin inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; Melatonin inhibits the reaction [Dextran Sulfate results in increased expression of TNF mRNA]; Melatonin inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased expression of TNF mRNA]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; Mesalamine inhibits the reaction [Dextran Sulfate results in increased secretion of TNF protein]; MIF protein affects the reaction [Dextran Sulfate results in increased expression of TNF mRNA]; Minocycline inhibits the reaction [Dextran Sulfate results in increased expression of TNF mRNA]; NFE2L2 protein affects the reaction [Butylated Hydroxyanisole affects the reaction [Dextran Sulfate affects the expression of TNF protein]]; NFE2L2 protein affects the reaction [Resveratrol affects the reaction [Dextran Sulfate affects the expression of TNF protein]]; Nicotine inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; notoginsenoside R1 inhibits the reaction [Dextran Sulfate results in increased expression of TNF mRNA]; notoginsenoside R1 inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; Plant Extracts inhibits the reaction [Dextran Sulfate results in increased expression of TNF mRNA]; Polymyxin B inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; Qingdai compound inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; resolvin D1 inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; resolvin D2 inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; Resveratrol affects the reaction [Dextran Sulfate affects the expression of TNF protein]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of TNF mRNA]; Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; SB 203580 inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased secretion of TNF protein]; Tetrachlorodibenzodioxin inhibits the reaction [Dextran Sulfate results in increased secretion of TNF protein]; thiamet G promotes the reaction [Dextran Sulfate results in increased expression of TNF mRNA]; TLR4 protein affects the reaction [Dextran Sulfate results in increased expression of TNF protein]; TLR4 protein affects the reaction [HU 211 inhibits the reaction [Dextran Sulfate results in increased expression of TNF mRNA]]; TLR4 protein affects the reaction [HU 211 inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]]; tussilagone inhibits the reaction [Dextran Sulfate results in increased expression of TNF mRNA]; tussilagone inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; Ursodeoxycholic Acid inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TNF mRNA]
[2,2-bis(4-glycidyloxyphenyl)propane co-treated with Dextran Sulfate co-treated with Rosiglitazone] results in increased expression of TNF protein; [2,2-bis(4-glycidyloxyphenyl)propane co-treated with Dextran Sulfate] results in increased expression of TNF protein; [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TNF protein; banxia xiexin decoction inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; celastrol inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; celastrol promotes the reaction [N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]]; Melatonin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TNF protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; Olmesartan Medoxomil inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; palmatine inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; Rosiglitazone inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]
Dextran Sulfate results in increased expression of TNF mRNA; Dextran Sulfate results in increased expression of TNF protein
CTD PMID:12105854 PMID:16774945 PMID:17438113 PMID:19028472 PMID:19285099 More... NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
G Tnfrsf11a tumor necrosis factor receptor superfamily, member 11a, NFKB activator multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TNFRSF11A mRNA CTD PMID:29950665 NCBI chr 1:105,708,443...105,777,172
Ensembl chr 1:105,708,443...105,775,709
JBrowse link
G Tnfrsf12a tumor necrosis factor receptor superfamily, member 12a multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TNFRSF12A mRNA CTD PMID:29950665 NCBI chr17:23,894,419...23,896,423
Ensembl chr17:23,894,419...23,896,442
JBrowse link
G Tnfrsf18 tumor necrosis factor receptor superfamily, member 18 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TNFRSF18 mRNA CTD PMID:29950665 NCBI chr 4:156,110,779...156,113,351
Ensembl chr 4:156,110,621...156,113,352
JBrowse link
G Tnfrsf1a tumor necrosis factor receptor superfamily, member 1a multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TNFRSF1A mRNA CTD PMID:29950665 NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
JBrowse link
G Tnfrsf1b tumor necrosis factor receptor superfamily, member 1b increases expression EXP Dextran Sulfate results in increased expression of TNFRSF1B mRNA CTD PMID:20824662 NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440
JBrowse link
G Tnfrsf8 tumor necrosis factor receptor superfamily, member 8 affects response to substance
multiple interactions
EXP TNFRSF8 protein affects the susceptibility to Dextran Sulfate
[TNFRSF8 protein affects the susceptibility to Dextran Sulfate] which affects the expression of IL1B protein; [TNFRSF8 protein affects the susceptibility to Dextran Sulfate] which affects the expression of IL6 protein; [TNFRSF8 protein affects the susceptibility to Dextran Sulfate] which affects the expression of TNF protein; [TNFRSF8 protein affects the susceptibility to Dextran Sulfate] which affects the secretion of IFNG protein; [TNFRSF8 protein affects the susceptibility to Dextran Sulfate] which affects the secretion of IL10 protein; [TNFRSF8 protein affects the susceptibility to Dextran Sulfate] which affects the secretion of IL17A protein; [TNFRSF8 protein affects the susceptibility to Dextran Sulfate] which affects the secretion of IL2 protein; [TNFRSF8 protein affects the susceptibility to Dextran Sulfate] which affects the secretion of IL4 protein
CTD PMID:21068411 NCBI chr 4:144,993,702...145,041,734
Ensembl chr 4:144,993,707...145,041,734
JBrowse link
G Tnfsf12 tumor necrosis factor (ligand) superfamily, member 12 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TNFSF12 mRNA CTD PMID:29950665 NCBI chr11:69,577,066...69,586,924
Ensembl chr11:69,577,076...69,586,675
JBrowse link
G Tnfsf14 tumor necrosis factor (ligand) superfamily, member 14 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TNFSF14 mRNA CTD PMID:29950665 NCBI chr17:57,496,437...57,501,182
Ensembl chr17:57,496,492...57,501,177
JBrowse link
G Tnfsf15 tumor necrosis factor (ligand) superfamily, member 15 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TNFSF15 mRNA CTD PMID:29950665 NCBI chr 4:63,642,837...63,663,296
Ensembl chr 4:63,642,840...63,663,350
JBrowse link
G Tnfsf8 tumor necrosis factor (ligand) superfamily, member 8 affects response to substance
increases expression
multiple interactions
EXP TNFSF8 protein affects the susceptibility to Dextran Sulfate
Dextran Sulfate results in increased expression of TNFSF8 protein
[TNFSF8 protein affects the susceptibility to Dextran Sulfate] which affects the expression of IL1B protein; [TNFSF8 protein affects the susceptibility to Dextran Sulfate] which affects the expression of IL6 protein; [TNFSF8 protein affects the susceptibility to Dextran Sulfate] which affects the expression of TNF protein; [TNFSF8 protein affects the susceptibility to Dextran Sulfate] which affects the secretion of IFNG protein; [TNFSF8 protein affects the susceptibility to Dextran Sulfate] which affects the secretion of IL10 protein; [TNFSF8 protein affects the susceptibility to Dextran Sulfate] which affects the secretion of IL17A protein; [TNFSF8 protein affects the susceptibility to Dextran Sulfate] which affects the secretion of IL2 protein; [TNFSF8 protein affects the susceptibility to Dextran Sulfate] which affects the secretion of IL4 protein
CTD PMID:21068411 NCBI chr 4:63,749,439...63,779,745
Ensembl chr 4:63,749,545...63,779,584
JBrowse link
G Tnfsf9 tumor necrosis factor (ligand) superfamily, member 9 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TNFSF9 mRNA CTD PMID:29950665 NCBI chr17:57,412,113...57,414,757
Ensembl chr17:57,412,325...57,414,757
JBrowse link
G Tnnc1 troponin C, cardiac/slow skeletal multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TNNC1 mRNA CTD PMID:29950665 NCBI chr14:30,930,274...30,933,671
Ensembl chr14:30,930,269...30,933,686
JBrowse link
G Tnnc2 troponin C2, fast multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TNNC2 mRNA CTD PMID:29950665 NCBI chr 2:164,619,081...164,621,654
Ensembl chr 2:164,619,081...164,621,887
JBrowse link
G Tnni1 troponin I, skeletal, slow 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TNNI1 mRNA CTD PMID:29950665 NCBI chr 1:135,709,252...135,738,727
Ensembl chr 1:135,707,172...135,738,727
JBrowse link
G Tnni2 troponin I, skeletal, fast 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TNNI2 mRNA CTD PMID:29950665 NCBI chr 7:141,995,553...141,998,147
Ensembl chr 7:141,995,545...141,998,147
JBrowse link
G Tnnt3 troponin T3, skeletal, fast multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TNNT3 mRNA CTD PMID:29950665 NCBI chr 7:142,052,530...142,069,746
Ensembl chr 7:142,052,573...142,069,746
JBrowse link
G Tollip toll interacting protein multiple interactions
decreases expression
EXP 7-hydroxyl-1-methylindole-3-acetonitrile inhibits the reaction [Dextran Sulfate results in decreased expression of TOLLIP protein]; Mesalamine inhibits the reaction [Dextran Sulfate results in decreased expression of TOLLIP protein] CTD PMID:36543318 NCBI chr 7:141,435,317...141,456,198
Ensembl chr 7:141,428,550...141,472,244
JBrowse link
G Tomm7 translocase of outer mitochondrial membrane 7 increases expression EXP Dextran Sulfate results in increased expression of TOMM7 mRNA CTD PMID:35093514 NCBI chr 5:24,043,942...24,049,143
Ensembl chr 5:24,043,942...24,049,159
JBrowse link
G Tpcn1 two pore channel 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TPCN1 mRNA CTD PMID:29950665 NCBI chr 5:120,672,222...120,726,731
Ensembl chr 5:120,672,218...120,726,738
JBrowse link
G Tph1 tryptophan hydroxylase 1 multiple interactions
increases expression
EXP Granisetron inhibits the reaction [Serotonin inhibits the reaction [Dextran Sulfate results in increased expression of TPH1 protein]]; Serotonin inhibits the reaction [Dextran Sulfate results in increased expression of TPH1 protein] CTD PMID:30611738 NCBI chr 7:46,294,065...46,321,961
Ensembl chr 7:46,294,065...46,321,961
JBrowse link
G Tpi1 triosephosphate isomerase 1 increases expression
decreases expression
EXP Dextran Sulfate results in increased expression of TPI1 mRNA
Dextran Sulfate results in decreased expression of TPI1 protein
CTD PMID:35093514 PMID:35999755 NCBI chr 6:124,787,549...124,791,121
Ensembl chr 6:124,787,549...124,791,259
JBrowse link
G Tpm2 tropomyosin 2, beta multiple interactions
decreases expression
EXP [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of TPM2 mRNA
Dextran Sulfate results in decreased expression of TPM2 protein
CTD PMID:26271895 PMID:35999755 NCBI chr 4:43,513,726...43,523,583
Ensembl chr 4:43,514,711...43,523,765
JBrowse link
G Tpm3 tropomyosin 3, gamma decreases expression EXP Dextran Sulfate results in decreased expression of TPM3 protein CTD PMID:35999755 NCBI chr 3:89,979,958...90,008,209
Ensembl chr 3:89,979,956...90,008,209
JBrowse link
G Tpm4 tropomyosin 4 decreases expression EXP Dextran Sulfate results in decreased expression of TPM4 protein CTD PMID:35999755 NCBI chr 8:72,889,132...72,906,986
Ensembl chr 8:72,884,018...72,906,986
JBrowse link
G Tpmt thiopurine methyltransferase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TPMT mRNA CTD PMID:29950665 NCBI chr13:47,175,463...47,196,833
Ensembl chr13:47,175,958...47,198,213
JBrowse link
G Tpsb2 tryptase beta 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TPSB2 mRNA CTD PMID:29950665 NCBI chr17:25,585,282...25,587,070
Ensembl chr17:25,585,170...25,588,079
JBrowse link
G Tpt1 tumor protein, translationally-controlled 1 decreases expression EXP Dextran Sulfate results in decreased expression of TPT1 protein CTD PMID:35999755 NCBI chr14:76,082,771...76,085,743
Ensembl chr14:76,082,533...76,085,965
JBrowse link
G Traf3ip1 TRAF3 interacting protein 1 increases expression EXP Dextran Sulfate results in increased expression of TRAF3IP1 mRNA CTD PMID:35093514 NCBI chr 1:91,422,311...91,457,029
Ensembl chr 1:91,422,369...91,457,029
JBrowse link
G Traf6 TNF receptor-associated factor 6 increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of TRAF6 protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of TRAF6 protein]; Sulfasalazine inhibits the reaction [Dextran Sulfate results in increased expression of TRAF6 protein]
CTD PMID:32272095 NCBI chr 2:101,508,765...101,532,013
Ensembl chr 2:101,508,774...101,532,014
JBrowse link
G Trank1 tetratricopeptide repeat and ankyrin repeat containing 1 decreases expression EXP Dextran Sulfate results in decreased expression of TRANK1 mRNA CTD PMID:35093514 NCBI chr 9:111,140,351...111,224,843
Ensembl chr 9:111,140,807...111,224,843
JBrowse link
G Trem2 triggering receptor expressed on myeloid cells 2 multiple interactions
increases expression
EXP huanglian-jie-du decoction inhibits the reaction [Dextran Sulfate results in increased expression of TREM2 protein] CTD PMID:37263316 NCBI chr17:48,653,429...48,659,304
Ensembl chr17:48,653,429...48,661,175
JBrowse link
G Trf transferrin multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TRF mRNA CTD PMID:29950665 NCBI chr 9:103,086,075...103,107,485
Ensembl chr 9:103,081,200...103,107,643
JBrowse link
G Trh thyrotropin releasing hormone multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of TRH mRNA CTD PMID:29950665 NCBI chr 6:92,219,042...92,221,631
Ensembl chr 6:92,219,042...92,221,631
JBrowse link
G Trib2 tribbles pseudokinase 2 decreases expression EXP Dextran Sulfate results in decreased expression of TRIB2 mRNA CTD PMID:35093514 NCBI chr12:15,841,726...15,866,963
Ensembl chr12:15,841,728...15,866,923
JBrowse link
G Trim25 tripartite motif-containing 25 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TRIM25 mRNA CTD PMID:29950665 NCBI chr11:88,890,194...88,911,119
Ensembl chr11:88,890,202...88,911,119
JBrowse link
G Trim41 tripartite motif-containing 41 increases expression EXP Dextran Sulfate results in increased expression of TRIM41 mRNA CTD PMID:35093514 NCBI chr11:48,697,230...48,709,026
Ensembl chr11:48,697,231...48,708,180
JBrowse link
G Trir telomerase RNA component interacting RNase increases expression EXP Dextran Sulfate results in increased expression of TRIR mRNA CTD PMID:35093514 NCBI chr 8:85,753,440...85,756,920
Ensembl chr 8:85,753,452...85,756,915
JBrowse link
G Trp53 transformation related protein 53 increases expression EXP Dextran Sulfate results in increased expression of TRP53 protein CTD PMID:16049979 NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
JBrowse link
G Trpc3 transient receptor potential cation channel, subfamily C, member 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TRPC3 mRNA CTD PMID:29950665 NCBI chr 3:36,674,626...36,744,276
Ensembl chr 3:36,674,631...36,744,316
JBrowse link
G Trpc6 transient receptor potential cation channel, subfamily C, member 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TRPC6 mRNA CTD PMID:29950665 NCBI chr 9:8,543,868...8,680,753
Ensembl chr 9:8,544,143...8,680,742
JBrowse link
G Trpc7 transient receptor potential cation channel, subfamily C, member 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TRPC7 mRNA CTD PMID:29950665 NCBI chr13:56,920,911...57,043,778
Ensembl chr13:56,920,926...57,043,806
JBrowse link
G Trpm1 transient receptor potential cation channel, subfamily M, member 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of TRPM1 mRNA CTD PMID:29950665 NCBI chr 7:63,803,583...63,923,630
Ensembl chr 7:63,803,583...63,919,523
JBrowse link
G Trpm4 transient receptor potential cation channel, subfamily M, member 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TRPM4 mRNA CTD PMID:29950665 NCBI chr 7:44,952,579...44,983,495
Ensembl chr 7:44,952,056...44,983,204
JBrowse link
G Trpm6 transient receptor potential cation channel, subfamily M, member 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TRPM6 mRNA CTD PMID:29950665 NCBI chr19:18,707,566...18,869,885
Ensembl chr19:18,727,347...18,869,875
JBrowse link
G Trpm8 transient receptor potential cation channel, subfamily M, member 8 increases expression EXP Dextran Sulfate results in increased expression of TRPM8 mRNA CTD PMID:23596210 NCBI chr 1:88,234,457...88,318,909
Ensembl chr 1:88,205,383...88,317,015
JBrowse link
G Trpv1 transient receptor potential cation channel, subfamily V, member 1 affects expression
multiple interactions
EXP Dextran Sulfate affects the expression of TRPV1 protein
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TRPV1 mRNA
CTD PMID:18687398 PMID:29950665 NCBI chr11:73,124,975...73,152,148
Ensembl chr11:73,125,118...73,152,068
JBrowse link
G Trpv2 transient receptor potential cation channel, subfamily V, member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TRPV2 mRNA CTD PMID:29950665 NCBI chr11:62,465,312...62,491,131
Ensembl chr11:62,465,312...62,491,341
JBrowse link
G Trpv4 transient receptor potential cation channel, subfamily V, member 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TRPV4 mRNA CTD PMID:29950665 NCBI chr 5:114,760,213...114,796,497
Ensembl chr 5:114,760,213...114,796,482
JBrowse link
G Trpv6 transient receptor potential cation channel, subfamily V, member 6 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TRPV6 mRNA CTD PMID:29950665 NCBI chr 6:41,597,553...41,613,339
Ensembl chr 6:41,597,558...41,613,339
JBrowse link
G Try4 trypsin 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PRSS3 mRNA; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TRY4 mRNA CTD PMID:29950665 NCBI chr 6:41,279,206...41,282,467
Ensembl chr 6:41,279,203...41,282,466
JBrowse link
G Try5 trypsin 5 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TRY5 mRNA CTD PMID:29950665 NCBI chr 6:41,288,166...41,291,644
Ensembl chr 6:41,288,167...41,293,775
JBrowse link
G Tsc2 TSC complex subunit 2 decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of TSC2 protein
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpinetin inhibits the reaction [Dextran Sulfate results in decreased expression of TSC2 protein]]; alpinetin inhibits the reaction [Dextran Sulfate results in decreased expression of TSC2 protein]
CTD PMID:31676321 NCBI chr17:24,814,788...24,851,607
Ensembl chr17:24,814,790...24,851,604
JBrowse link
G Tsc22d3 TSC22 domain family, member 3 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TSC22D3 mRNA CTD PMID:29950665 NCBI chr  X:139,440,277...139,501,257
Ensembl chr  X:139,440,277...139,501,408
JBrowse link
G Tsks testis-specific serine kinase substrate increases expression EXP Dextran Sulfate results in increased expression of TSKS mRNA CTD PMID:35093514 NCBI chr 7:44,579,044...44,607,465
Ensembl chr 7:44,592,628...44,607,459
JBrowse link
G Tsnax translin-associated factor X decreases expression
multiple interactions
EXP Dextran Sulfate results in decreased expression of TSNAX protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of TSNAX protein]
CTD PMID:32272095 NCBI chr 8:125,739,780...125,760,947
Ensembl chr 8:125,739,736...125,760,931
JBrowse link
G Tst thiosulfate sulfurtransferase, mitochondrial multiple interactions
decreases expression
EXP Dextran Sulfate affects the activity of and results in decreased expression of TST protein
Dextran Sulfate results in decreased expression of TST mRNA
CTD PMID:19647029 NCBI chr15:78,283,756...78,290,065
Ensembl chr15:78,283,756...78,290,107
JBrowse link
G Ttn titin multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TTN mRNA CTD PMID:29950665 NCBI chr 2:76,534,324...76,812,901
Ensembl chr 2:76,534,324...76,812,891
JBrowse link
G Ttr transthyretin multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TTR mRNA CTD PMID:29950665 NCBI chr18:20,797,266...20,807,383
Ensembl chr18:20,798,337...20,807,378
JBrowse link
G Tuba1a tubulin, alpha 1A decreases expression EXP Dextran Sulfate results in decreased expression of TUBA1A protein CTD PMID:35999755 NCBI chr15:98,847,728...98,851,382
Ensembl chr15:98,847,718...98,851,584
JBrowse link
G Tuba4a tubulin, alpha 4A decreases expression EXP Dextran Sulfate results in decreased expression of TUBA4A protein CTD PMID:35999755 NCBI chr 1:75,190,867...75,197,905
Ensembl chr 1:75,190,872...75,196,509
JBrowse link
G Tubb1 tubulin, beta 1 class VI decreases expression EXP Dextran Sulfate results in decreased expression of TUBB1 protein CTD PMID:35999755 NCBI chr 2:174,292,388...174,300,173
Ensembl chr 2:174,292,488...174,299,675
JBrowse link
G Tubb6 tubulin, beta 6 class V increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of TUBB6 protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of TUBB6 protein]
CTD PMID:32272095 NCBI chr18:67,523,801...67,535,819
Ensembl chr18:67,523,787...67,535,819
JBrowse link
G Tyms thymidylate synthase multiple interactions EXP [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TYMS mRNA CTD PMID:17893519 NCBI chr 5:30,243,544...30,279,261
Ensembl chr 5:30,263,200...30,278,615
JBrowse link
G Tyrobp TYRO protein tyrosine kinase binding protein increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of TYROBP mRNA; Dextran Sulfate results in increased expression of TYROBP protein
huanglian-jie-du decoction inhibits the reaction [Dextran Sulfate results in increased expression of TYROBP mRNA]; huanglian-jie-du decoction inhibits the reaction [Dextran Sulfate results in increased expression of TYROBP protein]
CTD PMID:37263316 NCBI chr 7:30,113,207...30,117,007
Ensembl chr 7:30,113,185...30,117,010
JBrowse link
G Uap1l1 UDP-N-acteylglucosamine pyrophosphorylase 1-like 1 increases expression
multiple interactions
EXP Dextran Sulfate results in increased expression of UAP1L1 protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of UAP1L1 protein]
CTD PMID:32272095 NCBI chr 2:25,251,501...25,255,695
Ensembl chr 2:25,249,901...25,255,694
JBrowse link
G Uba1 ubiquitin-like modifier activating enzyme 1 decreases expression EXP Dextran Sulfate results in decreased expression of UBA1 protein CTD PMID:35999755 NCBI chr  X:20,524,660...20,549,420
Ensembl chr  X:20,524,565...20,549,418
JBrowse link
G Uba7 ubiquitin-like modifier activating enzyme 7 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of UBA7 mRNA CTD PMID:29950665 NCBI chr 9:107,852,766...107,861,255
Ensembl chr 9:107,852,704...107,861,259
JBrowse link
G Ubqln1 ubiquilin 1 multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of UBQLN1 protein] CTD PMID:32272095 NCBI chr13:58,323,970...58,363,467
Ensembl chr13:58,323,970...58,363,467
JBrowse link
G Uck2 uridine-cytidine kinase 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of UCK2 mRNA CTD PMID:29950665 NCBI chr 1:167,050,464...167,112,657
Ensembl chr 1:167,050,452...167,112,889
JBrowse link
G Ugdh UDP-glucose dehydrogenase multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of UGDH mRNA CTD PMID:29950665 NCBI chr 5:65,570,550...65,593,185
Ensembl chr 5:65,570,564...65,593,292
JBrowse link
G Ugt1a10 UDP glycosyltransferase 1 family, polypeptide A10 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of UGT1A10 mRNA CTD PMID:29950665 NCBI chr 1:87,983,133...88,147,724
Ensembl chr 1:87,983,110...88,146,726
JBrowse link
G Ugt1a6a UDP glucuronosyltransferase 1 family, polypeptide A6A multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of UGT1A6A mRNA
Dextran Sulfate results in decreased expression of UGT1A6A mRNA
CTD PMID:29950665 PMID:35093514 NCBI chr 1:88,062,531...88,147,724
Ensembl chr 1:88,062,531...88,146,719
JBrowse link
G Ugt1a6b UDP glucuronosyltransferase 1 family, polypeptide A6B multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of UGT1A6B mRNA
Dextran Sulfate results in decreased expression of UGT1A6B mRNA
CTD PMID:29950665 PMID:35093514 NCBI chr 1:88,030,979...88,146,720
Ensembl chr 1:88,030,974...88,146,725
JBrowse link
G Ugt1a7c UDP glucuronosyltransferase 1 family, polypeptide A7C decreases expression EXP Dextran Sulfate results in decreased expression of UGT1A7C mRNA CTD PMID:35093514 NCBI chr 1:88,022,723...88,147,724
Ensembl chr 1:88,022,784...88,147,724
JBrowse link
G Ugt2a1 UDP glucuronosyltransferase 2 family, polypeptide A1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of UGT2A1 mRNA CTD PMID:29950665 NCBI chr 5:87,607,349...87,638,730
Ensembl chr 5:87,607,349...87,638,730
JBrowse link
G Ugt2b34 UDP glucuronosyltransferase 2 family, polypeptide B34 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of UGT2B34 mRNA CTD PMID:29950665 NCBI chr 5:87,037,613...87,054,805
Ensembl chr 5:87,037,626...87,054,796
JBrowse link
G Ugt2b37 UDP glucuronosyltransferase 2 family, polypeptide B37 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of UGT2B37 mRNA CTD PMID:29950665 NCBI chr 5:87,388,351...87,402,647
Ensembl chr 5:87,388,352...87,402,663
JBrowse link
G Ugt2b38 UDP glucuronosyltransferase 2 family, polypeptide B38 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of UGT2B38 mRNA CTD PMID:29950665 NCBI chr 5:87,557,798...87,572,062
Ensembl chr 5:87,557,801...87,572,062
JBrowse link
G Ulk1 unc-51 like kinase 1 decreases phosphorylation
multiple interactions
EXP Dextran Sulfate results in decreased phosphorylation of ULK1 protein
biochanin A inhibits the reaction [Dextran Sulfate results in decreased phosphorylation of ULK1 protein]
CTD PMID:38648921 NCBI chr 5:110,932,355...110,957,991
Ensembl chr 5:110,932,354...110,957,963
JBrowse link
G Unc80 unc-80, NALCN activator multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of UNC80 mRNA CTD PMID:29950665 NCBI chr 1:66,507,093...66,738,309
Ensembl chr 1:66,507,526...66,738,307
JBrowse link
G Upb1 ureidopropionase, beta multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of UPB1 mRNA CTD PMID:29950665 NCBI chr10:75,242,745...75,277,513
Ensembl chr10:75,236,949...75,277,513
JBrowse link
G Upf3a UPF3 regulator of nonsense transcripts homolog A (yeast) increases expression EXP Dextran Sulfate results in increased expression of UPF3A mRNA CTD PMID:35093514 NCBI chr 8:13,834,636...13,848,723
Ensembl chr 8:13,835,615...13,849,193
JBrowse link
G Upp2 uridine phosphorylase 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of UPP2 mRNA CTD PMID:29950665 NCBI chr 2:58,456,329...58,685,858
Ensembl chr 2:58,457,310...58,682,983
JBrowse link
G Uqcrq ubiquinol-cytochrome c reductase, complex III subunit VII increases expression EXP Dextran Sulfate results in increased expression of UQCRQ mRNA CTD PMID:35093514 NCBI chr11:53,318,749...53,321,658
Ensembl chr11:53,318,749...53,321,658
JBrowse link
G V1ra8 vomeronasal 1 receptor, A8 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of V1RA8 mRNA CTD PMID:29950665 NCBI chr 6:90,179,799...90,180,638
Ensembl chr 6:90,179,768...90,182,848
JBrowse link
G Vav1 vav 1 oncogene multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of VAV1 mRNA CTD PMID:29950665 NCBI chr17:57,586,080...57,636,236
Ensembl chr17:57,586,100...57,635,031
JBrowse link
G Vav3 vav 3 oncogene multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of VAV3 mRNA CTD PMID:29950665 NCBI chr 3:109,247,757...109,593,010
Ensembl chr 3:109,247,969...109,593,014
JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions
increases expression
EXP 17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid inhibits the reaction [Dextran Sulfate results in increased expression of VCAM1 mRNA]; Dexamethasone inhibits the reaction [Dextran Sulfate results in increased expression of VCAM1 mRNA]; flavokawain B inhibits the reaction [Dextran Sulfate results in increased expression of VCAM1 mRNA]; fraxinellone inhibits the reaction [Dextran Sulfate results in increased expression of VCAM1 mRNA]; resolvin D1 inhibits the reaction [Dextran Sulfate results in increased expression of VCAM1 mRNA]; resolvin D2 inhibits the reaction [Dextran Sulfate results in increased expression of VCAM1 mRNA] CTD PMID:21724996 PMID:25448682 PMID:38583725 NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
JBrowse link
G Vcan versican multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of VCAN mRNA CTD PMID:29950665 NCBI chr13:89,803,429...89,891,146
Ensembl chr13:89,803,431...89,890,628
JBrowse link
G Vcl vinculin decreases expression EXP Dextran Sulfate results in decreased expression of VCL protein CTD PMID:35999755 NCBI chr14:20,979,436...21,083,744
Ensembl chr14:20,979,466...21,083,744
JBrowse link
G Vdr vitamin D (1,25-dihydroxyvitamin D3) receptor multiple interactions
decreases expression
EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of VDR mRNA; Cholecalciferol inhibits the reaction [Dextran Sulfate results in decreased expression of VDR protein] CTD PMID:29950665 PMID:38588969 NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511
JBrowse link
G Vegfa vascular endothelial growth factor A increases expression EXP Dextran Sulfate results in increased expression of VEGFA mRNA; Dextran Sulfate results in increased expression of VEGFA protein CTD PMID:20025956 PMID:35093514 NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
JBrowse link
G Vegfc vascular endothelial growth factor C multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of VEGFC mRNA CTD PMID:29950665 NCBI chr 8:54,530,567...54,639,489
Ensembl chr 8:54,530,641...54,640,131
JBrowse link
G Vegfd vascular endothelial growth factor D multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of VEGFD mRNA CTD PMID:29950665 NCBI chr  X:163,156,282...163,185,643
Ensembl chr  X:163,156,374...163,185,646
JBrowse link
G Vim vimentin multiple interactions
increases expression
EXP 7-hydroxyl-1-methylindole-3-acetonitrile inhibits the reaction [Dextran Sulfate results in increased expression of VIM protein]; [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of VIM protein; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of VIM mRNA CTD PMID:29950665 PMID:34273909 PMID:36543318 NCBI chr 2:13,579,122...13,587,637
Ensembl chr 2:13,578,738...13,587,637
JBrowse link
G Vipr1 vasoactive intestinal peptide receptor 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of VIPR1 mRNA CTD PMID:29950665 NCBI chr 9:121,471,782...121,502,020
Ensembl chr 9:121,471,782...121,502,020
JBrowse link
G Vmn1r42 vomeronasal 1 receptor 42 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of VMN1R42 mRNA CTD PMID:29950665 NCBI chr 6:89,821,500...89,822,597
Ensembl chr 6:89,819,555...89,853,395
JBrowse link
G Vmn1r43 vomeronasal 1 receptor 43 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of VMN1R43 mRNA CTD PMID:29950665 NCBI chr 6:89,846,443...89,847,511
Ensembl chr 6:89,835,916...89,853,395
JBrowse link
G Vmn1r47 vomeronasal 1 receptor 47 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of VMN1R47 mRNA CTD PMID:29950665 NCBI chr 6:89,998,870...89,999,802
Ensembl chr 6:89,993,129...90,004,459
JBrowse link
G Vmn1r56 vomeronasal 1 receptor 56 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of VMN1R56 mRNA CTD PMID:29950665 NCBI chr 7:5,197,915...5,199,746
Ensembl chr 7:5,197,915...5,199,746
JBrowse link
G Vmn1r62 vomeronasal 1 receptor 62 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of VMN1R62 mRNA CTD PMID:29950665 NCBI chr 7:5,677,603...5,679,598
Ensembl chr 7:5,676,630...5,679,662
JBrowse link
G Vmn1r63 vomeronasal 1 receptor 63 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of VMN1R63 mRNA CTD PMID:29950665 NCBI chr 7:5,805,344...5,829,228
Ensembl chr 7:5,805,344...5,808,444
JBrowse link
G Wdr1 WD repeat domain 1 decreases expression EXP Dextran Sulfate results in decreased expression of WDR1 protein CTD PMID:35999755 NCBI chr 5:38,684,149...38,720,265
Ensembl chr 5:38,684,156...38,720,564
JBrowse link
G Wfdc17 WAP four-disulfide core domain 17 increases expression EXP Dextran Sulfate results in increased expression of WFDC17 mRNA CTD PMID:23894361 NCBI chr11:83,594,882...83,597,095
Ensembl chr11:83,594,817...83,597,094
JBrowse link
G Wfdc18 WAP four-disulfide core domain 18 increases expression EXP Dextran Sulfate results in increased expression of WFDC18 mRNA CTD PMID:23894361 NCBI chr11:83,599,830...83,602,186
Ensembl chr11:83,599,841...83,602,174
JBrowse link
G Wif1 Wnt inhibitory factor 1 multiple interactions EXP [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of WIF1 mRNA; [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of WIF1 protein; [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of WIF1 mRNA; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of WIF1 mRNA] CTD PMID:26271895 PMID:31715269 NCBI chr10:120,869,909...120,936,547
Ensembl chr10:120,869,865...120,936,555
JBrowse link
G Wnk1 WNK lysine deficient protein kinase 1 multiple interactions EXP [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of WNK1 mRNA CTD PMID:26271895 NCBI chr 6:119,900,930...120,015,659
Ensembl chr 6:119,900,930...120,015,633
JBrowse link
G Wnk4 WNK lysine deficient protein kinase 4 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of WNK4 mRNA CTD PMID:29950665 NCBI chr11:101,151,363...101,168,235
Ensembl chr11:101,151,393...101,168,235
JBrowse link
G Wnt10a wingless-type MMTV integration site family, member 10A multiple interactions EXP [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of WNT10A mRNA; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of WNT10A mRNA] CTD PMID:31715269 NCBI chr 1:74,831,178...74,843,335
Ensembl chr 1:74,830,675...74,843,338
JBrowse link
G Wnt2 wingless-type MMTV integration site family, member 2 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of WNT2 mRNA CTD PMID:29950665 NCBI chr 6:17,988,939...18,032,771
Ensembl chr 6:17,988,939...18,030,584
JBrowse link
G Wnt2b wingless-type MMTV integration site family, member 2B multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of WNT2B mRNA CTD PMID:29950665 NCBI chr 3:104,852,121...104,869,025
Ensembl chr 3:104,852,588...104,869,237
JBrowse link
G Wnt3 wingless-type MMTV integration site family, member 3 multiple interactions EXP [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of WNT3 mRNA; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of WNT3 mRNA] CTD PMID:31715269 NCBI chr11:103,665,000...103,708,854
Ensembl chr11:103,664,976...103,708,783
JBrowse link
G Wnt6 wingless-type MMTV integration site family, member 6 multiple interactions EXP [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of WNT6 mRNA; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of WNT6 mRNA] CTD PMID:31715269 NCBI chr 1:74,793,499...74,824,481
Ensembl chr 1:74,811,051...74,824,481
JBrowse link
G Wnt7b wingless-type MMTV integration site family, member 7B multiple interactions EXP [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of WNT7B mRNA; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of WNT7B mRNA] CTD PMID:31715269 NCBI chr15:85,419,638...85,466,022
Ensembl chr15:85,419,638...85,466,674
JBrowse link
G Xcl1 chemokine (C motif) ligand 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of XCL1 mRNA CTD PMID:29950665 NCBI chr 1:164,759,216...164,763,094
Ensembl chr 1:164,759,213...164,763,096
JBrowse link
G Xcr1 chemokine (C motif) receptor 1 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of XCR1 mRNA CTD PMID:29950665 NCBI chr 9:123,681,380...123,691,094
Ensembl chr 9:123,681,380...123,691,094
JBrowse link
G Xiap X-linked inhibitor of apoptosis multiple interactions EXP [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of XIAP protein; Aspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of XIAP protein]; Camptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of XIAP protein]; Plant Extracts inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of XIAP protein] CTD PMID:25449198 NCBI chr  X:41,148,483...41,198,541
Ensembl chr  X:41,148,556...41,198,533
JBrowse link
G Xpnpep2 X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of XPNPEP2 mRNA CTD PMID:29950665 NCBI chr  X:47,195,790...47,225,859
Ensembl chr  X:47,197,602...47,225,858
JBrowse link
G Yap1 yes-associated protein 1 multiple interactions EXP [RASSF1 gene mutant form results in increased susceptibility to Dextran Sulfate] which results in increased phosphorylation of and affects the localization of YAP1 protein CTD PMID:24146755 NCBI chr 9:7,932,000...8,004,890
Ensembl chr 9:7,932,000...8,004,597
JBrowse link
G Ybx2 Y box protein 2 increases expression EXP Dextran Sulfate results in increased expression of YBX2 mRNA CTD PMID:35093514 NCBI chr11:69,826,652...69,832,430
Ensembl chr11:69,826,622...69,832,431
JBrowse link
G Ywhae tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide decreases expression EXP Dextran Sulfate results in decreased expression of YWHAE protein CTD PMID:35999755 NCBI chr11:75,620,121...75,656,667
Ensembl chr11:75,623,695...75,656,671
JBrowse link
G Ywhah tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide decreases expression EXP Dextran Sulfate results in decreased expression of YWHAH protein CTD PMID:35999755 NCBI chr 5:33,176,160...33,185,310
Ensembl chr 5:33,176,160...33,185,310
JBrowse link
G Ywhaq tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of YWHAQ protein CTD PMID:35999755 NCBI chr12:21,440,330...21,467,437
Ensembl chr12:21,440,072...21,467,638
JBrowse link
G Ywhaz tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide decreases expression EXP Dextran Sulfate results in decreased expression of YWHAZ protein CTD PMID:35999755 NCBI chr15:36,770,505...36,803,228
Ensembl chr15:36,771,014...36,797,173
JBrowse link
G Zbp1 Z-DNA binding protein 1 increases expression EXP Dextran Sulfate results in increased expression of ZBP1 mRNA CTD PMID:23894361 NCBI chr 2:173,048,405...173,060,715
Ensembl chr 2:173,048,405...173,060,716
JBrowse link
G Zc3h18 zinc finger CCCH-type containing 18 multiple interactions
decreases expression
EXP Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of ZC3H18 protein] CTD PMID:32272095 NCBI chr 8:123,103,298...123,144,104
Ensembl chr 8:123,103,348...123,144,099
JBrowse link
G Zfp821 zinc finger protein 821 increases expression EXP Dextran Sulfate results in increased expression of ZFP821 mRNA CTD PMID:35093514 NCBI chr 8:110,421,884...110,451,564
Ensembl chr 8:110,432,178...110,451,564
JBrowse link
G Zfyve9 zinc finger, FYVE domain containing 9 multiple interactions EXP [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ZFYVE9 mRNA CTD PMID:29950665 NCBI chr 4:108,494,663...108,642,514
Ensembl chr 4:108,494,663...108,637,995
JBrowse link
G Znrf4 zinc and ring finger 4 increases expression EXP Dextran Sulfate results in increased expression of ZNRF4 mRNA CTD PMID:35093514 NCBI chr17:56,818,248...56,819,483
Ensembl chr17:56,818,248...56,819,431
JBrowse link
G Zp3r zona pellucida 3 receptor multiple interactions EXP [Dextran Sulfate co-treated with bisphenol A] results in increased expression of C4BPA protein CTD PMID:35999755 NCBI chr 1:130,474,847...130,557,371
Ensembl chr 1:130,504,450...130,557,358
JBrowse link
manumycin A term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akt1 thymoma viral proto-oncogene 1 multiple interactions ISO manumycin inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein] CTD PMID:19002579 NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
JBrowse link
G Casp3 caspase 3 increases activity
multiple interactions
ISO manumycin results in increased activity of CASP3
[Quercetin co-treated with manumycin] results in decreased expression of CASP3 protein; Acetylcysteine inhibits the reaction [manumycin results in increased activity of CASP3]
CTD PMID:14625852 PMID:19409983 NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
JBrowse link
G Ccnb1 cyclin B1 multiple interactions ISO manumycin inhibits the reaction [Plant Extracts results in decreased expression of CCNB1 mRNA] CTD PMID:25051199 NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078
JBrowse link
G Ccnd1 cyclin D1 multiple interactions
decreases expression
ISO Acetylcysteine inhibits the reaction [manumycin results in decreased expression of CCND1 protein] CTD PMID:19409983 NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
JBrowse link
G Cdc25c cell division cycle 25C multiple interactions ISO manumycin inhibits the reaction [Plant Extracts results in decreased expression of CDC25C mRNA] CTD PMID:25051199 NCBI chr18:34,866,046...34,884,644
Ensembl chr18:34,866,046...34,884,586
JBrowse link
G Cdkn1a cyclin dependent kinase inhibitor 1A multiple interactions
increases expression
ISO Acetylcysteine inhibits the reaction [manumycin results in decreased expression of CDKN1A protein]
manumycin results in increased expression of CDKN1A protein
CTD PMID:19409983 NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
JBrowse link
G Chrna5 cholinergic receptor, nicotinic, alpha polypeptide 5 multiple interactions ISO manumycin inhibits the reaction [Nicotine results in increased expression of CHRNA5 mRNA]; manumycin inhibits the reaction [Nicotine results in increased expression of CHRNA5 protein]; manumycin inhibits the reaction [Tobacco Smoke Pollution results in increased expression of CHRNA5 mRNA]; manumycin inhibits the reaction [Tobacco Smoke Pollution results in increased expression of CHRNA5 protein] CTD PMID:18450646 NCBI chr 9:54,888,112...54,918,704
Ensembl chr 9:54,888,164...54,915,063
JBrowse link
G Cybb cytochrome b-245, beta polypeptide multiple interactions EXP manumycin inhibits the reaction [Acetaminophen results in increased expression of CYBB mRNA] CTD PMID:19739265 NCBI chr  X:9,301,493...9,354,005
Ensembl chr  X:9,301,491...9,354,010
JBrowse link
G Fasl Fas ligand multiple interactions EXP manumycin inhibits the reaction [Acetaminophen results in increased expression of FASL mRNA] CTD PMID:19739265 NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
JBrowse link
G Fn1 fibronectin 1 multiple interactions ISO manumycin inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; manumycin inhibits the reaction [Pyruvaldehyde results in increased expression of FN1 mRNA] CTD PMID:16572112 PMID:17635749 NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359
JBrowse link
G Gata2 GATA binding protein 2 multiple interactions ISO manumycin inhibits the reaction [Nicotine results in increased expression of GATA2 mRNA]; manumycin inhibits the reaction [Nicotine results in increased expression of GATA2 protein]; manumycin inhibits the reaction [Tobacco Smoke Pollution results in increased expression of GATA2 mRNA]; manumycin inhibits the reaction [Tobacco Smoke Pollution results in increased expression of GATA2 protein] CTD PMID:18450646 NCBI chr 6:88,170,873...88,184,014
Ensembl chr 6:88,170,873...88,184,014
JBrowse link
G H2ax H2A.X variant histone multiple interactions
increases phosphorylation
ISO Acetylcysteine inhibits the reaction [manumycin results in increased phosphorylation of H2AX protein] CTD PMID:19409983 NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374
JBrowse link
G Hras Harvey rat sarcoma virus oncogene multiple interactions
decreases expression
EXP
ISO
manumycin inhibits the reaction [Acetaminophen results in increased activity of HRAS protein]
manumycin inhibits the reaction [Glucose results in increased activity of HRAS protein]; manumycin inhibits the reaction [INS1 protein results in increased farnesylation of HRAS protein]
manumycin results in decreased expression of HRAS protein
CTD PMID:16572112 PMID:19002579 PMID:19739265 PMID:19958823 NCBI chr 7:140,770,839...140,773,938
Ensembl chr 7:140,769,018...140,773,918
JBrowse link
G Ifng interferon gamma multiple interactions EXP manumycin inhibits the reaction [Acetaminophen results in increased expression of IFNG mRNA]; manumycin inhibits the reaction [Acetaminophen results in increased expression of IFNG protein] CTD PMID:19739265 NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
JBrowse link
G Il18 interleukin 18 multiple interactions EXP geraniol promotes the reaction [manumycin inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL18 protein]]; manumycin inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL18 protein] CTD PMID:21430599 NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
JBrowse link
G Il1b interleukin 1 beta multiple interactions
decreases response to substance
ISO
EXP
manumycin inhibits the reaction [IL1B protein results in increased expression of MMP13 mRNA]; manumycin inhibits the reaction [IL1B protein results in increased expression of MMP13 protein]
geraniol promotes the reaction [manumycin inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL1B protein]]; manumycin inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL1B protein]
manumycin results in decreased susceptibility to IL1B protein
CTD PMID:21211511 PMID:21430599 NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
JBrowse link
G Ins1 insulin I multiple interactions ISO manumycin inhibits the reaction [INS1 protein results in increased expression of RASGRF1 protein]; manumycin inhibits the reaction [INS1 protein results in increased farnesylation of HRAS protein]; manumycin inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein] CTD PMID:19002579 NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914
JBrowse link
G Kras Kirsten rat sarcoma viral oncogene homolog multiple interactions
decreases activity
ISO Acetylcysteine inhibits the reaction [manumycin results in decreased activity of KRAS protein] CTD PMID:19409983 NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965
JBrowse link
G Mapk3 mitogen-activated protein kinase 3 multiple interactions ISO manumycin inhibits the reaction [zinc chloride results in increased phosphorylation of MAPK3 protein] CTD PMID:21575692 NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
JBrowse link
G Mapk8 mitogen-activated protein kinase 8 multiple interactions EXP manumycin inhibits the reaction [Acetaminophen results in increased phosphorylation of and results in increased activity of MAPK8 protein] CTD PMID:19739265 NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
JBrowse link
G Mapk9 mitogen-activated protein kinase 9 multiple interactions EXP manumycin inhibits the reaction [Acetaminophen results in increased phosphorylation of and results in increased activity of MAPK9 protein] CTD PMID:19739265 NCBI chr11:49,737,558...49,777,248
Ensembl chr11:49,737,578...49,777,248
JBrowse link
G Mmp13 matrix metallopeptidase 13 multiple interactions ISO manumycin inhibits the reaction [IL1B protein results in increased expression of MMP13 mRNA]; manumycin inhibits the reaction [IL1B protein results in increased expression of MMP13 protein]; manumycin inhibits the reaction [TNF protein results in increased expression of MMP13 mRNA]; manumycin inhibits the reaction [TNF protein results in increased expression of MMP13 protein] CTD PMID:21211511 NCBI chr 9:7,272,514...7,283,333
Ensembl chr 9:7,272,514...7,283,331
JBrowse link
G Mras muscle and microspikes RAS multiple interactions ISO manumycin inhibits the reaction [Glucose results in increased activity of MRAS protein] CTD PMID:18569938 NCBI chr 9:99,267,473...99,319,505
Ensembl chr 9:99,267,473...99,319,434
JBrowse link
G Nos2 nitric oxide synthase 2, inducible multiple interactions EXP manumycin inhibits the reaction [Acetaminophen results in increased expression of NOS2 mRNA]; manumycin inhibits the reaction [Acetaminophen results in increased expression of NOS2 protein] CTD PMID:19739265 NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
JBrowse link
G Parp1 poly (ADP-ribose) polymerase family, member 1 increases cleavage
multiple interactions
ISO manumycin results in increased cleavage of PARP1; manumycin results in increased cleavage of PARP1 protein
Acetylcysteine inhibits the reaction [manumycin results in increased cleavage of PARP1]; Quercetin promotes the reaction [manumycin results in increased cleavage of PARP1 protein]
CTD PMID:14625852 PMID:19409983 NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
JBrowse link
G Raf1 v-raf-leukemia viral oncogene 1 multiple interactions ISO manumycin inhibits the reaction [Streptozocin results in increased expression of RAF1 protein]; manumycin inhibits the reaction [zinc chloride results in increased phosphorylation of RAF1 protein] CTD PMID:18569938 PMID:21575692 NCBI chr 6:115,595,530...115,653,596
Ensembl chr 6:115,595,028...115,653,596
JBrowse link
G Rasgrf1 RAS protein-specific guanine nucleotide-releasing factor 1 multiple interactions ISO manumycin inhibits the reaction [INS1 protein results in increased expression of RASGRF1 protein] CTD PMID:19002579 NCBI chr 9:89,791,565...89,909,032
Ensembl chr 9:89,791,961...89,909,030
JBrowse link
G Sod1 superoxide dismutase 1, soluble multiple interactions
decreases expression
ISO Acetylcysteine inhibits the reaction [manumycin results in decreased expression of SOD1] CTD PMID:19409983 NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
JBrowse link
G Stat3 signal transducer and activator of transcription 3 multiple interactions
decreases phosphorylation
ISO Acetylcysteine inhibits the reaction [manumycin results in decreased phosphorylation of STAT3 protein] CTD PMID:19409983 NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
JBrowse link
G Tert telomerase reverse transcriptase multiple interactions
decreases expression
ISO Acetylcysteine inhibits the reaction [manumycin results in decreased expression of TERT protein] CTD PMID:19409983 NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962
JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions ISO manumycin inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA] CTD PMID:16572112 NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
JBrowse link
G Tnf tumor necrosis factor multiple interactions
decreases response to substance
ISO
EXP
manumycin inhibits the reaction [TNF protein results in increased expression of MMP13 mRNA]; manumycin inhibits the reaction [TNF protein results in increased expression of MMP13 protein]
geraniol promotes the reaction [manumycin inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of TNF protein]]; manumycin inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of TNF protein]; manumycin inhibits the reaction [Acetaminophen results in increased expression of TNF mRNA]; manumycin inhibits the reaction [Acetaminophen results in increased expression of TNF protein]
manumycin results in decreased susceptibility to TNF protein
CTD PMID:19739265 PMID:21211511 PMID:21430599 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
G Tnpo1 transportin 1 multiple interactions ISO Acetylcysteine inhibits the reaction [manumycin results in decreased expression of TNPO1] CTD PMID:19409983 NCBI chr13:98,975,527...99,062,851
Ensembl chr13:98,975,527...99,062,892
JBrowse link
G Txn1 thioredoxin 1 decreases expression ISO manumycin results in decreased expression of TXN CTD PMID:19409983 NCBI chr 4:57,943,373...57,956,411
Ensembl chr 4:57,943,373...57,956,411
JBrowse link
G Vegfa vascular endothelial growth factor A multiple interactions ISO manumycin inhibits the reaction [Glucose results in increased expression of VEGFA mRNA]; manumycin inhibits the reaction [Streptozocin results in increased expression of VEGFA protein] CTD PMID:18569938 NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
JBrowse link
PJ34 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Itgam integrin alpha M decreases expression ISO PJ34 decreases expression of Itgam mRNA and protein in ischemic brain RGD PMID:23151666 RGD:329902065 NCBI chr 7:127,661,812...127,717,663
Ensembl chr 7:127,661,812...127,717,663
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 22306
    role 22291
      application 21905
        pharmaceutical 21260
          drug 21260
            cardiovascular drug 8927
              antiatherosclerotic agent 1945
                GSK126 0
                ML-236C + 0
                PF-06409577 0
                PJ34 1
                PJ34 hydrochloride 0
                baicalin 67
                beauveriolide I 0
                compactin diol lactone 0
                dextran sulfate 1904
                manumycin A 35
                xuezhikang 0
                xyloketal B 0
paths to the root